data_2mmz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 2.03 113.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.87 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.35 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 1.87 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.44 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 1.74 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 2.02 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 1.73 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 3.51 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 3.09 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.85 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 2.8 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 1.83 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 2.01 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 1.72 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 3.54 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 1.82 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 2.98 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81 114.887 -159.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 1.85 111.408 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81 112.883 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.37 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.66 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.64 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 2.22 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 2.07 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.43 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 3.95 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 2.51 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 3.31 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 1.95 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 1.66 112.994 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 1.85 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.55 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 1.77 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 1.75 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 5.39 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 1.95 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 1.97 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 5.41 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.38 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 3.27 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 1.64 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 1.6 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 3.42 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.14 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 2.18 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 2.57 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.28 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.64 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.36 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 1.84 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 4.87 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 3.16 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.67 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 1.69 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 2.3 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.43 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 3.21 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 2.35 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.41 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.69 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.51 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 3.5 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 6.5 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.89 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 3.02 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 1.69 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 3.92 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 1.71 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.83 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.86 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 3.69 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 2.43 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.81 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.58 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 2.48 115.428 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.65 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 2.42 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 1.68 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 1.71 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.84 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 1.94 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.55 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.45 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 1.61 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 1.64 109.38 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.06 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 1.79 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 1.66 112.677 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 2.49 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 2.47 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.07 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 1.97 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 3.1 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.57 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 1.9 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 1.68 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 4.05 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 114.412 1.264 . . . . 1.83 114.412 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.67 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.17 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 1.54 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.19 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 1.7 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 1.88 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 1.85 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.96 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 2.49 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.94 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 2.79 114.36 168.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 1.77 105.215 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 2.11 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 1.73 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 3.37 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 1.56 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 3.96 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.8 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 2.03 111.98 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.9 113.298 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.92 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.98 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 2.34 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 2.19 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.93 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 3.34 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.5 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.35 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 1.65 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 1.78 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 1.64 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 1.64 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 1.71 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 5.54 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 1.71 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 1.62 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 6.18 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.67 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 3.1 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 1.63 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 1.56 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 3.27 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.22 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 1.64 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 2.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.47 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.33 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 1.01 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 1.9 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 5.64 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.81 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.63 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 2.18 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 2.19 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 3.51 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.76 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.62 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.8 113.087 -171.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 2.37 114.89 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 4.59 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 4.41 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 1.4 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.82 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 1.73 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 3.79 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 1.79 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 1.02 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.57 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 3.58 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 2.54 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 1.01 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.87 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 1.53 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.39 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 2.76 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 1.59 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.71 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 2.04 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.425 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.58 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.425 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.52 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.51 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.67 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.85 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 1.76 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 2.02 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.58 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 1.59 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 1.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 3.14 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 2.52 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.72 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 1.52 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.8 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 1.68 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 1.76 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 4.21 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.85 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.026 0.75 . . . . 1.78 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.62 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 1.67 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 1.7 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 3.52 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 1.82 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 3.43 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 2.31 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.82 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 3.43 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 2.05 108.14 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 2.69 108.878 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 1.61 109.126 -167.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 3.07 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 1.61 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 2.17 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.85 112.191 -160.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 2.14 111.396 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.9 113.18 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.85 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 4.05 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 4.47 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 3.3 114.793 -159.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 2.26 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.26 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 3.95 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.86 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 3.09 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 1.95 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 1.7 113.628 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 1.63 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.42 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 1.86 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 1.71 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 4.54 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 1.83 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.49 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 1.91 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 8.02 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.47 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 3.32 111.023 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 1.6 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 1.48 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 3.53 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.35 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 1.84 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 2.44 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.06 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.9 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.78 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.16 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 2.16 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 4.11 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.94 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.81 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 1.85 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 2.84 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 3.55 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.96 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.87 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 2.17 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.51 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 3.74 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.97 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.98 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.85 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 1.91 109.21 160.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 3.08 109.487 166.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 1.93 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.96 113.686 -171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 3.39 110.645 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 2.6 110.32 -144.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 1.3 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 1.0 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 1.25 117.575 -165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.14 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 2.29 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 1.86 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 2.11 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.84 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 1.63 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.19 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.55 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.22 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 1.49 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 1.74 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.62 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.22 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 1.87 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 2.09 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 5.8 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 2.61 113.551 163.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.43 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 1.93 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.73 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.488 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.72 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 1.59 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 2.07 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.88 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.81 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.592 0.59 . . . . 2.63 112.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.4 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 2.02 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.83 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 1.76 111.042 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 1.97 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 1.55 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 3.27 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 3.52 113.707 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 2.22 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 1.52 104.052 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 2.44 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 1.85 109.182 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 3.37 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 1.79 110.597 -173.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 2.32 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 1.61 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.9 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.84 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 5.44 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.51 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 3.27 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.09 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 3.86 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 3.28 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 2.14 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 1.92 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 1.66 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.19 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 1.91 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 1.76 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 4.06 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 1.74 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.42 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.6 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 1.62 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 4.95 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.35 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 3.34 111.017 163.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 2.0 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 1.54 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 3.28 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.24 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 1.93 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 2.11 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.85 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.18 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.27 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.12 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 1.9 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 4.18 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 3.4 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.65 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 1.86 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 2.22 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.19 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 3.77 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 3.66 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.71 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.88 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 1.29 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 3.15 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 4.16 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.57 112.792 165.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.62 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 1.81 110.448 157.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 3.01 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 1.88 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 1.07 112.962 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 3.79 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 2.51 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.94 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.8 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 1.35 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.08 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 2.07 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 1.77 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 1.76 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.07 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 1.81 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.95 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.6 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 1.51 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 1.71 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.42 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.58 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 1.78 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 1.81 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 2.55 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 2.39 112.269 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.12 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 1.75 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.5 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55 110.25 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 1.65 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 1.85 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 3.0 113.988 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.63 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.14 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 114.07 1.137 . . . . 2.28 114.07 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.74 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 1.73 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.92 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.93 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 3.34 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 1.89 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 3.38 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 2.39 113.96 166.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.01 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 2.76 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 1.78 107.546 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 2.57 108.939 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 1.63 109.25 -169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 3.04 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 1.54 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 3.05 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.83 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 2.16 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.07 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.5 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.5 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.67 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 2.29 116.207 169.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 2.83 106.999 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.62 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 3.89 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 4.09 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 4.23 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 2.0 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 1.61 113.155 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 1.66 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.05 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 1.58 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 1.54 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 4.06 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 1.69 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.39 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.59 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 1.57 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 7.34 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 3.62 113.716 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 1.87 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 1.8 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 3.72 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.86 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 2.31 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 2.87 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.73 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.19 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 2.87 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 4.0 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 3.06 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.77 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 2.0 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 3.85 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.3 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 3.67 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.76 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.87 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.59 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 2.16 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.79 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 4.83 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.88 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.73 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 1.62 109.547 162.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 3.26 109.595 167.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 1.57 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.98 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.13 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 3.19 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 2.51 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 1.36 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.93 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 2.19 114.862 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 2.39 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 1.66 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 2.19 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 1.8 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.78 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.18 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.63 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.89 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 1.72 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 2.02 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.11 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 3.35 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 1.8 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 2.2 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.87 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 2.48 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 1.67 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.7 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.64 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 1.89 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 1.9 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 150' ' ' GLU . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 3.36 113.193 177.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.51 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' LEU . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.33 113.19 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.042 1.127 . . . . 2.41 114.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.69 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.45 110.263 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 1.89 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 1.67 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 1.94 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 1.85 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 3.71 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 2.9 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.92 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 2.4 115.083 172.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 1.7 104.736 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 2.38 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 1.68 109.455 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 3.26 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 1.85 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 3.06 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 1.76 111.337 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.84 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.87 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 2.31 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 2.41 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.548 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.02 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.19 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 3.19 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.39 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.32 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 1.6 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 1.51 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 1.72 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 1.62 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 1.56 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 5.14 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 1.66 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.7 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 1.69 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 5.72 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.43 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 3.3 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 1.69 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 1.55 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 3.3 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.16 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 1.75 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 2.09 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.26 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.24 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.2 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.36 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 1.87 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 4.59 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.85 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.71 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 1.95 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 2.03 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.86 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 3.38 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 3.39 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.9 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.68 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 3.52 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.75 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 1.44 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.5 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 1.83 109.958 164.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 4.57 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 1.68 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 1.12 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.85 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.86 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 4.22 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 2.44 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 1.15 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.96 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 1.37 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.86 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 3.99 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 1.69 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 2.83 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 1.75 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.88 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.41 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.82 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.59 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 1.86 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.402 HG11 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 1.69 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.69 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.88 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 1.71 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.402 ' HE3' HG11 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 1.66 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 3.4 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 2.43 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.94 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 1.96 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.9 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.71 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 1.71 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 1.83 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.96 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.18 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.21 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 1.85 114.561 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.93 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.16 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 2.02 113.443 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.87 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 1.57 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 1.87 111.808 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 1.53 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 3.82 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 3.38 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.65 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 2.42 115.321 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 1.8 105.309 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 2.31 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 1.62 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 3.05 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 1.93 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 3.06 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.87 113.876 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 1.7 110.951 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.06 113.223 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.61 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.44 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 3.21 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.477 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.41 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.68 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 3.34 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.36 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 4.14 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 1.66 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 2.07 113.064 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 2.02 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.65 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 1.57 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 1.72 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 5.88 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 1.92 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.06 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 1.73 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 5.77 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.45 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 3.52 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 1.74 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 1.52 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 3.33 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.24 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.74 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 2.5 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.43 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.21 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.41 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 1.7 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 4.69 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 4.61 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.9 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 1.84 113.04 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 2.29 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 3.67 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.41 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.93 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.51 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.62 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 3.36 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 4.95 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.86 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.06 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 1.66 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 2.63 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 1.61 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.72 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.65 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 3.78 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 2.33 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.89 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.66 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.57 117.298 -170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.16 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 2.77 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 1.73 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 2.08 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 1.64 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.57 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.06 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.82 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.84 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 1.62 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 1.53 109.871 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.43 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.65 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 1.87 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 2.23 113.495 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 2.4 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 2.3 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 1.54 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 2.22 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.72 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.83 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 2.0 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 3.13 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.49 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.401 0.889 . . . . 2.07 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.43 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.11 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 1.84 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.33 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 1.63 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 1.81 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 1.5 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 5.01 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 2.8 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.83 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 3.18 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 1.54 105.573 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 2.24 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 1.68 109.433 -168.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 3.38 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 1.95 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.86 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 1.68 111.548 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76 113.812 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.09 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.49 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.535 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 2.29 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.535 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 2.25 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 3.72 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.77 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 5.16 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 1.61 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 1.74 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 1.86 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.493 ' NE2' ' HE ' ' A' ' 78' ' ' ARG . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.44 110.594 168.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 1.62 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 1.65 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HE ' ' NE2' ' A' ' 75' ' ' GLN . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 5.44 114.001 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 1.9 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.42 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 1.7 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 7.63 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.22 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 3.18 108.75 153.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 1.81 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 1.73 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 3.32 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.18 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 1.89 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 2.2 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.53 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.96 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.89 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 1.7 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 5.29 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 4.14 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.58 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 1.81 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 3.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 3.5 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 3.11 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.89 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 2.02 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.32 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 4.32 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 4.41 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.71 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.72 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 1.66 110.282 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 2.93 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 1.75 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.69 112.984 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.72 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.17 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 3.28 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 2.38 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.8 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.6 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 2.47 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.39 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 2.12 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 1.75 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 2.06 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 1.5 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.5 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.03 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.71 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 1.73 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 1.65 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.19 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 1.66 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.98 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 4.23 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 2.38 112.669 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.85 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 1.61 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.7 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 1.7 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 1.82 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 3.44 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.76 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.56 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 115.007 1.484 . . . . 2.19 115.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 1.72 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.14 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 1.88 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 2.19 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 1.89 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 3.12 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 3.02 113.519 169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 2.56 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 1.7 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 2.9 107.379 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 1.83 108.097 -167.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 3.37 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 1.95 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.93 109.594 170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' CD2' ' A' ' 91' ' ' LEU . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.09 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.86 111.77 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.36 114.092 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.87 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 3.08 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 3.42 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 2.22 115.096 165.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 3.0 106.465 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 3.74 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.47 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 5.04 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 2.0 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 2.31 113.131 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 2.29 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.31 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 1.63 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 2.11 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 5.04 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 1.62 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.57 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 1.71 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 5.79 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.61 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 3.08 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 1.62 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 1.73 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 3.68 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.403 ' ND2' HD23 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.59 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 2.03 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 5.17 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.64 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.61 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.65 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.19 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 2.04 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 4.64 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.6 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.59 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 1.77 112.91 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 2.2 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.51 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 3.45 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 2.31 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.56 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 1.31 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 3.6 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 6.49 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.71 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.81 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 1.79 107.485 151.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 4.27 108.488 160.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 1.94 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.76 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.69 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.67 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 3.56 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.457 HG21 ' H ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 4.22 106.113 -156.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.457 ' H ' HG21 ' A' ' 119' ' ' VAL . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 1.21 114.11 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.9 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.67 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.41 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 2.79 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 2.09 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.98 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 2.1 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 1.92 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.7 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.03 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.83 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 1.49 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 1.78 110.342 -166.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.57 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.06 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 1.75 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 2.97 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 3.06 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 2.48 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.75 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 1.83 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.72 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.8 109.022 156.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.95 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.87 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 3.24 113.96 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.45 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.24 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.086 1.143 . . . . 2.15 114.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.43 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.39 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 1.8 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.82 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 1.78 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 2.84 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 1.85 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 3.54 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 2.24 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.36 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 2.6 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 1.49 103.999 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 2.26 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 1.62 109.876 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 3.32 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 1.77 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 2.73 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 2.1 111.806 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.76 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.83 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 2.32 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 2.45 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.536 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 2.63 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.44 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 4.11 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.96 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.68 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 1.75 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 1.93 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 2.13 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.72 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 1.59 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 1.66 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 5.69 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 1.99 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 1.71 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 5.26 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 3.08 109.611 158.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 1.76 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 1.75 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 3.35 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.3 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 1.76 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 2.3 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.8 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.28 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 1.02 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 1.86 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.7 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.79 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.59 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 1.85 113.069 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 2.38 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 3.69 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 3.68 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.56 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.72 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.42 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 4.12 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 4.09 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 1.46 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.59 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 1.7 109.954 155.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 2.58 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 1.78 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.85 113.314 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.6 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.82 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 3.48 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 2.39 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.8 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.66 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 1.48 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.84 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 3.0 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 1.92 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 1.82 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.75 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 1.46 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.54 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.54 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.86 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 1.75 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 1.68 109.832 -170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.82 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 1.72 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 1.71 113.384 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.81 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 2.49 112.377 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.82 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 1.89 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.69 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56 110.599 162.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 1.67 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 1.94 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 3.58 114.779 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.67 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.95 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 112.858 0.688 . . . . 1.86 112.858 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.97 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.15 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 1.72 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 1.7 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 2.7 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 1.62 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 3.34 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 2.43 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.06 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 2.55 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 1.74 104.004 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 2.06 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 1.68 109.657 -170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 3.32 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 1.55 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 2.85 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.74 112.968 -164.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 1.68 110.969 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.03 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.67 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 4.12 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 2.96 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 3.16 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 3.52 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.79 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.96 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 1.81 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 1.79 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 1.89 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.497 ' NE2' ' HE ' ' A' ' 78' ' ' ARG . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.61 109.788 169.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 1.67 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 1.57 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HE ' ' NE2' ' A' ' 75' ' ' GLN . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.92 115.272 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 1.72 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.48 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.69 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 1.92 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 4.42 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.76 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 3.17 111.886 157.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 1.69 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 1.6 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 3.28 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.22 111.404 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 1.7 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 2.63 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.36 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.59 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 1.01 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 1.84 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.83 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.57 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 1.7 112.502 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 2.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.09 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 3.46 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 2.07 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.57 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 2.51 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 3.16 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 4.48 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.62 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.57 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 1.64 109.682 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 4.04 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 1.78 109.877 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.89 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.72 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.61 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 3.65 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 2.66 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.83 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.61 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 1.48 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 2.07 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 2.09 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 1.56 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 1.87 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.53 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.12 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.64 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.84 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 1.49 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 2.03 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.84 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.32 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 1.74 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 1.94 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 3.87 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 3.86 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 1.87 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.47 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.72 110.607 161.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 1.7 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 1.71 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 3.23 115.891 -171.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.19 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.83 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 112.371 0.508 . . . . 2.48 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.19 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 1.8 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.57 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 1.51 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 2.14 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 1.83 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 3.9 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 2.91 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 2.55 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 1.54 104.172 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 2.31 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 1.58 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 3.12 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 1.78 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 3.4 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.74 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 1.95 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 2.12 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.44 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.58 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 2.22 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 2.3 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 2.18 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.92 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 3.53 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 2.29 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.27 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 1.67 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 1.83 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 1.76 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 1.58 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 1.6 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.98 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 1.61 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39 113.484 168.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.6 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 1.71 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.74 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.17 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 3.37 109.79 158.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 1.62 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 1.64 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 3.23 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.12 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 1.61 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 2.25 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.43 112.812 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.96 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.18 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 1.88 109.035 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 4.0 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 3.14 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.61 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 2.34 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 2.61 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.85 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 3.16 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.84 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.8 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.68 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.32 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 3.39 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 5.31 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.61 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.6 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 1.66 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 3.05 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 1.65 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.78 113.157 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.57 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 3.93 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 4.01 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 1.2 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.79 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.438 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 1.52 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.22 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 2.16 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 1.64 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 2.25 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 1.49 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.64 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.19 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.38 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.82 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.19 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 1.55 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 1.71 109.408 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.58 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 2.94 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 1.61 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 2.98 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 3.26 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 2.55 111.942 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 1.6 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.98 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.63 110.183 158.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 1.64 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 1.72 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 3.77 113.727 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.27 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.84 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.19 0.811 . . . . 2.25 113.19 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.74 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.41 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 1.83 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.58 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 2.15 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 3.18 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 1.56 113.606 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 3.17 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 2.79 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.39 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 2.76 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 1.74 108.916 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 2.81 109.173 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 1.7 108.888 -170.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 3.29 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 1.57 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 2.73 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.83 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 2.05 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.96 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.26 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.89 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.88 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 3.26 112.125 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 3.5 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.47 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 3.87 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 2.39 113.674 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 3.03 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 1.86 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 1.84 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 1.77 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.18 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 1.85 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 1.83 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.98 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 1.61 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.72 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 1.93 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 6.66 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.17 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 3.42 110.708 163.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 1.49 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 1.61 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 3.41 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.77 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 2.28 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.62 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.38 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.36 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 2.0 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 4.49 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 5.53 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.62 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 1.79 112.616 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 3.57 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.37 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 3.56 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 2.21 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.01 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.59 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.403 ' C ' ' HG1' ' A' ' 108' ' ' THR . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 2.53 115.13 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 3.48 112.735 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 4.63 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 1.46 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.49 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 1.59 109.396 158.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 3.79 108.36 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 1.81 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.86 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.84 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 3.73 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 2.42 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.87 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.67 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 1.54 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.24 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 2.14 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 1.88 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 2.02 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.12 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 1.52 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.73 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.11 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.32 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.69 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.91 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 1.96 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 1.68 109.851 -171.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.15 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 1.8 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 1.88 113.462 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 2.54 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 3.87 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 1.81 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.75 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.84 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 1.76 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.97 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 4.6 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.27 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 5.74 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.073 1.138 . . . . 2.3 114.073 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.03 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 1.82 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.37 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 1.82 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 1.97 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 1.94 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 3.42 116.232 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 2.15 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.66 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 2.12 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 1.78 104.91 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 2.08 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 1.65 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 3.06 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 1.82 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 2.15 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.83 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 1.76 110.582 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.7 111.705 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.66 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.47 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.61 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 3.56 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.05 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.99 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 4.55 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 3.39 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.92 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 1.94 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 1.7 113.391 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 1.98 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.93 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 1.77 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 1.73 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 4.37 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 1.7 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.82 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 1.71 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 5.99 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.4 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 3.49 110.331 166.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 1.49 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 1.56 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 3.39 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.24 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 1.62 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 2.15 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.36 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.43 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 2.07 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 1.81 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.73 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 3.16 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.88 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 2.0 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 3.08 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.85 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 3.6 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 2.04 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.41 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.24 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 2.3 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 4.37 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 5.6 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.97 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.79 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 1.61 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 2.65 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 1.7 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.69 113.298 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.73 117.871 -169.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.8 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 3.29 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 2.58 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.81 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.63 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 2.35 115.239 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.24 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 2.25 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 1.74 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 1.89 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 1.79 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.56 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.1 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.66 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 1.64 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 1.55 110.228 -166.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.69 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 1.82 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.69 113.277 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 3.31 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 2.41 111.912 165.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.07 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 1.92 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.79 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.53 109.153 155.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 1.69 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 1.64 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 3.01 111.532 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.81 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 113.864 1.061 . . . . 1.72 113.864 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.18 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 1.82 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.01 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 1.65 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 1.73 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 1.99 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 3.41 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 2.84 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 2.15 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 1.87 105.536 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 2.35 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 1.69 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 3.42 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 1.75 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.77 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.74 116.08 -164.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 1.61 112.099 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.72 114.022 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.49 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.84 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.39 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 2.28 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.501 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.89 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.15 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 3.89 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.33 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.15 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 1.91 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 1.97 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 1.7 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 1.77 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 1.82 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.99 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 1.73 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.63 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.74 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 2.2 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.97 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.13 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 3.42 111.358 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 1.8 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 1.75 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 3.32 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.24 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 1.64 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 2.37 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.53 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.85 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.27 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.05 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 1.65 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 4.83 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.74 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.5 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 2.21 112.716 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.85 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.89 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 3.15 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.77 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.5 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.76 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 2.71 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.79 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 4.43 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 1.46 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.57 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 1.6 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 2.71 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 1.8 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.97 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.84 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.58 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 3.81 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 2.52 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.82 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.61 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 1.49 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 2.18 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 1.83 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 2.45 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.9 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 1.44 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.93 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.54 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.3 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 1.01 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.14 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 1.79 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 1.66 110.141 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.42 110.793 166.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 140' ' ' LYS . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.93 111.789 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 1.84 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 2.22 113.694 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 137' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 2.67 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 3.79 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.82 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 1.79 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.44 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.62 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 1.69 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 1.93 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 3.27 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.74 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 113.499 0.926 . . . . 2.13 113.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.68 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.08 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 1.63 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.84 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 1.55 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 1.85 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 1.56 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 3.4 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 2.31 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.69 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 2.62 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 1.76 106.999 174.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 2.92 107.948 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 1.6 109.053 -169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 3.12 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 1.66 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 2.17 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 1.62 111.257 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76 114.314 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.66 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 2.22 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 2.32 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.86 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.05 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 4.16 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 2.52 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 4.27 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 1.98 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 1.87 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 1.8 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.88 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 1.93 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 1.77 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 5.79 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 2.17 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 1.69 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 4.56 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 3.11 109.923 157.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 1.51 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 1.74 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 3.76 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.3 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.72 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 2.21 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.4 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.84 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.28 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 1.72 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 4.57 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 4.03 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.67 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 1.69 112.675 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 2.65 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 3.15 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.77 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.7 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.58 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.4 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 3.06 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 5.08 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.61 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.55 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 1.58 109.71 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 2.62 108.428 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 1.7 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.36 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 3.25 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 2.44 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.83 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.69 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 1.59 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 2.06 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 1.99 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 1.66 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 2.33 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.73 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.44 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.99 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.45 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 1.66 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.436 HG11 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 1.66 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.58 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.63 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 1.63 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HE3' HG11 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 1.87 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 3.45 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 3.39 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.96 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 1.93 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 2.58 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 1.79 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 1.92 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 3.39 111.779 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.61 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.55 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 113.709 1.003 . . . . 1.9 113.709 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.53 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.19 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 1.72 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.57 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 1.8 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 2.64 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 1.65 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 4.98 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 2.72 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.22 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.96 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 1.78 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 2.77 108.654 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 1.65 109.568 -165.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 3.17 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 1.69 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 2.68 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.82 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 2.04 110.769 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.62 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 3.06 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.59 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.24 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.86 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.51 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 4.0 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.48 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 4.31 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 2.01 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 1.69 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 1.94 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.05 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 1.75 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 1.68 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 5.57 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 1.71 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.47 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 1.64 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 6.49 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.32 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 3.37 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 1.56 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 1.58 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 3.53 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.37 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 1.93 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 2.08 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.66 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.85 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.13 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.01 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 2.08 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.84 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 3.13 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.77 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 1.98 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 3.16 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.63 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 3.49 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.3 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.94 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.57 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 3.28 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 6.76 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.92 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 3.81 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 1.71 108.177 160.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 2.84 110.048 162.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 1.92 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.99 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 3.71 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 3.81 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.97 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.67 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 1.38 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.07 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 2.42 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 1.83 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 1.71 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 1.56 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.71 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.99 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.84 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.71 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 1.8 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 1.89 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.93 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 1.94 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 3.39 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 3.49 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 2.74 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 1.77 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.43 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.74 110.442 162.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 1.6 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 1.79 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 3.01 114.153 -170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.27 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.45 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.547 0.943 . . . . 2.13 113.547 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.45 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 1.8 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.24 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 1.97 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 1.96 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 1.79 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.99 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 2.21 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.91 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 2.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 1.98 105.114 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 2.19 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 1.67 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 3.14 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 1.67 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.421 ' C ' HE21 ' A' ' 66' ' ' GLN . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 2.77 110.164 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.9 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.97 110.027 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.99 112.308 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.08 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 3.25 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.81 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.421 HE21 ' C ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 3.34 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.3 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.59 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 4.1 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 2.23 113.587 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 3.04 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 1.85 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 1.65 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 1.81 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.34 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 1.61 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 1.74 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 4.09 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 2.1 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.59 113.679 169.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 1.82 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 4.3 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.02 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 3.28 111.312 161.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 1.79 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 1.59 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 3.24 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 1.77 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 2.49 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.74 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.66 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.67 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.3 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 2.0 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 4.31 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.97 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.62 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 1.69 112.37 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 2.87 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.57 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 3.04 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 2.25 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.01 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.91 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.64 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 4.19 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 4.98 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.5 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.53 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.79 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 2.86 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 1.8 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.86 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 3.99 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 3.82 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.4 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.98 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 1.61 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.64 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 2.32 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 1.67 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 1.88 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.2 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 2.01 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.69 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.08 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.16 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.74 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.9 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 1.69 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 1.53 109.999 -173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.95 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 1.87 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 1.79 112.484 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 3.08 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 2.42 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.88 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 1.79 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.68 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.7 111.58 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.9 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 1.86 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 3.14 112.926 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.85 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.74 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 113.979 1.103 . . . . 1.96 113.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.3 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.15 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 1.9 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.16 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 1.69 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 2.01 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 1.69 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 5.12 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 2.68 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.91 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 2.56 114.632 170.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 1.46 105.261 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 2.18 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 1.6 110.356 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 3.08 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 1.75 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 2.95 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.73 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 2.18 111.067 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.86 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 4.4 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.56 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 2.13 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.44 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 4.78 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 3.31 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.98 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 1.85 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 2.33 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 2.22 112.267 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.57 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 2.06 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 2.1 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 5.07 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 1.81 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 1.63 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 5.22 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.84 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 3.05 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 1.49 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 1.45 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 3.67 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.18 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 1.46 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 2.62 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.15 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.97 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.97 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 1.71 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 4.81 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 3.25 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.56 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 1.73 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 2.12 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 3.16 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.425 ' CB ' HE22 ' A' ' 111' ' ' GLN . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.51 113.937 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 2.23 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.9 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 1.29 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 3.55 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 4.45 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.62 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.425 HE22 ' CB ' ' A' ' 104' ' ' SER . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 2.31 111.757 -170.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 1.77 109.608 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 2.61 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 1.63 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.06 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.9 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 3.25 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 2.62 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 2.2 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 1.32 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.42 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 2.9 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 2.15 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.92 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.86 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 1.57 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.88 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.29 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.75 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.94 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 1.73 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 2.34 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.51 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.69 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 1.87 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 2.09 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.88 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 2.47 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.75 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 2.1 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.41 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.85 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 1.56 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 1.8 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 5.03 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.41 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.9 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.134 0.79 . . . . 2.22 113.134 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.22 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.36 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 2.06 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 1.59 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 2.02 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 1.72 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 3.22 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 2.54 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.12 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 2.24 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 1.8 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 2.17 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 1.74 108.839 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 3.09 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 1.76 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 3.5 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.11 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 2.22 106.558 166.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.42 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 4.64 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 2.22 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 2.44 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 2.38 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.09 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 3.43 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 2.39 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 3.05 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 1.86 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 1.76 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 1.65 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 1.77 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 1.82 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.78 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 1.9 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 1.89 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 4.68 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.82 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 3.44 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 1.65 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 1.98 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 3.38 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.91 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 2.95 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.24 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.35 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.12 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.03 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 2.49 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 6.5 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.56 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 1.03 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 2.17 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 2.57 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 3.78 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.21 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.92 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.56 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 5.35 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 4.23 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.6 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 153.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 2.88 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 1.63 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.46 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.69 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.93 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 4.05 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 3.77 104.629 -160.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 119' ' ' VAL . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 1.4 111.677 163.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 1.06 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 1.43 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.63 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 3.54 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 1.95 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 1.87 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 1.94 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.82 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.01 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.19 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.78 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.82 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 1.75 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 1.75 109.657 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.34 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 1.78 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 2.08 112.902 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 2.81 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 3.07 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 1.95 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 2.05 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.88 110.272 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 1.69 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 2.16 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 5.58 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.985 -0.846 . . . . 15.28 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.4 p -108.59 15.5 23.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.616 1.71 . . . . 12.91 115.616 -166.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 61.53 155.55 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.953 2.101 . . . . 15.87 114.967 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.8 p -88.96 166.43 13.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.396 1.258 . . . . 11.55 114.396 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.29 163.24 24.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 13.21 113.647 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.25 -12.73 0.02 OUTLIER Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.588 1.795 . . . . 8.14 117.588 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.0 171.81 14.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.787 1.793 . . . . 6.14 114.898 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.67 158.94 28.16 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.417 1.96 . . . . 5.63 113.128 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.62 168.25 29.49 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.925 1.25 . . . . 4.78 113.96 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.9 82.72 1.31 Allowed Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.1 -1.236 . . . . 4.21 113.184 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.84 2.34 29.43 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.583 1.563 . . . . 4.18 116.339 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.2 m -64.66 150.36 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.938 2.095 . . . . 4.02 112.996 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.61 70.86 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 2.03 113.193 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.87 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.35 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 1.87 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.44 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 1.74 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 2.02 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 1.73 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 3.51 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 3.09 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.85 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 2.8 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 1.83 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 2.01 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 1.72 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 3.54 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 1.82 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 2.98 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81 114.887 -159.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 1.85 111.408 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81 112.883 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.37 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.66 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.64 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 2.22 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 2.07 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.43 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 3.95 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 2.51 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 3.31 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 1.95 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 1.66 112.994 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 1.85 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.55 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 1.77 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 1.75 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 5.39 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 1.95 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 1.97 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 5.41 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.38 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 3.27 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 1.64 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 1.6 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 3.42 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.14 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 2.18 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 2.57 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.28 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.64 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.36 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 1.84 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 4.87 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 3.16 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.67 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 1.69 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 2.3 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.43 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 3.21 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 2.35 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.41 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.69 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.51 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 3.5 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 6.5 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.89 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 3.02 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 1.69 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 3.92 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 1.71 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.83 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.86 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 3.69 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 2.43 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.81 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.58 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 2.48 115.428 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.65 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 2.42 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 1.68 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 1.71 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.84 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 1.94 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.55 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.45 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 1.61 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 1.64 109.38 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.06 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 1.79 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 1.66 112.677 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 2.49 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 2.47 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.07 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 1.97 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 3.1 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.57 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 1.9 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 1.68 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 4.05 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.833 0 N-CA-C 110.405 -1.078 . . . . 14.16 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.1 p -67.99 -10.35 52.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.651 1.58 . . . . 15.38 114.761 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -134.44 171.14 14.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.971 1.709 . . . . 18.93 109.968 168.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.267 1.6 p 62.53 162.86 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.587 2.355 . . . . 14.64 115.281 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 178.13 4.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.084 1.754 . . . . 12.42 114.959 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 155.8 15.92 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 126.561 2.029 . . . . 8.71 111.47 158.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.19 -179.41 7.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.652 1.581 . . . . 7.66 113.012 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.62 153.65 19.27 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.411 1.005 . . . . 4.86 114.497 171.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.67 177.46 43.81 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.639 1.59 . . . . 3.92 113.825 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.58 41.08 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.95 1.738 . . . . 3.58 115.739 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.2 178.27 17.29 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.066 1.317 . . . . 3.23 112.077 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 t 63.11 -177.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 2.7 114.505 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.17 69.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.376 -1.453 . . . . 1.83 114.412 -167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.67 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.17 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 1.54 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.19 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 1.7 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 1.88 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 1.85 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.96 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 2.49 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.94 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 2.79 114.36 168.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 1.77 105.215 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 2.11 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 1.73 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 3.37 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 1.56 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 3.96 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.8 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 2.03 111.98 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.9 113.298 172.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.92 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.98 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 2.34 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 2.19 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.93 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 3.34 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.5 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.35 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 1.65 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 1.78 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 1.64 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 1.64 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 1.71 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 5.54 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 1.71 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 1.62 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 6.18 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.67 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 3.1 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 1.63 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 1.56 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 3.27 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.22 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 1.64 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 2.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.47 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.33 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 1.01 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 1.9 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 5.64 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.81 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.63 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 2.18 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 2.19 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 3.51 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.76 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.62 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.8 113.087 -171.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 2.37 114.89 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 4.59 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 4.41 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 1.4 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.82 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 1.73 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 3.79 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 1.79 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 1.02 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.57 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.409 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 3.58 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 2.54 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 1.01 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.87 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 1.53 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.39 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 2.76 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 1.59 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.71 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 2.04 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.425 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.58 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.425 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.52 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.51 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.67 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.85 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 1.76 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 2.02 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.58 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 1.59 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 1.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 3.14 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 2.52 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.72 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 1.52 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.8 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 1.68 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 1.76 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 4.21 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.85 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.97 -0.852 . . . . 24.44 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -91.28 144.23 25.82 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.015 0.908 . . . . 20.87 112.676 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.36 129.76 35.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.562 0.745 . . . . 21.26 110.347 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 p -142.81 168.93 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.76 1.224 . . . . 14.3 112.306 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.32 175.08 1.82 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.642 1.577 . . . . 11.59 113.224 167.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 154.07 11.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.467 1.508 . . . . 8.3 113.18 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.6 155.67 19.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.102 0.961 . . . . 7.82 112.655 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.43 17.47 58.68 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.498 0.959 . . . . 5.04 115.498 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.71 43.41 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.242 1.021 . . . . 4.99 110.949 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 36.34 4.84 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.095 0.948 . . . . 3.96 114.948 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.6 26.31 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.442 1.496 . . . . 3.55 115.392 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t 66.32 176.82 0.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.839 2.456 . . . . 2.47 113.689 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -35.9 72.78 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.659 -1.276 . . . . 1.78 113.026 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.62 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 1.67 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 1.7 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 3.52 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 1.82 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 3.43 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 2.31 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.82 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 3.43 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 2.05 108.14 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 2.69 108.878 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 1.61 109.126 -167.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 3.07 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 1.61 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 2.17 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.85 112.191 -160.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 2.14 111.396 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.9 113.18 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.85 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 4.05 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 4.47 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 3.3 114.793 -159.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 2.26 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.26 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 3.95 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.86 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 3.09 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 1.95 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 1.7 113.628 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 1.63 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.42 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 1.86 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 1.71 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 4.54 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 1.83 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.49 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 1.91 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 8.02 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.47 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 3.32 111.023 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 1.6 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 1.48 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 3.53 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.35 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 1.84 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 2.44 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.06 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.9 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.78 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.16 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 2.16 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 4.11 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.94 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.81 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 1.85 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 2.84 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 3.55 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.96 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.87 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 2.17 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.51 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 3.74 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.97 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.98 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.85 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 1.91 109.21 160.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 3.08 109.487 166.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 1.93 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.96 113.686 -171.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 3.39 110.645 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 2.6 110.32 -144.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 1.3 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 1.0 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 1.25 117.575 -165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.14 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 2.29 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 1.86 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 2.11 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.84 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 1.63 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.19 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.55 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.22 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 1.49 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 1.74 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.62 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.22 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 1.87 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 2.09 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 5.8 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 2.61 113.551 163.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.43 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 1.93 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.73 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.488 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.72 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 1.59 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 2.07 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.88 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.81 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.142 -0.783 . . . . 14.92 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -147.15 140.32 25.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.739 1.216 . . . . 12.33 111.296 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.32 43.19 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.877 0.871 . . . . 16.34 112.475 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -134.54 153.14 52.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.425 1.49 . . . . 12.53 110.763 170.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.7 mmt 25.68 115.25 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 130.151 3.38 . . . . 13.37 117.878 156.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.08 -144.22 16.69 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.849 2.166 . . . . 8.12 114.507 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.41 68.63 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.683 1.734 . . . . 8.36 115.683 -168.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.26 139.93 8.06 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.234 2.349 . . . . 5.28 115.864 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.49 177.65 35.69 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.89 1.709 . . . . 3.89 112.552 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.5 7.44 63.66 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 125.199 1.38 . . . . 3.61 115.524 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.36 178.0 43.01 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.798 2.618 . . . . 3.17 110.099 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.2 t 61.16 176.15 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 3.45 114.717 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.58 -35.0 65.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.048 1.339 . . . . 2.63 112.592 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.4 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 2.02 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.83 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 1.76 111.042 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 1.97 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 1.55 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 3.27 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 3.52 113.707 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 2.22 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 1.52 104.052 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 2.44 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 1.85 109.182 -170.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 3.37 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 1.79 110.597 -173.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 2.32 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 1.61 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.9 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.84 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 5.44 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.51 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 3.27 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.09 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 3.86 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 3.28 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 2.14 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 1.92 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 1.66 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.19 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 1.91 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 1.76 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 4.06 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 1.74 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.42 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.6 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 1.62 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 4.95 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.35 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 3.34 111.017 163.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 2.0 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 1.54 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 3.28 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.24 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 1.93 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 2.11 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.85 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.18 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.27 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.12 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 1.9 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 4.18 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 3.4 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.65 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 1.86 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 2.22 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.19 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 3.77 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 3.66 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.71 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.88 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 1.29 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 3.15 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 4.16 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.57 112.792 165.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.62 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 1.81 110.448 157.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 3.01 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 1.88 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 1.07 112.962 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 3.79 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 2.51 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.94 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.8 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 1.35 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.08 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 2.07 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 1.77 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 1.76 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.07 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 1.81 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.95 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.6 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 1.51 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 1.71 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.42 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.58 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 1.78 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 1.81 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 2.55 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 2.39 112.269 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.12 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 1.75 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.5 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55 110.25 162.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 1.65 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 1.85 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 3.0 113.988 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.63 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.14 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 111.113 -0.795 . . . . 17.47 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 53.22 36.28 22.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.819 1.648 . . . . 14.61 115.235 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' CD1' ' HE2' ' A' ' 51' ' ' LYS . 18.1 t80 -163.14 139.54 7.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.941 1.296 . . . . 18.22 110.713 -170.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.259 71.0 p 63.31 -10.93 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 118.593 2.812 . . . . 16.62 118.593 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.5 140.64 8.6 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 127.878 2.471 . . . . 15.06 108.645 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.28 -28.89 0.44 Allowed Glycine 0 CA--C 1.543 1.825 0 C-N-CA 124.526 1.06 . . . . 8.91 114.334 -162.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.86 173.35 11.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.114 2.566 . . . . 7.03 111.68 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.45 169.32 14.95 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.129 1.347 . . . . 4.44 116.208 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.57 2.72 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.034 1.778 . . . . 4.45 111.757 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.1 18.31 57.89 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.737 1.055 . . . . 3.69 115.737 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.32 -173.12 21.06 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.448 1.499 . . . . 3.36 113.63 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t 67.5 167.24 0.24 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.657 2.383 . . . . 2.7 113.636 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.58 61.42 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.788 1.635 . . . . 2.28 114.07 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.74 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 1.73 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.92 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.93 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 3.34 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 1.89 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 3.38 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HE2' ' CD1' ' A' ' 3' ' ' PHE . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 2.39 113.96 166.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.01 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 2.76 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 1.78 107.546 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 2.57 108.939 174.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 1.63 109.25 -169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 3.04 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 1.54 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 3.05 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.83 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 2.16 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.07 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.5 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.5 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.67 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 2.29 116.207 169.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 2.83 106.999 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.62 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 3.89 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 4.09 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 4.23 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 2.0 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 1.61 113.155 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 1.66 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.05 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 1.58 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 1.54 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 4.06 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 1.69 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.39 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.59 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 1.57 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 7.34 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 3.62 113.716 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 1.87 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 1.8 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 3.72 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.86 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 2.31 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 2.87 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.73 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.19 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 2.87 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 4.0 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 3.06 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.77 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 2.0 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 3.85 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.3 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 3.67 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.76 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.87 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.59 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 2.16 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.79 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 4.83 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.88 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.73 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 1.62 109.547 162.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 3.26 109.595 167.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 1.57 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.98 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.13 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 3.19 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 2.51 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 1.36 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.93 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 2.19 114.862 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 2.39 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 1.66 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 2.19 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 1.8 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.78 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.18 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.63 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.89 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 1.72 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 2.02 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.11 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 3.35 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 1.8 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.407 ' HE3' HG11 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 2.2 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.87 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 2.48 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 1.67 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.7 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.64 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 1.89 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 1.9 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 150' ' ' GLU . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 3.36 113.193 177.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.51 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 148' ' ' LEU . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.33 113.19 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.458 0 N-CA-C 112.123 -0.391 . . . . 18.59 112.123 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.1 p -79.8 -24.23 41.55 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.371 1.619 . . . . 15.38 115.371 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -103.03 149.3 24.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.343 1.057 . . . . 15.88 111.43 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -142.06 160.82 39.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.949 1.833 . . . . 13.63 115.949 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt 30.56 -98.18 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 118.24 2.682 . . . . 15.64 118.24 151.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.86 129.79 6.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.365 1.46 . . . . 7.71 110.956 -160.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.32 42.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.322 0.86 . . . . 6.1 113.322 -163.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.26 154.14 25.59 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.488 1.518 . . . . 5.2 110.97 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.97 -155.49 30.46 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.436 1.017 . . . . 4.54 114.344 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.48 21.17 2.92 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.767 1.175 . . . . 3.74 115.434 -172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.43 11.64 0.03 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 118.297 2.079 . . . . 3.48 118.297 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.9 t -91.52 170.25 10.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.816 1.308 . . . . 3.09 111.947 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.33 66.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.599 1.16 . . . . 2.41 114.042 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.69 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.45 110.263 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 1.89 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 1.67 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 1.94 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 1.85 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 3.71 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 2.9 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.92 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 2.4 115.083 172.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 1.7 104.736 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 2.38 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 1.68 109.455 -173.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 3.26 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 1.85 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 3.06 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 1.76 111.337 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.84 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.87 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 2.31 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 2.41 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.548 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.02 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.19 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 3.19 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.39 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.32 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 1.6 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 1.51 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 1.72 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 1.62 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 1.56 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 5.14 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 1.66 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.7 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 1.69 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 5.72 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.43 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 3.3 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 1.69 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 1.55 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 3.3 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.16 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 1.75 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 2.09 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.26 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.24 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.2 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.36 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 1.87 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 4.59 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.85 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.71 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 1.95 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 2.03 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.86 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 3.38 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 3.39 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.9 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.68 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 3.52 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.75 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 1.44 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.5 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 1.83 109.958 164.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 4.57 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 1.68 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 1.12 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.85 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.86 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 4.22 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 2.44 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 1.15 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.96 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 1.37 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.86 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 3.99 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 1.69 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 2.83 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 1.75 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.88 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.41 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.82 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.59 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 1.86 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.402 HG11 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 1.69 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.69 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.88 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 1.71 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.402 ' HE3' HG11 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 1.66 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 3.4 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 2.43 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.94 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 1.96 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.9 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.71 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 1.71 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 1.83 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.96 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.18 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.21 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.05 -0.82 . . . . 23.12 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 m -89.66 12.47 16.79 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.488 1.662 . . . . 23.63 115.488 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -135.33 136.5 41.58 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.783 1.233 . . . . 20.71 113.645 -170.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.1 p -141.4 154.99 45.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.168 1.387 . . . . 14.48 111.183 159.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 mmt 48.57 1.54 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 120.52 3.526 . . . . 13.36 120.52 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 174.64 50.54 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.762 -1.211 . . . . 10.48 113.843 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.42 179.69 7.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.839 1.255 . . . . 9.24 112.72 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.12 151.41 16.01 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.429 1.49 . . . . 7.1 113.349 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.47 -131.27 6.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.929 1.728 . . . . 5.7 113.051 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.39 17.67 62.22 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.208 1.243 . . . . 5.61 116.208 172.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.47 14.46 73.69 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.886 1.343 . . . . 4.43 114.715 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -66.75 144.87 56.07 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.596 1.159 . . . . 4.55 112.854 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 -29.36 70.47 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 1.85 114.561 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.93 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.16 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 2.02 113.443 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.87 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 1.57 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 1.87 111.808 173.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 1.53 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 3.82 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 3.38 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.65 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 2.42 115.321 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 1.8 105.309 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 2.31 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 1.62 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 3.05 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 1.93 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 3.06 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.87 113.876 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 1.7 110.951 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.06 113.223 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.61 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.44 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 3.21 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.477 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.41 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.477 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.68 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 3.34 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.36 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 4.14 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 1.66 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 2.07 113.064 170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 2.02 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.65 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 1.57 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 1.72 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 5.88 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 1.92 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.06 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 1.73 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 5.77 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.45 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 3.52 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 1.74 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 1.52 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 3.33 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.24 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.74 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 2.5 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.43 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.21 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.41 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 1.7 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 4.69 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 4.61 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.9 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 1.84 113.04 -175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 2.29 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 3.67 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.41 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.93 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.51 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.62 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 3.36 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 4.95 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.86 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.06 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 1.66 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 2.63 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 1.61 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.72 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.65 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 3.78 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 2.33 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.89 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.66 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.57 117.298 -170.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.16 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 2.77 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 1.73 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 2.08 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 1.64 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.57 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.06 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.82 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.84 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 1.62 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 1.53 109.871 -170.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.43 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.65 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 1.87 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 2.23 113.495 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 2.4 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 2.3 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 1.54 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 2.22 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.72 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.83 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 2.0 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 3.13 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.49 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.064 0 CA-C-O 119.086 -0.841 . . . . 19.83 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -72.71 162.33 29.62 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.793 1.296 . . . . 15.69 113.3 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 148.46 26.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.981 0.913 . . . . 18.17 109.851 163.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.8 p -70.92 154.29 41.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.436 0.902 . . . . 13.17 113.436 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 58.49 168.49 0.05 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.631 2.373 . . . . 12.93 115.61 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.4 143.63 6.54 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.621 1.105 . . . . 7.63 113.148 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.46 142.19 23.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.535 1.134 . . . . 6.64 112.533 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.77 -174.74 35.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.94 1.257 . . . . 4.25 113.24 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.62 -168.22 6.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.722 0.677 . . . . 3.55 113.673 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.61 13.77 2.15 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 116.553 1.381 . . . . 3.66 116.553 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.64 -167.59 38.65 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.355 1.931 . . . . 3.19 111.134 -171.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 60.3 171.61 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.914 1.686 . . . . 2.56 113.401 -165.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.08 64.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.175 1.39 . . . . 2.07 113.401 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.43 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.11 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 1.84 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.33 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 1.63 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 1.81 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 1.5 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 5.01 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 2.8 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.83 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 3.18 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 1.54 105.573 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 2.24 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 1.68 109.433 -168.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 3.38 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 1.95 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.86 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 1.68 111.548 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76 113.812 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.09 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.49 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.535 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 2.29 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.535 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 2.25 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 3.72 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.77 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 5.16 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 1.61 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 1.74 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 1.86 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.493 ' NE2' ' HE ' ' A' ' 78' ' ' ARG . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.44 110.594 168.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 1.62 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 1.65 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HE ' ' NE2' ' A' ' 75' ' ' GLN . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 5.44 114.001 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 1.9 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.42 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 1.7 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 7.63 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.22 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 3.18 108.75 153.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 1.81 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 1.73 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 3.32 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.18 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 1.89 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 2.2 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.53 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.96 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.89 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 1.7 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 5.29 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 4.14 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.58 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 1.81 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 3.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 3.5 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 3.11 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.89 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 2.02 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.32 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 4.32 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 4.41 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.71 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.72 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 1.66 110.282 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 2.93 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 1.75 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.69 112.984 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.72 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.17 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 3.28 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 2.38 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.8 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.6 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 2.47 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.39 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 2.12 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 1.75 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 2.06 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 1.5 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.5 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.03 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.71 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 1.73 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 1.65 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.19 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 1.66 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.98 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 4.23 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 2.38 112.669 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.85 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 1.61 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.7 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 1.7 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 1.82 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 3.44 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.76 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.56 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 109.877 -1.289 . . . . 15.84 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m -62.42 131.68 50.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.16 0.98 . . . . 13.79 111.598 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 58.94 20.38 8.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.242 1.817 . . . . 15.15 114.867 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -143.61 149.21 37.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.46 1.504 . . . . 14.86 112.831 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 56.22 172.02 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.703 2.401 . . . . 16.12 115.631 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.57 -118.18 12.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.666 1.127 . . . . 10.72 113.319 171.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.66 31.33 16.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.616 1.966 . . . . 10.09 116.253 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.73 -169.43 44.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.963 1.268 . . . . 5.87 115.795 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.32 -21.33 2.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.804 1.669 . . . . 4.01 114.553 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.41 -24.5 1.42 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 126.38 1.943 . . . . 3.73 115.727 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.12 -179.31 44.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.686 2.089 . . . . 3.15 111.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 t 63.52 169.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.936 2.094 . . . . 3.24 114.468 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.1 32.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.142 2.177 . . . . 2.19 115.007 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 1.72 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.14 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 1.88 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 2.19 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 1.89 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 3.12 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 3.02 113.519 169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 2.56 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 1.7 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 2.9 107.379 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 1.83 108.097 -167.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 3.37 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 1.95 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.93 109.594 170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' H ' ' CD2' ' A' ' 91' ' ' LEU . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.09 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.86 111.77 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.36 114.092 -176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.87 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 3.08 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 3.42 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 2.22 115.096 165.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 3.0 106.465 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 3.74 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.47 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 5.04 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 2.0 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 2.31 113.131 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 2.29 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.31 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 1.63 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 2.11 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 5.04 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 1.62 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.57 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 1.71 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 5.79 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.61 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 3.08 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 1.62 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 1.73 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 3.68 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.403 ' ND2' HD23 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.59 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 2.03 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.698 ' H ' ' CD2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 5.17 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.64 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.61 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.65 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.19 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 2.04 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 4.64 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.6 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.59 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 1.77 112.91 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 2.2 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.51 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 3.45 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 2.31 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.56 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 1.31 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 3.6 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 6.49 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.71 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.81 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 1.79 107.485 151.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 4.27 108.488 160.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 1.94 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.76 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.69 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.67 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 3.56 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.457 HG21 ' H ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 4.22 106.113 -156.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.457 ' H ' HG21 ' A' ' 119' ' ' VAL . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 1.21 114.11 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.9 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.67 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.41 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 2.79 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 2.09 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.98 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 2.1 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 1.92 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.7 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.03 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.83 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 1.49 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 1.78 110.342 -166.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.57 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.06 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 1.75 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 2.97 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 3.06 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 2.48 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.75 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 1.83 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.72 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.8 109.022 156.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.95 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.87 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 3.24 113.96 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.45 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.24 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.132 -0.787 . . . . 20.75 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -160.82 140.98 11.16 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.418 1.487 . . . . 18.14 112.455 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -123.94 43.75 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.159 1.384 . . . . 21.73 112.436 -167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -136.8 166.85 22.64 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.624 1.569 . . . . 13.23 113.136 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.95 163.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.837 2.855 . . . . 12.17 116.69 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.2 163.55 16.17 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.754 2.121 . . . . 8.86 112.301 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.01 43.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 7.53 112.004 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -48.07 88.11 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.695 1.141 . . . . 6.19 114.682 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.64 87.43 1.04 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 118.575 1.188 . . . . 4.99 112.405 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.14 -7.51 18.24 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 117.408 1.723 . . . . 5.2 117.408 -165.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.29 14.73 5.61 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.091 1.805 . . . . 4.33 113.953 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -89.07 156.97 18.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.205 1.802 . . . . 3.6 112.608 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.56 70.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.611 -1.306 . . . . 2.15 114.086 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.43 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.39 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 1.8 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.82 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 1.78 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 2.84 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 1.85 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 3.54 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 2.24 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.36 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 2.6 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 1.49 103.999 176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 2.26 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 1.62 109.876 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 3.32 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 1.77 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 2.73 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 2.1 111.806 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.76 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.83 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 2.32 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.536 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 2.45 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.536 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 2.63 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.44 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 4.11 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.96 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.68 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 1.75 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 1.93 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 2.13 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.72 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 1.59 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 1.66 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 5.69 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 1.99 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 1.71 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 5.26 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 3.08 109.611 158.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 1.76 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 1.75 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 3.35 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.3 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 1.76 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 2.3 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.8 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.28 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 1.02 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 1.86 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.7 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.79 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.59 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 1.85 113.069 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 2.38 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 3.69 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 3.68 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.56 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.72 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.42 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 4.12 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 4.09 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 1.46 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.59 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 1.7 109.954 155.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 2.58 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 1.78 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.85 113.314 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.6 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.82 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 3.48 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 2.39 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.8 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.66 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 1.48 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.84 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 3.0 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 1.92 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 1.82 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.75 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 1.46 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.54 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.54 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.86 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 1.75 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 1.68 109.832 -170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.82 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 1.72 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 1.71 113.384 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.81 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 2.49 112.377 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.82 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 1.89 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.69 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56 110.599 162.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 1.67 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 1.94 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 3.58 114.779 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.67 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.95 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 111.353 -0.699 . . . . 16.99 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m 64.43 2.2 1.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.99 2.218 . . . . 15.78 116.99 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -122.58 152.33 40.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.942 1.701 . . . . 16.28 114.093 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.3 p -136.46 155.39 50.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.903 0.881 . . . . 12.26 113.214 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.2 158.89 4.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.002 1.721 . . . . 11.53 114.964 -173.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.5 134.54 19.47 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.747 0.689 . . . . 9.68 112.637 170.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.68 -15.91 5.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.084 1.513 . . . . 8.25 115.084 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.18 162.54 39.77 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-N 118.95 0.795 . . . . 5.79 113.494 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.49 177.14 42.07 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.517 1.367 . . . . 4.81 116.517 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.62 33.87 37.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.865 1.698 . . . . 3.91 115.826 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.85 -174.92 54.7 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.211 1.005 . . . . 3.17 113.582 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 64.5 173.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.73 2.412 . . . . 2.5 114.092 -170.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -37.53 62.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.108 1.363 . . . . 1.86 112.858 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.97 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.15 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 1.72 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 1.7 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 2.7 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 1.62 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 3.34 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 2.43 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.06 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 2.55 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 1.74 104.004 177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 2.06 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 1.68 109.657 -170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 3.32 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 1.55 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 2.85 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.74 112.968 -164.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 1.68 110.969 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.03 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.67 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 4.12 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 2.96 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 3.16 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 3.52 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.79 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.96 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 1.81 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 1.79 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 1.89 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.497 ' NE2' ' HE ' ' A' ' 78' ' ' ARG . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.61 109.788 169.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 1.67 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 1.57 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HE ' ' NE2' ' A' ' 75' ' ' GLN . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.92 115.272 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 1.72 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.48 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.69 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 1.92 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 4.42 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.76 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 3.17 111.886 157.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 1.69 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 1.6 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 3.28 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.22 111.404 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 1.7 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 2.63 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.36 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.59 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 1.01 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 1.84 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.83 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.57 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 1.7 112.502 -177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 2.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.09 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 3.46 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 2.07 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.57 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 2.51 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 3.16 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 4.48 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.62 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.57 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 1.64 109.682 171.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 4.04 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 1.78 109.877 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.89 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.72 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.61 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 3.65 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 2.66 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.83 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.61 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 1.48 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 2.07 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 2.09 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 1.56 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 1.87 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.53 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.12 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.64 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.84 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 1.49 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 2.03 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.84 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.32 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 1.74 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 1.94 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 3.87 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 3.86 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 1.87 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.47 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.72 110.607 161.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 1.7 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 1.71 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 3.23 115.891 -171.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.19 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.83 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.232 -1.147 . . . . 15.22 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -140.73 165.47 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.421 1.089 . . . . 15.05 112.025 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -150.09 119.8 7.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.145 0.978 . . . . 15.71 112.615 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.2 p -141.77 163.45 32.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.991 1.316 . . . . 13.57 112.896 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -6.65 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.711 2.115 . . . . 15.74 116.711 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 140.6 48.04 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.897 1.519 . . . . 9.61 116.897 -159.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.26 170.16 0.08 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.393 2.277 . . . . 8.28 116.311 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.56 -141.42 8.57 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.887 0.756 . . . . 5.21 114.099 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.62 145.29 7.34 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.669 1.604 . . . . 4.09 111.385 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.65 104.75 0.61 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.87 0.748 . . . . 3.83 113.407 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.11 18.76 65.23 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 124.681 1.134 . . . . 4.1 115.893 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -78.54 154.51 30.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.164 1.482 . . . . 3.99 113.731 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.65 76.31 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.002 -1.061 . . . . 2.48 112.371 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.19 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 1.8 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.57 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 1.51 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 2.14 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 1.83 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 3.9 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 2.91 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 2.55 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 1.54 104.172 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 2.31 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 1.58 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 3.12 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 1.78 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 3.4 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.74 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 1.95 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 2.12 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.44 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.58 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 2.22 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 2.3 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.444 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 2.18 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.92 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 3.53 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 2.29 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.27 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 1.67 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 1.83 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 1.76 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 1.58 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 1.6 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.98 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 1.61 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39 113.484 168.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.6 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 1.71 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.74 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.17 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 3.37 109.79 158.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 1.62 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 1.64 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 3.23 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.12 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 1.61 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 2.25 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.43 112.812 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.96 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.18 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 1.88 109.035 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 4.0 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 3.14 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.61 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 2.34 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 2.61 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.85 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 3.16 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.84 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.8 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.68 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.32 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 3.39 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 5.31 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.61 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.6 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 1.66 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 3.05 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 1.65 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.78 113.157 178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.57 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 3.93 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 4.01 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 1.2 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.79 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.438 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 1.52 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.22 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 2.16 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 1.64 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 2.25 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 1.49 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.64 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.19 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.38 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.82 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.19 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 1.55 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 1.71 109.408 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.58 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 2.94 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 1.61 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 2.98 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 3.26 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 2.55 111.942 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 1.6 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.98 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.63 110.183 158.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 1.64 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 1.72 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 3.77 113.727 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.27 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.84 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.88 -1.288 . . . . 20.28 109.88 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m 50.64 29.98 4.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.049 1.739 . . . . 17.86 115.159 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -67.1 157.64 33.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.125 0.97 . . . . 21.35 112.91 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.2 p -94.36 156.72 16.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.466 1.506 . . . . 14.32 113.022 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -20.22 58.6 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.396 1.999 . . . . 12.29 116.396 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 23.47 77.82 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 116.439 1.336 . . . . 8.28 116.439 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.63 161.2 18.41 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.56 1.544 . . . . 6.16 112.801 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.31 178.72 46.31 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.431 1.015 . . . . 5.54 112.479 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.93 123.01 5.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.391 1.472 . . . . 5.31 110.651 -171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.89 122.31 29.69 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 122.144 -0.621 . . . . 5.35 111.956 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.59 4.45 61.26 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.955 1.264 . . . . 4.21 116.151 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -71.33 141.93 50.43 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.843 1.257 . . . . 3.86 111.761 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.62 91.04 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.384 -0.823 . . . . 2.25 113.19 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.74 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.41 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 1.83 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.58 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 2.15 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 3.18 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 1.56 113.606 169.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 3.17 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 2.79 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.39 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 2.76 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 1.74 108.916 174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 2.81 109.173 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 1.7 108.888 -170.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 3.29 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 1.57 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 2.73 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.83 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 2.05 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.96 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.26 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.89 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.88 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 3.26 112.125 -170.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 3.5 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.47 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 3.87 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 2.39 113.674 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 3.03 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 1.86 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 1.84 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 1.77 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.18 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 1.85 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 1.83 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.98 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 1.61 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.72 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 1.93 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 6.66 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.17 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 3.42 110.708 163.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 1.49 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 1.61 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 3.41 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.77 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 2.28 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.62 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.38 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.36 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 2.0 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 4.49 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 5.53 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.62 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 1.79 112.616 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 3.57 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.37 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 3.56 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 2.21 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.01 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.59 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.403 ' C ' ' HG1' ' A' ' 108' ' ' THR . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 2.53 115.13 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 3.48 112.735 -178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 4.63 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 1.46 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.49 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 1.59 109.396 158.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 3.79 108.36 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 1.81 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.86 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.84 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 3.73 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 2.42 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.87 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.67 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 1.54 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.24 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 2.14 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 1.88 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 2.02 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.12 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 1.52 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.73 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.11 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.32 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.69 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.91 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 1.96 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 1.68 109.851 -171.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.15 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 1.8 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 1.88 113.462 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 2.54 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 3.87 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 1.81 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.75 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.84 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 1.76 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.97 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 4.6 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.27 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 5.74 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.585 -0.606 . . . . 18.87 111.585 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.69 140.05 37.15 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.972 1.101 . . . . 16.24 113.972 -169.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.4 159.64 34.18 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.458 1.651 . . . . 17.53 115.458 -165.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -73.91 -68.45 0.51 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.938 1.695 . . . . 13.3 114.417 -171.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.1 mmt -117.44 -36.62 3.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.613 -1.63 . . . . 12.65 114.667 -159.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 158.4 27.03 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.603 1.573 . . . . 9.4 114.183 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.6 -1.17 26.23 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.642 2.09 . . . . 8.96 116.642 -169.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.25 24.51 67.41 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 117.416 1.727 . . . . 6.07 117.416 163.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.18 166.46 52.54 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 118.883 1.342 . . . . 5.69 115.661 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.14 97.91 0.95 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.443 1.973 . . . . 4.81 110.059 164.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.79 177.46 14.47 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.804 1.192 . . . . 3.26 113.476 -161.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t 61.31 176.11 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.916 2.086 . . . . 3.03 113.656 -171.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.6 -26.55 63.77 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.365 -1.459 . . . . 2.3 114.073 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.03 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 1.82 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.37 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 1.82 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 1.97 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 1.94 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 3.42 116.232 173.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 2.15 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.66 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 2.12 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 1.78 104.91 -177.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 2.08 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 1.65 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 3.06 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 1.82 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 2.15 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.83 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 1.76 110.582 176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.7 111.705 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.66 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.47 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.61 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 3.56 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.05 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.99 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 4.55 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 3.39 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.92 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 1.94 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 1.7 113.391 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 1.98 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.93 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 1.77 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 1.73 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 4.37 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 1.7 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.82 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 1.71 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 5.99 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.4 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 3.49 110.331 166.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 1.49 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 1.56 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 3.39 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.24 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 1.62 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 2.15 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.36 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.43 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 2.07 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 1.81 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.73 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 3.16 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.88 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 2.0 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 3.08 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.85 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 3.6 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 2.04 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.41 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.24 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 2.3 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 4.37 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 5.6 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.97 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.79 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 1.61 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 2.65 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 1.7 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.69 113.298 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.73 117.871 -169.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.8 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 3.29 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 2.58 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.81 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.63 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 2.35 115.239 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.24 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 2.25 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 1.74 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 1.89 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 1.79 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.56 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.1 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.66 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 1.64 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 1.55 110.228 -166.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.69 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 1.82 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.69 113.277 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 3.31 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 2.41 111.912 165.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.07 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 1.92 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.79 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.53 109.153 155.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 1.69 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 1.64 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 3.01 111.532 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.81 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 110.408 -1.077 . . . . 16.74 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 52.32 15.89 0.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.177 2.288 . . . . 14.54 117.177 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 55.83 26.08 9.21 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.86 1.664 . . . . 12.71 114.874 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 p -103.51 -20.75 13.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.051 1.34 . . . . 14.45 114.562 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.38 154.44 26.99 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 129.45 3.1 . . . . 13.95 109.782 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.1 74.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.158 -0.964 . . . . 9.49 114.605 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.4 11.35 5.65 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.764 1.282 . . . . 9.29 113.819 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.99 -178.3 43.82 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.579 2.514 . . . . 6.36 110.625 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.44 -161.01 32.5 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 118.545 1.173 . . . . 4.55 114.083 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.33 58.68 3.26 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.823 1.678 . . . . 3.27 114.062 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -160.7 52.74 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 123.239 1.466 . . . . 3.05 114.907 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t 64.23 178.12 0.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.898 2.479 . . . . 2.73 114.763 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.93 66.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.344 1.457 . . . . 1.72 113.864 -165.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.18 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 1.82 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.01 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 1.65 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 1.73 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 1.99 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 3.41 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 2.84 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 2.15 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 1.87 105.536 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 2.35 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 1.69 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 3.42 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 1.75 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.77 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.74 116.08 -164.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 1.61 112.099 -175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.72 114.022 -173.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.49 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.84 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.39 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 2.28 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.501 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.89 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.15 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 3.89 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.33 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.15 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 1.91 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 1.97 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 1.7 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 1.77 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 1.82 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.99 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 1.73 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.63 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.74 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 2.2 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.97 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.13 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 3.42 111.358 165.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 1.8 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 1.75 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 3.32 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.24 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 1.64 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 2.37 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.53 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.85 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.27 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.05 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 1.65 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 4.83 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.74 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.5 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 2.21 112.716 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.85 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.89 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 3.15 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.77 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.5 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.76 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 2.71 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.79 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 4.43 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 1.46 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.57 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 1.6 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 2.71 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 1.8 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.97 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.84 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.58 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 3.81 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 2.52 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.82 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.61 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 1.49 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 2.18 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 1.83 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 2.45 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.9 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 1.44 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.93 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.54 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.3 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 1.01 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.14 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 1.79 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 1.66 110.141 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.42 110.793 166.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 140' ' ' LYS . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.93 111.789 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 1.84 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 2.22 113.694 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 137' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 2.67 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 3.79 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.82 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 1.79 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.44 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.62 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 1.69 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 1.93 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 3.27 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.74 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 110.531 -1.027 . . . . 20.65 110.531 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 t 67.74 151.86 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.04 2.136 . . . . 18.79 115.634 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.33 19.1 7.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.892 2.077 . . . . 15.85 112.285 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -138.69 158.63 43.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.554 1.142 . . . . 13.18 113.53 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.61 165.35 0.6 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.6 -1.182 . . . . 14.76 112.37 154.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.21 -136.23 32.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.964 0.792 . . . . 12.61 113.178 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.91 150.7 22.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.358 1.063 . . . . 11.8 113.093 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.72 70.54 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.042 1.306 . . . . 7.88 115.7 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.78 150.32 51.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.754 1.169 . . . . 5.85 113.146 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.91 11.21 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.822 1.201 . . . . 3.97 115.954 -169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.96 -179.79 52.49 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 116.07 1.188 . . . . 3.53 116.07 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.7 t 66.3 169.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 128.754 2.822 . . . . 2.87 114.12 -169.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.68 47.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.545 1.538 . . . . 2.13 113.499 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.68 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.08 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 1.63 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.84 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 1.55 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 1.85 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 1.56 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 3.4 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 2.31 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.69 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 2.62 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 1.76 106.999 174.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 2.92 107.948 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 1.6 109.053 -169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 3.12 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 1.66 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 2.17 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 1.62 111.257 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76 114.314 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.66 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 2.22 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 2.32 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.86 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.05 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 4.16 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 2.52 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 4.27 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 1.98 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 1.87 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 1.8 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.88 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 1.93 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 1.77 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 5.79 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 2.17 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 1.69 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 4.56 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 3.11 109.923 157.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 1.51 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 1.74 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 3.76 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.3 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.72 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 2.21 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.4 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.84 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.28 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 1.72 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 4.57 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 4.03 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.67 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 1.69 112.675 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 2.65 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 3.15 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.77 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.7 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.58 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.4 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 3.06 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 5.08 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.61 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.55 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 1.58 109.71 174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 2.62 108.428 171.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 1.7 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.36 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 3.25 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 2.44 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.83 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.69 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 1.59 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 2.06 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 1.99 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 1.66 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 2.33 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.73 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.44 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.99 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.45 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 1.66 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.436 HG11 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 1.66 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.58 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.63 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 1.63 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.436 ' HE3' HG11 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 1.87 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 3.45 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 3.39 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.96 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 1.93 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 2.58 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 1.79 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 1.92 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 3.39 111.779 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.61 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.55 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 109.159 -1.577 . . . . 20.72 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.5 m -83.79 90.37 7.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.42 -0.956 . . . . 19.33 108.42 168.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -56.45 140.58 45.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.734 1.213 . . . . 18.84 113.874 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.9 p -74.25 152.31 39.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.689 1.737 . . . . 15.88 115.689 -155.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 167.4 3.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.219 2.207 . . . . 15.0 113.816 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.51 8.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.885 1.231 . . . . 10.63 113.808 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.34 45.09 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.959 1.704 . . . . 9.41 111.341 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.2 159.55 30.88 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.133 1.349 . . . . 6.13 112.481 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.72 -165.32 36.83 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.081 1.324 . . . . 5.01 111.845 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.28 134.88 8.52 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.577 1.561 . . . . 4.82 112.725 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.21 10.59 1.26 Allowed Glycine 0 N--CA 1.479 1.543 0 C-N-CA 127.325 2.393 . . . . 3.44 118.59 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 t -115.66 175.52 5.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.781 2.033 . . . . 3.06 110.392 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.57 -35.98 61.4 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 121.066 -1.022 . . . . 1.9 113.709 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.53 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.19 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 1.72 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.57 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 1.8 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 2.64 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 1.65 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 4.98 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 2.72 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.22 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.96 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 1.78 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 2.77 108.654 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 1.65 109.568 -165.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 3.17 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 1.69 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 2.68 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.82 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 2.04 110.769 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.62 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 3.06 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.59 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.24 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.86 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.51 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 4.0 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.48 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 4.31 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 2.01 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 1.69 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 1.94 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.05 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 1.75 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 1.68 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 5.57 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 1.71 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.47 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 1.64 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 6.49 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.32 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 3.37 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 1.56 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 1.58 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 3.53 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.37 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 1.93 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 2.08 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.66 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.85 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.13 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.01 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 2.08 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.84 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 3.13 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.77 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 1.98 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 3.16 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.63 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 3.49 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.3 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.94 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.57 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 3.28 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 6.76 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.92 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 3.81 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 1.71 108.177 160.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 2.84 110.048 162.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 1.92 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.99 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 3.71 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 3.81 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.97 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.67 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 1.38 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.07 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 2.42 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 1.83 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 1.71 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 1.56 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.71 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.99 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.84 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.71 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 1.8 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 1.89 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.93 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 1.94 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 3.39 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 3.49 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 2.74 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 1.77 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.43 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.74 110.442 162.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 1.6 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 1.79 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 3.01 114.153 -170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.27 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.45 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.001 0 CA-C-O 119.218 -0.768 . . . . 17.48 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -132.98 132.25 41.7 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.015 1.326 . . . . 17.67 111.776 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -146.35 26.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.13 1.53 . . . . 14.97 115.13 -164.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.289 14.1 p 56.23 -149.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.72 2.008 . . . . 18.73 114.451 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 172.07 14.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.966 1.707 . . . . 20.23 111.849 -176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.88 -157.18 10.73 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.561 0.585 . . . . 12.7 114.561 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.52 -16.11 5.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.266 1.58 . . . . 12.07 115.266 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.25 -12.67 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 N-CA-C 115.795 1.078 . . . . 7.15 115.795 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.39 -157.45 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.656 1.122 . . . . 5.62 114.961 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.56 51.2 3.15 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.5 1.048 . . . . 4.07 114.093 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 -165.01 47.83 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.466 1.031 . . . . 2.95 111.317 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 t 62.0 -176.7 0.13 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.87 2.068 . . . . 3.35 113.947 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.71 76.58 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.559 -1.338 . . . . 2.13 113.547 -168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.45 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 1.8 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.24 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 1.97 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 1.96 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 1.79 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.99 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 2.21 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.91 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 2.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 1.98 105.114 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 2.19 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 1.67 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 3.14 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 1.67 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.421 ' C ' HE21 ' A' ' 66' ' ' GLN . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 2.77 110.164 176.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.9 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.97 110.027 169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.99 112.308 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.08 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 3.25 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.81 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.421 HE21 ' C ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 3.34 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.3 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.59 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 4.1 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 2.23 113.587 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 3.04 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 1.85 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 1.65 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 1.81 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.34 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 1.61 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 1.74 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 4.09 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 2.1 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.59 113.679 169.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 1.82 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 4.3 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.02 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 3.28 111.312 161.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 1.79 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 1.59 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 3.24 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 1.77 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 2.49 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.74 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.66 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.67 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.3 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 2.0 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 4.31 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.97 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.62 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 1.69 112.37 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 2.87 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.57 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 3.04 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 2.25 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.01 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.91 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.64 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 4.19 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 4.98 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.5 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.53 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.79 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 2.86 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 1.8 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.86 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 3.99 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 3.82 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.4 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.98 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 1.61 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.64 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 2.32 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 1.67 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 1.88 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.2 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 2.01 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.69 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.08 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.16 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.74 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.9 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 1.69 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 1.53 109.999 -173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.95 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 1.87 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 1.79 112.484 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 3.08 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 2.42 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.88 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 1.79 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.68 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.7 111.58 162.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.9 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 1.86 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 3.14 112.926 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.85 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.74 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 110.812 -0.915 . . . . 15.6 110.812 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -141.78 -12.88 0.86 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.777 1.399 . . . . 14.29 114.777 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -146.48 157.4 43.75 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.086 1.312 . . . . 14.69 111.9 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.3 p -104.46 164.37 11.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.262 1.425 . . . . 13.12 113.733 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.6 mmt 44.21 -119.48 0.68 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.635 1.974 . . . . 13.96 115.257 163.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.97 -134.65 31.94 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 119.147 0.885 . . . . 8.28 113.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 56.36 -5.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 118.732 2.864 . . . . 7.21 118.732 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 168.13 53.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.77 1.168 . . . . 4.8 113.004 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.69 149.79 15.99 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.177 -0.602 . . . . 4.55 114.1 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.43 18.11 78.31 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.49 0.956 . . . . 3.79 115.49 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.48 -176.31 17.28 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.68 1.61 . . . . 3.38 114.293 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t 63.19 167.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.202 2.201 . . . . 2.7 113.883 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -29.09 20.49 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.544 1.938 . . . . 1.96 113.979 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.3 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.15 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 1.9 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.16 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 1.69 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 2.01 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 1.69 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 5.12 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 2.68 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.91 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 2.56 114.632 170.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 1.46 105.261 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 2.18 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 1.6 110.356 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 3.08 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 1.75 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 2.95 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.73 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 2.18 111.067 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.86 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 4.4 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.56 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 2.13 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.415 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.44 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 4.78 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 3.31 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.98 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 1.85 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 2.33 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 2.22 112.267 -177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.57 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 2.06 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 2.1 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 5.07 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 1.81 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 1.63 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 5.22 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.84 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 3.05 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 1.49 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 1.45 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 3.67 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.18 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 1.46 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 2.62 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.15 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.97 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.97 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 1.71 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 4.81 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 3.25 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.56 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 1.73 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 2.12 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 3.16 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.425 ' CB ' HE22 ' A' ' 111' ' ' GLN . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.51 113.937 173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 2.23 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.9 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 1.29 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 3.55 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 4.45 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.62 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.425 HE22 ' CB ' ' A' ' 104' ' ' SER . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 2.31 111.757 -170.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 1.77 109.608 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 2.61 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 1.63 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.06 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.9 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 3.25 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 2.62 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 2.2 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 1.32 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.42 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 2.9 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 2.15 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.92 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.86 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 1.57 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.88 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.29 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.75 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.94 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 1.73 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 2.34 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.51 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.69 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 1.87 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 2.09 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.88 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 2.47 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.75 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 2.1 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.41 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.85 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 1.56 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 1.8 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 5.03 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.41 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.9 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.693 -0.563 . . . . 18.54 111.693 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -143.52 18.39 1.86 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.894 1.442 . . . . 18.05 114.894 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -91.73 147.68 22.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.5 1.12 . . . . 18.69 110.559 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.8 p -134.57 159.67 40.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.963 1.097 . . . . 13.12 113.963 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.5 mmt 43.5 39.98 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 118.503 2.779 . . . . 11.63 118.503 158.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.36 -174.16 45.94 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.409 1.324 . . . . 7.49 116.409 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.52 120.36 23.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.643 1.177 . . . . 8.38 112.198 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.14 10.29 35.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 116.648 1.419 . . . . 4.96 116.648 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.48 157.17 30.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.639 1.59 . . . . 4.09 113.948 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 117.91 7.23 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.591 1.091 . . . . 4.01 114.189 -170.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.65 8.56 21.28 Favored Glycine 0 CA--C 1.536 1.393 0 N-CA-C 117.034 1.573 . . . . 4.1 117.034 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.0 m -66.31 147.21 53.64 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.031 1.416 . . . . 4.17 110.963 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -32.62 71.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.82 -1.175 . . . . 2.22 113.134 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.22 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.36 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 2.06 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 1.59 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 2.02 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 1.72 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 3.22 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 2.54 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.12 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 2.24 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 1.8 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 2.17 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 1.74 108.839 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 3.09 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 1.76 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 3.5 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.11 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 2.22 106.558 166.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.42 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 4.64 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 2.22 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 2.44 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 2.38 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.09 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 3.43 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 2.39 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 3.05 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 1.86 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 1.76 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 1.65 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 1.77 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 1.82 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.78 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 1.9 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 1.89 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 4.68 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.82 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 3.44 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 1.65 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 1.98 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 3.38 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.91 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 2.95 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.24 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.35 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.12 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.03 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 2.49 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 6.5 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.56 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 1.03 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 2.17 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 2.57 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 3.78 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.21 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.92 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.56 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 5.35 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 4.23 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.6 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 1.8 108.265 153.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 2.88 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 1.63 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.46 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.69 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.93 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 4.05 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 3.77 104.629 -160.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 119' ' ' VAL . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 1.4 111.677 163.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 1.06 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 1.43 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.63 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 3.54 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 1.95 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 1.87 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 1.94 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.82 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.01 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.19 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.78 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.82 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 1.75 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 1.75 109.657 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.34 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 1.78 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 2.08 112.902 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 2.81 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 3.07 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 1.95 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 2.05 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.88 110.272 169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 1.69 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 2.16 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 5.58 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 1.04 113.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.87 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.35 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 0.64 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.44 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 0.6 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 0.94 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 0.58 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 2.44 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 1.89 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.85 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 1.54 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 0.69 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 0.91 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 0.37 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 2.12 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 0.43 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 1.99 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81 114.887 -159.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 0.87 111.408 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81 112.883 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.37 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.38 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.23 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 1.82 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 1.91 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.43 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 2.41 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 1.94 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 2.96 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 0.65 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 0.57 112.994 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 0.59 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.55 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 0.46 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 0.37 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 4.07 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 0.66 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 0.48 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 4.28 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.38 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 1.99 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 0.44 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 0.45 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 2.12 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.14 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 1.87 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.28 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.43 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.36 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 0.66 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 3.98 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 2.8 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.64 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 0.65 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 1.38 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.43 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 1.95 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 1.75 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.37 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.48 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.09 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 2.73 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 5.66 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.18 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 2.3 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 0.65 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 2.3 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 0.51 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.76 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.86 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 2.41 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 1.55 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.55 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.42 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 73' ' ' VAL . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 0.72 115.428 -169.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.65 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 1.16 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 0.48 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 0.7 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.84 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 0.69 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.54 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.45 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 0.46 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 0.42 109.38 -165.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.06 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 0.48 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 135' ' ' VAL . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 0.74 112.677 177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 1.79 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 1.36 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.07 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 0.7 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 2.55 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.57 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 0.65 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 0.93 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 2.93 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 114.412 1.264 . . . . 0.81 114.412 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.67 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.17 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 0.54 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.19 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 0.58 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 0.91 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 0.47 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.15 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 1.55 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.94 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 1.63 114.36 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.484 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 0.6 105.215 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 0.92 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 0.34 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 0.42 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 2.64 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.8 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 0.7 111.98 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.9 113.298 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.92 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.43 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 1.97 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 1.65 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.02 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 2.05 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.01 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.12 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 0.56 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 0.66 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 0.55 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 0.36 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 0.39 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 4.65 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 0.44 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 0.41 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 4.95 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.67 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 1.82 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.42 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 0.38 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 1.94 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.22 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 0.93 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 1.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.47 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.33 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 0.89 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 0.6 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 4.97 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.52 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.58 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 0.68 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 1.46 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 2.15 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.36 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.62 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.61 113.087 -171.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 106' ' ' TRP . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 1.52 114.89 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 3.68 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 3.44 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 0.84 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.82 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 0.64 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 2.21 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 0.42 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 0.87 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.57 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 2.24 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 1.67 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 0.73 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.67 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 0.75 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.39 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 1.46 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 0.45 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.14 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 0.64 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.58 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.39 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.51 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.63 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.85 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 0.45 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 0.45 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.58 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 0.46 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 0.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 2.06 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 1.49 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.72 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 0.53 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.48 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 0.81 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 0.98 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 3.1 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.85 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.026 0.75 . . . . 0.77 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.62 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 0.5 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 0.59 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 2.03 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 0.67 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 2.5 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 1.44 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.82 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 2.43 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 0.96 108.14 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 1.5 108.878 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 112' ' ' VAL . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 0.31 109.126 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 1.79 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 0.33 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 1.39 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.85 112.191 -160.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 0.94 111.396 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.9 113.18 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.85 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 3.01 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 3.23 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 1.95 114.793 -159.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 1.79 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.26 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 2.46 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.6 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 2.9 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 0.72 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 0.61 113.628 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 0.56 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.42 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 0.45 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 0.43 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 3.64 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 0.51 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.45 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 0.64 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 6.85 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.47 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 2.04 111.023 169.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 0.55 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 0.61 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 2.27 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.35 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 0.85 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 1.34 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.06 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.9 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.6 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.16 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 1.0 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 3.42 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.43 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.73 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 0.73 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 1.85 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 2.27 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.52 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.84 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 1.84 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.14 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 2.73 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.21 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.34 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.1 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 56' ' ' VAL . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 0.75 109.21 160.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HB2' HG23 ' A' ' 55' ' ' VAL . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 1.99 109.487 166.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 0.6 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' HD21 ' A' ' 141' ' ' LEU . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.82 113.686 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HD1' ' H ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 2.25 110.645 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.426 ' H ' ' HD1' ' A' ' 118' ' ' PHE . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 1.64 110.32 -144.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 0.91 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 0.67 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.438 ' SG ' HG13 ' A' ' 73' ' ' VAL . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 0.71 117.575 -165.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.14 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 1.27 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 0.82 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 0.76 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.82 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 0.45 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.19 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.53 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.22 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 0.39 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 0.53 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.62 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.22 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 0.8 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 1.29 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 4.87 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 115' ' ' ASN . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 1.52 113.551 163.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.43 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 0.85 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.47 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.489 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.72 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 0.64 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 0.7 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.11 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.81 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.592 0.59 . . . . 1.43 112.592 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.4 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 0.88 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.83 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 0.61 111.042 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 0.97 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 0.49 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 2.41 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 2.33 113.707 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 1.28 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 0.63 104.052 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 1.3 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 112' ' ' VAL . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 0.5 109.182 -170.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 1.96 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 0.56 110.597 -173.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 1.43 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 0.74 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.78 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.84 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 4.24 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.19 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 2.95 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.09 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 2.36 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 2.95 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 0.86 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 0.54 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 0.54 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.19 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 0.51 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 0.47 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 3.43 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 0.5 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.39 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.6 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 0.43 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 3.99 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.35 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 1.94 111.017 163.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 0.64 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 0.8 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 1.99 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.24 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 0.84 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 1.38 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.85 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.18 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.11 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.12 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 0.64 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 3.52 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 2.6 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.62 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 0.77 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 1.48 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.19 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 2.37 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 2.67 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.58 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.64 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 0.98 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 2.73 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 3.47 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.11 112.792 165.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.62 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 56' ' ' VAL . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 0.65 110.448 157.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 1.96 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 0.76 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 0.96 112.962 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 2.43 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 1.59 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.78 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.64 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 0.98 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.08 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 1.03 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 0.72 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 0.8 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.07 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 0.48 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.95 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.59 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 0.4 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 0.46 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.42 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.58 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 0.51 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 0.81 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 1.88 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 1.29 112.269 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.12 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 0.54 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.26 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55 110.25 162.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 0.9 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 0.88 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 2.17 113.988 -175.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.63 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.14 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 114.07 1.137 . . . . 1.12 114.07 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.74 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 0.57 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.92 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.1 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 2.18 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 0.76 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 2.41 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 1.62 113.96 166.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.01 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 1.41 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 0.94 107.546 176.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 1.37 108.939 174.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 112' ' ' VAL . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 0.36 109.25 -169.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 1.76 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 0.34 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 1.99 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.83 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 0.98 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.07 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.46 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.42 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.26 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 1.74 116.207 169.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 1.64 106.999 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.62 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 2.33 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 3.54 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 3.3 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 0.68 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG13 ' SG ' ' A' ' 122' ' ' CYS . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 0.54 113.155 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 0.5 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.05 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 0.31 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 0.38 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 3.42 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 0.6 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.38 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.59 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 0.46 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 6.29 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 2.2 113.716 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 0.53 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 0.67 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 2.49 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.86 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 1.16 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 1.93 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.48 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.19 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 1.73 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 3.33 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 2.41 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.73 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 0.87 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 2.74 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.3 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 2.26 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.55 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.74 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.19 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 1.72 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.27 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 3.94 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.24 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.02 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 56' ' ' VAL . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 0.61 109.547 162.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.548 ' HB2' HG23 ' A' ' 55' ' ' VAL . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 2.13 109.595 167.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 0.53 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.98 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.13 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 1.99 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 1.61 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 0.85 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.63 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 73' ' ' VAL . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 0.78 114.862 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 1.4 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 0.54 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 1.03 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 0.83 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.71 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.18 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.63 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.89 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 0.68 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 0.55 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.11 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 2.42 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 0.54 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 1.12 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.09 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 1.46 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 0.66 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.38 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.5 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 0.76 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 0.79 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 2.52 113.193 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.51 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.33 113.19 167.583 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.042 1.127 . . . . 1.21 114.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.69 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.45 110.263 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 0.76 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 0.56 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 0.92 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 0.59 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 2.66 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 1.6 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.92 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 1.35 115.083 172.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 0.79 104.736 178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 1.16 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 112' ' ' VAL . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 0.28 109.455 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 1.96 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 0.43 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 1.89 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 0.65 111.337 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.84 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.45 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 1.96 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 1.8 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.01 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.19 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 1.93 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.0 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.1 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 0.56 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 0.51 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 0.49 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 0.32 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 0.39 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 4.33 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 0.53 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.7 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 0.58 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 4.89 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.43 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 2.01 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 0.36 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 0.36 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 2.02 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.16 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 0.84 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 1.47 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.26 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.24 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.05 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.36 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 0.66 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 3.86 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.54 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.66 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 0.7 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 1.36 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.86 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 2.14 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 2.4 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.73 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.38 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 2.69 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.01 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 0.93 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.17 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 56' ' ' VAL . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 0.53 109.958 164.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 2.92 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 0.48 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 0.96 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.79 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.86 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 2.79 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 1.59 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 0.89 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.73 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 0.69 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.86 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 2.69 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 0.61 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 1.37 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 0.87 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.84 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.33 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.82 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.59 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 0.59 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.454 HG12 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 0.52 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.69 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.88 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 0.57 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 0.99 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 2.12 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 1.42 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.92 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 0.92 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.53 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.71 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 0.76 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 0.83 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.0 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.18 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.21 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 0.86 114.561 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.93 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.16 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 0.66 113.443 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.87 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 0.47 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 0.92 111.808 173.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 0.44 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 2.85 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 2.18 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.65 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 1.39 115.321 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 0.85 105.309 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 0.94 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 0.3 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 1.75 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 0.47 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 2.06 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.81 113.876 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 0.87 110.951 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.06 113.223 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.61 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.28 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 2.72 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.37 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.11 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 2.08 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.05 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 3.31 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 0.73 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 0.98 113.064 170.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 0.99 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.65 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 0.32 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 0.61 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 4.96 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 0.82 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.06 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 0.73 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 4.77 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.45 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 2.1 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 0.42 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 0.39 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 2.0 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.24 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.14 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 1.89 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.43 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.07 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.41 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 0.58 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 3.98 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 3.58 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.71 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 0.7 113.04 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 1.54 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 2.22 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.13 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.93 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.33 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.16 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 2.67 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 3.94 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.14 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.06 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 0.54 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 1.58 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 0.47 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.72 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.65 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 2.42 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 1.44 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.6 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.48 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 73' ' ' VAL . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.12 117.298 -170.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.16 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 1.55 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 0.58 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 0.85 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 0.58 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.54 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.06 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.82 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.84 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 0.44 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 0.71 109.871 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.43 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.65 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 0.63 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 1.13 113.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 1.75 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 1.31 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 0.56 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 1.86 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.72 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.15 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 0.98 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 2.37 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.49 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.401 0.889 . . . . 0.96 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.43 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.11 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 0.48 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.33 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 0.49 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 0.89 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 0.54 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 3.96 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 1.44 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.83 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 1.83 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 0.56 105.573 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 1.0 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 112' ' ' VAL . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 0.32 109.433 -168.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 1.94 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 0.71 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.1 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 0.61 111.548 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76 113.812 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.09 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.05 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.532 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 1.67 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 1.87 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 2.37 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.61 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 4.45 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 0.6 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 0.69 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 0.71 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.44 110.594 168.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 0.31 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 0.4 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 4.61 114.001 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 0.54 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.42 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 0.63 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 6.83 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.22 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 1.91 108.75 153.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 0.4 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 0.43 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 1.98 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.18 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 0.82 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 1.33 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.53 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.85 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.89 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 0.61 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 4.42 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 3.17 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.52 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 0.65 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 2.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 2.08 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 2.38 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.89 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 1.74 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.01 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 3.75 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 3.63 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.13 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.72 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 56' ' ' VAL . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 0.54 110.282 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 1.84 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 0.43 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.496 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.59 112.984 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.72 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.17 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 2.03 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 1.51 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.56 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.42 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.424 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 0.78 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.39 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 1.14 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 0.72 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 0.71 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 0.58 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.49 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.01 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.71 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 0.38 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 0.47 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.19 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 0.74 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.07 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 3.13 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 115' ' ' ASN . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 1.49 112.669 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.77 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 0.66 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.27 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 0.89 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 0.83 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 2.58 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.76 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.56 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 115.007 1.484 . . . . 1.07 115.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 0.5 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.14 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 0.66 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 1.05 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 0.66 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 2.35 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 1.54 113.519 169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 1.52 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 0.73 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 1.53 107.379 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 112' ' ' VAL . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 0.56 108.097 -167.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 1.94 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 0.57 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HA ' HD22 ' A' ' 91' ' ' LEU . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.03 109.594 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 66' ' ' GLN . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.02 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.11 111.77 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.36 114.092 -176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.87 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 2.51 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 2.88 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' CB ' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 1.57 115.096 165.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 1.64 106.465 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 2.29 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.23 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 4.17 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 1.06 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' VAL . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 1.15 113.131 171.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 1.2 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.31 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 0.49 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 0.56 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 4.28 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 0.6 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.57 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 0.62 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 4.85 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.61 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 1.81 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 0.47 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 0.42 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 2.32 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' HD21 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.59 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 1.63 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.853 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 3.86 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.64 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.61 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.37 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.19 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 0.69 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 3.9 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.05 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.54 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 0.57 112.91 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 1.38 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.51 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 2.14 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 1.7 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.4 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 0.97 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 2.69 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 5.49 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.09 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.1 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 56' ' ' VAL . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 0.9 107.485 151.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 55' ' ' VAL . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 2.64 108.488 160.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 0.59 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.66 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.69 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.67 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 2.27 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 2.8 106.113 -156.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 0.92 114.11 166.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.67 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.24 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.41 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 1.47 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 0.77 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.07 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 1.8 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 0.63 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.67 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.03 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.78 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 0.46 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 145' ' ' SER . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 0.54 110.342 -166.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.57 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.06 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 0.48 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 1.54 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 2.13 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 1.35 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.72 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 0.63 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.41 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 148' ' ' LEU . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.8 109.022 156.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.13 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.23 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 2.47 113.96 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.45 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.24 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.086 1.143 . . . . 1.07 114.086 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.43 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.39 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 0.77 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.82 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 0.66 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 1.5 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 0.59 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 2.55 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 1.2 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.36 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 1.37 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 0.64 103.999 176.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.91 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 112' ' ' VAL . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 0.29 109.876 -170.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 1.91 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 0.54 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 1.75 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 0.76 111.806 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.76 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.29 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 1.9 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 1.75 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 1.95 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.44 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 2.46 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.77 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.38 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 0.55 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 0.58 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 0.66 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.72 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 0.32 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 0.34 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 4.68 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 0.71 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 0.52 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 4.33 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 1.79 109.611 158.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.5 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 0.37 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 2.0 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.3 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 0.88 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 1.39 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.8 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.28 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 0.9 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 0.64 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.04 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.25 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.54 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 0.7 113.069 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 1.49 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 2.28 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 2.66 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.56 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.48 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.06 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 3.54 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 3.26 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 0.94 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.59 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 56' ' ' VAL . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 0.65 109.954 155.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 1.56 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 0.48 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.77 113.314 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.6 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.82 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 2.11 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 1.52 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.55 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.46 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 0.83 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.84 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 1.79 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 0.55 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 0.71 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.73 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 0.49 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.48 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.51 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.86 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 0.4 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.4 HG12 ' HE3' ' A' ' 139' ' ' LYS . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 0.54 109.832 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.82 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 0.56 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 135' ' ' VAL . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 0.85 113.384 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.01 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 1.27 112.377 170.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.82 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 0.61 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.36 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56 110.599 162.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 0.82 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 0.92 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 2.44 114.779 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.67 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.95 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 112.858 0.688 . . . . 0.77 112.858 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.97 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.15 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 0.54 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 0.65 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 1.41 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 0.7 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 2.44 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 1.4 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.06 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 1.22 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 0.61 104.004 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 0.93 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 112' ' ' VAL . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 0.32 109.657 -170.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 1.89 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 0.36 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 1.8 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 89' ' ' ASN . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.74 112.968 -164.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 0.84 110.969 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.03 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.38 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 3.44 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 1.7 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 2.43 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 2.23 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.0 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.67 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 0.73 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 0.61 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 0.67 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.61 109.788 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 0.35 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 0.42 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.13 115.272 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 0.59 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.48 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.69 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 0.75 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 3.47 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.76 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 1.88 111.886 157.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 0.34 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 0.34 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 1.99 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 60' ' ' GLY . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.22 111.404 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 0.92 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 1.54 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.36 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.59 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 0.89 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 0.62 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.03 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.52 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 100' ' ' ILE . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 0.56 112.502 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 1.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.09 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 2.2 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 1.58 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.41 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 1.63 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 2.55 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 3.47 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.05 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.57 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' VAL . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 0.6 109.682 171.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 2.42 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.438 HD11 HG13 ' A' ' 54' ' ' VAL . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 0.6 109.877 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.71 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.72 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.61 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 2.4 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 1.51 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.58 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.46 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 0.91 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 1.15 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 0.63 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 0.7 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 0.52 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.48 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.12 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.59 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.84 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 0.55 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 0.74 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.84 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.32 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 0.79 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 0.99 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 2.89 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 2.65 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 0.63 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.25 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.72 110.607 161.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 0.76 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 0.77 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 2.25 115.891 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.19 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.83 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 112.371 0.508 . . . . 1.34 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.19 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 0.81 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.57 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 0.53 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 0.95 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 0.55 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 2.93 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 1.88 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 1.35 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 0.58 104.172 178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 0.93 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 0.3 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 1.83 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 0.38 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 2.29 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.74 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 0.71 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 1.13 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.44 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.15 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 1.84 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 1.67 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 1.9 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.92 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 2.21 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 1.91 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.06 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 0.59 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 0.67 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 0.52 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 0.33 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 0.32 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.21 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 0.44 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 135' ' ' VAL . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39 113.484 168.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.6 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 0.48 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.13 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.17 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 1.96 109.79 158.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 0.34 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 0.41 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 1.92 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.12 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 0.73 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 1.3 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 96' ' ' LEU . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.43 112.812 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.85 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.18 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 0.62 109.035 169.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 3.45 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 2.37 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.61 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 0.81 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 1.54 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.85 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 1.9 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.24 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.62 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.5 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.15 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 2.64 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 4.27 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.04 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.2 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 0.92 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 1.97 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 0.49 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.67 113.157 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.57 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 2.58 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 2.67 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 0.8 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.57 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 0.77 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.22 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 1.12 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 0.44 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 1.09 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 0.45 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.54 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.19 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.38 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.69 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.19 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 0.39 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 80' ' ' HIS . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 0.43 109.408 -174.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.58 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 1.72 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 0.43 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 1.25 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 2.15 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 1.35 111.942 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 0.56 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.59 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.5 110.183 158.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 0.74 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.91 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 2.74 113.727 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.27 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.84 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.19 0.811 . . . . 1.16 113.19 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.74 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.41 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 0.67 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.58 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 0.94 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 1.79 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HA ' HG21 ' A' ' 55' ' ' VAL . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 0.59 113.606 169.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 2.24 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 1.74 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.39 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 1.6 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 0.89 108.916 174.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 1.52 109.173 176.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 0.36 108.888 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 1.88 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 0.46 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 1.65 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.83 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 1.01 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.9 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.26 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.76 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.27 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.578 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 2.55 112.125 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 2.08 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.47 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 2.48 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HE22 ' A' ' 66' ' ' GLN . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 1.78 113.674 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 2.67 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 0.88 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 0.69 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 0.71 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.18 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 0.47 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 0.59 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.21 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 0.51 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.72 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 0.7 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 5.45 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.17 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 2.01 110.708 163.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 0.45 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 0.54 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 2.09 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.11 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 1.53 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.62 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.23 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.36 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 0.7 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 3.85 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 4.13 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.59 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 0.82 112.616 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 2.62 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.37 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 2.14 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 1.96 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.01 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.44 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 1.71 115.13 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 2.89 112.735 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 3.8 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 0.96 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.49 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 0.52 109.396 158.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 55' ' ' VAL . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 2.19 108.36 172.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 0.5 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.74 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.84 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 2.37 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 1.48 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.66 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.57 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 0.86 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.24 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 1.1 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 0.58 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 0.91 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.06 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 0.58 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.69 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.11 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.32 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.65 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.91 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 0.43 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 0.55 109.851 -171.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.15 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 0.5 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HE3' HG12 ' A' ' 135' ' ' VAL . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 0.93 113.462 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 1.74 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 2.52 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 0.7 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.39 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.84 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 0.74 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.36 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 3.57 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.27 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 4.44 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.073 1.138 . . . . 1.16 114.073 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.03 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 0.51 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.37 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 0.71 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 0.89 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 0.62 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 2.41 116.232 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 1.22 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.66 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 1.19 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 0.78 104.91 -177.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 1.03 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 0.32 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 1.78 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 0.39 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 1.39 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.83 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 0.73 110.582 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.7 111.705 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.66 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.14 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.03 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 2.9 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.05 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.99 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 3.14 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 2.48 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.76 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 0.83 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.429 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 0.64 113.391 171.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 0.61 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.93 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 0.42 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 0.42 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 3.44 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 0.57 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.82 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 0.5 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 4.92 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.4 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 2.08 110.331 166.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 0.42 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 0.37 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 2.04 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.24 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 0.81 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 1.33 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.36 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.43 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 1.77 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 0.59 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.12 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 2.86 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.83 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 1.11 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 2.26 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.85 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 2.32 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 1.73 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.31 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.03 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 1.92 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 3.58 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 4.63 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.29 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.06 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 0.65 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 1.62 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 0.43 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 141' ' ' LEU . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.62 113.298 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 50' ' ' LYS . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.73 117.871 -169.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.8 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 2.04 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 1.6 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.56 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.46 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.429 ' SG ' HG13 ' A' ' 73' ' ' VAL . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 0.64 115.239 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.24 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 1.17 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 0.55 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 0.63 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 0.45 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.55 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.03 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.6 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 0.4 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 0.55 110.228 -166.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.69 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 0.73 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.19 113.277 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 2.28 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 1.3 111.912 165.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.07 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 0.77 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.53 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.5 109.153 155.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 0.74 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 0.69 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 2.21 111.532 173.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.81 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 113.864 1.061 . . . . 0.78 113.864 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.18 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 0.48 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.01 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 0.79 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 0.9 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 0.78 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 2.46 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 1.71 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 1.25 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 0.99 105.536 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 1.11 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 0.37 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 2.01 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 0.4 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.03 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.74 116.08 -164.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 0.66 112.099 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.72 114.022 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.49 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.4 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.03 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 1.78 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.87 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.15 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 2.45 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.03 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.0 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 0.76 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 0.71 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 0.51 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 0.41 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 0.48 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.05 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 0.56 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.5 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.74 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 0.69 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.52 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.13 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 2.02 111.358 165.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 0.59 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 0.5 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 2.01 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.24 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 0.99 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 1.72 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.53 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.85 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.11 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.05 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 0.58 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 3.9 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.07 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.49 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 100' ' ' ILE . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 0.76 112.716 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.07 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.89 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 1.88 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.34 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.1 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.4 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 1.82 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.31 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 3.58 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 0.89 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.12 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 0.68 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 1.66 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 0.5 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.77 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.84 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.58 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 2.48 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 1.51 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.58 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.46 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 0.76 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 1.1 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 0.72 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 1.43 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.89 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 0.52 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.78 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.28 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.3 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 0.89 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.14 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 0.48 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.421 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 0.8 110.141 -173.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.42 110.793 166.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.93 111.789 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 0.67 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 1.1 113.694 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HE3' ' HG3' ' A' ' 136' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 1.83 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 2.58 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.82 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 0.59 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.19 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.52 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 0.69 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 0.98 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 2.37 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.74 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 113.499 0.926 . . . . 0.98 113.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.68 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.08 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 0.54 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.84 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 0.46 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 0.91 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 0.44 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 2.38 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 1.27 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.69 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 1.43 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.86 106.999 174.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 1.47 107.948 -178.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 112' ' ' VAL . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 0.26 109.053 -169.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 1.82 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 0.39 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 1.4 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 0.69 111.257 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76 114.314 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.08 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 1.84 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 1.69 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.58 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.05 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 2.69 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 1.93 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 3.34 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 0.79 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 0.71 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 0.57 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.88 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 0.6 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 0.57 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 4.56 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 0.83 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 0.69 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 3.65 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 1.83 109.923 157.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 0.43 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 0.39 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 2.39 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.3 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.21 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 1.46 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.4 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.84 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.11 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 0.63 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 3.73 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 3.93 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.53 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 0.63 112.675 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 1.67 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 1.88 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.37 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.54 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.26 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.17 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 2.34 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 4.13 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.01 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.55 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 56' ' ' VAL . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 0.56 109.71 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.514 ' HB2' HG23 ' A' ' 55' ' ' VAL . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 1.57 108.428 171.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 0.51 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.11 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 2.01 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 1.48 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.58 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.68 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.512 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 0.94 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 1.2 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 0.75 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 0.77 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 0.97 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.73 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.44 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.96 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.45 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 0.71 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.46 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 0.52 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.58 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.63 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 0.62 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HE3' HG12 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 0.82 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 2.44 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 2.35 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.84 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 0.9 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 1.98 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 148' ' ' LEU . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 0.77 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 0.78 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 2.55 111.779 168.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.61 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.55 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 113.709 1.003 . . . . 0.85 113.709 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.53 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.19 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 0.62 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.57 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 0.62 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 1.24 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 0.89 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 3.82 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 1.83 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.22 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.07 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 0.8 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 1.33 108.654 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 112' ' ' VAL . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 0.36 109.568 -165.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 1.86 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 0.5 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 1.54 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.82 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.87 110.769 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.62 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 2.73 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.17 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.24 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.86 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.51 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 2.7 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.03 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 3.96 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 0.83 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 0.54 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 0.59 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.05 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 0.35 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 0.35 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 4.22 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 0.49 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.47 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 0.45 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 5.2 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.32 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 1.96 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 0.42 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 0.35 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 2.21 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.37 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 0.89 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 1.35 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.66 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.85 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.01 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.01 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 0.71 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.32 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 2.44 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.67 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 0.91 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 2.2 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.63 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 2.05 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.13 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.69 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.07 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 2.54 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 5.75 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.17 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 2.89 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 56' ' ' VAL . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 0.91 108.177 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.44 ' HB2' HG23 ' A' ' 55' ' ' VAL . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 1.77 110.048 162.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 0.6 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.72 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 2.35 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 2.48 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.72 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.5 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 0.65 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.07 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 1.2 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 0.46 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 0.73 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 0.48 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.71 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.99 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.84 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.61 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 0.41 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 0.62 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.93 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 0.6 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 1.64 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 2.24 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 1.6 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 0.56 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.19 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.74 110.442 162.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 0.65 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 0.75 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 2.21 114.153 -170.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.27 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.45 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.547 0.943 . . . . 1.07 113.547 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.43 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 0.66 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.24 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 0.85 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 0.93 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 0.53 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.01 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 1.24 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.91 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 1.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 0.88 105.114 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 0.99 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 0.33 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 1.85 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 0.49 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 1.99 110.164 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.9 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.35 110.027 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.99 112.308 -175.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.08 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 2.83 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.24 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.464 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 2.46 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.3 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.59 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 2.57 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' HE22 ' A' ' 66' ' ' GLN . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 1.76 113.587 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 2.71 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 0.84 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 0.64 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 0.56 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.34 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 0.5 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 0.49 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 3.24 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 0.92 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 135' ' ' VAL . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.59 113.679 169.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 0.61 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 3.62 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.02 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 2.02 111.312 161.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 0.52 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 0.45 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 1.93 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 0.91 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 1.73 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.74 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.66 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.46 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.3 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 0.71 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 3.69 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.25 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.57 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 0.69 112.37 -174.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 1.78 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.57 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 1.81 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 1.87 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.01 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.73 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.25 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 3.47 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 3.99 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.0 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.43 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.19 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 1.78 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 0.61 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.78 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 2.72 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 2.52 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.07 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.72 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 0.85 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.64 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 1.18 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 0.59 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 0.87 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.12 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 0.71 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.66 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.06 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.16 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.65 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.9 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 0.46 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 0.62 109.999 -173.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.95 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 0.65 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' HG12 ' A' ' 135' ' ' VAL . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 0.88 112.484 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 2.17 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 1.25 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.74 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 0.63 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.45 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.7 111.58 162.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.2 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 0.75 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 2.17 112.926 173.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.85 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.74 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 113.979 1.103 . . . . 0.85 113.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.3 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.15 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 0.53 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.16 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 0.6 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 1.1 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 0.5 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 3.92 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 1.4 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.91 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 1.58 114.632 170.174 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 0.84 105.261 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 0.99 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 112' ' ' VAL . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 0.31 110.356 -172.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 1.79 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 0.38 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 1.92 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.73 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 0.84 111.067 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.86 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 3.72 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.18 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 1.79 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.36 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 3.38 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 2.88 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.65 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 0.88 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 0.95 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 62' ' ' PRO . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 0.93 112.267 -177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.57 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 0.58 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 0.56 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 4.31 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 0.56 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 0.57 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 4.25 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.84 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 1.78 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 0.41 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 0.41 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 2.33 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.18 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 0.88 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 1.65 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.15 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.86 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.97 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 0.65 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 3.91 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 2.49 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.52 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 0.56 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 1.41 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 1.92 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.15 113.937 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 1.91 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.59 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 0.98 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 2.68 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 3.65 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.01 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 1.94 111.757 -170.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 0.55 109.608 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 1.59 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 0.43 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.06 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.9 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 2.06 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 1.58 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 1.14 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 0.69 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.01 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 1.5 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 1.01 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.02 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.86 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 0.54 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.76 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.18 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.67 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.94 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 0.58 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 0.7 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.51 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.69 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 0.76 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 0.98 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.1 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 1.51 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.67 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 0.78 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.14 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.78 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 0.62 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 0.95 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 4.03 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.41 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.13 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.134 0.79 . . . . 1.03 113.134 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.22 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.36 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 0.78 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 0.55 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 1.1 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 0.44 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 2.38 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 1.45 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.12 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 1.26 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 0.63 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 1.07 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 0.4 108.839 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 1.8 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 0.61 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 2.26 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.11 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 0.95 106.558 166.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.42 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 3.8 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 1.86 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 1.89 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 1.62 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.09 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 2.15 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 1.92 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 2.84 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 0.65 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 0.64 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 0.51 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 0.46 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 0.51 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.06 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 0.61 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 0.64 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 3.79 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.82 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 2.03 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 0.53 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 0.49 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 2.09 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.03 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 1.88 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.24 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.35 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.03 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.03 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 1.3 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 5.11 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.04 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 0.92 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 1.1 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 1.61 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 2.32 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.06 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.55 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.25 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 4.69 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 3.44 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.08 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 0.93 108.265 153.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 1.8 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 0.49 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.26 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.69 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.93 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 2.62 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 2.58 104.629 -160.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 0.95 111.677 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 0.72 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 0.79 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.63 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 2.21 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 0.59 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 0.82 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 0.66 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.74 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.01 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.19 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.72 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.82 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 0.42 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 139' ' ' LYS . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 0.48 109.657 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.34 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 0.58 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 135' ' ' VAL . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 1.17 112.902 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 1.74 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 1.66 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 0.58 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 1.79 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.435 ' CB ' HG13 ' A' ' 135' ' ' VAL . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.58 110.272 169.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 0.69 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 1.61 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 4.41 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.985 -0.846 . . . . 14.86 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.4 p -108.59 15.5 23.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.616 1.71 . . . . 12.45 115.616 -166.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 61.53 155.55 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.953 2.101 . . . . 14.67 114.967 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.8 p -88.96 166.43 13.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.396 1.258 . . . . 11.03 114.396 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.29 163.24 24.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 12.34 113.647 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.25 -12.73 0.02 OUTLIER Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.588 1.795 . . . . 7.04 117.588 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.0 171.81 14.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.787 1.793 . . . . 5.88 114.898 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.67 158.94 28.16 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.417 1.96 . . . . 4.66 113.128 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.62 168.25 29.49 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.925 1.25 . . . . 4.18 113.96 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.9 82.72 1.31 Allowed Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.1 -1.236 . . . . 3.64 113.184 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.84 2.34 29.43 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.583 1.563 . . . . 4.18 116.339 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.2 m -64.66 150.36 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.938 2.095 . . . . 3.7 112.996 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.61 70.86 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 1.04 113.193 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.87 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.35 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 0.64 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.44 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 0.6 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 0.94 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 0.58 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 2.44 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 1.89 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.85 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 1.54 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 0.69 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 0.91 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 0.37 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 2.12 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 0.43 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 1.99 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81 114.887 -159.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 0.87 111.408 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81 112.883 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.37 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.38 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.23 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 1.82 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 1.91 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.43 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 2.41 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 1.94 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 2.96 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 0.65 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 0.57 112.994 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 0.59 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.55 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 0.46 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 0.37 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 4.07 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 0.66 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 0.48 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 4.28 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.38 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 1.99 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 0.44 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 0.45 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 2.12 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.14 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 1.87 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.28 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.43 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.36 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 0.66 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 3.98 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 2.8 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.64 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 0.65 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 1.38 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.43 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 1.95 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 1.75 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.37 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.48 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.09 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 2.73 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 5.66 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.18 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 2.3 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 0.65 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 2.3 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 0.51 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.76 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.86 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 2.41 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 1.55 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.55 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.42 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 73' ' ' VAL . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 0.72 115.428 -169.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.65 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 1.16 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 0.48 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 0.7 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.84 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 0.69 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.54 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.45 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 0.46 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 0.42 109.38 -165.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.06 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 0.48 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 135' ' ' VAL . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 0.74 112.677 177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 1.79 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 1.36 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.07 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 0.7 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 2.55 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.57 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 0.65 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 0.93 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 2.93 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.833 0 N-CA-C 110.405 -1.078 . . . . 13.74 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.1 p -67.99 -10.35 52.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.651 1.58 . . . . 14.77 114.761 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -134.44 171.14 14.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.971 1.709 . . . . 17.93 109.968 168.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.267 1.6 p 62.53 162.86 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.587 2.355 . . . . 14.03 115.281 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 178.13 4.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.084 1.754 . . . . 11.73 114.959 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 155.8 15.92 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 126.561 2.029 . . . . 8.45 111.47 158.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.19 -179.41 7.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.652 1.581 . . . . 6.71 113.012 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.62 153.65 19.27 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.411 1.005 . . . . 4.46 114.497 171.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.67 177.46 43.81 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.639 1.59 . . . . 3.36 113.825 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.58 41.08 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.95 1.738 . . . . 3.23 115.739 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.2 178.27 17.29 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.066 1.317 . . . . 3.23 112.077 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 t 63.11 -177.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 2.29 114.505 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.17 69.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.376 -1.453 . . . . 0.81 114.412 -167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.67 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.17 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 0.54 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.19 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 0.58 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 0.91 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 0.47 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.15 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 1.55 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.94 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 1.63 114.36 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.484 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 0.6 105.215 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 0.92 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 0.34 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 0.42 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 2.64 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.8 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 0.7 111.98 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.9 113.298 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.92 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.43 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 1.97 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 1.65 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.02 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 2.05 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.01 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.12 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 0.56 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 0.66 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 0.55 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 0.36 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 0.39 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 4.65 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 0.44 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 0.41 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 4.95 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.67 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 1.82 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.42 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 0.38 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 1.94 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.22 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 0.93 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 1.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.47 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.33 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 0.89 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 0.6 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 4.97 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.52 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.58 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 0.68 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 1.46 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 2.15 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.36 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.62 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.61 113.087 -171.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 106' ' ' TRP . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 1.52 114.89 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 3.68 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 3.44 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 0.84 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.82 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 0.64 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 2.21 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 0.42 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 0.87 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.57 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 2.24 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 1.67 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 0.73 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.67 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 0.75 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.39 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 1.46 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 0.45 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.14 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 0.64 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.58 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.39 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.51 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.63 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.85 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 0.45 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 0.45 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.58 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 0.46 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 0.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 2.06 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 1.49 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.72 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 0.53 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.48 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 0.81 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 0.98 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 3.1 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.85 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.97 -0.852 . . . . 23.43 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -91.28 144.23 25.82 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.015 0.908 . . . . 20.65 112.676 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.36 129.76 35.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.562 0.745 . . . . 20.43 110.347 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 p -142.81 168.93 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.76 1.224 . . . . 14.05 112.306 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.32 175.08 1.82 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.642 1.577 . . . . 10.76 113.224 167.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 154.07 11.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.467 1.508 . . . . 7.62 113.18 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.6 155.67 19.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.102 0.961 . . . . 7.02 112.655 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.43 17.47 58.68 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.498 0.959 . . . . 4.37 115.498 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.71 43.41 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.242 1.021 . . . . 3.94 110.949 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 36.34 4.84 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.095 0.948 . . . . 3.29 114.948 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.6 26.31 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.442 1.496 . . . . 3.55 115.392 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t 66.32 176.82 0.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.839 2.456 . . . . 2.17 113.689 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -35.9 72.78 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.659 -1.276 . . . . 0.77 113.026 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.62 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 0.5 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 0.59 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 2.03 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 0.67 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 2.5 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 1.44 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.82 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 2.43 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 0.96 108.14 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 1.5 108.878 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 112' ' ' VAL . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 0.31 109.126 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 1.79 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 0.33 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 1.39 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.85 112.191 -160.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 0.94 111.396 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.9 113.18 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.85 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 3.01 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 3.23 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 1.95 114.793 -159.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 1.79 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.26 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 2.46 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.6 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 2.9 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 0.72 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 0.61 113.628 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 0.56 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.42 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 0.45 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 0.43 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 3.64 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 0.51 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.45 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 0.64 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 6.85 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.47 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 2.04 111.023 169.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 0.55 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 0.61 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 2.27 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.35 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 0.85 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 1.34 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.06 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.9 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.6 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.16 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 1.0 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 3.42 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.43 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.73 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 0.73 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 1.85 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 2.27 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.52 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.84 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 1.84 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.14 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 2.73 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.21 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.34 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.1 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 56' ' ' VAL . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 0.75 109.21 160.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HB2' HG23 ' A' ' 55' ' ' VAL . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 1.99 109.487 166.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 0.6 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' HD21 ' A' ' 141' ' ' LEU . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.82 113.686 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HD1' ' H ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 2.25 110.645 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.426 ' H ' ' HD1' ' A' ' 118' ' ' PHE . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 1.64 110.32 -144.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 0.91 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 0.67 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.438 ' SG ' HG13 ' A' ' 73' ' ' VAL . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 0.71 117.575 -165.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.14 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 1.27 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 0.82 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 0.76 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.82 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 0.45 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.19 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.53 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.22 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 0.39 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 0.53 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.62 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.22 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 0.8 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 1.29 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 4.87 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 115' ' ' ASN . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 1.52 113.551 163.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.43 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 0.85 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.47 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.489 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.72 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 0.64 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 0.7 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.11 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.81 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.142 -0.783 . . . . 14.53 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -147.15 140.32 25.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.739 1.216 . . . . 12.22 111.296 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.32 43.19 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.877 0.871 . . . . 15.39 112.475 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -134.54 153.14 52.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.425 1.49 . . . . 12.06 110.763 170.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.407 ' SD ' ' HE2' ' A' ' 51' ' ' LYS . 14.7 mmt 25.68 115.25 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 130.151 3.38 . . . . 12.78 117.878 156.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -97.08 -144.22 16.69 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.849 2.166 . . . . 7.38 114.507 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.41 68.63 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.683 1.734 . . . . 7.35 115.683 -168.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.26 139.93 8.06 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.234 2.349 . . . . 4.78 115.864 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.49 177.65 35.69 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.89 1.709 . . . . 3.42 112.552 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.5 7.44 63.66 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 125.199 1.38 . . . . 2.79 115.524 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.36 178.0 43.01 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.798 2.618 . . . . 3.17 110.099 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.2 t 61.16 176.15 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 3.22 114.717 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.58 -35.0 65.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.048 1.339 . . . . 1.43 112.592 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.4 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 0.88 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.83 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 35' ' ' GLY . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 0.61 111.042 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 0.97 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 0.49 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 2.41 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HE2' ' SD ' ' A' ' 5' ' ' MET . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 2.33 113.707 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 1.28 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 0.63 104.052 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 1.3 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 112' ' ' VAL . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 0.5 109.182 -170.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 1.96 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 0.56 110.597 -173.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 1.43 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 0.74 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.78 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.84 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 4.24 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.19 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 2.95 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.09 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 2.36 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 2.95 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 0.86 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 0.54 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 0.54 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.19 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 0.51 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 0.47 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 3.43 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 0.5 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.39 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.6 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 0.43 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 3.99 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.35 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 1.94 111.017 163.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 0.64 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 0.8 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 1.99 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.24 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 0.84 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 1.38 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.85 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.18 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.11 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.12 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 0.64 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 3.52 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 2.6 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.62 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 0.77 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 1.48 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.19 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 2.37 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 2.67 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.58 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.64 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 0.98 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 2.73 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 3.47 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.11 112.792 165.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.62 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 56' ' ' VAL . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 0.65 110.448 157.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 1.96 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 0.76 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 0.96 112.962 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 2.43 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 1.59 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.78 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.64 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 0.98 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.08 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 1.03 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 0.72 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 0.8 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.07 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 0.48 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.95 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.59 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 0.4 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 0.46 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.42 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.58 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 0.51 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 0.81 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 1.88 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 1.29 112.269 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.12 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 0.54 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.26 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55 110.25 162.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 0.9 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 0.88 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 2.17 113.988 -175.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.63 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.14 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 111.113 -0.795 . . . . 16.93 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 53.22 36.28 22.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.819 1.648 . . . . 14.23 115.235 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' CD1' ' HE2' ' A' ' 51' ' ' LYS . 18.1 t80 -163.14 139.54 7.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.941 1.296 . . . . 16.92 110.713 -170.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.259 71.0 p 63.31 -10.93 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 118.593 2.812 . . . . 15.69 118.593 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.5 140.64 8.6 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 127.878 2.471 . . . . 14.1 108.645 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.28 -28.89 0.44 Allowed Glycine 0 CA--C 1.543 1.825 0 C-N-CA 124.526 1.06 . . . . 8.25 114.334 -162.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.86 173.35 11.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.114 2.566 . . . . 6.14 111.68 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.45 169.32 14.95 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.129 1.347 . . . . 4.32 116.208 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.57 2.72 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.034 1.778 . . . . 3.41 111.757 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.1 18.31 57.89 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.737 1.055 . . . . 2.91 115.737 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.32 -173.12 21.06 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.448 1.499 . . . . 3.36 113.63 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t 67.5 167.24 0.24 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.657 2.383 . . . . 2.39 113.636 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.58 61.42 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.788 1.635 . . . . 1.12 114.07 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.74 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 0.57 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.92 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.1 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 2.18 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 0.76 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 2.41 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 3' ' ' PHE . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 1.62 113.96 166.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.01 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 1.41 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 0.94 107.546 176.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 1.37 108.939 174.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 112' ' ' VAL . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 0.36 109.25 -169.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 1.76 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 0.34 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 1.99 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.83 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 0.98 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.07 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.46 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.42 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.26 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 1.74 116.207 169.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 1.64 106.999 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.62 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 2.33 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 3.54 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 3.3 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 0.68 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG13 ' SG ' ' A' ' 122' ' ' CYS . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 0.54 113.155 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 0.5 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.05 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 0.31 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 0.38 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 3.42 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 0.6 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.38 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.59 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 0.46 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 6.29 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 2.2 113.716 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 0.53 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 0.67 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 2.49 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.86 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 1.16 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 1.93 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.48 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.19 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 1.73 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 3.33 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 2.41 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.73 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 0.87 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 2.74 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.3 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 2.26 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.55 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.74 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.19 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 1.72 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.27 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 3.94 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.24 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.02 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 56' ' ' VAL . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 0.61 109.547 162.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.548 ' HB2' HG23 ' A' ' 55' ' ' VAL . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 2.13 109.595 167.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 0.53 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.98 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.13 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 1.99 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 1.61 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 0.85 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.63 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 73' ' ' VAL . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 0.78 114.862 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 1.4 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 0.54 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 1.03 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 0.83 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.71 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.18 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.63 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.89 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 0.68 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 0.55 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.11 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 2.42 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 0.54 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 1.12 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.09 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 1.46 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 0.66 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.38 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.5 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 0.76 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 0.79 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 2.52 113.193 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.51 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.33 113.19 167.583 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.458 0 N-CA-C 112.123 -0.391 . . . . 17.94 112.123 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.1 p -79.8 -24.23 41.55 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.371 1.619 . . . . 14.92 115.371 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -103.03 149.3 24.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.343 1.057 . . . . 14.92 111.43 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -142.06 160.82 39.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.949 1.833 . . . . 12.8 115.949 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt 30.56 -98.18 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 118.24 2.682 . . . . 14.7 118.24 151.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.86 129.79 6.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.365 1.46 . . . . 7.42 110.956 -160.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.32 42.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.322 0.86 . . . . 5.56 113.322 -163.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.26 154.14 25.59 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.488 1.518 . . . . 4.16 110.97 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.97 -155.49 30.46 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.436 1.017 . . . . 3.83 114.344 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.48 21.17 2.92 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.767 1.175 . . . . 2.87 115.434 -172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.43 11.64 0.03 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 118.297 2.079 . . . . 3.48 118.297 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.9 t -91.52 170.25 10.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.816 1.308 . . . . 2.88 111.947 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.33 66.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.599 1.16 . . . . 1.21 114.042 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.69 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.45 110.263 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 0.76 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 0.56 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 0.92 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 0.59 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 2.66 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 1.6 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.92 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 1.35 115.083 172.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 0.79 104.736 178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 1.16 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 112' ' ' VAL . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 0.28 109.455 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 1.96 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 0.43 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 1.89 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 0.65 111.337 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.84 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.45 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 1.96 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 1.8 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.01 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.19 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 1.93 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.0 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.1 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 0.56 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 0.51 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 0.49 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 0.32 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 0.39 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 4.33 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 0.53 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.7 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 0.58 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 4.89 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.43 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 2.01 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 0.36 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 0.36 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 2.02 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.16 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 0.84 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 1.47 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.26 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.24 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.05 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.36 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 0.66 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 3.86 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.54 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.66 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 0.7 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 1.36 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.86 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 2.14 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 2.4 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.73 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.38 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 2.69 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.01 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 0.93 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.17 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 56' ' ' VAL . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 0.53 109.958 164.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 2.92 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 0.48 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 0.96 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.79 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.86 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 2.79 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 1.59 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 0.89 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.73 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 0.69 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.86 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 2.69 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 0.61 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 1.37 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 0.87 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.84 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.33 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.82 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.59 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 0.59 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.454 HG12 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 0.52 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.69 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.88 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 0.57 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 0.99 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 2.12 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 1.42 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.92 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 0.92 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.53 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.71 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 0.76 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 0.83 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.0 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.18 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.21 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.05 -0.82 . . . . 22.26 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 m -89.66 12.47 16.79 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.488 1.662 . . . . 22.38 115.488 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -135.33 136.5 41.58 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.783 1.233 . . . . 19.98 113.645 -170.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.1 p -141.4 154.99 45.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.168 1.387 . . . . 13.51 111.183 159.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 mmt 48.57 1.54 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 120.52 3.526 . . . . 12.45 120.52 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 174.64 50.54 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.762 -1.211 . . . . 9.9 113.843 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.42 179.69 7.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.839 1.255 . . . . 8.05 112.72 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.12 151.41 16.01 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.429 1.49 . . . . 6.12 113.349 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.47 -131.27 6.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.929 1.728 . . . . 4.93 113.051 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.39 17.67 62.22 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.208 1.243 . . . . 5.11 116.208 172.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.47 14.46 73.69 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.886 1.343 . . . . 4.43 114.715 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -66.75 144.87 56.07 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.596 1.159 . . . . 3.35 112.854 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 -29.36 70.47 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 0.86 114.561 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.93 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.16 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 0.66 113.443 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.87 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 0.47 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 0.92 111.808 173.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 0.44 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 2.85 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 2.18 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.65 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 1.39 115.321 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 0.85 105.309 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 0.94 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 0.3 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 1.75 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 0.47 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 2.06 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.81 113.876 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 0.87 110.951 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.06 113.223 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.61 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.28 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 2.72 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.37 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.11 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 2.08 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.05 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 3.31 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 0.73 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 0.98 113.064 170.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 0.99 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.65 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 0.32 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 0.61 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 4.96 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 0.82 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.06 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 0.73 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 4.77 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.45 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 2.1 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 0.42 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 0.39 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 2.0 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.24 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.14 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 1.89 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.43 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.07 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.41 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 0.58 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 3.98 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 3.58 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.71 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 0.7 113.04 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 1.54 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 2.22 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.13 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.93 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.33 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.16 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 2.67 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 3.94 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.14 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.06 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 0.54 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 1.58 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 0.47 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.72 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.65 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 2.42 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 1.44 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.6 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.48 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 73' ' ' VAL . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.12 117.298 -170.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.16 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 1.55 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 0.58 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 0.85 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 0.58 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.54 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.06 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.82 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.84 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 0.44 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 0.71 109.871 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.43 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.65 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 0.63 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 1.13 113.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 1.75 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 1.31 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 0.56 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 1.86 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.72 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.15 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 0.98 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 2.37 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.49 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.064 0 CA-C-O 119.086 -0.841 . . . . 19.1 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -72.71 162.33 29.62 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.793 1.296 . . . . 15.56 113.3 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 148.46 26.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.981 0.913 . . . . 17.0 109.851 163.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.8 p -70.92 154.29 41.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.436 0.902 . . . . 12.38 113.436 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 58.49 168.49 0.05 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.631 2.373 . . . . 12.4 115.61 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.4 143.63 6.54 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.621 1.105 . . . . 7.39 113.148 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.46 142.19 23.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.535 1.134 . . . . 6.03 112.533 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.77 -174.74 35.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.94 1.257 . . . . 3.76 113.24 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.62 -168.22 6.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.722 0.677 . . . . 2.91 113.673 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.61 13.77 2.15 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 116.553 1.381 . . . . 3.66 116.553 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.64 -167.59 38.65 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.355 1.931 . . . . 3.19 111.134 -171.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 60.3 171.61 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.914 1.686 . . . . 2.29 113.401 -165.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.08 64.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.175 1.39 . . . . 0.96 113.401 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.43 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.11 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 0.48 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.33 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 0.49 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 0.89 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 0.54 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 3.96 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 1.44 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.83 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 1.83 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 0.56 105.573 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 1.0 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 112' ' ' VAL . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 0.32 109.433 -168.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 1.94 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 0.71 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.1 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 0.61 111.548 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76 113.812 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.09 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.05 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.532 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 1.67 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 1.87 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 2.37 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.61 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 4.45 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 0.6 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 0.69 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 0.71 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.44 110.594 168.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 0.31 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 0.4 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 4.61 114.001 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 0.54 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.42 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 0.63 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 6.83 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.22 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 1.91 108.75 153.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 0.4 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 0.43 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 1.98 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.18 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 0.82 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 1.33 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.53 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.85 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.89 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 0.61 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 4.42 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 3.17 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.52 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 0.65 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 2.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 2.08 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 2.38 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.89 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 1.74 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.01 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 3.75 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 3.63 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.13 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.72 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 56' ' ' VAL . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 0.54 110.282 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 1.84 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 0.43 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.496 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.59 112.984 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.72 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.17 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 2.03 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 1.51 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.56 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.42 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.424 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 0.78 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.39 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 1.14 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 0.72 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 0.71 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 0.58 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.49 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.01 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.71 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 0.38 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 0.47 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.19 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 0.74 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.07 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 3.13 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 115' ' ' ASN . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 1.49 112.669 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.77 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 0.66 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.27 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 0.89 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 0.83 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 2.58 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.76 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.56 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 109.877 -1.289 . . . . 15.23 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m -62.42 131.68 50.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.16 0.98 . . . . 12.96 111.598 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 58.94 20.38 8.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.242 1.817 . . . . 14.34 114.867 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -143.61 149.21 37.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.46 1.504 . . . . 14.26 112.831 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 56.22 172.02 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.703 2.401 . . . . 15.44 115.631 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.57 -118.18 12.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.666 1.127 . . . . 9.9 113.319 171.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 51' ' ' LYS . . . 62.66 31.33 16.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.616 1.966 . . . . 9.19 116.253 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.73 -169.43 44.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.963 1.268 . . . . 5.66 115.795 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.32 -21.33 2.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.804 1.669 . . . . 3.32 114.553 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.41 -24.5 1.42 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 126.38 1.943 . . . . 2.86 115.727 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.12 -179.31 44.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.686 2.089 . . . . 3.15 111.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 t 63.52 169.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.936 2.094 . . . . 2.83 114.468 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.1 32.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.142 2.177 . . . . 1.07 115.007 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 0.5 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.14 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 0.66 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 1.05 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 0.66 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 2.35 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 1.54 113.519 169.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 1.52 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 0.73 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 1.53 107.379 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 112' ' ' VAL . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 0.56 108.097 -167.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 1.94 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 0.57 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HA ' HD22 ' A' ' 91' ' ' LEU . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.03 109.594 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 66' ' ' GLN . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.02 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.11 111.77 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.36 114.092 -176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.87 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 2.51 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 2.88 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' CB ' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 1.57 115.096 165.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 1.64 106.465 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 2.29 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.23 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 4.17 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 1.06 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' VAL . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 1.15 113.131 171.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 1.2 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.31 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 0.49 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 0.56 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 4.28 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 0.6 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.57 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 0.62 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 4.85 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.61 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 1.81 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 0.47 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 0.42 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 2.32 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' HD21 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.59 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 1.63 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.853 ' H ' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 3.86 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.64 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.61 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.37 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.19 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 0.69 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 3.9 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.05 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.54 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 0.57 112.91 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 1.38 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.51 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 2.14 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 1.7 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.4 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 0.97 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 2.69 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 5.49 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.09 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.1 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 56' ' ' VAL . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 0.9 107.485 151.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 55' ' ' VAL . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 2.64 108.488 160.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 0.59 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.66 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.69 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.67 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 2.27 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 2.8 106.113 -156.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 0.92 114.11 166.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.67 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.24 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.41 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 1.47 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 0.77 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.07 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 1.8 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 0.63 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.67 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.03 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.78 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 0.46 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 145' ' ' SER . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 0.54 110.342 -166.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.57 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.06 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 0.48 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 1.54 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 2.13 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 1.35 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.72 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 0.63 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.41 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 148' ' ' LEU . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.8 109.022 156.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.13 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.23 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 2.47 113.96 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.45 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.24 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.132 -0.787 . . . . 19.87 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -160.82 140.98 11.16 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.418 1.487 . . . . 17.7 112.455 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -123.94 43.75 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.159 1.384 . . . . 20.51 112.436 -167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -136.8 166.85 22.64 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.624 1.569 . . . . 12.73 113.136 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.95 163.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.837 2.855 . . . . 11.09 116.69 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.2 163.55 16.17 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.754 2.121 . . . . 8.12 112.301 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.01 43.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 6.68 112.004 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -48.07 88.11 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.695 1.141 . . . . 6.19 114.682 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.64 87.43 1.04 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 118.575 1.188 . . . . 4.0 112.405 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.14 -7.51 18.24 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 117.408 1.723 . . . . 5.2 117.408 -165.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.29 14.73 5.61 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.091 1.805 . . . . 4.33 113.953 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -89.07 156.97 18.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.205 1.802 . . . . 3.42 112.608 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.56 70.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.611 -1.306 . . . . 1.07 114.086 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.43 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.39 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 0.77 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.82 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 0.66 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 1.5 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 0.59 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 2.55 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 1.2 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.36 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 1.37 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 0.64 103.999 176.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.91 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 112' ' ' VAL . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 0.29 109.876 -170.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 1.91 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 0.54 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 1.75 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 0.76 111.806 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.76 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.29 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 1.9 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 1.75 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 1.95 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.44 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 2.46 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.77 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.38 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 0.55 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 0.58 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 0.66 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.72 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 0.32 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 0.34 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 4.68 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 0.71 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 0.52 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 4.33 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 1.79 109.611 158.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.5 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 0.37 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 2.0 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.3 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 0.88 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 1.39 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.8 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.28 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 0.9 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 0.64 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.04 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.25 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.54 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 0.7 113.069 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 1.49 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 2.28 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 2.66 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.56 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.48 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.06 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 3.54 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 3.26 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 0.94 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.59 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 56' ' ' VAL . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 0.65 109.954 155.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 1.56 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 0.48 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.77 113.314 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.6 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.82 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 2.11 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 1.52 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.55 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.46 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 0.83 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.84 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 1.79 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 0.55 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 0.71 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.73 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 0.49 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.48 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.51 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.86 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 0.4 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.4 HG12 ' HE3' ' A' ' 139' ' ' LYS . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 0.54 109.832 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.82 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 0.56 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 135' ' ' VAL . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 0.85 113.384 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.01 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 1.27 112.377 170.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.82 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 0.61 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.36 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56 110.599 162.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 0.82 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 0.92 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 2.44 114.779 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.67 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.95 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 111.353 -0.699 . . . . 16.34 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m 64.43 2.2 1.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.99 2.218 . . . . 15.4 116.99 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -122.58 152.33 40.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.942 1.701 . . . . 15.35 114.093 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.3 p -136.46 155.39 50.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.903 0.881 . . . . 11.75 113.214 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.2 158.89 4.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.002 1.721 . . . . 10.8 114.964 -173.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.5 134.54 19.47 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.747 0.689 . . . . 8.78 112.637 170.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.68 -15.91 5.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.084 1.513 . . . . 7.5 115.084 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.18 162.54 39.77 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-N 118.95 0.795 . . . . 5.26 113.494 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.49 177.14 42.07 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.517 1.367 . . . . 3.92 116.517 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.62 33.87 37.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.865 1.698 . . . . 3.19 115.826 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.85 -174.92 54.7 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.211 1.005 . . . . 3.17 113.582 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 64.5 173.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.73 2.412 . . . . 2.26 114.092 -170.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -37.53 62.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.108 1.363 . . . . 0.77 112.858 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.97 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.15 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 0.54 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 0.65 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 1.41 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 0.7 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 2.44 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 1.4 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.06 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 1.22 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 0.61 104.004 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 0.93 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 112' ' ' VAL . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 0.32 109.657 -170.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 1.89 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 0.36 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 1.8 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 89' ' ' ASN . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.74 112.968 -164.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 0.84 110.969 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.03 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.38 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 3.44 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 1.7 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 2.43 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 2.23 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.0 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.67 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 0.73 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 0.61 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 0.67 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.61 109.788 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 0.35 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 0.42 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.13 115.272 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 0.59 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.48 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.69 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 0.75 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 3.47 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.76 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 1.88 111.886 157.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 0.34 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 0.34 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 1.99 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 60' ' ' GLY . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.22 111.404 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 0.92 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 1.54 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.36 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.59 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 0.89 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 0.62 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.03 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.52 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 100' ' ' ILE . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 0.56 112.502 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 1.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.09 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 2.2 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 1.58 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.41 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 1.63 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 2.55 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 3.47 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.05 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.57 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' VAL . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 0.6 109.682 171.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 2.42 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD11 HG13 ' A' ' 54' ' ' VAL . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 0.6 109.877 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.71 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.72 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.61 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 2.4 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 1.51 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.58 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.46 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 0.91 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 1.15 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 0.63 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 0.7 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 0.52 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.48 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.12 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.59 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.84 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 0.55 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 0.74 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.84 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.32 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 0.79 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 0.99 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 2.89 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 2.65 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 0.63 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.25 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.72 110.607 161.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 0.76 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 0.77 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 2.25 115.891 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.19 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.83 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.232 -1.147 . . . . 14.6 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -140.73 165.47 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.421 1.089 . . . . 14.26 112.025 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -150.09 119.8 7.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.145 0.978 . . . . 14.59 112.615 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.2 p -141.77 163.45 32.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.991 1.316 . . . . 12.81 112.896 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -6.65 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.711 2.115 . . . . 14.86 116.711 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 140.6 48.04 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.897 1.519 . . . . 8.95 116.897 -159.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.26 170.16 0.08 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.393 2.277 . . . . 7.23 116.311 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.56 -141.42 8.57 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.887 0.756 . . . . 4.52 114.099 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.62 145.29 7.34 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.669 1.604 . . . . 3.49 111.385 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.65 104.75 0.61 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.87 0.748 . . . . 3.33 113.407 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.11 18.76 65.23 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 124.681 1.134 . . . . 4.1 115.893 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -78.54 154.51 30.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.164 1.482 . . . . 3.77 113.731 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.65 76.31 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.002 -1.061 . . . . 1.34 112.371 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.19 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 0.81 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.57 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 0.53 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 0.95 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 0.55 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 2.93 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 1.88 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 1.35 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 0.58 104.172 178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 0.93 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 0.3 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 1.83 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 0.38 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 2.29 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.74 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 0.71 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 1.13 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.44 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.15 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 1.84 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 1.67 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 1.9 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.92 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 2.21 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 1.91 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.06 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 0.59 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 0.67 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 0.52 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 0.33 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 0.32 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.21 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 0.44 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 135' ' ' VAL . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39 113.484 168.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.6 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 0.48 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.13 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.17 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 1.96 109.79 158.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 0.34 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 0.41 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 1.92 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.12 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 0.73 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 1.3 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 96' ' ' LEU . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.43 112.812 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.85 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.18 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 0.62 109.035 169.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 3.45 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 2.37 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.61 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 0.81 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 1.54 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.85 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 1.9 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.24 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.62 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.5 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.15 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 2.64 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 4.27 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.04 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.2 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 0.92 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 1.97 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 0.49 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.67 113.157 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.57 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 2.58 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 2.67 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 0.8 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.57 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 0.77 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.22 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 1.12 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 0.44 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 1.09 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 0.45 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.54 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.19 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.38 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.69 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.19 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 0.39 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 80' ' ' HIS . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 0.43 109.408 -174.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.58 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 1.72 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 0.43 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 1.25 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 2.15 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 1.35 111.942 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 0.56 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.59 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.5 110.183 158.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 0.74 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.91 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 2.74 113.727 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.27 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.84 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.88 -1.288 . . . . 19.46 109.88 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m 50.64 29.98 4.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.049 1.739 . . . . 17.64 115.159 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -67.1 157.64 33.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.125 0.97 . . . . 19.87 112.91 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.2 p -94.36 156.72 16.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.466 1.506 . . . . 13.51 113.022 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -20.22 58.6 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.396 1.999 . . . . 11.4 116.396 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 23.47 77.82 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 116.439 1.336 . . . . 7.32 116.439 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.63 161.2 18.41 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.56 1.544 . . . . 5.58 112.801 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.31 178.72 46.31 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.431 1.015 . . . . 4.74 112.479 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.93 123.01 5.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.391 1.472 . . . . 4.49 110.651 -171.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.89 122.31 29.69 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 122.144 -0.621 . . . . 4.39 111.956 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.59 4.45 61.26 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.955 1.264 . . . . 4.21 116.151 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -71.33 141.93 50.43 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.843 1.257 . . . . 3.86 111.761 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.62 91.04 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.384 -0.823 . . . . 1.16 113.19 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.74 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.41 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 0.67 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.58 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 0.94 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 1.79 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HA ' HG21 ' A' ' 55' ' ' VAL . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 0.59 113.606 169.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 2.24 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 1.74 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.39 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 1.6 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 0.89 108.916 174.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 1.52 109.173 176.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 0.36 108.888 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 1.88 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 0.46 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 1.65 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.83 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 1.01 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.9 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.26 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.76 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.27 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.578 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 2.55 112.125 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 2.08 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.47 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 2.48 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HE22 ' A' ' 66' ' ' GLN . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 1.78 113.674 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 2.67 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 0.88 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 0.69 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 0.71 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.18 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 0.47 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 0.59 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.21 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 0.51 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.72 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 0.7 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 5.45 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.17 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 2.01 110.708 163.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 0.45 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 0.54 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 2.09 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.11 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 1.53 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.62 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.23 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.36 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 0.7 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 3.85 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 4.13 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.59 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 0.82 112.616 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 2.62 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.37 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 2.14 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 1.96 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.01 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.44 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 1.71 115.13 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 2.89 112.735 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 3.8 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 0.96 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.49 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 0.52 109.396 158.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 55' ' ' VAL . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 2.19 108.36 172.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 0.5 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.74 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.84 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 2.37 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 1.48 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.66 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.57 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 0.86 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.24 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 1.1 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 0.58 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 0.91 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.06 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 0.58 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.69 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.11 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.32 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.65 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.91 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 0.43 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 0.55 109.851 -171.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.15 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 0.5 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HE3' HG12 ' A' ' 135' ' ' VAL . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 0.93 113.462 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 1.74 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 2.52 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 0.7 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.39 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.84 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 0.74 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.36 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 3.57 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.27 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 4.44 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.585 -0.606 . . . . 18.15 111.585 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.69 140.05 37.15 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.972 1.101 . . . . 15.87 113.972 -169.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.4 159.64 34.18 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.458 1.651 . . . . 16.39 115.458 -165.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -73.91 -68.45 0.51 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.938 1.695 . . . . 12.7 114.417 -171.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.1 mmt -117.44 -36.62 3.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.613 -1.63 . . . . 11.92 114.667 -159.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 158.4 27.03 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.603 1.573 . . . . 8.43 114.183 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.6 -1.17 26.23 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.642 2.09 . . . . 8.08 116.642 -169.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.25 24.51 67.41 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 117.416 1.727 . . . . 5.5 117.416 163.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.18 166.46 52.54 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 118.883 1.342 . . . . 4.79 115.661 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.14 97.91 0.95 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.443 1.973 . . . . 4.12 110.059 164.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.79 177.46 14.47 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.804 1.192 . . . . 3.26 113.476 -161.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t 61.31 176.11 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.916 2.086 . . . . 2.63 113.656 -171.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.6 -26.55 63.77 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.365 -1.459 . . . . 1.16 114.073 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.03 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 0.51 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.37 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 0.71 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 0.89 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 0.62 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 2.41 116.232 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 1.22 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.66 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 1.19 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 0.78 104.91 -177.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 1.03 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 0.32 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 1.78 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 0.39 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 1.39 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.83 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 0.73 110.582 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.7 111.705 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.66 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.14 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.03 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 2.9 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.05 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.99 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 3.14 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 2.48 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.76 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 0.83 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 0.64 113.391 171.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 0.61 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.93 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 0.42 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 0.42 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 3.44 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 0.57 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.82 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 0.5 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 4.92 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.4 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 2.08 110.331 166.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 0.42 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 0.37 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 2.04 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.24 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 0.81 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 1.33 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.36 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.43 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 1.77 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 0.59 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.12 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 2.86 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.83 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 1.11 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 2.26 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.85 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 2.32 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 1.73 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.31 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.03 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 1.92 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 3.58 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 4.63 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.29 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.06 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 0.65 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 1.62 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 0.43 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 141' ' ' LEU . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.62 113.298 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 50' ' ' LYS . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.73 117.871 -169.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.8 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 2.04 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 1.6 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.56 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.46 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.429 ' SG ' HG13 ' A' ' 73' ' ' VAL . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 0.64 115.239 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.24 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 1.17 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 0.55 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 0.63 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 0.45 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.55 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.03 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.6 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 0.4 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 0.55 110.228 -166.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.69 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 0.73 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.19 113.277 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 2.28 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 1.3 111.912 165.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.07 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 0.77 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.53 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.5 109.153 155.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 0.74 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 0.69 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 2.21 111.532 173.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.81 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 110.408 -1.077 . . . . 16.27 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 52.32 15.89 0.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.177 2.288 . . . . 14.36 117.177 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 55.83 26.08 9.21 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.86 1.664 . . . . 11.97 114.874 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 p -103.51 -20.75 13.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.051 1.34 . . . . 13.65 114.562 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.38 154.44 26.99 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 129.45 3.1 . . . . 12.89 109.782 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.1 74.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.158 -0.964 . . . . 8.6 114.605 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.4 11.35 5.65 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.764 1.282 . . . . 8.36 113.819 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.99 -178.3 43.82 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.579 2.514 . . . . 5.41 110.625 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.44 -161.01 32.5 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 118.545 1.173 . . . . 3.82 114.083 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.33 58.68 3.26 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.823 1.678 . . . . 3.15 114.062 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -160.7 52.74 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 123.239 1.466 . . . . 3.05 114.907 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t 64.23 178.12 0.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.898 2.479 . . . . 2.46 114.763 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.93 66.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.344 1.457 . . . . 0.78 113.864 -165.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.18 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 0.48 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.01 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 0.79 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 0.9 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 0.78 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 2.46 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 1.71 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 1.25 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 0.99 105.536 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 1.11 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 0.37 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 2.01 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 0.4 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.03 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.74 116.08 -164.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 0.66 112.099 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.72 114.022 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.49 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.4 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.03 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 1.78 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.87 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.15 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 2.45 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.03 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.0 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 0.76 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 0.71 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 0.51 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 0.41 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 0.48 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.05 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 0.56 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.5 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.74 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 0.69 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.52 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.13 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 2.02 111.358 165.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 0.59 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 0.5 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 2.01 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.24 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 0.99 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 1.72 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.53 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.85 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.11 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.05 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 0.58 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 3.9 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.07 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.49 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 100' ' ' ILE . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 0.76 112.716 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.07 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.89 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 1.88 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.34 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.1 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.4 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 1.82 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.31 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 3.58 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 0.89 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.12 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 0.68 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 1.66 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 0.5 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.77 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.84 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.58 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 2.48 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 1.51 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.58 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.46 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 0.76 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 1.1 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 0.72 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 1.43 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.89 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 0.52 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.78 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.28 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.3 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 0.89 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.14 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 0.48 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.421 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 0.8 110.141 -173.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.42 110.793 166.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.93 111.789 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 0.67 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 1.1 113.694 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HE3' ' HG3' ' A' ' 136' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 1.83 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 2.58 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.82 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 0.59 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.19 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.52 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 0.69 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 0.98 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 2.37 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.74 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 110.531 -1.027 . . . . 20.0 110.531 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 t 67.74 151.86 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.04 2.136 . . . . 17.81 115.634 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.33 19.1 7.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.892 2.077 . . . . 14.71 112.285 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -138.69 158.63 43.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.554 1.142 . . . . 12.39 113.53 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.61 165.35 0.6 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.6 -1.182 . . . . 13.99 112.37 154.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.21 -136.23 32.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.964 0.792 . . . . 11.6 113.178 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.91 150.7 22.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.358 1.063 . . . . 10.66 113.093 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.72 70.54 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.042 1.306 . . . . 6.84 115.7 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.78 150.32 51.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.754 1.169 . . . . 5.23 113.146 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.91 11.21 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.822 1.201 . . . . 3.48 115.954 -169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.96 -179.79 52.49 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 116.07 1.188 . . . . 3.53 116.07 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.7 t 66.3 169.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 128.754 2.822 . . . . 2.48 114.12 -169.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.68 47.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.545 1.538 . . . . 0.98 113.499 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.68 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.08 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 0.54 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.84 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 0.46 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 0.91 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 0.44 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 2.38 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 1.27 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.69 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 1.43 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.86 106.999 174.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 1.47 107.948 -178.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 112' ' ' VAL . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 0.26 109.053 -169.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 1.82 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 0.39 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 1.4 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 0.69 111.257 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76 114.314 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.08 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 1.84 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 1.69 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.58 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.05 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 2.69 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 1.93 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 3.34 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 0.79 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 0.71 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 0.57 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.88 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 0.6 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 0.57 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 4.56 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 0.83 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 0.69 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 3.65 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 1.83 109.923 157.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 0.43 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 0.39 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 2.39 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.3 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.21 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 1.46 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.4 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.84 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.11 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 0.63 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 3.73 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 3.93 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.53 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 0.63 112.675 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 1.67 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 1.88 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.37 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.54 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.26 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.17 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 2.34 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 4.13 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.01 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.55 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 56' ' ' VAL . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 0.56 109.71 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.514 ' HB2' HG23 ' A' ' 55' ' ' VAL . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 1.57 108.428 171.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 0.51 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.11 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 2.01 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 1.48 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.58 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.68 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.512 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 0.94 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 1.2 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 0.75 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 0.77 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 0.97 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.73 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.44 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.96 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.45 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 0.71 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 0.52 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.58 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.63 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 0.62 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HE3' HG12 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 0.82 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 2.44 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 2.35 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.84 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 0.9 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 1.98 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 148' ' ' LEU . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 0.77 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 0.78 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 2.55 111.779 168.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.61 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.55 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 109.159 -1.577 . . . . 19.8 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.5 m -83.79 90.37 7.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.42 -0.956 . . . . 18.98 108.42 168.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -56.45 140.58 45.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.734 1.213 . . . . 17.9 113.874 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.9 p -74.25 152.31 39.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.689 1.737 . . . . 15.3 115.689 -155.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 167.4 3.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.219 2.207 . . . . 14.07 113.816 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.51 8.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.885 1.231 . . . . 10.06 113.808 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.34 45.09 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.959 1.704 . . . . 8.53 111.341 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.2 159.55 30.88 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.133 1.349 . . . . 5.91 112.481 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.72 -165.32 36.83 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.081 1.324 . . . . 4.48 111.845 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.28 134.88 8.52 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.577 1.561 . . . . 4.26 112.725 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.21 10.59 1.26 Allowed Glycine 0 N--CA 1.479 1.543 0 C-N-CA 127.325 2.393 . . . . 3.44 118.59 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 t -115.66 175.52 5.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.781 2.033 . . . . 2.59 110.392 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.57 -35.98 61.4 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 121.066 -1.022 . . . . 0.85 113.709 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.53 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.19 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 0.62 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.57 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 0.62 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 1.24 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 0.89 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 3.82 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 1.83 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.22 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.07 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 0.8 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 1.33 108.654 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 112' ' ' VAL . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 0.36 109.568 -165.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 1.86 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 0.5 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 1.54 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.82 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.87 110.769 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.62 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 2.73 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.17 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.24 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.86 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.51 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 2.7 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.03 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 3.96 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 0.83 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 0.54 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 0.59 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.05 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 0.35 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 0.35 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 4.22 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 0.49 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.47 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 0.45 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 5.2 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.32 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 1.96 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 0.42 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 0.35 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 2.21 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.37 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 0.89 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 1.35 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.66 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.85 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.01 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.01 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 0.71 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.32 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 2.44 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.67 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 0.91 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 2.2 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.63 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 2.05 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.13 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.69 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.07 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 2.54 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 5.75 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.17 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 2.89 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 56' ' ' VAL . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 0.91 108.177 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.44 ' HB2' HG23 ' A' ' 55' ' ' VAL . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 1.77 110.048 162.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 0.6 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.72 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 2.35 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 2.48 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.72 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.5 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 0.65 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.07 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 1.2 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 0.46 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 0.73 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 0.48 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.71 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.99 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.84 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.61 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 0.41 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 0.62 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.93 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 0.6 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 1.64 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 2.24 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 1.6 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 0.56 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.19 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.74 110.442 162.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 0.65 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 0.75 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 2.21 114.153 -170.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.27 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.45 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.001 0 CA-C-O 119.218 -0.768 . . . . 16.77 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -132.98 132.25 41.7 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.015 1.326 . . . . 17.33 111.776 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -146.35 26.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.13 1.53 . . . . 14.71 115.13 -164.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.289 14.1 p 56.23 -149.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.72 2.008 . . . . 17.96 114.451 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 172.07 14.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.966 1.707 . . . . 19.39 111.849 -176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.88 -157.18 10.73 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.561 0.585 . . . . 12.18 114.561 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.52 -16.11 5.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.266 1.58 . . . . 11.33 115.266 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.25 -12.67 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 N-CA-C 115.795 1.078 . . . . 7.15 115.795 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.39 -157.45 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.656 1.122 . . . . 4.92 114.961 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.56 51.2 3.15 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.5 1.048 . . . . 3.47 114.093 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 -165.01 47.83 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.466 1.031 . . . . 2.95 111.317 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 t 62.0 -176.7 0.13 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.87 2.068 . . . . 3.03 113.947 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.71 76.58 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.559 -1.338 . . . . 1.07 113.547 -168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.43 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 0.66 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.24 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 0.85 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 0.93 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 0.53 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.01 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 1.24 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.91 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 1.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 0.88 105.114 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 0.99 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 0.33 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 1.85 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 0.49 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 1.99 110.164 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.9 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.35 110.027 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.99 112.308 -175.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.08 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 2.83 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.24 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.464 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 2.46 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.3 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.59 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 2.57 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' HE22 ' A' ' 66' ' ' GLN . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 1.76 113.587 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 2.71 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 0.84 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 0.64 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 0.56 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.34 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 0.5 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 0.49 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 3.24 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 0.92 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 135' ' ' VAL . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.59 113.679 169.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 0.61 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 3.62 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.02 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 2.02 111.312 161.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 0.52 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 0.45 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 1.93 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 0.91 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 1.73 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.74 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.66 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.46 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.3 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 0.71 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 3.69 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.25 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.57 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 0.69 112.37 -174.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 1.78 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.57 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 1.81 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 1.87 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.01 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.73 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.25 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 3.47 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 3.99 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.0 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.43 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.19 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 1.78 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 0.61 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.78 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 2.72 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 2.52 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.07 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.72 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 0.85 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.64 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 1.18 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 0.59 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 0.87 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.12 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 0.71 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.66 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.06 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.16 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.65 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.9 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 0.46 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 0.62 109.999 -173.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.95 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 0.65 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' HG12 ' A' ' 135' ' ' VAL . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 0.88 112.484 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 2.17 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 1.25 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.74 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 0.63 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.45 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.7 111.58 162.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.2 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 0.75 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 2.17 112.926 173.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.85 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.74 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 110.812 -0.915 . . . . 15.06 110.812 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -141.78 -12.88 0.86 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.777 1.399 . . . . 13.73 114.777 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -146.48 157.4 43.75 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.086 1.312 . . . . 13.65 111.9 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.3 p -104.46 164.37 11.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.262 1.425 . . . . 12.41 113.733 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.6 mmt 44.21 -119.48 0.68 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.635 1.974 . . . . 13.24 115.257 163.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.97 -134.65 31.94 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 119.147 0.885 . . . . 7.49 113.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 56.36 -5.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 118.732 2.864 . . . . 6.55 118.732 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 168.13 53.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.77 1.168 . . . . 4.53 113.004 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.69 149.79 15.99 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.177 -0.602 . . . . 3.48 114.1 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.43 18.11 78.31 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.49 0.956 . . . . 3.0 115.49 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.48 -176.31 17.28 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.68 1.61 . . . . 3.38 114.293 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t 63.19 167.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.202 2.201 . . . . 2.61 113.883 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -29.09 20.49 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.544 1.938 . . . . 0.85 113.979 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.3 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.15 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 0.53 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.16 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 0.6 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 1.1 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 0.5 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 3.92 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 1.4 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.91 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 1.58 114.632 170.174 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 0.84 105.261 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 0.99 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 112' ' ' VAL . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 0.31 110.356 -172.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 1.79 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 0.38 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 1.92 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.73 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 0.84 111.067 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.86 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 3.72 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.18 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 1.79 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.36 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 3.38 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 2.88 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.65 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 0.88 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 0.95 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 62' ' ' PRO . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 0.93 112.267 -177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.57 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 0.58 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 0.56 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 4.31 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 0.56 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 0.57 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 4.25 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.84 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 1.78 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 0.41 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 0.41 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 2.33 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.18 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 0.88 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 1.65 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.15 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.86 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.97 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 0.65 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 3.91 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 2.49 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.52 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 0.56 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 1.41 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 1.92 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.15 113.937 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 1.91 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.59 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 0.98 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 2.68 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 3.65 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.01 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 1.94 111.757 -170.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 0.55 109.608 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 1.59 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 0.43 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.06 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.9 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 2.06 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 1.58 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 1.14 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 0.69 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.01 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 1.5 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 1.01 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.02 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.86 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 0.54 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.76 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.18 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.67 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.94 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 0.58 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 0.7 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.51 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.69 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 0.76 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 0.98 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.1 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 1.51 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.67 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 0.78 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.14 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.78 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 0.62 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 0.95 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 4.03 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.41 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.13 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.693 -0.563 . . . . 17.66 111.693 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -143.52 18.39 1.86 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.894 1.442 . . . . 17.56 114.894 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -91.73 147.68 22.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.5 1.12 . . . . 17.46 110.559 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.8 p -134.57 159.67 40.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.963 1.097 . . . . 12.23 113.963 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.5 mmt 43.5 39.98 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 118.503 2.779 . . . . 10.74 118.503 158.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.36 -174.16 45.94 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.409 1.324 . . . . 6.7 116.409 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.52 120.36 23.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.643 1.177 . . . . 7.68 112.198 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.14 10.29 35.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 116.648 1.419 . . . . 4.96 116.648 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.48 157.17 30.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.639 1.59 . . . . 3.45 113.948 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 117.91 7.23 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.591 1.091 . . . . 3.26 114.189 -170.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.65 8.56 21.28 Favored Glycine 0 CA--C 1.536 1.393 0 N-CA-C 117.034 1.573 . . . . 4.1 117.034 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.0 m -66.31 147.21 53.64 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.031 1.416 . . . . 3.54 110.963 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -32.62 71.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.82 -1.175 . . . . 1.03 113.134 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.22 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.36 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 0.78 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 0.55 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 1.1 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 0.44 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 2.38 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 1.45 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.12 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 1.26 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 0.63 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 1.07 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 0.4 108.839 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 1.8 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 0.61 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 2.26 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.11 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 0.95 106.558 166.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.42 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 3.8 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 1.86 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 1.89 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 1.62 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.09 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 2.15 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 1.92 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 2.84 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 0.65 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 0.64 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 0.51 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 0.46 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 0.51 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.06 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 0.61 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 0.64 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 3.79 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.82 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 2.03 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 0.53 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 0.49 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 2.09 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.03 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 1.88 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.24 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.35 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.03 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.03 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 1.3 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 5.11 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.04 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 0.92 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 1.1 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 1.61 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 2.32 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.06 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.55 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.25 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 4.69 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 3.44 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.08 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 0.93 108.265 153.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 1.8 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 0.49 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.26 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.69 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.93 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 2.62 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 2.58 104.629 -160.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 0.95 111.677 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 0.72 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 0.79 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.63 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 2.21 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 0.59 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 0.82 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 0.66 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.74 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.01 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.19 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.72 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.82 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 0.42 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 139' ' ' LYS . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 0.48 109.657 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.34 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 0.58 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 135' ' ' VAL . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 1.17 112.902 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 1.74 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 1.66 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 0.58 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 1.79 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.435 ' CB ' HG13 ' A' ' 135' ' ' VAL . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.58 110.272 169.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 0.69 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 1.61 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 4.41 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 1.04 113.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.8700000000000001 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.3500000000000001 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 0.64000000000000001 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.4399999999999999 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 0.59999999999999998 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 0.93999999999999995 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 0.57999999999999996 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 2.4399999999999999 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 1.8899999999999999 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.8500000000000001 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 1.54 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 0.68999999999999995 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 0.91000000000000003 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 0.37 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 2.1200000000000001 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 0.42999999999999999 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 1.99 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81000000000000005 114.887 -159.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 0.87 111.408 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81000000000000005 112.883 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.3700000000000001 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.3799999999999999 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.23 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 1.8200000000000001 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 1.9099999999999999 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.4300000000000002 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 2.4100000000000001 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 1.9399999999999999 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 2.96 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 0.65000000000000002 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 0.56999999999999995 112.994 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 0.58999999999999997 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.5499999999999998 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 0.46000000000000002 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 0.37 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 4.0700000000000003 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 0.66000000000000003 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45000000000000001 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91000000000000003 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 0.47999999999999998 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 4.2800000000000002 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.3799999999999999 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 1.99 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 0.44 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 0.45000000000000001 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 2.1200000000000001 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.1400000000000001 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 1.8700000000000001 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.2799999999999998 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.4299999999999999 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.3599999999999999 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 0.66000000000000003 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 3.98 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 2.7999999999999998 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.64000000000000001 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 0.65000000000000002 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 1.3799999999999999 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.4300000000000002 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 1.95 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 1.75 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.3700000000000001 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.48 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.0900000000000001 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 2.73 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 5.6600000000000001 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.1799999999999999 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 2.2999999999999998 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 0.65000000000000002 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 2.2999999999999998 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 0.51000000000000001 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.76000000000000001 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.8600000000000001 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 2.4100000000000001 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 1.55 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.55000000000000004 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.41999999999999998 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 73' ' ' VAL . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 0.71999999999999997 115.428 -169.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.6499999999999999 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 1.1599999999999999 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 0.47999999999999998 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 0.69999999999999996 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.83999999999999997 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 0.68999999999999995 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.54000000000000004 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6000000000000001 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66000000000000003 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.4500000000000002 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 0.46000000000000002 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 0.41999999999999998 109.38 -165.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.0600000000000001 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 0.47999999999999998 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 135' ' ' VAL . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 0.73999999999999999 112.677 177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 1.79 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 1.3600000000000001 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.0700000000000001 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 0.69999999999999996 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 2.5499999999999998 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.56999999999999995 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 0.65000000000000002 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 0.93000000000000005 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 2.9300000000000002 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7000000000000002 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9000000000000004 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 114.412 1.264 . . . . 0.81000000000000005 114.412 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.6699999999999999 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.1699999999999999 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 0.54000000000000004 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.1899999999999999 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 0.57999999999999996 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 0.91000000000000003 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 0.46999999999999997 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.1499999999999999 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 1.55 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.9399999999999999 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 1.6299999999999999 114.36 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.484 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 0.59999999999999998 105.215 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 0.92000000000000004 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 0.34000000000000002 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 0.41999999999999998 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 2.6400000000000001 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 0.69999999999999996 111.98 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.90000000000000002 113.298 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.9199999999999999 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.4300000000000002 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 1.97 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 1.6499999999999999 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.02 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 2.0499999999999998 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.0099999999999998 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.1200000000000001 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 0.56000000000000005 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 0.66000000000000003 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 0.55000000000000004 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 0.35999999999999999 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 0.39000000000000001 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 4.6500000000000004 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 0.44 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56000000000000005 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 0.40999999999999998 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 4.9500000000000002 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.6699999999999999 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 1.8200000000000001 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.41999999999999998 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 0.38 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 1.9399999999999999 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.2200000000000002 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 0.93000000000000005 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 1.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.4700000000000002 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.3300000000000001 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 0.89000000000000001 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1000000000000001 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 0.59999999999999998 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 4.9699999999999998 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.52 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.57999999999999996 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 0.68000000000000005 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 1.46 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 2.1499999999999999 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.3599999999999999 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.6200000000000001 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.6100000000000001 113.087 -171.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 106' ' ' TRP . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 1.52 114.89 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 3.6800000000000002 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 3.4399999999999999 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 0.83999999999999997 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.8199999999999998 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 0.64000000000000001 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 2.21 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 0.41999999999999998 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 0.87 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.56999999999999995 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 2.2400000000000002 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 1.6699999999999999 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 0.72999999999999998 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.67000000000000004 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 0.75 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.3900000000000001 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 1.46 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 0.45000000000000001 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.1399999999999999 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89000000000000001 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.57999999999999996 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.3899999999999999 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.5099999999999998 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.63 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.8500000000000001 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 0.45000000000000001 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 0.45000000000000001 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.5800000000000001 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 0.46000000000000002 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 0.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 2.0600000000000001 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 1.49 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.71999999999999997 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 0.53000000000000003 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.48 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56000000000000005 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 0.81000000000000005 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 0.97999999999999998 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 3.1000000000000001 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.8499999999999996 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 113.026 0.75 . . . . 0.77000000000000002 113.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.6200000000000001 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 0.5 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 0.58999999999999997 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 2.0299999999999998 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 0.67000000000000004 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 2.5 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 1.4399999999999999 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.8200000000000001 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 2.4300000000000002 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 0.95999999999999996 108.14 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 1.5 108.878 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 112' ' ' VAL . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 0.31 109.126 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 1.79 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 0.33000000000000002 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 1.3899999999999999 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.84999999999999998 112.191 -160.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 0.93999999999999995 111.396 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.90000000000000002 113.18 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.8500000000000001 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 3.0099999999999998 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 3.23 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 1.95 114.793 -159.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 1.79 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.2599999999999998 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 2.46 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.6000000000000001 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 2.8999999999999999 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 0.71999999999999997 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.438 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 0.60999999999999999 113.628 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 0.56000000000000005 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.4199999999999999 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 0.45000000000000001 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 0.42999999999999999 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 3.6400000000000001 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 0.51000000000000001 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.45000000000000001 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78000000000000003 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 0.64000000000000001 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 6.8499999999999996 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.4700000000000002 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 2.04 111.023 169.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 0.55000000000000004 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 0.60999999999999999 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 2.27 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.3500000000000001 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 0.84999999999999998 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 1.3400000000000001 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.0600000000000001 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.8999999999999999 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.6000000000000001 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.1600000000000001 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 1.0 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 3.4199999999999999 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.4300000000000002 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.72999999999999998 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 0.72999999999999998 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 1.8500000000000001 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 2.27 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.52 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.8400000000000001 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 1.8400000000000001 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.1399999999999999 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 2.73 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.21 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.3400000000000001 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.1000000000000001 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 56' ' ' VAL . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 0.75 109.21 160.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HB2' HG23 ' A' ' 55' ' ' VAL . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 1.99 109.487 166.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 0.59999999999999998 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' HD21 ' A' ' 141' ' ' LEU . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.81999999999999995 113.686 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52000000000000002 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HD1' ' H ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 2.25 110.645 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.426 ' H ' ' HD1' ' A' ' 118' ' ' PHE . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 1.6399999999999999 110.32 -144.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 0.91000000000000003 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 0.67000000000000004 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.438 ' SG ' HG13 ' A' ' 73' ' ' VAL . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 0.70999999999999996 117.575 -165.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.1400000000000001 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 1.27 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 0.81999999999999995 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 0.76000000000000001 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.81999999999999995 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 0.45000000000000001 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64000000000000001 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.1899999999999999 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.53000000000000003 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.2200000000000002 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 0.39000000000000001 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 0.53000000000000003 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.6200000000000001 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.2200000000000002 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 0.80000000000000004 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 1.29 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 4.8700000000000001 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 115' ' ' ASN . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 1.52 113.551 163.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.4299999999999999 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 0.84999999999999998 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.47 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.489 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.71999999999999997 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 0.64000000000000001 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 0.69999999999999996 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.1099999999999999 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.8099999999999996 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.592 0.59 . . . . 1.4299999999999999 112.592 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.3999999999999999 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 0.88 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.8300000000000001 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 0.60999999999999999 111.042 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 0.96999999999999997 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 0.48999999999999999 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 2.4100000000000001 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 2.3300000000000001 113.707 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 1.28 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 0.63 104.052 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 1.3 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 112' ' ' VAL . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 0.5 109.182 -170.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 1.96 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 0.56000000000000005 110.597 -173.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 1.4299999999999999 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 0.73999999999999999 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.78000000000000003 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.8399999999999999 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 4.2400000000000002 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.1899999999999999 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 2.9500000000000002 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.0899999999999999 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 2.3599999999999999 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 2.9500000000000002 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 0.85999999999999999 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 0.54000000000000004 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 0.54000000000000004 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.1899999999999999 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 0.51000000000000001 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 0.46999999999999997 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 3.4300000000000002 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 0.5 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.39000000000000001 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.59999999999999998 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 0.42999999999999999 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 3.9900000000000002 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.3500000000000001 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 1.9399999999999999 111.017 163.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 0.64000000000000001 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 0.80000000000000004 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 1.99 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.2400000000000002 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 0.83999999999999997 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 1.3799999999999999 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.8500000000000001 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.1800000000000002 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.1100000000000001 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.1200000000000001 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 0.64000000000000001 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 3.52 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 2.6000000000000001 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.62 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 0.77000000000000002 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 1.48 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.1899999999999999 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 2.3700000000000001 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 2.6699999999999999 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.5800000000000001 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.6399999999999999 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 0.97999999999999998 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 2.73 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 3.4700000000000002 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.1100000000000001 112.792 165.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.6200000000000001 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 56' ' ' VAL . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 0.65000000000000002 110.448 157.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 1.96 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 0.76000000000000001 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 0.95999999999999996 112.962 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78000000000000003 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2000000000000002 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 2.4300000000000002 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 1.5900000000000001 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.78000000000000003 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.64000000000000001 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 0.97999999999999998 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.0800000000000001 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 1.03 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 0.71999999999999997 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 0.80000000000000004 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.0700000000000001 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 0.47999999999999998 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79000000000000004 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.9500000000000002 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.58999999999999997 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 0.40000000000000002 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 0.46000000000000002 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.4199999999999999 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.5800000000000001 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 0.51000000000000001 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 0.81000000000000005 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 1.8799999999999999 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 1.29 112.269 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.1200000000000001 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 0.54000000000000004 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.26 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55000000000000004 110.25 162.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 0.90000000000000002 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 0.88 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 2.1699999999999999 113.988 -175.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.6299999999999999 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.1399999999999997 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.842 0 N-CA-C 114.07 1.137 . . . . 1.1200000000000001 114.07 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.7400000000000002 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 0.56999999999999995 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.9199999999999999 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.1000000000000001 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 2.1800000000000002 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 0.76000000000000001 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 2.4100000000000001 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 1.6200000000000001 113.96 166.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.0099999999999998 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 1.4099999999999999 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 0.93999999999999995 107.546 176.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 1.3700000000000001 108.939 174.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 112' ' ' VAL . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 0.35999999999999999 109.25 -169.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 1.76 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 0.34000000000000002 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 1.99 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.8300000000000001 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 0.97999999999999998 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.0700000000000001 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.46 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.4199999999999999 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.2599999999999998 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 1.74 116.207 169.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 1.6399999999999999 106.999 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.6200000000000001 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 2.3300000000000001 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 3.54 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 3.2999999999999998 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 0.68000000000000005 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.447 HG13 ' SG ' ' A' ' 122' ' ' CYS . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 0.54000000000000004 113.155 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 0.5 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.0499999999999998 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 0.31 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 0.38 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 3.4199999999999999 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 0.59999999999999998 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.38 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.58999999999999997 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 0.46000000000000002 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 6.29 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 2.2000000000000002 113.716 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 0.53000000000000003 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 0.67000000000000004 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 2.4900000000000002 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.8600000000000003 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 1.1599999999999999 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 1.9299999999999999 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.48 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.1899999999999999 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 1.73 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 3.3300000000000001 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 2.4100000000000001 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.72999999999999998 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 0.87 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 2.7400000000000002 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.2999999999999998 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 2.2599999999999998 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.5499999999999998 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.74 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.1899999999999999 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 1.72 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.27 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 3.9399999999999999 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.24 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.02 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 56' ' ' VAL . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 0.60999999999999999 109.547 162.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.548 ' HB2' HG23 ' A' ' 55' ' ' VAL . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 2.1299999999999999 109.595 167.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 0.53000000000000003 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.97999999999999998 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91000000000000003 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.1299999999999999 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 1.99 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 1.6100000000000001 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 0.84999999999999998 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.63 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 73' ' ' VAL . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 0.78000000000000003 114.862 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 1.3999999999999999 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 0.54000000000000004 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 1.03 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 0.82999999999999996 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.70999999999999996 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.1799999999999999 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.6299999999999999 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.8899999999999999 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 0.68000000000000005 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 0.55000000000000004 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.1099999999999999 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 2.4199999999999999 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 0.54000000000000004 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 1.1200000000000001 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.0899999999999999 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 1.46 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 0.66000000000000003 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.3799999999999999 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.5 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 0.76000000000000001 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 0.79000000000000004 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 2.52 113.193 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.5099999999999998 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.3300000000000001 113.19 167.583 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.042 1.127 . . . . 1.21 114.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.6899999999999999 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.4500000000000002 110.263 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 0.76000000000000001 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 0.56000000000000005 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 0.92000000000000004 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 0.58999999999999997 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 2.6600000000000001 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 1.6000000000000001 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.9199999999999999 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.466 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 1.3500000000000001 115.083 172.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 0.79000000000000004 104.736 178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 1.1599999999999999 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 112' ' ' VAL . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 0.28000000000000003 109.455 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 1.96 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 0.42999999999999999 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 1.8899999999999999 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78000000000000003 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 0.65000000000000002 111.337 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.8399999999999999 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.4500000000000002 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 1.96 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 1.8 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.0099999999999998 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.1899999999999999 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 1.9299999999999999 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.0 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.0999999999999996 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 0.56000000000000005 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 0.51000000000000001 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 0.48999999999999999 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 0.32000000000000001 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 0.39000000000000001 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 4.3300000000000001 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 0.53000000000000003 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55000000000000004 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.69999999999999996 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 0.57999999999999996 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 4.8899999999999997 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.4300000000000002 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 2.0099999999999998 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 0.35999999999999999 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 0.35999999999999999 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 2.02 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.1600000000000001 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 0.83999999999999997 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 1.47 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.2599999999999998 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.2400000000000002 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.05 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.3599999999999999 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 0.66000000000000003 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 3.8599999999999999 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.54 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.66000000000000003 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 0.69999999999999996 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 1.3600000000000001 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.8600000000000001 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 2.1400000000000001 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 2.3999999999999999 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.73 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.3799999999999999 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 2.6899999999999999 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.0099999999999998 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 0.93000000000000005 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.1699999999999999 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 56' ' ' VAL . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 0.53000000000000003 109.958 164.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 2.9199999999999999 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 0.47999999999999998 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 0.95999999999999996 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.79000000000000004 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.8600000000000001 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 2.79 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 1.5900000000000001 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 0.89000000000000001 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.72999999999999998 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 0.68999999999999995 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.8599999999999999 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 2.6899999999999999 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 0.60999999999999999 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 1.3700000000000001 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 0.87 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.83999999999999997 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.3300000000000001 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.81999999999999995 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.5899999999999999 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 0.58999999999999997 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.454 HG12 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 0.52000000000000002 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.6899999999999999 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.8799999999999999 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 0.98999999999999999 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 2.1200000000000001 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 1.4199999999999999 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.92000000000000004 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 0.92000000000000004 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.53 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.70999999999999996 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 0.76000000000000001 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 0.82999999999999996 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.0 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.1799999999999997 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.2100000000000009 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 0.85999999999999999 114.561 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.9300000000000002 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.1599999999999999 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 0.66000000000000003 113.443 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.8700000000000001 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 0.92000000000000004 111.808 173.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 0.44 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 2.8500000000000001 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 2.1800000000000002 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.6499999999999999 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 1.3899999999999999 115.321 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 0.84999999999999998 105.309 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 0.93999999999999995 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 0.29999999999999999 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 1.75 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 0.46999999999999997 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 2.0600000000000001 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.81000000000000005 113.876 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 0.87 110.951 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.0600000000000001 113.223 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.6099999999999999 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.2799999999999998 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 2.7200000000000002 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.3700000000000001 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.1099999999999999 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 2.0800000000000001 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.0499999999999998 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 3.3100000000000001 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 0.72999999999999998 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 0.97999999999999998 113.064 170.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 0.98999999999999999 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.6499999999999999 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 0.32000000000000001 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 0.60999999999999999 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 4.96 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 0.81999999999999995 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54000000000000004 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.0600000000000001 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 0.72999999999999998 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 4.7699999999999996 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.4500000000000002 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 2.1000000000000001 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 0.41999999999999998 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 0.39000000000000001 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 2.0 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.2400000000000002 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.1399999999999999 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 1.8899999999999999 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.4300000000000002 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.0700000000000001 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.4100000000000001 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 0.57999999999999996 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 3.98 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 3.5800000000000001 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.70999999999999996 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 0.69999999999999996 113.04 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 1.54 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 2.2200000000000002 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.1299999999999999 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.9299999999999999 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.3300000000000001 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.1599999999999999 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 2.6699999999999999 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 3.9399999999999999 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.1399999999999999 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.0600000000000001 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 0.54000000000000004 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 1.5800000000000001 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 0.46999999999999997 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77000000000000002 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.71999999999999997 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.6499999999999999 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 2.4199999999999999 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 1.4399999999999999 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.59999999999999998 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.47999999999999998 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 73' ' ' VAL . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.1200000000000001 117.298 -170.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.1600000000000001 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 1.55 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 0.57999999999999996 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 0.84999999999999998 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 0.57999999999999996 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.54000000000000004 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.0600000000000001 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.8199999999999998 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.8400000000000001 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 0.44 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 0.70999999999999996 109.871 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.4300000000000002 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.6499999999999999 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 0.63 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 1.1299999999999999 113.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 1.75 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 1.3100000000000001 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 0.56000000000000005 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 1.8600000000000001 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.71999999999999997 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.1499999999999999 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 0.97999999999999998 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 2.3700000000000001 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.4900000000000002 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.401 0.889 . . . . 0.95999999999999996 113.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.4300000000000002 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.1100000000000001 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 0.47999999999999998 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.3300000000000001 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 0.48999999999999999 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 0.89000000000000001 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 0.54000000000000004 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 3.96 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 1.4399999999999999 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.8300000000000001 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 1.8300000000000001 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 0.56000000000000005 105.573 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 1.0 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 112' ' ' VAL . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 0.32000000000000001 109.433 -168.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 1.9399999999999999 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 0.70999999999999996 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.1000000000000001 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 0.60999999999999999 111.548 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76000000000000001 113.812 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.0899999999999999 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.0499999999999998 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.532 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 1.6699999999999999 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 1.8700000000000001 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 2.3700000000000001 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.6099999999999999 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 4.4500000000000002 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 0.59999999999999998 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 0.68999999999999995 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 0.70999999999999996 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.4399999999999999 110.594 168.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 0.31 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 0.40000000000000002 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 4.6100000000000003 114.001 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 0.54000000000000004 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.41999999999999998 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 0.63 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 6.8300000000000001 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.2199999999999998 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 1.9099999999999999 108.75 153.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 0.40000000000000002 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 0.42999999999999999 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 1.98 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.1800000000000002 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 0.81999999999999995 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 1.3300000000000001 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.5299999999999998 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1000000000000001 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.84999999999999998 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.8900000000000001 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 0.60999999999999999 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 4.4199999999999999 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 3.1699999999999999 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.52000000000000002 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 0.65000000000000002 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 2.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 2.0800000000000001 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 2.3799999999999999 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.8899999999999999 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 1.74 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.01 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 3.75 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 3.6299999999999999 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.1299999999999999 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.7200000000000002 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 56' ' ' VAL . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 0.54000000000000004 110.282 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 1.8400000000000001 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 0.42999999999999999 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.496 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.58999999999999997 112.984 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.71999999999999997 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.1699999999999999 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 2.0299999999999998 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 1.51 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.56000000000000005 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.41999999999999998 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.424 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 0.78000000000000003 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.3900000000000001 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 1.1399999999999999 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 0.71999999999999997 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 0.70999999999999996 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 0.57999999999999996 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.48999999999999999 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.01 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.70999999999999996 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 0.38 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 0.46999999999999997 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.1899999999999999 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6000000000000001 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 0.73999999999999999 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.0700000000000001 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 3.1299999999999999 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 115' ' ' ASN . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 1.49 112.669 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.77000000000000002 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 0.66000000000000003 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.27 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55000000000000004 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 0.89000000000000001 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 0.82999999999999996 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 2.5800000000000001 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.7599999999999998 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.5599999999999996 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 115.007 1.484 . . . . 1.0700000000000001 115.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 0.5 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.1400000000000001 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 0.66000000000000003 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 1.05 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 0.66000000000000003 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 2.3500000000000001 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 1.54 113.519 169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 1.52 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 0.72999999999999998 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 1.53 107.379 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 112' ' ' VAL . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 0.56000000000000005 108.097 -167.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 1.9399999999999999 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 0.56999999999999995 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HA ' HD22 ' A' ' 91' ' ' LEU . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.0299999999999998 109.594 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 66' ' ' GLN . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.02 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.1100000000000001 111.77 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.3600000000000001 114.092 -176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.8700000000000001 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 2.5099999999999998 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 2.8799999999999999 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.467 ' CB ' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 1.5700000000000001 115.096 165.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 1.6399999999999999 106.465 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 2.29 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.23 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 4.1699999999999999 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 1.0600000000000001 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' VAL . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 1.1499999999999999 113.131 171.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 1.2 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.3100000000000001 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 0.48999999999999999 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 0.56000000000000005 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 4.2800000000000002 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 0.62 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 4.8499999999999996 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.6099999999999999 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 1.8100000000000001 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 0.46999999999999997 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 0.41999999999999998 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 2.3199999999999998 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' HD21 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.5899999999999999 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 1.6299999999999999 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.853 HD23 ' H ' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 3.8599999999999999 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.6400000000000001 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.6099999999999999 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.3700000000000001 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.1900000000000004 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 0.68999999999999995 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 3.8999999999999999 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.0499999999999998 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.54000000000000004 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 0.56999999999999995 112.91 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 1.3799999999999999 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.5099999999999998 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 2.1400000000000001 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 1.7 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.3999999999999999 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 0.96999999999999997 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 2.6899999999999999 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 5.4900000000000002 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.0900000000000001 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.1000000000000001 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 56' ' ' VAL . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 0.90000000000000002 107.485 151.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 55' ' ' VAL . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 2.6400000000000001 108.488 160.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 0.58999999999999997 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.66000000000000003 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.68999999999999995 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.6699999999999999 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 2.27 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 2.7999999999999998 106.113 -156.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 0.92000000000000004 114.11 166.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.67000000000000004 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.24 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.4100000000000001 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 1.47 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 0.77000000000000002 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.0700000000000001 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 1.8 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 0.63 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.67000000000000004 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.0299999999999998 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.78000000000000003 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 0.46000000000000002 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 145' ' ' SER . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 0.54000000000000004 110.342 -166.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.5699999999999998 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.0600000000000001 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 0.47999999999999998 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 1.54 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 2.1299999999999999 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 1.3500000000000001 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.71999999999999997 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 0.63 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.4099999999999999 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 148' ' ' LEU . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.80000000000000004 109.022 156.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.1299999999999999 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.23 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 2.4700000000000002 113.96 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.4500000000000002 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.2400000000000002 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.086 1.143 . . . . 1.0700000000000001 114.086 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.4300000000000002 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.3899999999999999 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 0.77000000000000002 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.8200000000000001 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 0.66000000000000003 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 1.5 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 0.58999999999999997 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 2.5499999999999998 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 1.2 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.3599999999999999 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 1.3700000000000001 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 0.64000000000000001 103.999 176.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.91000000000000003 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 112' ' ' VAL . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 0.28999999999999998 109.876 -170.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 1.9099999999999999 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 0.54000000000000004 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 1.75 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76000000000000001 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 0.76000000000000001 111.806 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.7599999999999998 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.29 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 1.8999999999999999 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 1.75 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 1.95 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.4399999999999999 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 2.46 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.77 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.3799999999999999 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 0.55000000000000004 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 0.57999999999999996 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 0.66000000000000003 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.7200000000000002 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 0.32000000000000001 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 0.34000000000000002 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 4.6799999999999997 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 0.70999999999999996 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45000000000000001 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66000000000000003 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 0.52000000000000002 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 4.3300000000000001 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7000000000000002 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 1.79 109.611 158.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.5 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 0.37 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 2.0 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.2999999999999998 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 0.88 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 1.3899999999999999 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.7999999999999998 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.2799999999999998 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 0.90000000000000002 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 0.64000000000000001 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.04 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.25 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.54000000000000004 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 0.69999999999999996 113.069 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 1.49 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.8100000000000001 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 2.2799999999999998 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 2.6600000000000001 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.5600000000000001 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.48 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.0600000000000001 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 3.54 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 3.2599999999999998 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 0.93999999999999995 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.5899999999999999 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 56' ' ' VAL . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 0.65000000000000002 109.954 155.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 1.5600000000000001 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 0.47999999999999998 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.77000000000000002 113.314 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.59999999999999998 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.8200000000000001 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 2.1099999999999999 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 1.52 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.55000000000000004 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.46000000000000002 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 0.82999999999999996 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.8399999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 1.79 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 0.55000000000000004 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 0.70999999999999996 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.72999999999999998 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 0.48999999999999999 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.47999999999999998 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.51000000000000001 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.8600000000000001 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 0.40000000000000002 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.4 HG12 ' HE3' ' A' ' 139' ' ' LYS . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 0.54000000000000004 109.832 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.8199999999999998 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 0.56000000000000005 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 135' ' ' VAL . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 0.84999999999999998 113.384 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.0099999999999998 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 1.27 112.377 170.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.81999999999999995 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 0.60999999999999999 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.3600000000000001 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56000000000000005 110.599 162.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 0.81999999999999995 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 0.92000000000000004 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 2.4399999999999999 114.779 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.6699999999999999 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.9500000000000002 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 112.858 0.688 . . . . 0.77000000000000002 112.858 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.9700000000000002 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.1499999999999999 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 0.54000000000000004 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 0.65000000000000002 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 1.4099999999999999 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 0.69999999999999996 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 2.4399999999999999 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 1.3999999999999999 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.0600000000000001 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 1.22 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 0.60999999999999999 104.004 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 0.93000000000000005 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 112' ' ' VAL . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 0.32000000000000001 109.657 -170.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 1.8899999999999999 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 0.35999999999999999 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 1.8 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 89' ' ' ASN . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.73999999999999999 112.968 -164.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 0.83999999999999997 110.969 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.0300000000000002 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.3799999999999999 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 3.4399999999999999 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 1.7 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 2.4300000000000002 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 2.23 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.0 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.6699999999999999 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 0.72999999999999998 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 0.60999999999999999 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 0.67000000000000004 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.6099999999999999 109.788 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 0.41999999999999998 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.1299999999999999 115.272 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 0.58999999999999997 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.47999999999999998 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.68999999999999995 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 0.75 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 3.4700000000000002 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.7599999999999998 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 1.8799999999999999 111.886 157.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 0.34000000000000002 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 0.34000000000000002 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 1.99 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 60' ' ' GLY . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.2200000000000002 111.404 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 0.92000000000000004 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 1.54 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.3599999999999999 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.5899999999999999 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 0.89000000000000001 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 0.62 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.0300000000000002 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.52000000000000002 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 100' ' ' ILE . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 112.502 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 1.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.0899999999999999 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 2.2000000000000002 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 1.5800000000000001 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.4099999999999999 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 1.6299999999999999 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 2.5499999999999998 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 3.4700000000000002 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.05 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.5699999999999998 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' VAL . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 0.59999999999999998 109.682 171.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 2.4199999999999999 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.438 HD11 HG13 ' A' ' 54' ' ' VAL . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 0.59999999999999998 109.877 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.70999999999999996 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.71999999999999997 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.6100000000000001 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 2.3999999999999999 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 1.51 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.57999999999999996 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.46000000000000002 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 0.91000000000000003 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 1.1499999999999999 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 0.63 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 0.69999999999999996 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81000000000000005 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 0.52000000000000002 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.47999999999999998 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.1200000000000001 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1000000000000001 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.58999999999999997 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.8399999999999999 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 0.55000000000000004 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 0.73999999999999999 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.8399999999999999 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.3199999999999998 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 0.79000000000000004 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 0.98999999999999999 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 2.8900000000000001 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 2.6499999999999999 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 0.63 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.25 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.71999999999999997 110.607 161.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 0.76000000000000001 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 0.77000000000000002 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 2.25 115.891 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.1900000000000004 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.8300000000000001 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.756 0 N-CA-C 112.371 0.508 . . . . 1.3400000000000001 112.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.1899999999999999 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 0.81000000000000005 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.5699999999999998 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 0.53000000000000003 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 0.94999999999999996 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 0.55000000000000004 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 2.9300000000000002 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 1.8799999999999999 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 1.3500000000000001 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 0.57999999999999996 104.172 178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 0.93000000000000005 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 0.29999999999999999 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 1.8300000000000001 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 0.38 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 2.29 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.73999999999999999 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 0.70999999999999996 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 1.1299999999999999 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.4399999999999999 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.1499999999999999 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 1.8400000000000001 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 1.6699999999999999 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 1.8999999999999999 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.9199999999999999 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 2.21 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 1.9099999999999999 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.0600000000000001 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 0.58999999999999997 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 0.67000000000000004 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 0.52000000000000002 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 0.33000000000000002 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 0.32000000000000001 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.21 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 0.44 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 135' ' ' VAL . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39000000000000001 113.484 168.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.59999999999999998 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 0.47999999999999998 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.1299999999999999 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.1699999999999999 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 1.96 109.79 158.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 0.34000000000000002 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 0.40999999999999998 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 1.9199999999999999 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.1200000000000001 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 0.72999999999999998 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 1.3 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7000000000000002 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 96' ' ' LEU . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.4300000000000002 112.812 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.84999999999999998 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.1800000000000002 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 0.62 109.035 169.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 3.4500000000000002 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 2.3700000000000001 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.60999999999999999 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 0.81000000000000005 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 1.54 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.8500000000000001 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 1.8999999999999999 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.2400000000000002 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.6200000000000001 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.5 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.1499999999999999 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 2.6400000000000001 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 4.2699999999999996 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.04 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.2000000000000002 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 0.92000000000000004 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 1.97 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 0.48999999999999999 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.67000000000000004 113.157 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.56999999999999995 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 2.5800000000000001 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 2.6699999999999999 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 0.80000000000000004 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.56999999999999995 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 0.77000000000000002 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.2200000000000002 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 1.1200000000000001 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 0.44 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 1.0900000000000001 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78000000000000003 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 0.45000000000000001 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.54000000000000004 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.1899999999999999 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.3799999999999999 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.68999999999999995 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.1899999999999999 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 0.39000000000000001 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 80' ' ' HIS . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 0.42999999999999999 109.408 -174.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.5800000000000001 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 1.72 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 0.42999999999999999 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 1.25 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 2.1499999999999999 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 1.3500000000000001 111.942 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67000000000000004 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 0.56000000000000005 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.5900000000000001 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.5 110.183 158.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 0.73999999999999999 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.91000000000000003 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 2.7400000000000002 113.727 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.2699999999999996 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.8399999999999999 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 113.19 0.811 . . . . 1.1599999999999999 113.19 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.7400000000000002 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.4099999999999999 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 0.67000000000000004 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.5800000000000001 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 0.93999999999999995 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 1.79 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HA ' HG21 ' A' ' 55' ' ' VAL . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 0.58999999999999997 113.606 169.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 2.2400000000000002 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 1.74 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.3900000000000001 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 1.6000000000000001 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 0.89000000000000001 108.916 174.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 1.52 109.173 176.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 0.35999999999999999 108.888 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 1.8799999999999999 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 0.46000000000000002 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 1.6499999999999999 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.82999999999999996 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 1.01 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.90000000000000002 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.2599999999999998 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.7599999999999998 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.27 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.578 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 2.5499999999999998 112.125 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 2.0800000000000001 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.4700000000000002 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 2.48 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HE22 ' A' ' 66' ' ' GLN . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 1.78 113.674 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 2.6699999999999999 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 0.88 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 0.68999999999999995 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 0.70999999999999996 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.1800000000000002 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 0.46999999999999997 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 0.58999999999999997 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.21 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 0.51000000000000001 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51000000000000001 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.71999999999999997 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 0.69999999999999996 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 5.4500000000000002 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.1699999999999999 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 2.0099999999999998 110.708 163.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 0.45000000000000001 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 0.54000000000000004 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 2.0899999999999999 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.1100000000000001 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 1.53 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.6200000000000001 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.23 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.3599999999999999 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 0.69999999999999996 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 3.8500000000000001 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 4.1299999999999999 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.58999999999999997 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 0.81999999999999995 112.616 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 2.6200000000000001 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.3700000000000001 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 2.1400000000000001 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 1.96 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.0099999999999998 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.4399999999999999 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 1.71 115.13 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 2.8900000000000001 112.735 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 3.7999999999999998 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 0.95999999999999996 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.4900000000000002 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 158.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 55' ' ' VAL . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 2.1899999999999999 108.36 172.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 0.5 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.73999999999999999 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89000000000000001 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.8400000000000001 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 2.3700000000000001 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 1.48 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.66000000000000003 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.56999999999999995 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 0.85999999999999999 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.2400000000000002 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 1.1000000000000001 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 0.57999999999999996 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 0.91000000000000003 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.0600000000000001 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 0.57999999999999996 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.68999999999999995 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.1100000000000001 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.3199999999999998 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.65000000000000002 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.9099999999999999 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 0.42999999999999999 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.475 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 0.55000000000000004 109.851 -171.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.1499999999999999 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 0.5 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HE3' HG12 ' A' ' 135' ' ' VAL . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 0.93000000000000005 113.462 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 1.74 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 2.52 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76000000000000001 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 0.69999999999999996 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.3899999999999999 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.83999999999999997 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 0.73999999999999999 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.3600000000000001 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 3.5699999999999998 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.2699999999999996 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 4.4400000000000004 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 114.073 1.138 . . . . 1.1599999999999999 114.073 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.0300000000000002 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 0.51000000000000001 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.3700000000000001 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 0.70999999999999996 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 0.89000000000000001 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 0.62 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 2.4100000000000001 116.232 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 1.22 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.6599999999999999 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 1.1899999999999999 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 0.78000000000000003 104.91 -177.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 1.03 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 0.32000000000000001 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 1.78 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 0.39000000000000001 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 1.3899999999999999 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.82999999999999996 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 0.72999999999999998 110.582 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.69999999999999996 111.705 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.6600000000000001 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.1400000000000001 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.0299999999999998 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 2.8999999999999999 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.0499999999999998 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.9900000000000002 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 3.1400000000000001 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 2.48 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.7599999999999998 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 0.82999999999999996 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.429 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 0.64000000000000001 113.391 171.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 0.60999999999999999 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.9300000000000002 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 0.41999999999999998 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 0.41999999999999998 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 3.4399999999999999 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 0.56999999999999995 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51000000000000001 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.81999999999999995 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 0.5 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 4.9199999999999999 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.3999999999999999 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 2.0800000000000001 110.331 166.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 0.41999999999999998 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 0.37 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 2.04 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.2400000000000002 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 0.81000000000000005 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 1.3300000000000001 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.3599999999999999 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.4300000000000002 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 1.77 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 0.58999999999999997 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.1200000000000001 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 2.8599999999999999 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.82999999999999996 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 1.1100000000000001 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 2.2599999999999998 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.8500000000000001 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 2.3199999999999998 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 1.73 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.3100000000000001 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.0299999999999998 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 1.9199999999999999 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 3.5800000000000001 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 4.6299999999999999 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.29 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.0600000000000001 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 0.65000000000000002 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 1.6200000000000001 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 0.42999999999999999 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 141' ' ' LEU . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.62 113.298 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 50' ' ' LYS . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.72999999999999998 117.871 -169.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.7999999999999998 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 2.04 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 1.6000000000000001 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.56000000000000005 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.46000000000000002 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.429 ' SG ' HG13 ' A' ' 73' ' ' VAL . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 0.64000000000000001 115.239 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.2400000000000002 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 1.1699999999999999 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 0.55000000000000004 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 0.63 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81000000000000005 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 0.45000000000000001 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.55000000000000004 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.0299999999999998 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.59999999999999998 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 0.40000000000000002 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 0.55000000000000004 110.228 -166.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.6899999999999999 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 0.72999999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.1899999999999999 113.277 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 2.2799999999999998 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 1.3 111.912 165.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.0700000000000001 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 0.77000000000000002 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.53 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.5 109.153 155.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 0.73999999999999999 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 0.68999999999999995 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 2.21 111.532 173.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.8100000000000001 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 113.864 1.061 . . . . 0.78000000000000003 113.864 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.1800000000000002 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1000000000000001 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 0.47999999999999998 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.0099999999999998 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 0.79000000000000004 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 0.90000000000000002 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 0.78000000000000003 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 2.46 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 1.71 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 1.25 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 0.98999999999999999 105.536 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 1.1100000000000001 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 0.37 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 2.0099999999999998 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 0.40000000000000002 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.0299999999999998 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.73999999999999999 116.08 -164.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 0.66000000000000003 112.099 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.71999999999999997 114.022 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.4900000000000002 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.3999999999999999 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.0299999999999998 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 1.78 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.8700000000000001 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.1499999999999999 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 2.4500000000000002 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.0299999999999998 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.0 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 0.76000000000000001 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 0.70999999999999996 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 0.51000000000000001 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 0.40999999999999998 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 0.47999999999999998 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.0499999999999998 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 0.56000000000000005 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.5 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.73999999999999999 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 0.68999999999999995 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.52 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.1299999999999999 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 2.02 111.358 165.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 0.58999999999999997 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 0.5 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 2.0099999999999998 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.2400000000000002 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 0.98999999999999999 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 1.72 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.5299999999999998 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.8500000000000001 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.1100000000000001 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.0499999999999998 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 0.57999999999999996 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 3.8999999999999999 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.0699999999999998 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.48999999999999999 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 100' ' ' ILE . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 0.76000000000000001 112.716 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.0699999999999998 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.8899999999999999 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 1.8799999999999999 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.3399999999999999 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.1000000000000001 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.3999999999999999 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 1.8200000000000001 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.3100000000000001 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 3.5800000000000001 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 0.89000000000000001 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.1200000000000001 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 0.68000000000000005 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 1.6599999999999999 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 0.5 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.77000000000000002 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.83999999999999997 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.5800000000000001 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 2.48 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 1.51 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.57999999999999996 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.46000000000000002 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 0.76000000000000001 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2000000000000002 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 1.1000000000000001 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 0.71999999999999997 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 1.4299999999999999 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.89000000000000001 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 0.52000000000000002 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.78000000000000003 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.28 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.2999999999999998 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 0.89000000000000001 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.1400000000000001 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 0.47999999999999998 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.421 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 0.80000000000000004 110.141 -173.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.4199999999999999 110.793 166.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.9299999999999999 111.789 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 0.67000000000000004 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 1.1000000000000001 113.694 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HE3' ' HG3' ' A' ' 136' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 1.8300000000000001 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 2.5800000000000001 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.81999999999999995 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 0.58999999999999997 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.1899999999999999 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.52000000000000002 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 0.68999999999999995 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 0.97999999999999998 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 2.3700000000000001 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.7400000000000002 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 113.499 0.926 . . . . 0.97999999999999998 113.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.6800000000000002 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.0800000000000001 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 0.54000000000000004 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.8400000000000001 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 0.46000000000000002 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 0.91000000000000003 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 0.44 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 2.3799999999999999 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 1.27 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.6899999999999999 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 1.4299999999999999 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.85999999999999999 106.999 174.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 1.47 107.948 -178.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 112' ' ' VAL . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 0.26000000000000001 109.053 -169.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 1.8200000000000001 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 0.39000000000000001 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 1.3999999999999999 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78000000000000003 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 0.68999999999999995 111.257 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76000000000000001 114.314 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.0800000000000001 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 1.8400000000000001 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 1.6899999999999999 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.5800000000000001 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.0499999999999998 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 2.6899999999999999 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 1.9299999999999999 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 3.3399999999999999 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 0.79000000000000004 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 0.70999999999999996 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.8799999999999999 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 0.59999999999999998 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 0.56999999999999995 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 4.5599999999999996 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 0.82999999999999996 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45000000000000001 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81000000000000005 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 0.68999999999999995 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 3.6499999999999999 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 1.8300000000000001 109.923 157.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 0.42999999999999999 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 0.39000000000000001 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 2.3900000000000001 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.2999999999999998 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.21 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 1.46 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.3999999999999999 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.8400000000000001 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.1100000000000001 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 0.63 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 3.73 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 3.9300000000000002 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.53000000000000003 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 0.63 112.675 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 1.6699999999999999 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 1.8799999999999999 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.3700000000000001 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.54 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.2599999999999998 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.1699999999999999 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 2.3399999999999999 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 4.1299999999999999 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.01 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.5499999999999998 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 56' ' ' VAL . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 0.56000000000000005 109.71 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.514 ' HB2' HG23 ' A' ' 55' ' ' VAL . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 1.5700000000000001 108.428 171.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 0.51000000000000001 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.1100000000000001 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55000000000000004 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 2.0099999999999998 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 1.48 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.57999999999999996 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.68000000000000005 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.512 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 0.93999999999999995 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 1.2 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 0.75 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 0.77000000000000002 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 0.96999999999999997 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.72999999999999998 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.4399999999999999 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.95999999999999996 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.4500000000000002 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 0.70999999999999996 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.46 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 0.52000000000000002 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.5800000000000001 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.6299999999999999 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 0.62 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HE3' HG12 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 0.81999999999999995 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 2.4399999999999999 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 2.3500000000000001 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.83999999999999997 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 0.90000000000000002 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 1.98 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 148' ' ' LEU . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 0.77000000000000002 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 0.78000000000000003 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 2.5499999999999998 111.779 168.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.6099999999999999 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.5499999999999998 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 113.709 1.003 . . . . 0.84999999999999998 113.709 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.5299999999999998 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.1899999999999999 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 0.62 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.5699999999999998 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 0.62 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 1.24 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 0.89000000000000001 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 3.8199999999999998 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 1.8300000000000001 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.2200000000000002 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.0700000000000001 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 0.80000000000000004 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 1.3300000000000001 108.654 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 112' ' ' VAL . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 0.35999999999999999 109.568 -165.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 1.8600000000000001 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 0.5 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 1.54 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.81999999999999995 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.87 110.769 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.6200000000000001 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 2.73 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.1699999999999999 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.2400000000000002 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.8599999999999999 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.5099999999999998 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 2.7000000000000002 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.0299999999999998 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 3.96 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 0.82999999999999996 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 0.54000000000000004 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 0.58999999999999997 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.0499999999999998 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 0.34999999999999998 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 0.34999999999999998 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 4.2199999999999998 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 0.48999999999999999 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.46999999999999997 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64000000000000001 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 0.45000000000000001 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 5.2000000000000002 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.3199999999999998 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 1.96 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 0.41999999999999998 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 0.34999999999999998 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 2.21 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.3700000000000001 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 0.89000000000000001 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 1.3500000000000001 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.6600000000000001 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.8500000000000001 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.01 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.0099999999999998 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 0.70999999999999996 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.3199999999999998 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 2.4399999999999999 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.67000000000000004 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 0.91000000000000003 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 2.2000000000000002 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.6299999999999999 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 2.0499999999999998 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.1299999999999999 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1000000000000001 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.6899999999999999 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.0700000000000001 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 2.54 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 5.75 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.1699999999999999 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 2.8900000000000001 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 56' ' ' VAL . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 0.91000000000000003 108.177 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.44 ' HB2' HG23 ' A' ' 55' ' ' VAL . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 1.77 110.048 162.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 0.59999999999999998 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.71999999999999997 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54000000000000004 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 2.3500000000000001 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 2.48 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.71999999999999997 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.5 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 0.65000000000000002 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.0699999999999998 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 1.2 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 0.46000000000000002 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 0.72999999999999998 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93000000000000005 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 0.47999999999999998 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.70999999999999996 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.98999999999999999 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.8399999999999999 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.60999999999999999 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 0.40999999999999998 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 0.62 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.9300000000000002 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 0.59999999999999998 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 1.6399999999999999 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 2.2400000000000002 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 1.6000000000000001 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79000000000000004 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 0.56000000000000005 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.1899999999999999 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.73999999999999999 110.442 162.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 0.75 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 2.21 114.153 -170.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.2699999999999996 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.4500000000000002 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 113.547 0.943 . . . . 1.0700000000000001 113.547 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.4299999999999999 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 0.66000000000000003 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.2400000000000002 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 0.84999999999999998 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 0.93000000000000005 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 0.53000000000000003 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.0099999999999998 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 1.24 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.9099999999999999 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 1.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 0.88 105.114 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 0.98999999999999999 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 0.33000000000000002 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 1.8500000000000001 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 0.48999999999999999 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 1.99 110.164 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.90000000000000002 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.3500000000000001 110.027 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.98999999999999999 112.308 -175.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.0800000000000001 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 2.8300000000000001 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.2400000000000002 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.464 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 2.46 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.2999999999999998 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.5899999999999999 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 2.5699999999999998 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' HE22 ' A' ' 66' ' ' GLN . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 1.76 113.587 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 2.71 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 0.83999999999999997 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 0.64000000000000001 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 0.56000000000000005 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.3399999999999999 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 0.5 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 0.48999999999999999 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 3.2400000000000002 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 0.92000000000000004 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 135' ' ' VAL . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.58999999999999997 113.679 169.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 0.60999999999999999 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 3.6200000000000001 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.0199999999999996 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 2.02 111.312 161.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 0.45000000000000001 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 1.9299999999999999 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 0.91000000000000003 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 1.73 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.7400000000000002 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.6600000000000001 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.46 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.2999999999999998 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 0.70999999999999996 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 3.6899999999999999 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.25 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.56999999999999995 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 0.68999999999999995 112.37 -174.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 1.78 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.5699999999999998 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 1.8100000000000001 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 1.8700000000000001 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.0099999999999998 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.73 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.25 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 3.4700000000000002 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 3.9900000000000002 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.0 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.4300000000000002 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.1899999999999999 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 1.78 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 0.60999999999999999 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.78000000000000003 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68000000000000005 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 2.7200000000000002 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 2.52 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.0700000000000001 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.71999999999999997 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 0.84999999999999998 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.6400000000000001 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 1.1799999999999999 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 0.58999999999999997 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 0.87 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.1200000000000001 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 0.70999999999999996 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.66000000000000003 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.0600000000000001 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.1600000000000001 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.65000000000000002 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.8999999999999999 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 0.46000000000000002 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 0.62 109.999 -173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.9500000000000002 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 0.65000000000000002 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' HG12 ' A' ' 135' ' ' VAL . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 0.88 112.484 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 2.1699999999999999 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 1.25 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.73999999999999999 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 0.63 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.45 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.69999999999999996 111.58 162.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.2 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 0.75 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 2.1699999999999999 112.926 173.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.8500000000000001 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.7400000000000002 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 113.979 1.103 . . . . 0.84999999999999998 113.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.2999999999999998 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.1499999999999999 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 0.53000000000000003 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.1600000000000001 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 0.59999999999999998 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 1.1000000000000001 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 0.5 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 3.9199999999999999 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 1.3999999999999999 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.9099999999999999 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 1.5800000000000001 114.632 170.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 0.83999999999999997 105.261 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 0.98999999999999999 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 112' ' ' VAL . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 0.31 110.356 -172.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 1.79 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 0.38 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 1.9199999999999999 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.72999999999999998 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 0.83999999999999997 111.067 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.8600000000000003 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 3.7200000000000002 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.1800000000000002 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 1.79 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.3599999999999999 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 3.3799999999999999 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 2.8799999999999999 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.6499999999999999 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 0.88 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 0.94999999999999996 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 62' ' ' PRO . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 0.93000000000000005 112.267 -177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.5699999999999998 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 0.57999999999999996 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 0.56000000000000005 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 4.3099999999999996 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 0.56000000000000005 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89000000000000001 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 0.56999999999999995 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 4.25 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.8399999999999999 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 1.78 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 0.40999999999999998 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 0.40999999999999998 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 2.3300000000000001 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.1800000000000002 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 0.88 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 1.6499999999999999 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.1499999999999999 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.85999999999999999 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.9700000000000002 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 0.65000000000000002 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 3.9100000000000001 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 2.4900000000000002 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.52000000000000002 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 0.56000000000000005 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 1.4099999999999999 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 1.9199999999999999 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.1499999999999999 113.937 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 1.9099999999999999 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.5900000000000001 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 0.97999999999999998 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 2.6800000000000002 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 3.6499999999999999 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.01 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 1.9399999999999999 111.757 -170.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 0.55000000000000004 109.608 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 1.5900000000000001 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 0.42999999999999999 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.0600000000000001 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.90000000000000002 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 2.0600000000000001 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 1.5800000000000001 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 1.1399999999999999 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 0.68999999999999995 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.01 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 1.5 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 1.01 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.02 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.85999999999999999 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 0.54000000000000004 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.76000000000000001 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.1799999999999999 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.67000000000000004 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.9399999999999999 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 0.57999999999999996 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 0.69999999999999996 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.5099999999999998 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.6899999999999999 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 0.76000000000000001 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 0.97999999999999998 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.1000000000000001 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 1.51 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.67000000000000004 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 0.78000000000000003 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.78000000000000003 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 0.62 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 0.94999999999999996 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 4.0300000000000002 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.4100000000000001 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.1299999999999999 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.134 0.79 . . . . 1.03 113.134 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.2200000000000002 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.3600000000000001 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 0.78000000000000003 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 0.55000000000000004 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 1.1000000000000001 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 0.44 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 2.3799999999999999 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 1.45 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.1200000000000001 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 1.26 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 0.63 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 1.0700000000000001 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 0.40000000000000002 108.839 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 1.8 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 0.60999999999999999 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 2.2599999999999998 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.1099999999999999 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 0.94999999999999996 106.558 166.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.4199999999999999 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 3.7999999999999998 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 1.8600000000000001 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 1.8899999999999999 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 1.6200000000000001 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.0899999999999999 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 2.1499999999999999 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 1.9199999999999999 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 2.8399999999999999 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 0.65000000000000002 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 0.64000000000000001 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 0.51000000000000001 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 0.46000000000000002 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 0.51000000000000001 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.0600000000000001 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 0.60999999999999999 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68000000000000005 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92000000000000004 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 0.64000000000000001 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 3.79 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.8199999999999998 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 2.0299999999999998 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 0.53000000000000003 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 0.48999999999999999 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 2.0899999999999999 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9000000000000004 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.03 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 1.8799999999999999 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.2400000000000002 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.3500000000000001 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.03 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.0299999999999998 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 1.3 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 5.1100000000000003 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.04 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 0.92000000000000004 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 1.1000000000000001 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 1.6100000000000001 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 2.3199999999999998 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.0600000000000001 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.5499999999999998 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.25 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 4.6900000000000004 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 3.4399999999999999 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.0800000000000001 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 0.93000000000000005 108.265 153.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 1.8 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 0.48999999999999999 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.26 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.68999999999999995 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.9299999999999999 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 2.6200000000000001 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 2.5800000000000001 104.629 -160.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 0.94999999999999996 111.677 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 0.71999999999999997 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 0.79000000000000004 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.6299999999999999 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 2.21 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 0.58999999999999997 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 0.81999999999999995 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76000000000000001 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 0.66000000000000003 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.73999999999999999 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.0099999999999998 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.1899999999999999 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.71999999999999997 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.8200000000000001 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 0.41999999999999998 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 139' ' ' LYS . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 0.47999999999999998 109.657 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.3399999999999999 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 0.57999999999999996 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 135' ' ' VAL . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 1.1699999999999999 112.902 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 1.74 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 1.6599999999999999 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 0.57999999999999996 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 1.79 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.435 ' CB ' HG13 ' A' ' 135' ' ' VAL . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.57999999999999996 110.272 169.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 0.68999999999999995 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 1.6100000000000001 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 4.4100000000000001 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.985 -0.846 . . . . 14.859999999999999 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.4 p -108.59 15.5 23.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.616 1.71 . . . . 12.449999999999999 115.616 -166.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 61.53 155.55 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.953 2.101 . . . . 14.67 114.967 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.8 p -88.96 166.43 13.93 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.396 1.258 . . . . 11.029999999999999 114.396 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.29 163.24 24.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 12.34 113.647 173.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.25 -12.73 0.02 OUTLIER Glycine 0 CA--C 1.539 1.584 0 N-CA-C 117.588 1.795 . . . . 7.04 117.588 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.0 171.81 14.61 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 119.787 1.793 . . . . 5.8799999999999999 114.898 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.67 158.94 28.16 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.417 1.96 . . . . 4.6600000000000001 113.128 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.62 168.25 29.49 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.925 1.25 . . . . 4.1799999999999997 113.96 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.9 82.72 1.31 Allowed Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.1 -1.236 . . . . 3.6400000000000001 113.184 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.84 2.34 29.43 Favored Glycine 0 N--CA 1.478 1.477 0 C-N-CA 125.583 1.563 . . . . 4.1799999999999997 116.339 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.2 m -64.66 150.36 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.938 2.095 . . . . 3.7000000000000002 112.996 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.56 -39.61 70.86 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.193 0.812 . . . . 1.04 113.193 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -62.52 -25.02 67.81 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.447 1.277 . . . . 2.8700000000000001 114.447 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.8 -49.14 10.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.86 1.264 . . . . 1.3500000000000001 111.027 172.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -33.13 67.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.48 1.112 . . . . 0.64000000000000001 111.77 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -58.89 -46.83 86.9 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.834 1.654 . . . . 2.4399999999999999 111.76 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.59 -30.21 64.19 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.034 -1.041 . . . . 0.59999999999999998 109.591 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.16 -47.26 74.61 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.213 1.405 . . . . 0.93999999999999995 112.365 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.4 -20.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 120.045 1.293 . . . . 0.57999999999999996 112.992 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -90.01 6.71 41.05 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 116.007 1.854 . . . . 2.4399999999999999 116.007 174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -76.09 -25.66 55.7 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.883 1.438 . . . . 1.8899999999999999 114.883 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -144.65 178.9 7.65 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.921 0.782 . . . . 1.8500000000000001 111.547 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -13.06 34.84 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.374 1.25 . . . . 1.54 114.374 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.27 81.58 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 105.632 -1.988 . . . . 0.68999999999999995 105.632 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.68 113.47 35.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 113.304 -1.771 . . . . 0.91000000000000003 106.88 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -105.55 150.91 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.56 1.544 . . . . 0.37 108.866 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -148.21 108.1 4.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.276 -0.638 . . . . 2.1200000000000001 109.276 -158.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.93 155.95 42.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.158 0.435 . . . . 0.42999999999999999 111.123 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -79.91 63.0 4.31 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.624 -1.297 . . . . 1.99 109.501 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 161.18 -166.74 35.87 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 114.887 0.715 . . . . 0.81000000000000005 114.887 -159.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 43.2 p -128.59 161.84 54.75 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 126.611 1.964 . . . . 0.87 111.408 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 71.8 Cg_endo -70.84 -19.28 31.19 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.445 2.097 . . . . 0.81000000000000005 112.883 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.01 -11.88 25.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.678 1.733 . . . . 4.3700000000000001 115.678 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -142.68 128.29 10.34 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 124.509 1.124 . . . . 2.3799999999999999 111.554 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.12 85.06 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 124.273 3.315 . . . . 2.23 112.23 -176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.444 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.3 -65.67 0.13 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.168 2.587 . . . . 1.8200000000000001 114.279 167.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.1 t -161.75 175.9 11.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 129.887 3.275 . . . . 1.9099999999999999 106.586 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.8 150.07 1.49 Allowed Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.251 1.405 . . . . 2.4300000000000002 116.007 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.473 16.0 p90 61.28 17.4 8.21 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 118.44 2.756 . . . . 2.4100000000000001 118.44 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.6 p -80.25 -28.07 38.53 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.434 -1.417 . . . . 1.9399999999999999 114.728 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -84.94 -26.45 27.2 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.529 0.732 . . . . 2.96 111.093 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.32 -35.2 75.06 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.144 0.884 . . . . 0.65000000000000002 112.544 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.99 -40.04 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.821 0.848 . . . . 0.56999999999999995 112.994 172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.34 -35.52 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.899 0.88 . . . . 0.58999999999999997 111.656 -176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -55.3 -53.21 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.378 1.471 . . . . 2.5499999999999998 110.411 166.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.4 mt -61.47 -45.55 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 119.308 0.958 . . . . 0.46000000000000002 110.881 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 71.7 mt -60.71 -53.24 59.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 119.092 -0.48 . . . . 0.37 112.265 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -65.27 -32.84 74.71 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.234 1.198 . . . . 4.0700000000000003 114.234 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -61.72 -42.46 98.98 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.957 1.303 . . . . 0.66000000000000003 111.334 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -72.92 -1.59 17.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.727 1.211 . . . . 0.45000000000000001 113.739 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.97 16.21 63.61 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-N 120.204 1.366 . . . . 0.91000000000000003 114.295 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.44 108.35 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.69 1.196 . . . . 0.47999999999999998 109.996 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -133.97 -11.48 2.6 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.299 1.84 . . . . 4.2800000000000002 114.028 -171.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -102.75 29.7 5.19 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.03 2.532 . . . . 4.3799999999999999 112.203 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -63.76 167.06 6.32 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 122.38 1.086 . . . . 1.99 108.234 167.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.97 109.71 22.39 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.445 -1.317 . . . . 0.44 107.445 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.2 104.64 15.94 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.55 -1.278 . . . . 0.45000000000000001 107.55 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -82.72 113.45 20.39 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.708 1.203 . . . . 2.1200000000000001 111.532 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -74.95 112.42 11.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.955 -1.02 . . . . 2.1400000000000001 110.624 163.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.18 7.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.9 mt -91.11 -15.92 28.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.192 0.997 . . . . 1.8700000000000001 112.821 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -68.78 -43.79 74.97 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.875 1.27 . . . . 3.04 111.946 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.18 131.57 24.33 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.463 1.905 . . . . 2.2799999999999998 112.603 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.79 -29.73 59.04 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.334 2.023 . . . . 1.4299999999999999 111.815 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -66.41 -37.74 85.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.735 1.214 . . . . 3.3599999999999999 113.1 173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 mt -63.43 -48.0 79.58 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.046 -0.724 . . . . 0.66000000000000003 109.046 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.1 -62.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.967 1.307 . . . . 3.98 112.539 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -75.19 -31.34 60.92 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.695 -0.628 . . . . 2.7999999999999998 112.018 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.1 -46.14 94.21 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 117.957 -1.468 . . . . 0.64000000000000001 112.016 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.1 tp -77.53 -37.18 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 119.518 1.659 . . . . 0.65000000000000002 112.22 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -57.43 -49.34 76.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.942 0.497 . . . . 1.3799999999999999 110.994 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.09 -48.13 66.35 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 2.4300000000000002 112.853 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -55.21 -40.94 71.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.683 1.193 . . . . 1.95 111.865 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.8 m -82.87 -11.44 58.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.028 1.331 . . . . 1.75 114.432 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 49.02 35.62 7.17 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.111 2.164 . . . . 2.3700000000000001 114.748 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.68 150.16 67.51 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.365 1.466 . . . . 1.48 111.033 -172.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.42 -35.6 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.818 2.345 . . . . 1.0900000000000001 112.869 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 t -163.55 130.46 3.35 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.164 -0.96 . . . . 2.73 111.95 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.11 162.76 41.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.406 1.882 . . . . 5.6600000000000001 110.331 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -98.35 140.94 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 CA-C-O 118.414 -0.744 . . . . 1.1799999999999999 111.67 131.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -128.16 162.27 27.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.493 1.117 . . . . 2.2999999999999998 111.92 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.78 138.35 50.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 109.481 -0.563 . . . . 0.65000000000000002 109.481 157.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -111.82 130.09 55.93 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.954 -1.128 . . . . 2.2999999999999998 107.954 172.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 125.73 51.5 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.118 0.567 . . . . 0.51000000000000001 110.171 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 56.54 33.57 22.88 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.315 0.857 . . . . 0.76000000000000001 113.315 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.79 1.92 55.64 Favored Glycine 0 CA--C 1.541 1.657 0 N-CA-C 117.365 1.706 . . . . 0.63 117.365 -169.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -103.42 146.43 28.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.181 1.99 . . . . 1.8600000000000001 111.214 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.77 136.99 33.11 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 124.626 2.155 . . . . 2.4100000000000001 113.059 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.34 -42.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 110.897 -2.865 . . . . 1.55 108.065 -134.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 162.93 172.29 30.22 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 119.685 -1.245 . . . . 0.55000000000000004 115.955 136.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 171.09 52.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 123.986 0.803 . . . . 0.41999999999999998 112.616 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 73' ' ' VAL . 9.3 t -63.97 -26.85 68.77 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.428 1.64 . . . . 0.71999999999999997 115.428 -169.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -68.73 -37.94 79.83 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.915 -1.115 . . . . 3.6499999999999999 112.927 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.0 -44.79 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.021 1.328 . . . . 1.1599999999999999 110.644 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.2 tp -54.99 -34.96 63.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.335 0.654 . . . . 0.47999999999999998 111.96 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.11 -26.32 63.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.471 1.508 . . . . 0.69999999999999996 112.307 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -77.16 -52.45 9.24 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 121.111 -0.993 . . . . 0.83999999999999997 111.131 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.6 mtp -71.0 -30.95 67.34 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.699 1.199 . . . . 0.68999999999999995 113.858 -169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -51.2 -49.81 60.27 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 123.025 1.393 . . . . 0.54000000000000004 111.071 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -92.11 -22.18 20.03 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 111.626 -2.534 . . . . 1.0 110.659 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -80.97 -33.05 34.13 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.047 1.339 . . . . 2.6000000000000001 112.956 162.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.38 24.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 119.063 0.847 . . . . 0.66000000000000003 113.769 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.88 -11.45 59.81 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.431 -1.629 . . . . 2.4500000000000002 113.666 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.6 mt -74.14 -23.74 59.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 122.296 1.046 . . . . 0.46000000000000002 111.527 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.437 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.0 t -80.38 -40.58 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 127.519 2.328 . . . . 0.41999999999999998 109.38 -165.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -66.73 -41.16 88.35 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.364 1.866 . . . . 2.52 111.314 169.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -60.4 -43.65 96.47 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.208 1.003 . . . . 2.0600000000000001 111.362 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 34.8 mt -63.21 -38.11 89.89 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.355 1.062 . . . . 0.47999999999999998 112.097 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.437 ' HE3' HG12 ' A' ' 135' ' ' VAL . 65.6 mttt -63.63 -28.02 69.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.869 -1.062 . . . . 0.73999999999999999 112.677 177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -57.2 -41.81 80.09 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 120.709 1.595 . . . . 1.79 111.897 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.97 -15.97 60.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.446 1.098 . . . . 1.3600000000000001 113.146 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.33 59.25 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.141 0.877 . . . . 1.0700000000000001 113.425 -165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.5 mt -93.52 143.68 11.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 118.434 1.117 . . . . 0.69999999999999996 110.74 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -115.73 109.47 17.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.533 1.533 . . . . 2.5499999999999998 111.975 -174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.1 t -57.62 118.38 5.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.592 1.157 . . . . 0.56999999999999995 111.505 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.7 -4.06 2.77 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.601 1.56 . . . . 0.65000000000000002 114.913 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -78.28 -12.97 60.04 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.663 1.985 . . . . 0.93000000000000005 112.377 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.18 -33.88 76.78 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.239 1.815 . . . . 2.9300000000000002 112.33 168.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -93.63 13.32 22.46 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.899 1.28 . . . . 4.7000000000000002 114.346 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.562 2.345 . . . . 4.9000000000000004 113.0 177.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.833 0 N-CA-C 110.405 -1.078 . . . . 13.74 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.1 p -67.99 -10.35 52.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.651 1.58 . . . . 14.77 114.761 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -134.44 171.14 14.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.971 1.709 . . . . 17.93 109.968 168.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.267 1.6 p 62.53 162.86 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.587 2.355 . . . . 14.029999999999999 115.281 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.35 178.13 4.14 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.084 1.754 . . . . 11.73 114.959 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 155.8 15.92 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 126.561 2.029 . . . . 8.4499999999999993 111.47 158.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.19 -179.41 7.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.652 1.581 . . . . 6.71 113.012 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.62 153.65 19.27 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.411 1.005 . . . . 4.46 114.497 171.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.67 177.46 43.81 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 125.639 1.59 . . . . 3.3599999999999999 113.825 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.58 41.08 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.95 1.738 . . . . 3.23 115.739 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.2 178.27 17.29 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.066 1.317 . . . . 3.23 112.077 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 t 63.11 -177.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 2.29 114.505 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.04 -34.17 69.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.376 -1.453 . . . . 0.81000000000000005 114.412 -167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -67.03 -23.98 65.95 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.246 1.202 . . . . 2.6699999999999999 114.246 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -79.32 -48.74 13.56 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.47 0.708 . . . . 1.1699999999999999 110.228 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -60.71 -32.12 71.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.212 0.605 . . . . 0.54000000000000004 112.22 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.82 -40.53 96.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.885 1.674 . . . . 3.1899999999999999 110.655 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.07 -29.6 63.07 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.524 -1.36 . . . . 0.57999999999999996 110.326 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -49.98 55.36 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.064 2.146 . . . . 0.91000000000000003 111.511 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.75 -20.62 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 119.11 0.868 . . . . 0.46999999999999997 113.028 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.306 2.6 tptm -88.5 10.52 19.97 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 117.532 2.419 . . . . 2.1499999999999999 117.532 171.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -68.58 -35.42 77.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.312 -1.492 . . . . 1.55 113.406 168.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.95 179.05 6.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.657 0.742 . . . . 1.9399999999999999 111.697 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -90.82 -12.07 37.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.36 1.245 . . . . 1.6299999999999999 114.36 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.484 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -137.6 85.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.632 0 N-CA-C 105.215 -2.143 . . . . 0.59999999999999998 105.215 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.46 114.78 42.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.967 -1.015 . . . . 0.92000000000000004 108.691 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.32 149.76 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 125.181 1.392 . . . . 0.34000000000000002 109.43 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -145.99 107.57 4.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.415 -0.957 . . . . 1.95 108.415 -160.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.22 153.2 39.52 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.875 0.307 . . . . 0.41999999999999998 111.403 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 63.7 5.26 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.086 -1.009 . . . . 2.6400000000000001 109.688 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.41 -158.28 28.57 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 113.84 -160.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 30.3 p -139.79 165.02 34.03 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.302 1.441 . . . . 0.69999999999999996 111.98 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 65.6 Cg_endo -74.1 -21.9 17.54 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.554 2.169 . . . . 0.90000000000000002 113.298 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.11 -20.88 22.61 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.321 1.23 . . . . 3.9199999999999999 114.321 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -133.16 125.68 19.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.236 1.414 . . . . 2.4300000000000002 110.334 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.57 95.45 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.739 2.293 . . . . 1.97 110.169 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.3 pt20 -32.92 -58.37 0.36 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.946 2.498 . . . . 1.6499999999999999 113.138 165.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.51 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -157.75 -136.61 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.522 1.929 . . . . 2.02 107.566 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.12 -172.94 7.11 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-N 119.174 0.897 . . . . 2.0 113.575 159.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 63.5 -32.16 0.11 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 129.546 3.139 . . . . 2.0499999999999998 117.522 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 p -70.78 -37.17 73.3 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.155 1.382 . . . . 2.0099999999999998 114.323 -163.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -83.23 -28.16 29.43 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.043 0.937 . . . . 3.1200000000000001 111.041 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.98 89.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.621 0.768 . . . . 0.56000000000000005 112.227 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.7 m -71.98 -37.36 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 113.119 0.785 . . . . 0.66000000000000003 113.119 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.4 t -75.8 -33.91 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.995 0.918 . . . . 0.55000000000000004 111.691 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -61.95 -46.8 87.71 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.309 1.044 . . . . 2.5 111.236 169.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.63 -43.39 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.885 1.22 . . . . 0.35999999999999999 110.55 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -59.89 -57.98 10.54 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.565 -0.731 . . . . 0.39000000000000001 112.671 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -65.47 -30.47 71.25 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.195 1.362 . . . . 4.6500000000000004 114.489 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.5 mt -62.07 -38.17 87.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.992 1.269 . . . . 0.44 111.779 171.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -76.74 2.74 13.44 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.104 1.361 . . . . 0.37 113.356 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.88 3.48 70.56 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 124.97 1.271 . . . . 0.56000000000000005 115.291 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.87 121.8 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 118.683 1.242 . . . . 0.40999999999999998 112.727 -167.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 -140.26 -10.2 1.11 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.084 2.154 . . . . 4.9500000000000002 114.775 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -89.39 26.08 1.77 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.375 1.87 . . . . 3.6699999999999999 112.894 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -68.61 163.87 22.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.028 0.918 . . . . 1.8200000000000001 109.522 166.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.8 110.44 23.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.41999999999999998 107.695 157.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.51 101.5 14.24 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.079 -0.711 . . . . 0.38 109.079 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -81.1 115.42 20.53 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.272 1.429 . . . . 1.9399999999999999 112.078 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.74 111.08 9.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 124.242 1.017 . . . . 2.2200000000000002 111.399 163.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -86.02 6.08 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 114.694 1.368 . . . . 0.93000000000000005 114.694 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.2 mt -92.29 -14.25 29.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.081 0.953 . . . . 1.79 112.342 166.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.69 -38.3 83.49 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.677 1.191 . . . . 2.4700000000000002 112.643 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -133.28 131.94 21.87 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.938 2.095 . . . . 2.3300000000000001 111.656 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -66.22 -23.02 52.86 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.053 1.835 . . . . 0.89000000000000001 111.789 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -62.25 -41.79 98.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.116 1.767 . . . . 3.1000000000000001 113.011 169.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.4 mt -68.0 -41.96 81.46 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.991 -0.374 . . . . 0.59999999999999998 109.991 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -60.31 -54.01 50.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.564 0.579 . . . . 4.9699999999999998 112.564 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -65.09 -44.81 87.65 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.868 0.867 . . . . 3.52 111.401 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -50.89 -44.11 49.22 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.789 -1.006 . . . . 0.57999999999999996 112.126 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.4 tp -85.05 -34.49 8.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 118.351 1.075 . . . . 0.68000000000000005 112.955 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.19 -31.29 71.04 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.271 0.941 . . . . 1.46 112.167 173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -83.29 -48.92 9.92 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.729 -0.607 . . . . 1.97 112.581 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.94 -25.73 63.79 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.785 1.402 . . . . 2.1499999999999999 114.785 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.7 p -93.51 -3.52 52.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.33 1.052 . . . . 2.3599999999999999 113.588 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 51.78 22.18 1.62 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.558 1.943 . . . . 1.6200000000000001 114.658 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -124.1 141.92 38.45 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 120.286 1.403 . . . . 1.6100000000000001 113.087 -171.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 106' ' ' TRP . 72.0 Cg_exo -57.33 -35.01 98.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.641 2.894 . . . . 1.52 114.89 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 m 174.69 124.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 127.748 2.419 . . . . 3.6800000000000002 109.972 150.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.5 mm -138.35 134.4 17.58 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.559 1.944 . . . . 3.4399999999999999 107.965 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.23 140.95 12.56 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 CA-C-N 120.96 1.378 . . . . 0.83999999999999997 110.263 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -150.6 174.66 12.72 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.724 0.81 . . . . 2.8199999999999998 111.962 -163.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.97 139.54 42.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 121.592 -0.692 . . . . 0.64000000000000001 110.462 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.426 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 38.5 m-85 -109.47 128.1 54.91 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.772 1.229 . . . . 2.21 109.368 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.02 128.24 55.29 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.827 0.851 . . . . 0.41999999999999998 110.529 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 57.9 35.57 25.48 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.195 0.998 . . . . 0.87 112.37 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.77 28.78 Favored Glycine 0 CA--C 1.55 2.254 0 C-N-CA 127.075 2.274 . . . . 0.56999999999999995 118.364 -167.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -107.4 147.9 29.79 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 123.138 3.469 . . . . 1.97 112.067 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HB2' ' CE2' ' A' ' 113' ' ' TYR . 23.5 t80 -77.46 140.62 39.87 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 123.786 1.755 . . . . 2.2400000000000002 112.275 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.69 -39.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 111.751 -2.477 . . . . 1.6699999999999999 108.772 -139.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.16 164.6 26.16 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 116.931 1.532 . . . . 0.72999999999999998 116.931 144.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.96 166.51 28.75 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 124.642 1.115 . . . . 0.67000000000000004 112.23 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.0 t -53.01 -41.57 64.8 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.512 1.671 . . . . 0.75 115.512 -167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -68.09 -29.69 68.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.778 1.172 . . . . 2.3900000000000001 112.379 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.3 mm -79.35 -44.78 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.353 1.461 . . . . 1.46 110.552 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.1 tp -54.06 -34.17 59.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.893 1.277 . . . . 0.45000000000000001 110.945 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -53.16 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 1.1399999999999999 110.335 173.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -56.67 -50.4 72.23 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.215 -0.928 . . . . 0.89000000000000001 111.545 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.3 mtp -70.87 -30.74 67.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.311 1.444 . . . . 0.64000000000000001 113.595 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 130' ' ' GLN . 34.8 t60 -58.35 -52.31 66.15 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.902 1.334 . . . . 0.57999999999999996 110.243 170.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.413 ' HG2' ' CD2' ' A' ' 129' ' ' HIS . 5.2 mt-30 -91.72 -6.13 52.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 112.81 -1.996 . . . . 1.3899999999999999 111.277 -160.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -95.52 -35.12 11.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 129.007 2.923 . . . . 2.5099999999999998 113.274 159.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.91 10.94 33.64 Favored Glycine 0 N--CA 1.478 1.478 0 O-C-N 120.489 -1.382 . . . . 0.63 114.557 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 119.984 -1.892 . . . . 1.8500000000000001 113.09 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.8 mt -72.03 -25.05 61.65 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.314 1.054 . . . . 0.45000000000000001 111.243 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 t -77.88 -35.35 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 127.454 2.301 . . . . 0.45000000000000001 109.303 -170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -69.62 -37.16 76.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.716 1.206 . . . . 2.5800000000000001 111.491 171.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -67.5 -38.01 83.67 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.864 0.866 . . . . 1.95 111.989 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.39 -39.46 93.29 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.973 -1.079 . . . . 0.46000000000000002 112.0 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -64.32 -29.08 70.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.937 0.895 . . . . 0.87 112.613 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -67.55 -17.75 64.76 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.847 -1.158 . . . . 2.0600000000000001 113.951 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.57 0.27 44.59 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.794 1.638 . . . . 1.49 112.739 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.52 4.52 75.26 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.923 1.725 . . . . 0.71999999999999997 114.536 -173.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.5 mt -81.58 136.06 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.128 1.464 . . . . 0.53000000000000003 111.006 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -83.95 114.16 21.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 1.48 111.603 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.6 t -63.59 120.6 12.06 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 121.551 -0.718 . . . . 0.56000000000000005 109.739 164.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.18 -19.2 31.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.33 1.452 . . . . 0.81000000000000005 114.708 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 mt -69.14 -15.08 63.33 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.141 2.176 . . . . 0.97999999999999998 113.147 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.5 -16.38 62.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.559 1.944 . . . . 3.1000000000000001 114.199 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -126.35 21.68 7.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.385 1.074 . . . . 3.5 113.679 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.251 1.184 0 C-N-CA 127.093 2.157 . . . . 5.8499999999999996 113.451 -179.773 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.986 0 N-CA-C 110.97 -0.852 . . . . 23.43 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.3 p -91.28 144.23 25.82 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.015 0.908 . . . . 20.649999999999999 112.676 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -78.36 129.76 35.35 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.562 0.745 . . . . 20.43 110.347 168.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 p -142.81 168.93 18.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.76 1.224 . . . . 14.050000000000001 112.306 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.32 175.08 1.82 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.642 1.577 . . . . 10.76 113.224 167.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 154.07 11.99 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.467 1.508 . . . . 7.6200000000000001 113.18 -177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.6 155.67 19.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.102 0.961 . . . . 7.0199999999999996 112.655 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.43 17.47 58.68 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 115.498 0.959 . . . . 4.3700000000000001 115.498 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.77 139.71 43.41 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.242 1.021 . . . . 3.9399999999999999 110.949 169.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.69 36.34 4.84 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 118.095 0.948 . . . . 3.29 114.948 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.02 -175.6 26.31 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.442 1.496 . . . . 3.5499999999999998 115.392 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.0 t 66.32 176.82 0.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.839 2.456 . . . . 2.1699999999999999 113.689 -167.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.42 -35.9 72.78 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.659 -1.276 . . . . 0.77000000000000002 113.026 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -59.73 -21.28 60.45 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.751 1.62 . . . . 2.6200000000000001 114.902 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -87.42 -51.13 6.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.99 1.316 . . . . 1.48 111.982 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -54.65 -36.46 64.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.464 1.106 . . . . 0.5 112.398 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.37 -40.09 95.16 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.463 1.125 . . . . 2.0 111.126 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 -31.98 63.72 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 120.802 -1.186 . . . . 0.58999999999999997 110.38 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -47.3 86.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.573 1.949 . . . . 2.0299999999999998 110.989 172.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.2 -28.17 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 120.67 -1.269 . . . . 0.67000000000000004 112.821 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -77.85 2.7 16.4 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 116.877 2.177 . . . . 2.5 116.877 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -59.04 -41.64 88.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.808 1.243 . . . . 1.4399999999999999 112.305 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.78 172.5 12.61 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.873 0.844 . . . . 1.8200000000000001 111.25 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -22.81 51.16 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 118.086 -0.959 . . . . 2.4300000000000002 112.812 169.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -130.74 113.46 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 122.821 1.296 . . . . 0.95999999999999996 108.14 178.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -133.52 119.95 36.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 124.36 1.064 . . . . 1.5 108.878 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 112' ' ' VAL . 44.7 t -113.69 152.17 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 125.968 1.707 . . . . 0.31 109.126 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.12 108.06 4.52 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 119.14 -0.457 . . . . 1.79 110.275 -158.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.82 149.07 26.03 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.081 0.467 . . . . 0.33000000000000002 111.697 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -78.35 61.08 2.7 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 120.43 -1.419 . . . . 1.3899999999999999 109.613 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 168.04 -169.38 41.37 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.313 0.958 . . . . 0.84999999999999998 112.191 -160.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 42.4 p -141.81 158.46 62.4 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 124.188 0.995 . . . . 0.93999999999999995 111.396 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 44.3 Cg_endo -64.11 -31.95 64.42 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.33 2.02 . . . . 0.90000000000000002 113.18 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -83.95 -15.52 47.57 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.88 1.067 . . . . 3.8500000000000001 113.88 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -137.05 85.14 23.16 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.817 1.647 . . . . 3.0099999999999998 110.809 174.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.47 121.43 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 124.19 3.26 . . . . 3.23 109.984 175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 5.0 pm0 -73.97 -30.3 62.44 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.793 1.405 . . . . 1.95 114.793 -159.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 14.0 t -164.14 -146.6 0.1 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.076 1.75 . . . . 1.79 107.575 -164.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.95 153.71 52.3 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.539 -1.351 . . . . 2.2599999999999998 113.158 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.437 30.4 p90 58.29 -6.61 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.74 3.237 . . . . 2.46 119.74 170.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -29.41 70.66 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 119.113 -2.242 . . . . 2.6000000000000001 115.985 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -81.53 -27.41 34.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 118.774 -0.632 . . . . 2.8999999999999999 112.005 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -36.83 76.68 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.99 0.814 . . . . 0.71999999999999997 112.081 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.438 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.3 m -68.64 -37.51 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 O-C-N 121.118 -0.989 . . . . 0.60999999999999999 113.628 173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.14 -36.35 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.36 1.064 . . . . 0.56000000000000005 111.355 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -57.47 -54.06 51.16 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.133 1.773 . . . . 2.4199999999999999 110.623 166.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.2 mt -58.83 -43.56 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 118.891 0.768 . . . . 0.45000000000000001 110.755 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.35 -55.64 29.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.188 0.595 . . . . 0.42999999999999999 112.561 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -61.72 -34.87 76.57 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.154 1.168 . . . . 3.6400000000000001 114.154 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.85 -38.24 90.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.416 1.086 . . . . 0.51000000000000001 111.596 173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -77.03 1.35 18.17 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.909 1.284 . . . . 0.45000000000000001 113.776 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.92 24.36 35.41 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.934 -0.926 . . . . 0.78000000000000003 114.387 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -126.02 122.62 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.491 1.116 . . . . 0.64000000000000001 111.93 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.63 -2.09 2.73 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.304 1.842 . . . . 6.8499999999999996 112.825 171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.09 23.37 2.86 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.214 2.206 . . . . 3.4700000000000002 112.217 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.1 p90 -69.67 166.13 19.79 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.707 0.803 . . . . 2.04 111.023 169.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.7 109.49 21.22 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.019 -1.104 . . . . 0.55000000000000004 108.019 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 98.31 11.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.683 0.793 . . . . 0.60999999999999999 109.727 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -66.34 112.98 4.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.113 1.765 . . . . 2.27 111.464 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.28 94.97 9.47 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 126.3 1.84 . . . . 2.3500000000000001 111.251 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 m -82.34 8.56 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.095 1.517 . . . . 0.84999999999999998 115.095 -173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.63 -31.42 41.6 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.58 -0.7 . . . . 1.3400000000000001 112.549 167.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -68.64 -35.12 76.85 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.832 0.678 . . . . 2.0600000000000001 112.832 -166.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -130.45 123.2 20.3 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.057 1.743 . . . . 2.8999999999999999 111.584 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -67.28 -17.84 50.03 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.404 2.069 . . . . 1.6000000000000001 112.744 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.81 -45.83 92.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.534 1.534 . . . . 4.1600000000000001 112.1 165.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mt -66.62 -44.43 82.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.382 0.673 . . . . 1.0 109.618 175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -54.1 -58.73 6.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.672 1.189 . . . . 3.4199999999999999 111.79 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -63.69 -39.5 94.47 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.456 -0.777 . . . . 2.4300000000000002 112.434 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.39 -41.22 79.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.692 1.139 . . . . 0.72999999999999998 112.249 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.8 tp -87.33 -34.1 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.798 1.299 . . . . 0.72999999999999998 112.82 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 107' ' ' PRO . 56.9 mtpt -55.73 -33.81 64.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.576 0.751 . . . . 1.8500000000000001 111.909 168.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -80.87 -58.63 3.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.726 0.41 . . . . 2.0 111.988 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.13 -35.54 78.26 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.483 1.29 . . . . 2.27 114.483 -166.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 m -97.87 7.52 46.23 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.966 1.307 . . . . 2.52 112.001 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.97 12.1 1.13 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.384 2.674 . . . . 1.8400000000000001 118.032 169.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.24 143.86 51.08 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-N 120.03 1.287 . . . . 1.8400000000000001 112.787 -175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HA ' ' HE3' ' A' ' 101' ' ' LYS . 33.2 Cg_endo -63.87 -34.82 59.15 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.936 2.424 . . . . 1.1399999999999999 114.944 -172.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.5 m -165.37 115.15 1.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.913 1.285 . . . . 2.73 110.355 166.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.89 132.46 13.86 Favored Pre-proline 0 N--CA 1.469 0.519 0 C-N-CA 127.686 2.395 . . . . 3.21 107.797 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -68.21 134.71 32.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 122.488 1.924 . . . . 1.3400000000000001 110.853 168.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -127.85 164.65 21.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.988 0.813 . . . . 2.1000000000000001 111.542 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 56' ' ' VAL . 7.4 p -136.43 134.49 49.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.21 -0.663 . . . . 0.75 109.21 160.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.503 ' HB2' HG23 ' A' ' 55' ' ' VAL . 16.6 m-85 -99.14 135.94 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.248 0.619 . . . . 1.99 109.487 166.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mp -113.4 125.77 54.62 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.365 0.666 . . . . 0.59999999999999998 111.338 173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB2' HD21 ' A' ' 141' ' ' LEU . 10.5 t-20 52.48 30.0 7.78 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.686 0.995 . . . . 0.81999999999999995 113.686 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.4 3.92 90.54 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 118.345 2.098 . . . . 0.52000000000000002 118.345 -173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -105.46 143.83 33.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 121.168 2.484 . . . . 2.73 111.392 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.426 ' HD1' ' H ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -78.43 133.2 37.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 124.205 1.955 . . . . 2.25 110.645 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.426 ' H ' ' HD1' ' A' ' 118' ' ' PHE . 1.2 t -146.96 -27.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 112.188 -2.278 . . . . 1.6399999999999999 110.32 -144.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.2 162.74 27.57 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.996 0.758 . . . . 0.91000000000000003 114.996 144.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.37 167.78 26.39 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.221 1.391 . . . . 0.67000000000000004 112.002 163.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.438 ' SG ' HG13 ' A' ' 73' ' ' VAL . 4.7 t -66.17 -21.58 66.33 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 117.575 2.435 . . . . 0.70999999999999996 117.575 -165.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -77.68 -35.58 52.16 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.813 -1.18 . . . . 3.1400000000000001 112.195 168.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.3 -43.8 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.384 1.474 . . . . 1.27 110.808 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.12 -31.89 67.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.93 0.892 . . . . 0.81999999999999995 111.449 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -19.3 62.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.967 1.307 . . . . 0.76000000000000001 112.967 176.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -84.21 -55.76 4.01 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.051 -1.031 . . . . 0.81999999999999995 110.018 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 89.7 mtp -66.53 -30.4 70.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 114.029 1.122 . . . . 0.45000000000000001 114.029 -168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -54.98 -43.95 73.99 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 122.616 1.198 . . . . 0.64000000000000001 111.748 171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -94.76 -37.85 11.06 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 112.69 -2.05 . . . . 1.02 109.862 -157.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -71.41 -26.32 62.71 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.196 2.198 . . . . 2.1899999999999999 112.744 162.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.71 14.07 57.22 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 120.497 -1.377 . . . . 0.53000000000000003 113.125 171.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -70.65 -11.0 60.66 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.231 1.013 . . . . 2.2200000000000002 112.108 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.0 -28.69 43.44 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.307 -0.871 . . . . 0.39000000000000001 110.542 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.88 -36.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 125.378 1.471 . . . . 0.53000000000000003 109.585 -171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.05 -40.61 75.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.898 0.879 . . . . 2.6200000000000001 110.37 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.4 -40.26 90.33 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.161 0.584 . . . . 2.2200000000000002 111.832 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.62 -45.35 83.44 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.208 -0.933 . . . . 0.80000000000000004 111.75 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -61.02 -34.39 74.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.371 0.987 . . . . 1.29 112.02 175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -69.96 -26.57 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.847 1.259 . . . . 4.8700000000000001 112.982 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 115' ' ' ASN . 1.5 mm? -76.62 -12.33 59.99 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.748 1.219 . . . . 1.52 113.551 163.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.84 -8.67 68.59 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.998 1.761 . . . . 1.4299999999999999 114.432 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.49 135.4 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 119.171 1.485 . . . . 0.84999999999999998 111.408 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -88.84 110.97 21.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.951 2.1 . . . . 1.47 110.328 170.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.489 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 1.5 t -55.91 144.58 27.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.501 1.143 . . . . 0.71999999999999997 110.893 162.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.92 -21.47 62.36 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 120.769 -1.207 . . . . 0.64000000000000001 112.046 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.6 -7.71 58.7 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.427 1.491 . . . . 0.69999999999999996 113.135 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.9 OUTLIER -61.04 -22.84 64.96 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.245 1.418 . . . . 2.1099999999999999 113.036 169.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -133.56 34.99 3.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.275 1.83 . . . . 3.23 111.798 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.428 2.291 . . . . 4.8099999999999996 112.259 174.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.142 -0.783 . . . . 14.529999999999999 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -147.15 140.32 25.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.739 1.216 . . . . 12.220000000000001 111.296 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.32 43.19 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.877 0.871 . . . . 15.390000000000001 112.475 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 p -134.54 153.14 52.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.425 1.49 . . . . 12.06 110.763 170.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.407 ' SD ' ' HE2' ' A' ' 51' ' ' LYS . 14.7 mmt 25.68 115.25 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 130.151 3.38 . . . . 12.779999999999999 117.878 156.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 47' ' ' ALA . . . -97.08 -144.22 16.69 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.849 2.166 . . . . 7.3799999999999999 114.507 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.41 68.63 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 115.683 1.734 . . . . 7.3499999999999996 115.683 -168.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.26 139.93 8.06 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 127.234 2.349 . . . . 4.7800000000000002 115.864 167.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.49 177.65 35.69 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.89 1.709 . . . . 3.4199999999999999 112.552 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.5 7.44 63.66 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 125.199 1.38 . . . . 2.79 115.524 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.36 178.0 43.01 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 127.798 2.618 . . . . 3.1699999999999999 110.099 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.2 t 61.16 176.15 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.309 1.444 . . . . 3.2200000000000002 114.717 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.58 -35.0 65.29 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.048 1.339 . . . . 1.4299999999999999 112.592 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.7 -30.75 67.65 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.429 1.27 . . . . 2.3999999999999999 114.429 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 -52.0 10.33 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 121.282 -0.886 . . . . 1.54 110.66 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -61.31 -31.84 71.7 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.713 0.805 . . . . 0.88 112.302 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.33 -40.93 97.98 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.073 1.349 . . . . 1.8300000000000001 111.213 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 35' ' ' GLY . . . -75.09 -28.89 60.46 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.094 -1.004 . . . . 0.60999999999999999 111.042 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.92 -48.79 72.89 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.343 1.457 . . . . 0.96999999999999997 112.158 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.7 -19.81 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.757 -1.214 . . . . 0.48999999999999999 113.92 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 tptm -88.05 3.42 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 116.372 1.99 . . . . 2.4100000000000001 116.372 172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HE2' ' SD ' ' A' ' 5' ' ' MET . 51.2 mttt -71.93 -14.51 61.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.636 -1.29 . . . . 2.3300000000000001 113.707 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.65 -176.95 5.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.516 0.726 . . . . 2.04 111.934 163.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -18.16 30.38 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.388 1.625 . . . . 1.28 115.388 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -136.59 92.06 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 104.052 -2.573 . . . . 0.63 104.052 178.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.93 117.6 53.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.504 -0.924 . . . . 1.3 108.504 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 112' ' ' VAL . 39.7 t -112.05 148.03 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.342 1.457 . . . . 0.5 109.182 -170.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -145.66 107.6 4.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.458 -0.571 . . . . 1.96 109.458 -158.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -150.01 149.27 30.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 117.875 0.307 . . . . 0.56000000000000005 110.597 -173.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -82.63 62.97 6.54 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.087 -1.633 . . . . 1.4299999999999999 109.348 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.95 -171.24 41.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.18 0.895 . . . . 0.75 111.514 -152.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 44.8 p -140.91 165.77 27.24 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 125.159 1.383 . . . . 0.73999999999999999 109.882 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 25.0 Cg_endo -60.77 -15.98 41.14 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.746 2.297 . . . . 0.78000000000000003 114.616 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.78 -15.11 53.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.851 1.26 . . . . 3.8399999999999999 113.619 172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -128.46 120.07 20.76 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.937 0.895 . . . . 4.2400000000000002 113.194 -167.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.82 69.76 2.9 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.752 2.301 . . . . 2.1899999999999999 109.242 156.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -33.49 -47.24 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.347 2.259 . . . . 2.9500000000000002 114.425 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.9 t -151.74 46.56 0.79 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.528 3.131 . . . . 2.98 107.686 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.69 -69.41 3.21 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.736 1.16 . . . . 3.0899999999999999 113.463 -168.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -58.44 -29.57 66.24 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.76 2.133 . . . . 2.3599999999999999 116.76 -154.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -64.45 -26.48 68.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.647 1.179 . . . . 2.9500000000000002 112.083 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.88 -33.54 26.96 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.084 -1.01 . . . . 3.0 113.042 173.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.26 -41.32 79.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.468 0.707 . . . . 0.85999999999999999 112.224 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.26 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.396 1.078 . . . . 0.54000000000000004 113.686 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -75.85 -34.37 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.094 0.958 . . . . 0.54000000000000004 111.901 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -56.58 -50.87 70.65 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.751 1.22 . . . . 2.1899999999999999 110.926 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.11 -43.6 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.417 1.008 . . . . 0.51000000000000001 111.497 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.85 -59.39 5.45 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.426 0.69 . . . . 0.46999999999999997 112.586 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.75 -31.64 69.82 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.8 1.407 . . . . 3.4300000000000002 114.8 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.8 -40.93 96.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.641 1.177 . . . . 0.5 111.28 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.68 1.24 8.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.013 1.116 . . . . 0.39000000000000001 114.013 170.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.68 73.89 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.146 -0.971 . . . . 0.59999999999999998 114.449 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.88 121.21 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.529 1.132 . . . . 0.42999999999999999 111.984 -168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -130.4 -20.01 3.03 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.089 2.555 . . . . 3.9900000000000002 113.316 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -82.58 27.37 0.52 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.528 2.731 . . . . 3.3500000000000001 113.325 -175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 14.9 p90 -70.56 170.05 12.96 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.558 1.17 . . . . 1.9399999999999999 111.017 163.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.79 32.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.811 -1.181 . . . . 0.64000000000000001 107.811 153.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.5 120.14 34.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.607 0.763 . . . . 0.80000000000000004 109.31 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.27 122.97 37.36 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.492 2.317 . . . . 1.99 112.331 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -86.04 100.42 12.15 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.443 1.897 . . . . 2.2400000000000002 111.937 174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.58 8.79 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.544 1.313 . . . . 0.83999999999999997 114.544 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.4 mt -78.45 -40.69 34.91 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.322 -0.861 . . . . 1.3799999999999999 112.695 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.44 73.83 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.615 0.766 . . . . 2.8500000000000001 111.883 -174.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -116.0 100.25 53.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.822 2.049 . . . . 2.1800000000000002 111.777 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -66.0 -18.87 57.78 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.448 2.099 . . . . 1.1100000000000001 112.822 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -56.91 -53.29 59.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.977 2.111 . . . . 3.1200000000000001 112.492 164.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.1 mt -65.29 -41.92 93.65 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.549 0.74 . . . . 0.64000000000000001 110.161 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -55.96 -54.47 44.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.977 1.311 . . . . 3.52 110.795 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -62.26 -47.75 83.0 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.234 1.013 . . . . 2.6000000000000001 112.478 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.7 -39.14 75.12 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-N 115.232 -0.895 . . . . 0.62 112.511 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.0 tp -88.1 -32.08 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.115 0.966 . . . . 0.77000000000000002 112.557 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -59.29 -37.06 76.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.364 0.666 . . . . 1.48 112.014 168.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.92 -56.37 5.27 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.652 0.612 . . . . 2.1899999999999999 112.652 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.77 -34.31 77.88 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.677 -1.264 . . . . 2.3700000000000001 113.557 -171.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.2 t -87.94 -1.05 57.74 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.778 1.231 . . . . 2.6699999999999999 113.411 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 52.23 24.72 2.95 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.757 2.423 . . . . 1.5800000000000001 116.199 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.44 135.59 27.8 Favored Pre-proline 0 N--CA 1.468 0.46 0 O-C-N 120.662 -1.274 . . . . 1.6399999999999999 110.99 -172.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.1 -31.17 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.665 1.576 . . . . 0.97999999999999998 113.658 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.33 84.74 0.99 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.143 1.338 . . . . 2.73 114.257 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -137.81 147.58 57.41 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 126.076 1.75 . . . . 3.4700000000000002 109.935 167.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 58' ' ' LEU . 84.6 Cg_endo -96.43 155.17 1.29 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 123.893 3.062 . . . . 1.1100000000000001 112.792 165.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -134.92 169.21 17.74 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.986 1.314 . . . . 2.6200000000000001 113.608 -168.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 56' ' ' VAL . 12.7 p -133.59 143.57 38.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 123.777 0.831 . . . . 0.65000000000000002 110.448 157.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -123.6 130.55 52.84 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.569 1.548 . . . . 1.96 108.398 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.25 128.09 54.78 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.355 0.662 . . . . 0.76000000000000001 111.365 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.0 t-20 53.94 34.98 20.76 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.765 0.793 . . . . 0.95999999999999996 112.962 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.83 11.02 73.28 Favored Glycine 0 CA--C 1.545 1.952 0 N-CA-C 117.503 1.761 . . . . 0.78000000000000003 117.503 -172.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -113.76 143.57 44.41 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 120.698 2.249 . . . . 2.2000000000000002 111.379 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -84.43 141.01 31.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 123.663 1.696 . . . . 2.4300000000000002 111.892 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -157.51 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 111.049 -2.796 . . . . 1.5900000000000001 107.455 -133.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 167.95 28.18 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 117.454 1.741 . . . . 0.78000000000000003 117.454 138.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.3 170.43 52.42 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.044 1.307 . . . . 0.64000000000000001 112.763 166.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.5 t -62.6 -28.22 69.74 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.059 1.874 . . . . 0.97999999999999998 116.059 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.93 -32.07 57.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.962 1.256 . . . . 2.0800000000000001 111.823 172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.2 mm -72.63 -43.55 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.753 1.221 . . . . 1.03 110.447 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.0 -32.72 66.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.365 0.666 . . . . 0.71999999999999997 111.896 174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -32.25 72.92 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.236 1.014 . . . . 0.80000000000000004 111.894 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -69.92 -55.99 8.22 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.959 -1.088 . . . . 1.0700000000000001 110.25 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 90.8 mtp -71.51 -29.38 64.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.424 1.09 . . . . 0.47999999999999998 113.82 -165.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -56.75 -50.32 72.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.657 1.218 . . . . 0.79000000000000004 111.124 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -92.7 -16.3 25.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 112.677 -2.056 . . . . 1.48 111.158 -157.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.44 -34.63 15.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.388 1.875 . . . . 2.9500000000000002 112.494 161.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.24 13.73 30.22 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.866 1.212 . . . . 0.58999999999999997 114.403 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -71.92 -9.77 58.82 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.391 -1.653 . . . . 2.27 111.979 174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.26 -25.04 61.46 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 119.257 0.935 . . . . 0.40000000000000002 111.052 170.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 -38.37 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.906 1.282 . . . . 0.46000000000000002 110.129 -165.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -69.3 -35.28 75.83 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.206 1.402 . . . . 2.4199999999999999 110.884 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -66.03 -42.3 89.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.815 0.846 . . . . 1.5800000000000001 111.747 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 29.0 mt -62.6 -36.32 82.37 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.12 0.968 . . . . 0.51000000000000001 112.111 173.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -65.36 -22.31 66.79 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 118.252 -0.88 . . . . 0.81000000000000005 112.998 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -61.68 -34.26 75.44 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.393 1.452 . . . . 1.8799999999999999 112.846 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -88.74 0.31 56.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.417 1.887 . . . . 1.29 112.269 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.98 1.21 55.47 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.857 1.218 . . . . 1.1200000000000001 115.02 -173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.5 mt -71.97 132.47 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 118.956 1.378 . . . . 0.54000000000000004 110.779 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -80.25 113.1 18.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.256 1.422 . . . . 1.26 111.042 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.5 t -62.98 127.68 32.36 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 121.299 -0.875 . . . . 0.55000000000000004 110.25 162.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.22 -0.9 0.88 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.275 1.83 . . . . 0.90000000000000002 114.167 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.3 mt -97.74 -5.75 34.36 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.782 2.433 . . . . 0.88 112.983 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -55.13 -31.33 61.2 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.916 1.686 . . . . 2.1699999999999999 113.988 -175.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -123.15 34.71 5.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.077 1.751 . . . . 4.6299999999999999 111.505 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 127.171 2.188 . . . . 4.1399999999999997 113.147 176.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.966 0 N-CA-C 111.113 -0.795 . . . . 16.93 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 53.22 36.28 22.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.819 1.648 . . . . 14.23 115.235 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' CD1' ' HE2' ' A' ' 51' ' ' LYS . 18.1 t80 -163.14 139.54 7.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.941 1.296 . . . . 16.920000000000002 110.713 -170.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.259 71.0 p 63.31 -10.93 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 118.593 2.812 . . . . 15.69 118.593 -173.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.5 140.64 8.6 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 127.878 2.471 . . . . 14.1 108.645 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.28 -28.89 0.44 Allowed Glycine 0 CA--C 1.543 1.825 0 C-N-CA 124.526 1.06 . . . . 8.25 114.334 -162.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.86 173.35 11.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.114 2.566 . . . . 6.1399999999999997 111.68 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.45 169.32 14.95 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.129 1.347 . . . . 4.3200000000000003 116.208 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.57 2.72 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.034 1.778 . . . . 3.4100000000000001 111.757 -175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.1 18.31 57.89 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 115.737 1.055 . . . . 2.9100000000000001 115.737 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.32 -173.12 21.06 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.448 1.499 . . . . 3.3599999999999999 113.63 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t 67.5 167.24 0.24 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.657 2.383 . . . . 2.3900000000000001 113.636 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -36.58 61.42 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.788 1.635 . . . . 1.1200000000000001 114.07 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -68.88 -21.78 64.23 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.104 1.15 . . . . 2.7400000000000002 114.104 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -71.96 -52.04 19.08 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.842 1.201 . . . . 1.2 110.913 170.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -61.35 -34.62 75.59 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.527 1.131 . . . . 0.56999999999999995 110.817 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.95 -41.82 92.69 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 123.443 1.592 . . . . 1.9199999999999999 112.633 170.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.53 -20.9 42.46 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.023 0.929 . . . . 1.1000000000000001 110.777 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mt -72.0 -50.82 25.49 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.445 2.298 . . . . 2.1800000000000002 111.237 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.18 -30.6 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 119.93 -1.731 . . . . 0.76000000000000001 113.231 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.377 3.3 tptm -76.76 11.99 1.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 116.642 2.09 . . . . 2.4100000000000001 116.642 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HE2' ' CD1' ' A' ' 3' ' ' PHE . 5.0 mptp? -64.58 -38.45 91.05 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.96 1.096 . . . . 1.6200000000000001 113.96 166.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -143.47 174.01 11.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.342 0.974 . . . . 2.0099999999999998 112.702 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -23.06 53.21 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 119.281 -0.39 . . . . 1.4099999999999999 112.016 174.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -134.51 120.17 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 C-N-CA 126.242 1.817 . . . . 0.93999999999999995 107.546 176.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -130.67 119.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.904 0.859 . . . . 1.3700000000000001 108.939 174.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 112' ' ' VAL . 61.7 t -110.17 150.88 12.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 125.943 1.697 . . . . 0.35999999999999999 109.25 -169.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -142.55 105.25 4.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 118.167 0.439 . . . . 1.76 110.698 -159.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.03 157.28 37.35 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.787 1.032 . . . . 0.34000000000000002 113.787 -172.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -92.99 65.31 4.03 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.77 -1.206 . . . . 1.99 111.452 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.56 -128.83 1.03 Allowed Glycine 0 N--CA 1.467 0.709 0 CA-C-N 114.819 -1.082 . . . . 1.8300000000000001 114.382 -170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -166.65 160.23 11.69 Favored Pre-proline 0 N--CA 1.48 1.046 1 C-N-CA 133.722 4.809 . . . . 0.97999999999999998 107.646 171.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.45 -24.18 42.97 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.215 1.944 . . . . 1.0700000000000001 115.131 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -93.11 -18.45 22.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.474 1.657 . . . . 3.46 115.474 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -109.94 138.66 20.8 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 119.917 1.235 . . . . 3.4199999999999999 112.278 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.78 70.12 7.67 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.531 2.821 . . . . 2.2599999999999998 110.954 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.4 OUTLIER -31.06 -53.41 0.2 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.629 2.372 . . . . 1.74 116.207 169.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.443 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.2 t -162.78 -172.61 3.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.865 2.866 . . . . 1.6399999999999999 106.999 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.58 139.2 39.59 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 121.26 -0.9 . . . . 2.6200000000000001 114.691 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.459 19.1 p90 55.97 15.48 1.76 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 120.048 3.351 . . . . 2.3300000000000001 120.048 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.39 -20.73 31.41 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.972 1.842 . . . . 3.54 115.972 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.13 -28.23 38.99 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.519 -1.363 . . . . 3.2999999999999998 111.371 167.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.55 75.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.891 0.876 . . . . 0.68000000000000005 112.476 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.447 HG13 ' SG ' ' A' ' 122' ' ' CYS . 17.0 m -67.14 -38.13 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 113.155 0.798 . . . . 0.54000000000000004 113.155 173.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 66.1 t -76.84 -35.45 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.318 1.047 . . . . 0.5 111.9 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -58.0 -55.72 31.23 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 125.033 1.333 . . . . 2.0499999999999998 109.639 166.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.18 -42.01 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.662 1.119 . . . . 0.31 111.172 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.19 -59.07 6.0 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.08 0.77 . . . . 0.38 113.08 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -63.4 -31.05 72.09 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 114.798 1.407 . . . . 3.4199999999999999 114.798 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.21 -39.56 94.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.843 1.257 . . . . 0.59999999999999998 110.7 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -76.08 3.74 9.87 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.076 1.139 . . . . 0.38 114.076 170.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.7 8.98 66.94 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-N 119.997 1.271 . . . . 0.58999999999999997 115.055 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.7 123.56 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.661 1.184 . . . . 0.46000000000000002 112.077 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 1.66 6.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.911 2.485 . . . . 6.29 110.784 165.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.43 9.68 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 129.582 3.153 . . . . 3.79 114.295 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.9 p90 -75.13 163.88 27.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 113.716 1.006 . . . . 2.2000000000000002 113.716 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.38 115.36 30.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.983 -1.008 . . . . 0.53000000000000003 108.726 150.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.76 101.57 11.0 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.069 -1.085 . . . . 0.67000000000000004 108.069 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -64.85 115.26 5.14 Favored 'General case' 0 C--O 1.239 0.513 0 O-C-N 120.776 -1.203 . . . . 2.4900000000000002 110.498 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -91.77 98.19 11.46 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.893 -1.503 . . . . 4.8600000000000003 109.468 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.9 m -73.85 -3.85 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 119.887 -0.725 . . . . 1.1599999999999999 112.541 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.71 -36.38 83.68 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.471 1.509 . . . . 1.9299999999999999 112.888 165.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.56 -22.76 53.88 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.939 0.718 . . . . 2.46 112.939 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.9 105.16 4.49 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.745 1.218 . . . . 1.76 114.241 -168.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -73.79 -22.74 17.35 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.808 2.339 . . . . 1.48 113.704 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.99 -37.84 84.95 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.636 -1.29 . . . . 3.1899999999999999 111.614 170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.23 -37.96 63.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.567 1.147 . . . . 1.73 109.946 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -55.11 -51.48 66.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.149 1.38 . . . . 3.3300000000000001 111.598 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.5 -42.24 95.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.162 0.892 . . . . 2.4100000000000001 111.649 174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.36 60.58 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 119.197 -0.78 . . . . 0.72999999999999998 112.998 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.4 tp -86.97 -33.95 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.768 1.227 . . . . 0.87 113.046 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -59.78 -28.7 67.64 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.995 0.918 . . . . 2.7400000000000002 112.406 169.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -81.61 -62.81 1.54 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.16 0.584 . . . . 2.2999999999999998 111.621 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.41 -50.08 74.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 2.2599999999999998 113.56 -172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.9 m -86.61 -1.9 58.05 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.255 1.022 . . . . 2.5499999999999998 113.458 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.7 t30 60.08 -1.13 0.2 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.357 2.354 . . . . 1.74 117.357 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.25 138.38 21.2 Favored Pre-proline 0 N--CA 1.467 0.386 0 CA-C-N 120.146 1.339 . . . . 3.1899999999999999 112.407 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.78 -36.46 40.44 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.153 1.902 . . . . 1.72 113.821 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -164.16 -4.84 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 119.879 3.289 . . . . 3.27 119.879 -167.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.21 139.71 72.48 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-O 117.802 -1.094 . . . . 3.9399999999999999 109.801 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -66.45 140.9 59.34 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 120.78 1.314 . . . . 1.24 111.339 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.75 161.96 22.95 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.795 0.725 . . . . 2.02 111.175 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.499 HG23 HG22 ' A' ' 56' ' ' VAL . 10.0 p -135.44 129.6 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-O 121.422 0.629 . . . . 0.60999999999999999 109.547 162.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.548 ' HB2' HG23 ' A' ' 55' ' ' VAL . 15.2 m-85 -96.71 129.7 44.07 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.261 1.024 . . . . 2.1299999999999999 109.595 167.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.88 133.11 53.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.651 0.78 . . . . 0.53000000000000003 109.22 170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 55.68 37.43 28.87 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.762 0.825 . . . . 0.97999999999999998 113.017 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.74 18.64 76.05 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 117.253 1.661 . . . . 0.91000000000000003 117.253 -175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -139.74 149.41 43.58 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.853 2.327 . . . . 3.1299999999999999 113.62 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.74 140.04 47.53 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 123.633 1.682 . . . . 1.99 112.021 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.89 -35.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 111.396 -2.638 . . . . 1.6100000000000001 110.351 -143.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.79 153.38 13.86 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 115.696 1.038 . . . . 0.84999999999999998 115.696 157.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.43 165.13 31.03 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.506 1.05 . . . . 0.63 111.464 158.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' A' ' 73' ' ' VAL . 16.7 t -59.66 -38.16 80.68 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.008 1.904 . . . . 0.78000000000000003 114.862 -171.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.23 -23.97 63.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.767 -1.208 . . . . 2.29 113.363 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.8 mm -79.41 -45.28 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.911 1.685 . . . . 1.3999999999999999 110.592 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.88 -34.41 67.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.933 0.893 . . . . 0.54000000000000004 112.102 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.37 -21.43 63.8 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.679 1.591 . . . . 1.03 112.088 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -83.98 -54.24 5.0 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.789 -1.195 . . . . 1.49 110.478 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -62.77 -31.61 72.61 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.677 0.991 . . . . 0.82999999999999996 113.677 -172.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.58 -50.36 65.74 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.606 1.194 . . . . 0.70999999999999996 111.125 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -92.69 -17.08 24.73 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 113.026 -1.897 . . . . 1.1799999999999999 111.129 -158.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -80.24 -33.95 37.57 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.438 1.895 . . . . 2.6299999999999999 112.394 156.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.65 16.01 44.15 Favored Glycine 0 N--CA 1.474 1.203 0 O-C-N 120.822 -1.174 . . . . 1.05 112.518 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.51 -11.76 60.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.994 1.718 . . . . 1.8899999999999999 112.233 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.31 -23.18 47.21 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.73 1.212 . . . . 0.68000000000000005 111.308 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -77.04 -35.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.156 1.382 . . . . 0.55000000000000004 109.103 -173.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -61.51 -47.0 87.6 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.022 0.929 . . . . 3.1099999999999999 111.867 167.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.96 -42.05 88.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.442 1.097 . . . . 2.4199999999999999 113.566 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.4 mt -64.95 -45.16 86.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.607 1.163 . . . . 0.54000000000000004 112.37 170.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -61.92 -32.12 72.5 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.103 0.961 . . . . 1.1200000000000001 112.543 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -58.73 -36.84 74.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.866 1.266 . . . . 2.0899999999999999 112.519 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.43 -14.85 58.66 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.227 1.011 . . . . 1.46 113.537 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.63 17.87 74.53 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.322 0.963 . . . . 0.88 113.855 -167.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.01 134.48 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.796 1.298 . . . . 0.66000000000000003 110.825 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -78.59 116.33 18.9 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.751 1.221 . . . . 1.3799999999999999 111.27 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.3 t -66.6 120.41 13.38 Favored 'General case' 0 C--O 1.215 -0.763 0 O-C-N 121.677 -0.639 . . . . 0.5 110.059 159.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.13 -13.8 5.6 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 119.938 -1.726 . . . . 0.76000000000000001 114.266 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -80.28 -2.77 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.633 1.973 . . . . 0.79000000000000004 113.397 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.03 -23.62 20.58 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.605 1.962 . . . . 2.52 113.193 177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.67 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.859 2.464 . . . . 4.5099999999999998 115.062 173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 C--O 1.256 1.447 0 C-N-CA 128.171 2.588 . . . . 9.3300000000000001 113.19 167.583 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.458 0 N-CA-C 112.123 -0.391 . . . . 17.940000000000001 112.123 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.1 p -79.8 -24.23 41.55 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.371 1.619 . . . . 14.92 115.371 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -103.03 149.3 24.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.343 1.057 . . . . 14.92 111.43 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -142.06 160.82 39.45 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 115.949 1.833 . . . . 12.800000000000001 115.949 -169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.7 mmt 30.56 -98.18 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 118.24 2.682 . . . . 14.699999999999999 118.24 151.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.86 129.79 6.74 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.365 1.46 . . . . 7.4199999999999999 110.956 -160.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.54 134.32 42.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.322 0.86 . . . . 5.5599999999999996 113.322 -163.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.26 154.14 25.59 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.488 1.518 . . . . 4.1600000000000001 110.97 173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.97 -155.49 30.46 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.436 1.017 . . . . 3.8300000000000001 114.344 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.48 21.17 2.92 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.767 1.175 . . . . 2.8700000000000001 115.434 -172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.43 11.64 0.03 OUTLIER Glycine 0 N--CA 1.472 1.069 0 N-CA-C 118.297 2.079 . . . . 3.48 118.297 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.9 t -91.52 170.25 10.1 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.816 1.308 . . . . 2.8799999999999999 111.947 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.37 -28.33 66.77 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.599 1.16 . . . . 1.21 114.042 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -70.17 -26.25 63.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.51 1.524 . . . . 2.6899999999999999 114.247 171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -81.6 -52.22 7.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.441 1.096 . . . . 3.4500000000000002 110.263 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -50.71 -37.53 42.07 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.628 1.571 . . . . 0.76000000000000001 112.738 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.33 -43.05 92.77 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.35 1.072 . . . . 2.21 111.721 172.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.59 -26.6 60.03 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.202 -0.937 . . . . 0.56000000000000005 110.762 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.54 -49.36 71.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.663 1.585 . . . . 0.92000000000000004 110.852 168.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.88 -17.95 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 120.516 -1.365 . . . . 0.58999999999999997 113.879 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -88.42 3.2 50.82 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 115.159 1.54 . . . . 2.6600000000000001 115.159 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -70.25 -17.85 63.13 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.512 0.93 . . . . 1.6000000000000001 113.512 171.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.25 -175.66 4.92 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.767 0.827 . . . . 1.9199999999999999 112.191 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.466 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -92.35 -15.67 27.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.083 1.512 . . . . 1.3500000000000001 115.083 172.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.5 OUTLIER -137.27 80.96 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 104.736 -2.32 . . . . 0.79000000000000004 104.736 178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.74 115.48 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.138 -1.06 . . . . 1.1599999999999999 108.138 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 112' ' ' VAL . 47.9 t -106.86 148.47 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 C-N-CA 126.13 1.772 . . . . 0.28000000000000003 109.455 -173.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -146.15 108.3 4.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 122.694 0.398 . . . . 1.96 110.175 -161.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.44 154.96 38.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.394 0.278 . . . . 0.42999999999999999 110.495 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -77.96 63.04 2.88 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.121 -1.612 . . . . 1.8899999999999999 110.987 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.85 -164.9 36.69 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 116.469 1.348 . . . . 0.78000000000000003 116.469 -161.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 67.7 p -127.37 162.5 48.18 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.084 1.754 . . . . 0.65000000000000002 111.337 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.1 Cg_endo -76.49 -20.23 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.86 2.373 . . . . 0.87 112.931 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.31 -19.27 20.11 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.656 1.354 . . . . 3.8399999999999999 114.656 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -129.44 126.58 22.89 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.035 1.334 . . . . 2.4500000000000002 110.53 172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.74 90.36 1.23 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.667 2.245 . . . . 1.96 111.177 -178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.571 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 2.3 pt20 -25.75 -60.73 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.939 2.895 . . . . 1.8 114.278 167.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.571 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.1 t -159.5 -141.4 0.08 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.586 2.354 . . . . 2.0099999999999998 107.168 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.45 -179.02 3.94 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.297 0.953 . . . . 2.1899999999999999 113.496 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 63.99 -35.51 0.16 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 119.203 3.038 . . . . 1.9299999999999999 119.203 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 p -65.86 -30.48 71.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.137 1.375 . . . . 2.0 114.097 -163.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -81.76 -33.2 31.08 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.492 1.117 . . . . 4.0999999999999996 113.229 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.75 83.37 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.749 0.82 . . . . 0.56000000000000005 111.528 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.39 -39.84 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 121.638 -0.664 . . . . 0.51000000000000001 112.789 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.5 t -76.41 -32.61 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.043 0.937 . . . . 0.48999999999999999 112.068 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -63.67 -48.93 75.17 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.425 1.49 . . . . 2.21 111.032 168.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.56 -40.6 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.999 1.272 . . . . 0.32000000000000001 110.809 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.59 -59.54 5.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.884 0.698 . . . . 0.39000000000000001 112.884 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -61.51 -31.75 71.76 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.585 1.328 . . . . 4.3300000000000001 114.585 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.9 -40.27 96.12 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.589 1.086 . . . . 0.53000000000000003 111.05 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -74.73 -0.13 17.13 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.157 1.169 . . . . 0.55000000000000004 114.157 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.23 8.0 64.97 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 119.924 1.238 . . . . 0.69999999999999996 114.782 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.5 t -103.58 127.83 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.447 1.499 . . . . 0.57999999999999996 111.755 -171.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -12.27 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.143 1.777 . . . . 4.8899999999999997 113.774 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -90.31 26.56 1.9 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.491 1.916 . . . . 3.4300000000000002 113.202 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -67.46 161.89 24.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.682 0.753 . . . . 2.0099999999999998 109.957 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.98 117.69 35.53 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.086 -1.079 . . . . 0.35999999999999999 108.086 155.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.43 107.53 20.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.716 0.807 . . . . 0.35999999999999999 109.161 -175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -87.63 114.74 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.072 1.749 . . . . 2.02 112.099 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -74.96 107.36 6.97 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 124.692 1.197 . . . . 2.1600000000000001 110.976 166.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.2 m -81.96 3.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.308 1.225 . . . . 0.83999999999999997 114.308 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt -81.6 -27.7 34.1 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.086 0.857 . . . . 1.47 111.93 169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -68.38 -33.11 73.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.268 1.027 . . . . 2.2599999999999998 112.946 -168.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -126.94 127.25 24.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.895 1.678 . . . . 2.2400000000000002 111.808 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.21 -25.2 80.4 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.363 2.042 . . . . 1.05 112.344 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.57 -45.95 90.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.471 1.908 . . . . 3.3599999999999999 112.485 171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -44.24 86.04 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.231 0.612 . . . . 0.66000000000000003 110.28 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -56.98 -56.52 20.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.153 0.981 . . . . 3.8599999999999999 111.654 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -68.45 -39.99 81.24 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.158 0.429 . . . . 2.54 112.158 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.98 81.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.777 -0.457 . . . . 0.66000000000000003 112.112 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 tp -83.71 -38.16 13.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 118.413 1.107 . . . . 0.69999999999999996 112.697 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -58.87 -27.1 64.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.741 0.816 . . . . 1.3600000000000001 112.646 170.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.17 -58.41 3.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.179 0.592 . . . . 1.8600000000000001 111.545 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -60.04 -40.2 88.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.757 1.223 . . . . 2.1400000000000001 113.343 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.5 m -103.03 9.76 38.42 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.743 1.016 . . . . 2.3999999999999999 113.743 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 59.93 2.38 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.123 2.169 . . . . 2.46 116.848 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -107.32 133.93 20.15 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 120.368 1.44 . . . . 1.73 113.313 -167.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.88 -35.71 43.08 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.295 1.997 . . . . 1.3799999999999999 112.367 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -157.67 69.73 0.56 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.477 1.288 . . . . 2.6899999999999999 114.477 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.3 mm -136.9 122.0 12.84 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.762 -1.211 . . . . 4.0099999999999998 108.898 162.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.62 153.35 43.72 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.218 1.946 . . . . 0.93000000000000005 111.411 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -125.3 161.8 26.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.561 1.144 . . . . 3.1699999999999999 111.596 -162.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 56' ' ' VAL . 7.8 p -139.57 139.4 38.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.528 -0.733 . . . . 0.53000000000000003 109.958 164.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -123.0 123.43 40.87 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.822 -1.177 . . . . 2.9199999999999999 107.822 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.8 127.52 51.28 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.128 0.571 . . . . 0.47999999999999998 111.024 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 55.67 26.84 9.77 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.112 0.565 . . . . 0.95999999999999996 112.286 -172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.37 66.7 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 127.375 2.417 . . . . 0.79000000000000004 118.029 -169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.94 148.46 22.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.373 2.087 . . . . 1.8600000000000001 111.099 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -82.95 135.93 34.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 124.002 1.858 . . . . 2.79 112.151 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.04 -49.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 110.656 -2.975 . . . . 1.5900000000000001 107.459 -133.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.37 172.32 28.57 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.356 1.303 . . . . 0.89000000000000001 116.356 141.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.6 166.25 54.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.859 0.742 . . . . 0.72999999999999998 112.524 164.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 21.3 t -57.33 -21.42 35.21 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.887 1.439 . . . . 0.68999999999999995 114.887 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.62 -35.15 67.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.176 -0.953 . . . . 2.8599999999999999 112.09 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.5 mt -80.06 -39.75 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 126.927 2.091 . . . . 2.6899999999999999 110.228 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.0 tp -55.6 -33.77 64.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.712 0.805 . . . . 0.60999999999999999 111.76 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -17.63 62.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.515 1.526 . . . . 1.3700000000000001 113.619 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -86.07 -56.55 3.41 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.54 1.136 . . . . 1.48 109.393 167.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 82.8 mtp -68.48 -32.2 72.01 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 114.144 1.164 . . . . 0.87 114.144 -168.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -55.18 -45.23 75.78 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 123.141 1.448 . . . . 0.83999999999999997 111.036 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -94.17 -27.01 16.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 111.979 -2.373 . . . . 1.3300000000000001 110.26 -158.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -77.15 -31.89 55.93 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.373 1.869 . . . . 2.29 113.406 160.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.12 44.64 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.229 0.919 . . . . 0.81999999999999995 113.801 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -14.01 61.53 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.089 1.356 . . . . 2.5899999999999999 112.35 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.65 -25.81 59.45 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.655 0.74 . . . . 0.58999999999999997 110.611 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.454 HG12 ' HE3' ' A' ' 139' ' ' LYS . 5.5 t -77.4 -36.76 24.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 126.117 1.767 . . . . 0.52000000000000002 109.772 -168.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -68.98 -46.65 67.54 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.122 1.369 . . . . 2.6899999999999999 110.515 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -57.99 -35.13 70.77 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.835 0.454 . . . . 1.8799999999999999 112.203 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.65 -44.35 64.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.183 1.393 . . . . 0.56999999999999995 112.782 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 135' ' ' VAL . 73.6 mttt -56.9 -35.88 69.48 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.784 1.175 . . . . 0.98999999999999999 111.168 173.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.2 mtpt -74.5 -14.56 60.83 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.867 1.667 . . . . 2.1200000000000001 114.105 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.18 -9.75 54.39 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.452 1.101 . . . . 1.4199999999999999 112.927 161.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 7.04 85.82 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.546 1.546 . . . . 0.92000000000000004 114.574 -170.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.5 mt -86.54 137.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.842 1.257 . . . . 0.92000000000000004 111.132 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -93.43 112.13 23.96 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.058 1.743 . . . . 1.53 110.808 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.9 t -57.42 122.95 13.82 Favored 'General case' 0 C--O 1.221 -0.437 0 O-C-N 121.527 -0.733 . . . . 0.70999999999999996 110.12 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.23 -9.4 7.71 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.788 1.635 . . . . 0.76000000000000001 113.943 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.73 -9.68 57.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.674 1.989 . . . . 0.82999999999999996 113.005 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.57 -21.5 62.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.349 1.86 . . . . 3.0 113.386 173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.45 28.3 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.893 1.677 . . . . 4.1799999999999997 113.605 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.427 2.291 . . . . 8.2100000000000009 112.389 171.558 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.137 0 N-CA-C 111.05 -0.82 . . . . 22.260000000000002 111.05 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.0 m -89.66 12.47 16.79 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.488 1.662 . . . . 22.379999999999999 115.488 -169.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -135.33 136.5 41.58 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.783 1.233 . . . . 19.98 113.645 -170.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.1 p -141.4 154.99 45.94 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.168 1.387 . . . . 13.51 111.183 159.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.9 mmt 48.57 1.54 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 120.52 3.526 . . . . 12.449999999999999 120.52 166.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.02 174.64 50.54 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.762 -1.211 . . . . 9.9000000000000004 113.843 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.42 179.69 7.24 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.839 1.255 . . . . 8.0500000000000007 112.72 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.12 151.41 16.01 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.429 1.49 . . . . 6.1200000000000001 113.349 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.47 -131.27 6.77 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.929 1.728 . . . . 4.9299999999999997 113.051 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.39 17.67 62.22 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 116.208 1.243 . . . . 5.1100000000000003 116.208 172.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.47 14.46 73.69 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.886 1.343 . . . . 4.4299999999999997 114.715 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.7 m -66.75 144.87 56.07 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.596 1.159 . . . . 3.3500000000000001 112.854 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 -29.36 70.47 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.561 1.319 . . . . 0.85999999999999999 114.561 -171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -70.41 -21.36 62.84 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.395 -1.441 . . . . 2.9300000000000002 113.949 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -82.7 -49.04 10.2 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.5 1.12 . . . . 1.1599999999999999 111.0 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 1.5 mm? -57.95 -32.33 67.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.054 0.941 . . . . 0.66000000000000003 113.443 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -62.62 -41.49 99.04 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 123.189 1.471 . . . . 1.8700000000000001 111.792 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 -34.62 68.62 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 109.537 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -62.88 -50.07 72.36 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.543 1.537 . . . . 0.92000000000000004 111.808 173.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.14 -21.99 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.779 1.172 . . . . 0.44 112.666 172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 5.5 tptp -86.32 8.28 22.08 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 118.134 2.642 . . . . 2.8500000000000001 118.134 171.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -70.49 -32.12 69.5 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.866 1.212 . . . . 2.1800000000000002 113.644 168.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.85 177.51 8.29 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.91 0.862 . . . . 1.6499999999999999 112.761 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -89.33 -17.54 28.69 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.321 1.6 . . . . 1.3899999999999999 115.321 173.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -134.01 78.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 105.309 -2.108 . . . . 0.84999999999999998 105.309 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.65 114.18 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 114.696 -1.138 . . . . 0.93999999999999995 108.045 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -106.17 148.59 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 125.729 1.612 . . . . 0.29999999999999999 109.153 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -146.18 110.66 5.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.281 -1.007 . . . . 1.75 108.281 -159.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.14 153.71 31.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.772 0.26 . . . . 0.46999999999999997 111.289 -175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -81.85 64.6 6.62 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.532 -1.355 . . . . 2.0600000000000001 111.225 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.16 -153.79 24.56 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.46 1.505 . . . . 0.81000000000000005 113.876 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 72.7 p -135.48 157.76 75.8 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 127.45 2.3 . . . . 0.87 110.951 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 53.9 Cg_endo -64.92 -29.35 58.02 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.38 2.053 . . . . 1.0600000000000001 113.223 -174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -91.78 -14.29 30.11 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.815 1.783 . . . . 3.6099999999999999 115.815 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -127.99 132.34 24.29 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 119.523 1.056 . . . . 2.2799999999999998 112.586 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.1 76.55 4.32 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.48 3.454 . . . . 2.7200000000000002 112.833 -173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.496 ' HB3' ' HA3' ' A' ' 60' ' ' GLY . 0.7 OUTLIER -32.39 -60.99 0.27 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 129.086 2.954 . . . . 2.3700000000000001 115.142 163.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 3.8 m -160.01 -175.66 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 129.808 3.243 . . . . 3.1099999999999999 106.584 -171.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.56 150.84 25.54 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 121.083 -1.01 . . . . 2.25 114.737 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.411 0.2 OUTLIER 57.33 10.02 0.83 Allowed 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 118.375 2.731 . . . . 2.0800000000000001 118.375 170.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -61.0 -29.53 69.76 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.137 -1.602 . . . . 2.0499999999999998 115.25 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -86.14 -30.1 22.77 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 124.805 1.242 . . . . 3.3100000000000001 112.54 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.71 75.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.123 0.569 . . . . 0.72999999999999998 112.263 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 15.9 m -65.06 -41.77 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 121.449 -0.782 . . . . 0.97999999999999998 113.064 170.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.25 -35.75 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.334 1.054 . . . . 0.98999999999999999 111.901 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -60.98 -49.57 76.9 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.098 1.359 . . . . 2.6499999999999999 110.836 169.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.67 -42.38 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.895 1.225 . . . . 0.32000000000000001 110.675 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.98 -57.02 14.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 118.727 -0.654 . . . . 0.60999999999999999 112.623 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -57.04 -36.51 70.58 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.119 1.525 . . . . 4.96 115.119 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.7 mt -67.91 -34.51 76.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.629 1.172 . . . . 0.81999999999999995 111.513 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -76.56 2.49 13.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.443 1.097 . . . . 0.54000000000000004 113.711 166.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.54 -11.06 66.91 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.25 1.405 . . . . 1.0600000000000001 115.278 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.9 t -92.1 134.9 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.225 1.41 . . . . 0.72999999999999998 113.584 -161.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.05 -18.78 1.55 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 127.845 2.458 . . . . 4.7699999999999996 113.392 176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.81 27.64 0.37 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.124 1.77 . . . . 3.4500000000000002 113.303 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -69.79 159.47 33.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.229 1.014 . . . . 2.1000000000000001 111.303 164.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.67 117.14 33.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.592 -1.186 . . . . 0.41999999999999998 107.83 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.05 102.24 14.3 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.538 -0.912 . . . . 0.39000000000000001 108.538 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -81.31 115.88 20.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.813 1.245 . . . . 2.0 111.662 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -75.23 108.36 7.94 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 123.803 0.841 . . . . 2.2400000000000002 110.807 165.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 m -85.56 11.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 114.111 1.152 . . . . 1.1399999999999999 114.111 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.4 mt -90.76 -24.11 20.45 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.201 0.909 . . . . 1.8899999999999999 112.3 165.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.61 -43.64 79.96 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.691 1.197 . . . . 2.5 112.333 -168.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.33 125.6 29.43 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.923 1.689 . . . . 2.4300000000000002 110.283 169.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -61.53 -25.91 80.1 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.806 1.67 . . . . 1.0700000000000001 111.364 169.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -63.47 -40.55 97.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.918 2.087 . . . . 3.4100000000000001 111.902 173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.81 -41.82 82.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.018 0.527 . . . . 0.57999999999999996 110.815 169.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -59.12 -55.76 30.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.941 0.896 . . . . 3.98 111.778 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.8 -40.39 91.86 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.925 -0.484 . . . . 3.5800000000000001 111.758 174.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -44.87 -51.56 8.23 Favored Glycine 0 CA--C 1.524 0.612 0 O-C-N 123.948 0.78 . . . . 0.70999999999999996 112.121 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.1 tp -84.15 -33.14 8.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 117.896 0.848 . . . . 0.69999999999999996 113.04 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.681 0.673 . . . . 1.54 112.462 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -82.75 -47.3 12.11 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.945 0.498 . . . . 1.79 111.609 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.2 -32.89 71.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.478 0.918 . . . . 2.2200000000000002 113.478 -173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -85.3 -6.37 59.25 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.543 0.942 . . . . 2.1299999999999999 113.543 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.15 19.51 6.17 Favored 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 125.888 1.675 . . . . 1.9299999999999999 115.5 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -122.06 149.29 53.79 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 1.3300000000000001 113.69 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -65.23 -36.21 37.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.564 2.842 . . . . 1.1599999999999999 114.423 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.2 m -167.36 133.53 2.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.401 1.88 . . . . 2.6699999999999999 109.739 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -139.95 -179.25 0.97 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 126.732 2.013 . . . . 3.9399999999999999 108.917 167.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -94.16 142.65 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 120.937 1.091 . . . . 1.1399999999999999 110.986 131.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -123.0 160.2 26.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.308 1.043 . . . . 3.0600000000000001 110.733 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.91 134.68 53.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 121.469 -0.769 . . . . 0.54000000000000004 109.838 160.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -112.31 126.0 54.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.622 1.169 . . . . 1.5800000000000001 108.159 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.98 133.39 49.85 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.968 0.507 . . . . 0.46999999999999997 110.069 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 52.8 37.27 23.55 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.764 0.793 . . . . 0.77000000000000002 112.873 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.4 17.87 74.77 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 118.156 2.023 . . . . 0.71999999999999997 118.156 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.66 149.61 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.862 2.331 . . . . 2.6499999999999999 113.293 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -81.82 140.22 34.3 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 124.16 1.933 . . . . 2.4199999999999999 113.321 -172.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.73 -42.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 111.479 -2.6 . . . . 1.4399999999999999 108.347 -136.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.59 169.83 33.34 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 116.649 1.42 . . . . 0.59999999999999998 116.649 144.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.19 169.23 36.06 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.499 1.047 . . . . 0.47999999999999998 112.828 163.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 73' ' ' VAL . 1.8 t -67.14 -18.98 65.53 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 117.298 2.333 . . . . 1.1200000000000001 117.298 -170.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.29 -37.81 63.56 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.551 1.068 . . . . 2.1600000000000001 112.014 168.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 29.5 mm -75.54 -42.24 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.037 1.335 . . . . 1.55 111.321 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.6 tp -53.9 -34.69 60.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.665 1.186 . . . . 0.57999999999999996 111.947 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -28.94 67.44 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.775 1.23 . . . . 0.84999999999999998 111.582 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -77.07 -50.92 12.0 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.875 -1.141 . . . . 1.04 111.031 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 88.8 mtp -70.72 -28.6 64.85 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.003 1.321 . . . . 0.57999999999999996 113.815 -171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -52.69 -49.28 65.62 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.919 1.342 . . . . 0.54000000000000004 111.33 172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -93.38 -27.25 16.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 112.767 -2.015 . . . . 1.0600000000000001 110.518 -156.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.31 -33.1 55.71 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.779 1.232 . . . . 2.8199999999999998 112.053 161.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.54 28.4 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.706 1.146 . . . . 0.62 114.321 175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.82 -10.45 59.57 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.244 -1.739 . . . . 1.8400000000000001 112.412 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.6 mt -76.35 -25.83 55.08 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.409 1.004 . . . . 0.44 110.864 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.6 t -77.96 -42.15 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 125.598 1.559 . . . . 0.70999999999999996 109.871 -170.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.47 -31.49 72.72 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.868 0.867 . . . . 2.4300000000000002 111.279 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.51 -32.63 62.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.251 1.42 . . . . 1.6499999999999999 112.887 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.66 -37.03 62.83 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.783 2.033 . . . . 0.63 112.098 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.4 mttt -63.65 -23.63 67.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.495 0.924 . . . . 1.1299999999999999 113.495 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.91 -29.05 68.09 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.014 1.279 . . . . 1.75 113.471 168.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.71 -8.11 44.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.37 1.468 . . . . 1.3100000000000001 112.566 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.73 3.93 89.24 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.182 1.372 . . . . 0.88 115.106 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.4 mt -69.7 132.44 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 119.505 1.652 . . . . 0.56000000000000005 110.977 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -70.99 105.68 3.39 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.173 1.389 . . . . 1.8600000000000001 111.104 166.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 3.2 t -60.32 116.41 4.24 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.773 -0.825 . . . . 0.71999999999999997 108.773 154.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.17 12.13 Favored 'General case' 0 CA--C 1.549 0.923 0 O-C-N 120.359 -1.463 . . . . 1.1499999999999999 113.505 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.79 -11.03 53.61 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.617 2.367 . . . . 0.97999999999999998 114.151 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 0.8 OUTLIER -56.72 -43.16 80.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.161 1.784 . . . . 2.3700000000000001 112.012 171.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -109.61 22.23 15.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.504 1.521 . . . . 3.4900000000000002 113.146 -169.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.312 1.845 . . . . 3.98 110.634 169.015 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.064 0 CA-C-O 119.086 -0.841 . . . . 19.100000000000001 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -72.71 162.33 29.62 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.793 1.296 . . . . 15.56 113.3 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -104.59 148.46 26.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.981 0.913 . . . . 17.0 109.851 163.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.8 p -70.92 154.29 41.95 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.436 0.902 . . . . 12.380000000000001 113.436 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 58.49 168.49 0.05 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.631 2.373 . . . . 12.4 115.61 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.4 143.63 6.54 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.621 1.105 . . . . 7.3899999999999997 113.148 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.46 142.19 23.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.535 1.134 . . . . 6.0300000000000002 112.533 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.77 -174.74 35.59 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.94 1.257 . . . . 3.7599999999999998 113.24 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.62 -168.22 6.19 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.722 0.677 . . . . 2.9100000000000001 113.673 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.61 13.77 2.15 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 116.553 1.381 . . . . 3.6600000000000001 116.553 -175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.64 -167.59 38.65 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 126.355 1.931 . . . . 3.1899999999999999 111.134 -171.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 60.3 171.61 0.09 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.914 1.686 . . . . 2.29 113.401 -165.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.08 64.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.175 1.39 . . . . 0.95999999999999996 113.401 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -62.73 -23.82 67.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.44 1.274 . . . . 3.4300000000000002 114.44 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -80.5 -52.5 7.56 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.283 1.033 . . . . 1.1100000000000001 110.866 173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -59.39 -35.22 73.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.988 0.915 . . . . 0.47999999999999998 112.201 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -59.37 -44.83 92.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.137 1.446 . . . . 2.3300000000000001 112.057 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.81 -31.79 69.88 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.322 -0.854 . . . . 0.48999999999999999 110.149 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mt -67.4 -48.63 66.78 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.17 2.188 . . . . 0.89000000000000001 111.912 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.97 -15.25 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.535 1.061 . . . . 0.54000000000000004 113.178 172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.51 -12.94 47.46 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.501 2.408 . . . . 3.96 117.501 173.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -64.67 -25.69 68.06 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.478 1.911 . . . . 1.4399999999999999 113.3 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -136.72 179.97 6.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.315 1.046 . . . . 1.8300000000000001 109.751 164.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.21 -10.55 41.23 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.129 1.159 . . . . 1.8300000000000001 114.129 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -138.29 89.06 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.91 2.084 . . . . 0.56000000000000005 105.573 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.7 t -112.37 116.98 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.357 -1.292 . . . . 1.0 109.105 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 112' ' ' VAL . 41.0 t -114.4 149.29 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.776 1.63 . . . . 0.32000000000000001 109.433 -168.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -145.65 103.46 3.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.306 -0.257 . . . . 1.9399999999999999 110.306 -157.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.38 159.18 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.429 0.633 . . . . 0.70999999999999996 111.726 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -83.23 60.97 5.85 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.787 -1.196 . . . . 2.1000000000000001 109.93 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.41 -169.2 37.64 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 115.817 1.087 . . . . 0.75 115.817 -159.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.9 p -130.82 157.17 78.64 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 126.767 2.027 . . . . 0.60999999999999999 111.548 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.2 Cg_endo -67.54 -23.05 43.74 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.761 2.307 . . . . 0.76000000000000001 113.812 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -88.37 -30.6 19.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.186 1.394 . . . . 3.23 114.511 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -116.98 127.48 26.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.5 1.12 . . . . 4.0899999999999999 111.196 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 89.84 0.79 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.43 2.753 . . . . 2.0499999999999998 111.499 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.532 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.7 OUTLIER -33.86 -63.81 0.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.582 2.353 . . . . 1.6699999999999999 113.168 169.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.532 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 11.8 t -142.75 -137.0 0.1 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.605 1.962 . . . . 1.8700000000000001 106.606 169.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.91 -169.28 3.65 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 122.496 1.053 . . . . 2.04 113.509 155.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 3.3 m-85 68.01 -41.12 0.43 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 129.368 3.067 . . . . 2.3700000000000001 117.795 160.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 t -70.14 -37.76 75.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.279 0.945 . . . . 2.6099999999999999 113.015 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -64.84 -37.93 89.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 120.845 -1.159 . . . . 4.4500000000000002 112.352 170.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -37.21 86.52 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.567 0.58 . . . . 0.59999999999999998 112.567 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.45 -36.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 124.068 0.947 . . . . 0.68999999999999995 112.85 173.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -74.09 -37.6 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.705 1.202 . . . . 0.70999999999999996 112.444 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.9 -46.09 90.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.853 -0.594 . . . . 3.4399999999999999 110.594 168.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.88 -44.75 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 119.57 1.077 . . . . 0.31 110.915 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -59.6 -53.0 63.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.14 0.576 . . . . 0.40000000000000002 112.377 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.25 -37.17 84.41 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.001 1.111 . . . . 4.6100000000000003 114.001 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.8 mt -64.38 -35.23 80.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.422 1.089 . . . . 0.54000000000000004 111.761 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -76.15 1.89 14.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.562 1.145 . . . . 0.41999999999999998 114.027 169.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.45 6.04 84.17 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.073 1.306 . . . . 0.63 114.76 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -104.68 114.04 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.679 1.192 . . . . 0.63 110.494 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -127.77 -29.35 2.61 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 126.963 2.105 . . . . 6.8300000000000001 111.876 -167.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -83.73 33.11 0.47 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.539 2.736 . . . . 4.2199999999999998 113.297 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.5 p90 -66.96 160.54 26.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.048 -1.461 . . . . 1.9099999999999999 108.75 153.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.4 112.53 24.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.135 -1.802 . . . . 0.40000000000000002 106.135 160.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.18 115.64 26.84 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.149 -1.056 . . . . 0.42999999999999999 108.149 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -89.6 116.09 27.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.75 1.62 . . . . 1.98 111.224 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -83.98 109.31 17.53 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 124.5 1.12 . . . . 2.1800000000000002 111.445 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.0 m -81.15 -6.53 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.819 1.414 . . . . 0.81999999999999995 114.819 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 99.4 mt -66.12 -39.03 89.6 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.861 1.21 . . . . 1.3300000000000001 112.084 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -72.64 -32.59 66.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.499 1.12 . . . . 2.5299999999999998 112.991 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -122.43 106.0 35.76 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.676 1.99 . . . . 2.1000000000000001 112.474 -171.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -65.24 -21.29 62.15 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.118 1.879 . . . . 0.84999999999999998 113.318 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.48 -46.86 88.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.957 1.303 . . . . 3.8900000000000001 113.124 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.94 -41.1 87.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.102 0.561 . . . . 0.60999999999999999 109.88 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -55.2 -56.95 14.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.174 1.39 . . . . 4.4199999999999999 111.368 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.32 -39.83 74.53 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.956 -0.465 . . . . 3.1699999999999999 112.118 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.79 -44.14 70.29 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.117 -0.824 . . . . 0.52000000000000002 112.016 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 tp -87.2 -35.51 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 118.519 1.16 . . . . 0.65000000000000002 112.758 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.484 0.584 . . . . 2.27 111.832 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -80.31 -61.55 1.94 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.402 0.519 . . . . 1.97 112.402 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -62.57 -35.98 81.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.922 1.289 . . . . 2.0800000000000001 113.958 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.4 m -97.57 7.52 46.32 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.242 1.417 . . . . 2.3799999999999999 113.2 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.9 18.63 3.12 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 117.29 2.33 . . . . 1.8899999999999999 117.29 169.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -126.87 137.95 31.61 Favored Pre-proline 0 N--CA 1.479 0.994 0 CA-C-N 119.894 1.224 . . . . 1.74 113.366 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.39 -25.88 48.54 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.072 1.848 . . . . 1.01 113.439 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -135.3 -14.04 2.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 120.274 3.435 . . . . 3.75 120.274 -169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 6.8 mm -77.49 138.69 63.26 Favored Pre-proline 0 N--CA 1.474 0.754 0 CA-C-O 117.871 -1.062 . . . . 3.6299999999999999 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -93.94 151.15 2.19 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.396 3.397 . . . . 1.1299999999999999 111.782 165.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.35 174.62 10.75 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.109 0.964 . . . . 2.7200000000000002 113.517 -167.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 56' ' ' VAL . 10.2 p -138.72 140.59 38.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 124.144 0.978 . . . . 0.54000000000000004 110.282 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.85 131.87 55.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.281 1.432 . . . . 1.8400000000000001 109.935 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -112.02 125.6 54.25 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.452 0.701 . . . . 0.42999999999999999 111.03 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.496 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.8 t-20 56.0 34.31 23.46 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-O 122.036 0.922 . . . . 0.58999999999999997 112.984 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -3.46 18.6 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 126.584 2.04 . . . . 0.71999999999999997 117.967 -167.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -94.67 143.6 26.3 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 121.741 2.77 . . . . 2.1699999999999999 112.42 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -74.79 135.7 41.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 124.124 1.916 . . . . 2.0299999999999998 112.511 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -156.67 -36.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 112.29 -2.232 . . . . 1.51 108.891 -139.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.96 169.7 21.88 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.068 -1.063 . . . . 0.56000000000000005 114.929 130.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.8 168.42 54.22 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 122.943 0.306 . . . . 0.41999999999999998 112.703 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.424 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.6 t -60.43 -27.02 67.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.644 1.72 . . . . 0.78000000000000003 115.644 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.71 -34.86 69.95 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.039 -1.038 . . . . 2.3900000000000001 111.235 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.1 mm -78.29 -42.21 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.455 1.502 . . . . 1.1399999999999999 111.753 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 tp -57.55 -31.53 66.19 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.118 0.567 . . . . 0.71999999999999997 111.764 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -19.19 62.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.916 1.286 . . . . 0.70999999999999996 113.086 176.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -83.78 -54.52 4.84 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.187 0.994 . . . . 1.04 109.678 168.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.9 mtp -70.61 -27.62 64.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 114.261 1.208 . . . . 0.57999999999999996 114.261 -167.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -53.22 -46.78 69.24 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.833 1.301 . . . . 0.48999999999999999 111.751 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -92.9 -35.21 13.46 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 112.489 -2.141 . . . . 1.01 110.004 -155.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.85 52.08 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.652 1.581 . . . . 2.98 112.41 163.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.57 9.65 58.67 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.905 -1.122 . . . . 0.70999999999999996 113.169 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.7 -12.98 39.06 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.01 -1.288 . . . . 2.0 112.204 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.9 mt -75.74 -31.84 59.76 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.113 0.959 . . . . 0.38 109.957 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.47 -37.41 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 127.357 2.263 . . . . 0.46999999999999997 109.961 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -62.41 -43.04 99.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.163 1.385 . . . . 3.1899999999999999 110.1 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -64.44 -46.33 83.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.324 1.45 . . . . 1.6000000000000001 111.479 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.0 mt -60.91 -38.93 87.43 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.463 -0.773 . . . . 0.73999999999999999 111.141 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -62.76 -36.43 83.03 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 117.715 -1.136 . . . . 1.0700000000000001 112.232 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -69.11 -22.15 64.0 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.684 1.584 . . . . 3.1299999999999999 114.432 171.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 115' ' ' ASN . 3.9 mm? -86.54 -7.02 58.73 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.701 1.2 . . . . 1.49 112.669 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.27 65.69 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.3 1.429 . . . . 0.77000000000000002 114.631 -171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -72.89 142.25 15.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.695 1.598 . . . . 0.66000000000000003 111.12 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -82.3 108.91 16.11 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.732 1.613 . . . . 2.27 111.471 164.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 148' ' ' LEU . 4.7 t -58.32 121.06 9.88 Favored 'General case' 0 C--O 1.215 -0.75 0 O-C-N 121.693 -0.63 . . . . 0.55000000000000004 109.315 152.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.81 -24.63 23.71 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 119.872 -1.767 . . . . 0.89000000000000001 113.618 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.99 -5.38 34.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.002 2.121 . . . . 0.82999999999999996 113.524 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 145' ' ' SER . 1.7 mp -55.08 -27.29 43.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.708 1.603 . . . . 2.5800000000000001 112.541 165.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.73 22.37 10.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.048 1.499 . . . . 3.7599999999999998 115.048 -173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.207 1.803 . . . . 4.5599999999999996 111.663 172.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 109.877 -1.289 . . . . 15.23 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.6 m -62.42 131.68 50.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.16 0.98 . . . . 12.960000000000001 111.598 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 58.94 20.38 8.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.242 1.817 . . . . 14.34 114.867 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -143.61 149.21 37.0 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.46 1.504 . . . . 14.26 112.831 -170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 56.22 172.02 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.703 2.401 . . . . 15.44 115.631 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.57 -118.18 12.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.666 1.127 . . . . 9.9000000000000004 113.319 171.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 51' ' ' LYS . . . 62.66 31.33 16.78 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.616 1.966 . . . . 9.1899999999999995 116.253 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.73 -169.43 44.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.963 1.268 . . . . 5.6600000000000001 115.795 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.32 -21.33 2.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.804 1.669 . . . . 3.3199999999999998 114.553 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.41 -24.5 1.42 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 126.38 1.943 . . . . 2.8599999999999999 115.727 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.12 -179.31 44.63 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.686 2.089 . . . . 3.1499999999999999 111.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 t 63.52 169.35 0.15 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.936 2.094 . . . . 2.8300000000000001 114.468 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.37 -29.1 32.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.142 2.177 . . . . 1.0700000000000001 115.007 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -69.72 -29.52 66.93 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.939 -1.101 . . . . 3.46 113.206 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -74.34 -51.78 14.13 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.093 -1.005 . . . . 1.22 110.495 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.61 -33.42 69.99 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.394 1.077 . . . . 0.5 112.651 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -65.7 -42.87 90.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.374 1.083 . . . . 2.1400000000000001 112.286 171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.47 -28.9 68.94 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.236 -0.915 . . . . 0.66000000000000003 110.819 174.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.67 -45.5 71.55 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.242 2.217 . . . . 1.05 112.654 176.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -67.13 -29.76 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 O-C-N 121.672 -0.643 . . . . 0.66000000000000003 112.502 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -80.48 3.2 22.33 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 116.452 2.019 . . . . 2.3500000000000001 116.452 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HE2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 mttm -68.31 -17.05 64.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.658 1.983 . . . . 1.54 113.519 169.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.01 177.65 9.95 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.63 0.772 . . . . 1.77 111.402 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -24.67 29.27 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.104 0.779 . . . . 1.52 113.104 166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.93 114.9 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 107.04 -1.467 . . . . 0.72999999999999998 107.04 176.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.1 OUTLIER -134.14 119.49 31.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 107.379 -1.341 . . . . 1.53 107.379 -177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 112' ' ' VAL . 44.5 t -117.27 142.87 29.33 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 125.319 1.447 . . . . 0.56000000000000005 108.097 -167.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -140.46 104.04 4.68 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.973 -0.751 . . . . 1.9399999999999999 108.973 -155.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . 0.263 0.0 OUTLIER -140.72 152.38 45.25 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-O 122.944 1.354 . . . . 0.56999999999999995 113.506 -173.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HA ' HD22 ' A' ' 91' ' ' LEU . 12.1 ptpt -81.48 62.17 5.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.471 -1.695 . . . . 2.0299999999999998 109.594 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 66' ' ' GLN . . . 150.65 -153.55 25.08 Favored Glycine 0 CA--C 1.543 1.793 1 C-N-CA 131.125 4.202 . . . . 1.02 115.196 -164.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.501 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 34.9 p -136.36 161.77 60.24 Favored Pre-proline 0 N--CA 1.485 1.325 0 C-N-CA 127.978 2.511 . . . . 1.1100000000000001 111.77 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 28.8 Cg_endo -59.81 -31.23 93.64 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.718 2.946 . . . . 1.3600000000000001 114.092 -176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -97.82 -29.62 13.24 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.278 1.584 . . . . 3.8700000000000001 115.278 -174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.14 135.68 21.27 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 119.416 1.007 . . . . 2.5099999999999998 112.344 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.58 62.48 7.75 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.492 3.462 . . . . 2.8799999999999999 112.253 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.467 ' CB ' ' HA3' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -31.88 -51.5 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.794 2.838 . . . . 1.5700000000000001 115.096 165.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.0 t -154.96 -153.24 0.44 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.386 3.074 . . . . 1.6399999999999999 106.465 176.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.41 50.56 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 120.268 1.395 . . . . 1.95 114.133 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.452 0.7 OUTLIER 51.39 21.09 1.11 Allowed 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 119.589 3.181 . . . . 2.29 119.589 168.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.7 p -83.29 -29.87 28.01 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.123 -1.61 . . . . 2.23 114.812 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -86.51 -25.32 25.17 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 123.78 0.832 . . . . 4.1699999999999999 111.476 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.33 69.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.094 0.958 . . . . 1.0600000000000001 112.922 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 73' ' ' VAL . 14.5 m -67.79 -42.7 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 123.926 0.89 . . . . 1.1499999999999999 113.131 171.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.21 -34.81 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.491 1.516 . . . . 1.2 111.825 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -56.9 -56.5 20.87 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 125.033 1.333 . . . . 2.3100000000000001 109.674 168.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.58 -42.17 93.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.752 0.706 . . . . 0.48999999999999999 110.677 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -60.0 -57.76 11.48 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.056 0.761 . . . . 0.56000000000000005 113.056 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -62.13 -32.8 73.44 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.828 1.418 . . . . 4.2800000000000002 114.828 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -64.18 -38.35 90.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 111.417 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -75.08 -4.46 38.64 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.559 1.144 . . . . 0.56999999999999995 113.518 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.16 13.87 56.87 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 119.868 1.213 . . . . 0.88 114.993 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.24 129.26 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.819 1.648 . . . . 0.62 111.019 -173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -7.56 0.99 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.472 1.509 . . . . 4.8499999999999996 113.312 -168.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -112.21 25.75 11.25 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 130.628 3.571 . . . . 3.6099999999999999 111.105 -158.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -70.21 165.94 21.09 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.882 0.873 . . . . 1.8100000000000001 110.916 169.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.58 109.56 21.28 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.948 -1.501 . . . . 0.46999999999999997 106.948 158.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.88 105.38 17.02 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.24 -1.022 . . . . 0.41999999999999998 108.24 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -73.27 114.14 11.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.418 1.887 . . . . 2.3199999999999998 112.033 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' HD21 ' A' ' 91' ' ' LEU . 10.2 t-20 -74.22 89.28 2.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.103 1.761 . . . . 2.5899999999999999 108.318 160.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.7 m -68.69 -29.18 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.643 0.735 . . . . 1.6299999999999999 112.774 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.853 HD23 ' H ' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -59.41 -21.73 60.37 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 131.21 3.804 . . . . 3.8599999999999999 115.203 176.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.63 -22.93 34.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.768 1.167 . . . . 2.6400000000000001 113.539 174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -125.66 102.74 28.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.462 1.505 . . . . 2.6099999999999999 111.32 -168.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -57.45 -29.21 83.79 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.164 1.91 . . . . 1.3700000000000001 113.063 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -61.72 -46.24 90.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.812 1.645 . . . . 4.1900000000000004 113.435 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.3 -44.34 91.93 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.626 -0.509 . . . . 0.68999999999999995 109.626 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -62.39 -55.03 31.82 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.156 1.782 . . . . 3.8999999999999999 111.498 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.06 -44.78 83.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.416 0.524 . . . . 4.0499999999999998 112.416 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.63 -44.04 59.71 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 114.934 -1.03 . . . . 0.54000000000000004 112.144 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -83.75 -34.59 10.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.204 1.002 . . . . 0.56999999999999995 112.91 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -62.51 -37.0 84.32 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 118.886 0.766 . . . . 1.3799999999999999 112.312 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -73.96 -54.89 6.93 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.354 1.061 . . . . 2.5099999999999998 110.985 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -57.41 -37.79 73.28 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.092 1.357 . . . . 2.1400000000000001 113.571 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.2 m -83.93 -12.78 54.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.811 1.245 . . . . 1.7 113.971 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.36 25.99 6.52 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 125.435 1.494 . . . . 1.54 113.677 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -131.12 143.59 50.01 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.21 1.804 . . . . 1.3999999999999999 112.244 -175.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.91 -26.81 9.15 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 0.96999999999999997 114.418 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.8 t -157.36 129.33 7.13 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.624 1.102 . . . . 2.6899999999999999 113.804 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.02 164.44 27.16 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.565 1.946 . . . . 5.4900000000000002 110.645 174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -99.86 143.37 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 120.406 1.181 . . . . 1.0900000000000001 111.816 127.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -126.13 163.35 23.31 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.258 0.936 . . . . 2.1000000000000001 111.027 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 56' ' ' VAL . 8.3 p -118.37 155.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.485 -1.302 . . . . 0.90000000000000002 107.485 151.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 55' ' ' VAL . 55.6 m-85 -121.17 138.07 54.38 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.084 -1.01 . . . . 2.6400000000000001 108.488 160.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.59 125.59 52.72 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.628 0.771 . . . . 0.58999999999999997 111.29 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 53.74 41.39 32.08 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.002 0.906 . . . . 0.66000000000000003 112.086 -175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.19 2.97 28.44 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 117.299 1.68 . . . . 0.68999999999999995 117.299 -170.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -111.9 145.65 39.15 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.235 2.017 . . . . 1.6699999999999999 113.26 -171.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -77.61 139.58 39.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 124.15 1.929 . . . . 2.27 112.909 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 -58.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 130.129 3.372 . . . . 2.7999999999999998 106.113 -156.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.59 173.58 29.34 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.31 1.433 . . . . 0.92000000000000004 114.11 166.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.24 171.94 48.1 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.65 1.119 . . . . 0.67000000000000004 113.02 167.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.33 -30.17 70.33 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.651 1.352 . . . . 1.24 114.651 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.15 -34.08 75.66 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.079 -1.013 . . . . 2.4100000000000001 112.22 172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.42 -43.02 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.416 1.086 . . . . 1.47 111.062 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 19.3 tp -50.72 -36.7 37.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.054 1.342 . . . . 0.77000000000000002 112.362 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -25.16 64.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.664 1.585 . . . . 1.0700000000000001 111.902 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -85.7 -50.43 7.19 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 120.777 -1.202 . . . . 1.8 111.16 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.5 mtp -61.37 -28.77 69.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.448 0.907 . . . . 0.63 113.448 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -53.98 -48.17 70.65 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.907 1.336 . . . . 0.67000000000000004 112.375 171.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.54 -24.33 16.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 112.926 -1.943 . . . . 1.3 111.246 -158.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.05 -29.68 31.77 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.04 1.336 . . . . 3.0299999999999998 112.024 161.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.16 12.62 41.9 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 119.255 0.934 . . . . 0.78000000000000003 114.723 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -70.24 -8.57 51.18 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.522 1.161 . . . . 1.97 111.973 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.65 -26.77 45.2 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.953 0.882 . . . . 0.46000000000000002 111.262 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 145' ' ' SER . 5.4 t -80.73 -42.76 20.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.609 1.564 . . . . 0.54000000000000004 110.342 -166.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -72.97 -20.5 61.02 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.003 1.721 . . . . 2.5699999999999998 110.242 173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.34 -48.42 28.3 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.559 -0.713 . . . . 2.0600000000000001 111.811 167.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.1 mt -58.76 -34.04 70.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.732 1.213 . . . . 0.47999999999999998 112.23 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -46.73 9.66 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.258 2.623 . . . . 1.54 112.35 166.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -61.94 -24.89 67.26 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.648 1.179 . . . . 2.1299999999999999 114.169 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.53 -3.36 55.22 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.869 1.268 . . . . 1.3500000000000001 112.234 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.9 5.36 74.86 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.456 1.026 . . . . 0.71999999999999997 113.894 -167.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.62 133.9 30.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 119.375 1.588 . . . . 0.63 111.005 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -78.4 109.81 12.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.155 1.382 . . . . 1.4099999999999999 111.338 164.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 148' ' ' LEU . 3.1 t -60.75 118.21 6.35 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.022 -0.733 . . . . 0.80000000000000004 109.022 156.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.84 -16.72 12.58 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.53 -1.356 . . . . 1.1299999999999999 113.689 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.4 mt -78.39 -3.47 43.4 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.627 1.971 . . . . 1.23 113.605 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.66 -39.36 36.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.884 1.673 . . . . 2.4700000000000002 113.96 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.68 27.43 7.79 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.589 1.956 . . . . 5.4500000000000002 112.615 -177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.326 1.85 . . . . 4.2400000000000002 113.671 -177.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 111.132 -0.787 . . . . 19.870000000000001 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -160.82 140.98 11.16 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.418 1.487 . . . . 17.699999999999999 112.455 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -123.94 43.75 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.159 1.384 . . . . 20.510000000000002 112.436 -167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -136.8 166.85 22.64 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.624 1.569 . . . . 12.73 113.136 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 60.95 163.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.837 2.855 . . . . 11.09 116.69 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.2 163.55 16.17 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.754 2.121 . . . . 8.1199999999999992 112.301 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.01 43.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 6.6799999999999997 112.004 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -48.07 88.11 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.695 1.141 . . . . 6.1900000000000004 114.682 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.64 87.43 1.04 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 118.575 1.188 . . . . 4.0 112.405 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.14 -7.51 18.24 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 117.408 1.723 . . . . 5.2000000000000002 117.408 -165.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.29 14.73 5.61 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.091 1.805 . . . . 4.3300000000000001 113.953 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -89.07 156.97 18.51 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.205 1.802 . . . . 3.4199999999999999 112.608 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.56 70.75 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.611 -1.306 . . . . 1.0700000000000001 114.086 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -65.26 -23.34 67.02 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.238 1.815 . . . . 2.4300000000000002 114.769 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -88.53 -48.26 7.72 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.474 1.51 . . . . 1.3899999999999999 111.269 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -54.58 -31.78 57.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.065 0.946 . . . . 0.77000000000000002 112.184 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -62.42 -47.99 81.68 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 122.151 0.977 . . . . 1.8200000000000001 112.51 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.3 -33.22 73.21 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.693 -1.254 . . . . 0.66000000000000003 110.664 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.44 -42.9 82.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.559 1.943 . . . . 1.5 112.108 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.4 m -72.15 -17.82 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 121.454 -0.779 . . . . 0.58999999999999997 113.083 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -92.27 -2.07 56.69 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 116.499 2.037 . . . . 2.5499999999999998 116.499 175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -54.47 -49.55 69.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.635 0.774 . . . . 1.2 110.618 169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.81 174.66 9.27 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.063 0.945 . . . . 2.3599999999999999 112.351 -170.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -22.19 25.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.868 1.062 . . . . 1.3700000000000001 113.868 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -135.72 111.36 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 103.999 -2.593 . . . . 0.64000000000000001 103.999 176.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t -123.26 116.62 49.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.91000000000000003 109.865 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 112' ' ' VAL . 36.9 t -111.08 146.92 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 C-N-CA 125.785 1.634 . . . . 0.28999999999999998 109.876 -170.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -145.75 109.22 4.7 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.599 0.76 . . . . 1.9099999999999999 109.914 -159.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.87 158.61 38.31 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.338 -0.245 . . . . 0.54000000000000004 110.338 -172.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -86.61 63.75 8.14 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 119.797 -1.814 . . . . 1.75 110.649 175.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.86 -165.17 38.56 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.665 1.126 . . . . 0.76000000000000001 115.04 -163.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 26.8 p -137.32 160.3 66.16 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 125.626 1.571 . . . . 0.76000000000000001 111.806 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.4 Cg_endo -67.07 -16.52 49.44 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.025 2.484 . . . . 0.88 114.969 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.2 -32.39 10.56 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.922 1.453 . . . . 3.7599999999999998 114.922 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -106.21 121.34 45.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 120.02 1.282 . . . . 2.29 111.498 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.67 71.62 6.94 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.703 2.935 . . . . 1.8999999999999999 112.796 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.2 OUTLIER -18.74 -63.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 128.73 2.812 . . . . 1.75 116.367 169.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 29.1 t -169.78 177.06 4.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.867 2.467 . . . . 1.95 106.814 -168.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.22 137.51 49.23 Favored Glycine 0 CA--C 1.543 1.785 0 N-CA-C 109.898 -1.281 . . . . 3.4399999999999999 109.898 156.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 5.3 m-85 -120.91 20.92 11.54 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 117.491 -3.358 . . . . 2.46 113.529 4.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.1 t -58.44 -31.57 67.89 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.313 1.597 . . . . 2.77 115.313 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -69.35 -39.76 77.92 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.4 -1.437 . . . . 4.3799999999999999 113.274 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.18 88.83 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.392 -0.817 . . . . 0.55000000000000004 112.561 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -70.95 -40.88 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.914 0.886 . . . . 0.57999999999999996 112.849 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.54 -38.52 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.296 1.038 . . . . 0.66000000000000003 111.771 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -68.02 -44.43 76.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 118.049 -0.977 . . . . 3.7200000000000002 111.053 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.2 mt -55.53 -43.98 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 120.602 1.547 . . . . 0.32000000000000001 110.863 175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.8 mt -61.05 -55.86 27.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.329 0.652 . . . . 0.34000000000000002 112.178 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -64.38 -30.05 71.1 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 114.934 1.457 . . . . 4.6799999999999997 114.934 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.9 mt -66.18 -37.81 86.52 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.622 1.169 . . . . 0.70999999999999996 111.254 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -75.17 4.62 6.58 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.392 . . . . 0.45000000000000001 114.036 167.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.99 3.23 83.14 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 120.792 -1.193 . . . . 0.66000000000000003 114.911 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.5 t -95.7 115.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.592 1.157 . . . . 0.52000000000000002 111.504 -170.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -132.48 -5.27 3.32 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.599 2.36 . . . . 4.3300000000000001 113.096 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.34 29.58 4.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.678 2.391 . . . . 3.7000000000000002 112.656 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 10.7 p90 -67.77 162.28 24.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.421 1.105 . . . . 1.79 109.611 158.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.57 122.36 37.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.5 107.622 153.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 99.29 8.91 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.222 -0.658 . . . . 0.37 109.222 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -77.67 113.33 15.41 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.62 1.168 . . . . 2.0 112.428 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -73.15 116.19 13.39 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 115.866 -0.606 . . . . 2.2999999999999998 111.609 158.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 m -85.18 -4.58 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.507 1.299 . . . . 0.88 114.507 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.08 -23.49 60.55 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.835 -1.166 . . . . 1.3899999999999999 111.969 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.98 -35.88 80.95 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.225 1.01 . . . . 2.7999999999999998 112.068 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -141.25 130.53 12.69 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.635 1.574 . . . . 2.2799999999999998 113.28 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.1 -20.59 33.06 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.456 2.104 . . . . 0.90000000000000002 112.311 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -45.24 93.81 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.081 1.752 . . . . 3.02 112.219 169.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.4 mt -64.56 -43.51 93.69 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.74 0.416 . . . . 0.64000000000000001 110.098 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -57.71 -55.55 33.45 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.874 0.869 . . . . 4.04 112.718 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -69.09 -39.56 78.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.868 0.467 . . . . 2.25 111.221 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.47 -45.25 59.18 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.907 -0.941 . . . . 0.54000000000000004 112.427 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.3 tp -83.0 -35.86 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 118.675 1.238 . . . . 0.69999999999999996 113.069 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -59.62 -34.28 72.57 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 118.844 -0.598 . . . . 1.49 111.577 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.56 -48.12 15.85 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.834 0.679 . . . . 1.8100000000000001 112.834 171.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.55 -37.19 84.45 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.836 -1.165 . . . . 2.2799999999999998 113.871 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.6 t -86.94 -3.68 59.1 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.699 1.2 . . . . 2.6600000000000001 112.751 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 t30 47.29 30.76 1.57 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.036 2.135 . . . . 1.5600000000000001 115.387 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.63 140.95 40.15 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 121.088 -1.007 . . . . 1.48 112.018 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.92 -41.3 38.05 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.71 2.274 . . . . 1.0600000000000001 112.804 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -150.16 82.81 1.37 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.954 1.094 . . . . 3.54 113.954 -173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.2 mm -138.55 144.24 41.52 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.813 1.645 . . . . 3.2599999999999998 109.416 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -98.25 149.84 0.74 Allowed 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.645 3.563 . . . . 0.93999999999999995 112.019 162.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -130.57 165.55 22.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.963 1.305 . . . . 2.5899999999999999 113.131 -167.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.443 HG23 HG22 ' A' ' 56' ' ' VAL . 8.7 p -133.71 141.95 42.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.405 0.621 . . . . 0.65000000000000002 109.954 155.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -118.98 131.92 56.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.534 1.534 . . . . 1.5600000000000001 108.016 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.45 131.08 55.47 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.102 0.561 . . . . 0.47999999999999998 109.686 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' HD21 ' A' ' 141' ' ' LEU . 9.7 t-20 58.45 25.75 13.35 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 113.314 0.857 . . . . 0.77000000000000002 113.314 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.07 11.91 79.18 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 117.723 1.849 . . . . 0.59999999999999998 117.723 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -112.97 147.43 37.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.72 1.76 . . . . 1.8200000000000001 112.132 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -81.55 138.02 35.47 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 124.559 2.123 . . . . 2.1099999999999999 112.721 -175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 t -156.8 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 110.478 -3.055 . . . . 1.52 107.36 -135.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.49 168.96 24.12 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 119.715 -1.231 . . . . 0.55000000000000004 115.654 135.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 175.39 55.09 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 123.704 0.669 . . . . 0.46000000000000002 112.388 161.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 3.6 t -68.29 -19.26 64.69 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.375 1.991 . . . . 0.82999999999999996 116.375 -171.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -70.75 -40.72 72.53 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.35 0.977 . . . . 2.8399999999999999 110.86 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.08 -38.86 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.033 1.333 . . . . 1.79 111.418 -176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.03 -32.11 69.44 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.359 -0.838 . . . . 0.55000000000000004 112.226 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 -18.77 61.88 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.69 1.196 . . . . 0.70999999999999996 112.626 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -85.57 -54.71 4.38 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.032 -1.042 . . . . 0.72999999999999998 109.939 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 85.4 mtp -65.91 -30.7 71.33 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 114.314 1.228 . . . . 0.48999999999999999 114.314 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -55.81 -47.83 76.48 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.777 1.275 . . . . 0.47999999999999998 111.251 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -93.56 -20.98 19.72 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 112.745 -2.025 . . . . 1.0 110.92 -157.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -27.72 22.02 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.819 2.047 . . . . 3.0 113.119 162.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.99 13.08 44.23 Favored Glycine 0 N--CA 1.475 1.269 0 C-N-CA 124.621 1.105 . . . . 0.51000000000000001 114.451 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.76 -12.27 61.5 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.011 -1.287 . . . . 1.8600000000000001 112.566 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.7 mt -75.53 -24.8 56.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.526 1.155 . . . . 0.40000000000000002 111.239 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.4 HG12 ' HE3' ' A' ' 139' ' ' LYS . 7.0 t -77.89 -36.26 21.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.922 2.089 . . . . 0.54000000000000004 109.832 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -73.33 -36.53 66.22 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.283 1.433 . . . . 2.8199999999999998 110.899 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.52 0.728 . . . . 1.74 111.469 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.2 mt -59.9 -38.79 83.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.574 -0.704 . . . . 0.56000000000000005 111.862 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.4 ' HE3' HG12 ' A' ' 135' ' ' VAL . 72.4 mttt -66.6 -23.39 66.18 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 118.082 -0.961 . . . . 0.84999999999999998 113.384 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -67.0 -24.0 65.98 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.471 1.487 . . . . 2.0099999999999998 113.525 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.1 mm? -91.49 -10.45 40.78 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.975 1.71 . . . . 1.27 112.377 170.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.37 16.59 80.28 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.122 1.344 . . . . 0.81999999999999995 114.315 -167.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.1 mt -83.81 137.04 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.561 1.681 . . . . 0.60999999999999999 111.467 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -87.05 112.6 22.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.762 2.025 . . . . 1.3600000000000001 112.185 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.8 t -60.65 127.65 32.72 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-O 121.913 0.863 . . . . 0.56000000000000005 110.599 162.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.74 -3.63 5.18 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.008 -1.682 . . . . 0.81999999999999995 113.706 173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -96.71 4.79 51.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.683 1.993 . . . . 0.92000000000000004 113.001 172.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -53.68 -27.08 25.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.293 1.837 . . . . 2.4399999999999999 114.779 -177.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -112.88 25.26 11.58 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.234 1.814 . . . . 4.6699999999999999 113.975 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 127.417 2.287 . . . . 4.9500000000000002 110.832 174.296 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 111.353 -0.699 . . . . 16.34 111.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 m 64.43 2.2 1.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.99 2.218 . . . . 15.4 116.99 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -122.58 152.33 40.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.942 1.701 . . . . 15.35 114.093 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.3 p -136.46 155.39 50.06 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.903 0.881 . . . . 11.75 113.214 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.2 158.89 4.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.002 1.721 . . . . 10.800000000000001 114.964 -173.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.5 134.54 19.47 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.747 0.689 . . . . 8.7799999999999994 112.637 170.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.68 -15.91 5.38 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.084 1.513 . . . . 7.5 115.084 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.18 162.54 39.77 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-N 118.95 0.795 . . . . 5.2599999999999998 113.494 174.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.49 177.14 42.07 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.517 1.367 . . . . 3.9199999999999999 116.517 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.62 33.87 37.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.865 1.698 . . . . 3.1899999999999999 115.826 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.85 -174.92 54.7 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 118.211 1.005 . . . . 3.1699999999999999 113.582 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 t 64.5 173.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.73 2.412 . . . . 2.2599999999999998 114.092 -170.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.32 -37.53 62.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.108 1.363 . . . . 0.77000000000000002 112.858 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -65.57 -23.83 66.94 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.615 1.339 . . . . 2.9700000000000002 114.615 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -74.9 -52.61 10.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.566 0.746 . . . . 1.1499999999999999 110.258 169.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.02 -34.96 72.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.986 0.915 . . . . 0.54000000000000004 111.426 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.05 -46.39 88.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.212 1.805 . . . . 1.79 111.771 170.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -27.34 64.37 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 120.75 -1.219 . . . . 0.65000000000000002 110.293 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.32 -33.84 42.81 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.356 1.462 . . . . 1.4099999999999999 112.962 178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.26 -17.26 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 120.43 -1.419 . . . . 0.69999999999999996 112.25 164.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -93.54 4.85 53.31 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 116.26 1.948 . . . . 2.4399999999999999 116.26 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.84 -35.39 69.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.038 1.335 . . . . 1.3999999999999999 112.998 175.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.28 -178.47 4.76 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.019 1.327 . . . . 2.0600000000000001 110.731 170.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 -18.83 24.71 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.717 1.006 . . . . 1.22 113.717 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -133.73 111.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.004 -2.591 . . . . 0.60999999999999999 104.004 177.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.2 116.45 46.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.48 -0.563 . . . . 0.93000000000000005 109.48 -176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 112' ' ' VAL . 41.6 t -110.82 146.91 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 C-N-CA 125.863 1.665 . . . . 0.32000000000000001 109.657 -170.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -144.16 106.83 4.43 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 122.861 0.465 . . . . 1.8899999999999999 109.923 -160.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.85 157.25 39.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.453 0.538 . . . . 0.35999999999999999 112.453 -173.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -80.65 59.38 3.58 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.753 -1.217 . . . . 1.8 110.235 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 89' ' ' ASN . . . 172.66 -173.71 45.52 Favored Glycine 0 N--CA 1.468 0.809 0 O-C-N 121.396 -0.815 . . . . 0.73999999999999999 112.968 -164.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -126.43 161.31 53.24 Favored Pre-proline 0 N--CA 1.486 1.343 0 C-N-CA 123.56 0.744 . . . . 0.83999999999999997 110.969 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 72.3 Cg_endo -72.47 -28.37 14.74 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 121.676 1.584 . . . . 1.23 111.544 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -77.17 -26.56 53.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.287 1.035 . . . . 4.0300000000000002 113.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -137.92 79.14 33.93 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 126.605 1.962 . . . . 2.3799999999999999 110.79 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -58.52 129.42 32.46 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.774 2.983 . . . . 3.4399999999999999 109.91 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -75.5 -29.17 59.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.984 1.475 . . . . 1.7 114.984 -155.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -159.22 -138.16 0.05 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.651 1.581 . . . . 2.4300000000000002 107.14 -164.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.59 -162.07 8.83 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.214 -0.929 . . . . 1.97 111.883 155.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 56.59 -62.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 129.048 2.939 . . . . 2.23 116.145 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 p -45.31 -35.1 3.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.78 2.432 . . . . 2.0 115.239 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -78.07 -42.79 31.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 117.99 -1.005 . . . . 4.6699999999999999 112.559 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.9 71.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.242 1.383 . . . . 0.72999999999999998 112.075 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 m -68.22 -39.71 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 113.293 0.849 . . . . 0.60999999999999999 113.293 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.6 t -76.2 -35.92 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.678 0.791 . . . . 0.67000000000000004 112.085 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -59.49 -49.82 76.32 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.92 0.888 . . . . 3.6099999999999999 109.788 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.8 mt -60.05 -42.08 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.558 1.072 . . . . 0.34999999999999998 111.063 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.0 mt -60.16 -58.92 6.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.244 0.618 . . . . 0.41999999999999998 112.443 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -60.17 -31.34 70.02 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.272 1.582 . . . . 5.1299999999999999 115.272 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.44 -34.79 74.95 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.247 1.419 . . . . 0.58999999999999997 111.997 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -76.04 3.63 10.01 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.201 1.0 . . . . 0.47999999999999998 113.395 167.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.92 9.78 73.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 121.14 -0.975 . . . . 0.68999999999999995 114.744 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.7 t -100.5 128.22 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.852 1.326 . . . . 0.75 112.77 -169.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -133.23 -11.06 2.89 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 128.064 2.545 . . . . 3.4700000000000002 112.875 165.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -76.14 24.11 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.83 2.452 . . . . 3.7599999999999998 113.424 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 22.1 p90 -75.32 160.16 30.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.955 1.36 . . . . 1.8799999999999999 111.886 157.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.58 115.46 28.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.212 -1.358 . . . . 0.34000000000000002 107.456 153.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.96 105.78 17.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.59 -0.522 . . . . 0.34000000000000002 109.59 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -83.52 119.37 24.62 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.604 1.561 . . . . 1.99 112.598 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 60' ' ' GLY . 24.1 t-20 -83.61 100.95 11.15 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.605 2.362 . . . . 2.2200000000000002 111.404 174.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.14 -6.86 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.719 1.007 . . . . 0.92000000000000004 113.719 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.32 -26.87 65.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.384 1.074 . . . . 1.54 113.439 173.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.95 -35.49 20.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.268 0.84 . . . . 2.3599999999999999 113.268 -177.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.76 107.43 42.47 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.268 1.427 . . . . 2.5899999999999999 111.803 -171.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -63.71 -25.89 68.6 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.023 1.815 . . . . 0.89000000000000001 112.185 174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.0 -41.91 97.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.322 1.849 . . . . 3.73 113.334 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.3 mt -67.98 -42.54 80.68 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.303 -0.629 . . . . 0.62 109.303 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -60.4 -52.05 66.86 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.217 1.007 . . . . 5.0300000000000002 111.168 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -58.94 -50.25 74.76 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.536 0.734 . . . . 3.04 111.619 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -63.39 -32.03 82.76 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.117 -0.824 . . . . 0.52000000000000002 112.624 -174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 100' ' ' ILE . 5.1 tp -86.72 -34.77 8.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 118.672 1.236 . . . . 0.56000000000000005 112.502 -177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -60.47 -39.73 88.66 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.607 0.363 . . . . 1.76 111.214 168.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -64.29 -57.82 8.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.078 0.951 . . . . 2.0899999999999999 110.737 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.63 -37.44 83.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.355 1.062 . . . . 2.2000000000000002 113.589 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.8 m -83.8 -10.05 58.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.731 1.213 . . . . 1.5800000000000001 112.915 176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.8 t30 51.72 29.57 5.9 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.815 2.046 . . . . 1.55 114.581 -168.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -130.63 134.77 26.42 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.791 -1.193 . . . . 1.4099999999999999 112.35 -167.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.09 -43.78 53.24 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.277 2.652 . . . . 1.6299999999999999 113.788 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.0 m -163.68 98.5 0.88 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.947 1.299 . . . . 2.5499999999999998 112.713 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.8 mm -139.18 144.32 40.15 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 126.637 1.975 . . . . 3.4700000000000002 107.362 155.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -92.2 149.04 3.07 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.379 2.719 . . . . 1.05 111.952 162.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.6 173.2 12.03 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.016 0.926 . . . . 2.5699999999999998 112.465 -169.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' VAL . 10.4 p -134.88 143.83 36.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.511 0.725 . . . . 0.59999999999999998 109.682 171.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -118.16 131.95 56.37 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.889 1.275 . . . . 2.4199999999999999 108.322 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.438 HD11 HG13 ' A' ' 54' ' ' VAL . 5.3 mp -111.16 126.12 54.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.421 0.629 . . . . 0.59999999999999998 109.877 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 54.34 33.9 19.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.937 1.295 . . . . 0.70999999999999996 113.262 -176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.67 11.84 82.92 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 117.527 1.771 . . . . 0.71999999999999997 117.527 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -114.75 145.67 41.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.158 1.479 . . . . 1.6100000000000001 111.287 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.97 132.68 34.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.373 2.035 . . . . 2.3999999999999999 112.163 -169.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.83 -39.05 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 112.228 -2.26 . . . . 1.51 108.651 -134.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.2 164.45 18.28 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.216 -1.468 . . . . 0.57999999999999996 116.186 135.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.5 168.85 54.87 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.267 0.937 . . . . 0.46000000000000002 113.083 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.7 t -61.07 -28.42 69.06 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 115.652 1.723 . . . . 0.91000000000000003 115.652 -169.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.98 -30.54 50.29 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.237 1.38 . . . . 2.21 112.329 173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.762 1.625 . . . . 1.1499999999999999 110.42 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.41 -34.69 64.63 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.783 0.833 . . . . 0.63 111.619 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.01 -19.49 62.51 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.278 1.431 . . . . 0.69999999999999996 112.975 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -83.95 -54.85 4.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.951 0.9 . . . . 0.81000000000000005 110.437 166.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 94.9 mtp -67.55 -28.3 67.68 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 114.208 1.188 . . . . 0.52000000000000002 114.208 -168.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -54.07 -46.82 72.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.049 1.404 . . . . 0.47999999999999998 111.405 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.39 -26.6 17.97 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 112.651 -2.068 . . . . 1.1200000000000001 109.802 -159.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -73.22 -34.47 65.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.76 2.024 . . . . 2.1000000000000001 113.336 160.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.0 19.65 33.15 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-N 119.163 0.892 . . . . 0.58999999999999997 113.219 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -79.84 -13.07 59.68 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.494 -1.592 . . . . 2.8399999999999999 112.726 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.14 -24.23 57.94 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.507 1.146 . . . . 0.55000000000000004 111.024 173.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.72 -37.3 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.097 1.759 . . . . 0.73999999999999999 109.732 -172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -40.57 95.55 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.917 1.687 . . . . 2.8399999999999999 111.461 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -66.54 -42.03 87.81 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.657 1.183 . . . . 2.3199999999999998 112.985 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 -44.79 95.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.142 0.577 . . . . 0.79000000000000004 111.628 170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.53 -33.13 74.3 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.082 -0.961 . . . . 0.98999999999999999 113.56 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.45 -36.74 74.15 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.546 1.521 . . . . 2.8900000000000001 112.995 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.5 mt -83.44 -1.35 53.33 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.571 1.548 . . . . 2.6499999999999999 114.787 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.166 -0.797 . . . . 1.22 113.403 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.6 mt -91.12 131.54 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 122.604 1.193 . . . . 0.63 111.461 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -84.21 109.93 18.14 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 127.258 2.223 . . . . 1.25 111.891 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.438 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -59.21 140.73 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.173 0.987 . . . . 0.71999999999999997 110.607 161.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.97 -6.16 53.53 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.661 -1.275 . . . . 0.76000000000000001 113.15 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -92.17 -2.76 56.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.88 2.072 . . . . 0.77000000000000002 113.33 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -56.06 -17.2 6.33 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.269 2.228 . . . . 2.25 115.891 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -126.42 15.78 7.69 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.153 1.538 . . . . 4.1900000000000004 115.153 -178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.598 1.959 . . . . 3.8300000000000001 114.029 -168.789 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.232 -1.147 . . . . 14.6 110.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -140.73 165.47 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.421 1.089 . . . . 14.26 112.025 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -150.09 119.8 7.04 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.145 0.978 . . . . 14.59 112.615 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.2 p -141.77 163.45 32.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.991 1.316 . . . . 12.81 112.896 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -6.65 52.83 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.711 2.115 . . . . 14.859999999999999 116.711 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.63 140.6 48.04 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 116.897 1.519 . . . . 8.9499999999999993 116.897 -159.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.26 170.16 0.08 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.393 2.277 . . . . 7.2300000000000004 116.311 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.56 -141.42 8.57 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.887 0.756 . . . . 4.5199999999999996 114.099 173.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.62 145.29 7.34 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.669 1.604 . . . . 3.4900000000000002 111.385 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.65 104.75 0.61 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 123.87 0.748 . . . . 3.3300000000000001 113.407 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.11 18.76 65.23 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 124.681 1.134 . . . . 4.0999999999999996 115.893 -176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -78.54 154.51 30.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.164 1.482 . . . . 3.77 113.731 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.65 76.31 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.002 -1.061 . . . . 1.3400000000000001 112.371 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.79 -23.84 67.37 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.917 1.081 . . . . 3.1899999999999999 113.917 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -45.12 13.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.017 1.327 . . . . 1.45 110.293 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -59.54 -32.64 70.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.456 1.102 . . . . 0.81000000000000005 112.205 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.23 -40.32 78.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.078 0.942 . . . . 2.5699999999999998 111.134 174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.65 -27.71 66.24 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.243 -0.911 . . . . 0.53000000000000003 110.183 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -47.46 52.77 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.797 2.039 . . . . 0.94999999999999996 112.84 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.65 -23.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 120.21 1.368 . . . . 0.55000000000000004 112.187 168.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.85 6.2 29.3 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.399 1.629 . . . . 2.9300000000000002 115.399 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -65.43 -54.45 28.41 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.438 1.017 . . . . 1.8799999999999999 111.715 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.2 174.95 7.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.616 1.167 . . . . 1.8 110.187 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.66 -19.3 33.1 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.336 0.865 . . . . 1.3500000000000001 113.336 175.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -136.24 102.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 N-CA-C 104.172 -2.529 . . . . 0.57999999999999996 104.172 178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.71 114.44 46.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.509 -0.923 . . . . 0.93000000000000005 108.509 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.5 t -106.75 152.66 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 C-N-CA 124.701 1.2 . . . . 0.29999999999999999 108.984 -172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -146.91 104.85 3.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.007 -0.738 . . . . 1.8300000000000001 109.007 -159.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.6 153.44 38.34 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.601 0.715 . . . . 0.38 112.168 -177.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.65 62.67 5.59 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.69 -1.256 . . . . 2.29 109.408 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.33 -170.84 38.88 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 114.844 -1.071 . . . . 0.73999999999999999 113.07 -160.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 61.7 p -129.5 165.68 31.13 Favored Pre-proline 0 N--CA 1.484 1.254 0 C-N-CA 124.758 1.223 . . . . 0.70999999999999996 110.876 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.07 -37.66 14.32 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.906 1.738 . . . . 1.1299999999999999 112.31 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -72.47 -22.91 61.0 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.621 1.568 . . . . 3.4399999999999999 114.218 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -130.69 127.55 22.28 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.856 1.262 . . . . 2.1499999999999999 112.049 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -71.17 94.65 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.92 2.413 . . . . 1.8400000000000001 111.17 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -36.83 -51.06 0.88 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.555 2.342 . . . . 1.6699999999999999 113.077 161.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.433 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 5.4 t -157.91 -152.12 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.38 1.872 . . . . 1.8999999999999999 108.642 -176.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.33 -179.91 1.62 Allowed Glycine 0 CA--C 1.538 1.516 0 O-C-N 121.68 -0.638 . . . . 1.9199999999999999 112.522 155.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.5 m-30 65.35 -33.49 0.17 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 128.016 2.526 . . . . 2.21 117.201 171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -72.02 -33.07 67.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.58 1.082 . . . . 1.9099999999999999 113.556 -166.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -82.06 -31.89 30.63 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-O 118.111 -0.947 . . . . 3.0600000000000001 111.428 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.59 78.43 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.07 1.305 . . . . 0.58999999999999997 112.583 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.78 -37.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 124.161 0.985 . . . . 0.67000000000000004 113.556 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -77.87 -33.34 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.027 0.931 . . . . 0.52000000000000002 111.998 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -58.39 -47.69 83.04 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.407 1.483 . . . . 2.25 110.25 167.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.2 -43.91 94.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 O-C-N 120.935 -1.103 . . . . 0.33000000000000002 111.229 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.13 -56.2 23.61 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.58 0.585 . . . . 0.32000000000000001 112.58 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -64.02 -30.86 71.9 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.543 1.312 . . . . 3.21 114.543 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -36.53 82.93 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.152 1.342 . . . . 0.44 111.866 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' HG22 ' A' ' 135' ' ' VAL . 50.6 m-70 -76.08 2.21 13.49 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.021 0.928 . . . . 0.39000000000000001 113.484 168.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.34 6.99 80.4 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.593 1.088 . . . . 0.59999999999999998 114.88 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.1 t -105.02 123.03 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.124 1.37 . . . . 0.47999999999999998 112.027 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.9 ptt85 -136.6 -12.82 1.77 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.72 2.408 . . . . 4.1299999999999999 113.902 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.77 25.1 0.07 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.065 2.146 . . . . 3.1699999999999999 113.708 170.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 17.3 p90 -70.48 161.68 30.14 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.893 -1.129 . . . . 1.96 109.79 158.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 114.84 28.79 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.187 -1.042 . . . . 0.34000000000000002 108.187 155.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.8 100.95 13.33 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 118.134 0.425 . . . . 0.40999999999999998 110.262 -176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -78.19 118.15 20.14 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.662 -1.274 . . . . 1.9199999999999999 112.857 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.93 102.93 7.57 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 126.417 1.887 . . . . 2.1200000000000001 111.47 170.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.3 m -79.09 -2.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 114.092 1.145 . . . . 0.72999999999999998 114.092 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -76.15 -30.36 58.1 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.246 -0.909 . . . . 1.3 112.0 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.33 -46.01 78.29 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.798 1.239 . . . . 2.7000000000000002 112.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.419 ' HB3' ' H ' ' A' ' 96' ' ' LEU . 1.1 m-20 -115.69 117.79 39.72 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.699 1.6 . . . . 2.4300000000000002 112.812 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -68.81 -17.87 41.82 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.781 1.654 . . . . 0.84999999999999998 112.339 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -70.38 -37.22 74.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.836 1.655 . . . . 3.1800000000000002 113.151 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASP . 38.8 mt -66.34 -44.01 84.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.035 -0.728 . . . . 0.62 109.035 169.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -55.9 -56.14 24.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.305 1.442 . . . . 3.4500000000000002 111.714 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -68.69 -40.09 80.2 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.716 -0.615 . . . . 2.3700000000000001 112.599 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.81 81.02 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 119.437 -0.646 . . . . 0.60999999999999999 112.559 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -84.67 -33.13 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.107 0.954 . . . . 0.81000000000000005 112.551 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 107' ' ' PRO . 92.8 mttt -54.81 -41.09 70.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.282 0.633 . . . . 1.54 111.765 167.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.56 -58.52 3.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.93 0.892 . . . . 2.8500000000000001 112.162 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.76 -43.47 90.34 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.865 1.266 . . . . 1.8999999999999999 112.721 -172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.6 t -93.43 3.85 54.91 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.031 1.333 . . . . 2.2400000000000002 113.073 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 56.44 25.48 9.67 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 115.906 1.817 . . . . 1.6200000000000001 115.906 170.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 142.76 46.59 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 125.886 1.674 . . . . 1.5 110.968 -174.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 101' ' ' LYS . 38.5 Cg_endo -65.7 -38.4 24.53 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.055 1.836 . . . . 1.1499999999999999 113.067 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -169.51 115.7 0.57 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.652 1.215 . . . . 2.6400000000000001 113.106 170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.1 pt -142.24 137.23 15.49 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.906 2.882 . . . . 4.2699999999999996 110.144 164.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.69 145.46 11.58 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.781 1.654 . . . . 1.04 110.419 167.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.17 177.65 11.24 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.705 -0.622 . . . . 2.2000000000000002 112.093 -159.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.42 155.93 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 123.599 0.76 . . . . 0.92000000000000004 109.716 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.23 141.09 51.2 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.529 1.531 . . . . 1.97 110.676 157.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.97 126.23 54.92 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.689 1.195 . . . . 0.48999999999999999 110.196 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 141' ' ' LEU . 6.3 t-20 58.96 34.21 23.48 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.193 0.997 . . . . 0.67000000000000004 113.157 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.72 2.04 55.52 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 126.961 2.219 . . . . 0.56999999999999995 117.337 -168.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -120.46 148.22 44.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.6 1.7 . . . . 1.98 112.961 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.251 3.0 t80 -78.89 147.75 33.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 125.054 2.359 . . . . 2.5800000000000001 117.061 -170.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -53.52 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 109.279 -3.601 . . . . 2.6699999999999999 107.113 -158.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.03 174.95 20.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.382 0.991 . . . . 0.80000000000000004 115.199 161.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.54 172.33 45.58 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.578 1.085 . . . . 0.56999999999999995 112.892 166.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 43.9 t -54.76 -37.53 66.08 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.12 1.156 . . . . 0.77000000000000002 114.12 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.62 -30.72 69.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.696 1.134 . . . . 2.2200000000000002 112.013 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.06 -44.08 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.546 1.139 . . . . 1.1200000000000001 110.442 175.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.2 tp -55.05 -33.8 63.02 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.373 0.669 . . . . 0.44 111.657 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.3 -19.61 63.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.935 1.694 . . . . 1.0900000000000001 113.835 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -83.35 -55.08 4.53 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.69 0.796 . . . . 0.78000000000000003 109.411 168.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.44 -30.26 67.06 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.382 1.073 . . . . 0.45000000000000001 113.866 -166.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.6 t60 -56.11 -48.36 76.33 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.29 1.519 . . . . 0.54000000000000004 110.917 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -91.84 -20.98 20.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 112.356 -2.202 . . . . 1.1899999999999999 110.042 -158.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -80.5 -34.74 35.51 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.694 1.598 . . . . 2.3799999999999999 112.632 157.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.14 23.6 19.39 Favored Glycine 0 N--CA 1.474 1.173 0 O-C-N 120.651 -1.281 . . . . 0.68999999999999995 113.427 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.84 -13.26 59.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.081 -1.246 . . . . 2.1899999999999999 113.133 175.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.9 mt -71.93 -24.5 61.63 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 122.655 1.217 . . . . 0.39000000000000001 110.443 176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.414 HG22 ' CE1' ' A' ' 80' ' ' HIS . 3.5 t -74.61 -41.6 48.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 127.178 2.191 . . . . 0.42999999999999999 109.408 -174.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.63 -22.28 60.04 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.798 2.039 . . . . 2.5800000000000001 111.374 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.34 -49.36 19.33 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.038 . . . . 1.72 110.97 167.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.69 -37.07 72.84 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.32 -0.862 . . . . 0.42999999999999999 111.766 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.89 -49.48 10.96 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 128.521 2.729 . . . . 1.25 112.952 168.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -65.69 -27.18 68.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.499 1.12 . . . . 2.1499999999999999 113.557 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.6 mm? -88.03 -5.34 58.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.158 1.383 . . . . 1.3500000000000001 111.942 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 2.97 77.01 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.898 1.713 . . . . 0.67000000000000004 114.604 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 69.1 mt -75.65 131.99 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 118.669 1.234 . . . . 0.56000000000000005 110.991 -175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -78.36 108.99 12.1 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.664 1.586 . . . . 1.5900000000000001 111.736 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.9 t -59.84 121.91 12.9 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 122.967 0.507 . . . . 0.5 110.183 158.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.46 -22.21 4.54 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.962 -1.712 . . . . 0.73999999999999999 113.647 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.3 -0.58 26.0 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.79 2.036 . . . . 0.91000000000000003 113.604 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -57.33 -35.65 70.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.295 1.838 . . . . 2.7400000000000002 113.727 -176.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -116.63 26.2 10.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.644 1.578 . . . . 4.2699999999999996 112.776 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.876 1.671 . . . . 4.8399999999999999 114.269 -164.064 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.88 -1.288 . . . . 19.460000000000001 109.88 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m 50.64 29.98 4.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.049 1.739 . . . . 17.640000000000001 115.159 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -67.1 157.64 33.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.125 0.97 . . . . 19.870000000000001 112.91 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.2 p -94.36 156.72 16.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.466 1.506 . . . . 13.51 113.022 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -20.22 58.6 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.396 1.999 . . . . 11.4 116.396 -176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 23.47 77.82 Favored Glycine 0 CA--C 1.541 1.662 0 N-CA-C 116.439 1.336 . . . . 7.3200000000000003 116.439 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.63 161.2 18.41 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.56 1.544 . . . . 5.5800000000000001 112.801 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 176.31 178.72 46.31 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.431 1.015 . . . . 4.7400000000000002 112.479 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.93 123.01 5.19 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.391 1.472 . . . . 4.4900000000000002 110.651 -171.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.89 122.31 29.69 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 122.144 -0.621 . . . . 4.3899999999999997 111.956 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.59 4.45 61.26 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.955 1.264 . . . . 4.21 116.151 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -71.33 141.93 50.43 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.843 1.257 . . . . 3.8599999999999999 111.761 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.62 91.04 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.384 -0.823 . . . . 1.1599999999999999 113.19 -173.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 pm0 -62.57 -26.23 68.48 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.137 . . . . 2.7400000000000002 114.05 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -80.03 -51.24 9.28 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.204 -0.935 . . . . 1.4099999999999999 110.281 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -49.83 -33.86 18.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.555 1.142 . . . . 0.67000000000000004 113.274 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.27 -51.61 68.22 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.616 0.644 . . . . 2.5800000000000001 111.14 173.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.67 73.06 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.847 -1.158 . . . . 0.93999999999999995 111.809 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -41.97 95.68 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.86 2.064 . . . . 1.79 111.55 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.518 ' HA ' HG21 ' A' ' 55' ' ' VAL . 34.3 m -76.56 -25.37 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 113.606 0.965 . . . . 0.58999999999999997 113.606 169.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -83.64 4.79 26.94 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 115.174 1.546 . . . . 2.2400000000000002 115.174 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -53.81 -35.52 61.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.42 1.488 . . . . 1.74 112.723 163.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -151.72 178.05 9.76 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.846 0.831 . . . . 2.3900000000000001 112.629 -168.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.3 -22.39 35.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 117.688 -1.149 . . . . 1.6000000000000001 113.107 162.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.02 121.85 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 122.49 1.138 . . . . 0.89000000000000001 108.916 174.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.5 OUTLIER -134.98 121.05 32.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 122.454 1.121 . . . . 1.52 109.173 176.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 61.8 t -112.09 143.3 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 125.942 1.697 . . . . 0.35999999999999999 108.888 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -140.79 103.84 4.58 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.145 -0.687 . . . . 1.8799999999999999 109.145 -159.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.65 150.07 28.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 111.96 0.356 . . . . 0.46000000000000002 111.96 -170.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -73.97 60.34 0.75 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.68 -1.263 . . . . 1.6499999999999999 110.473 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 169.99 -174.35 44.14 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 118.641 -2.537 . . . . 0.82999999999999996 113.0 -163.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 47.0 p -116.2 162.04 28.18 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 117.684 0.742 . . . . 1.01 111.645 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.73 -29.03 5.92 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.39 2.06 . . . . 0.90000000000000002 112.519 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -71.99 -33.3 68.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.503 1.121 . . . . 3.2599999999999998 112.693 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -133.52 84.87 44.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.519 1.928 . . . . 2.7599999999999998 109.907 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -57.66 128.85 30.83 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.508 2.806 . . . . 3.27 110.795 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.578 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -65.44 -45.31 84.3 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.296 1.046 . . . . 2.5499999999999998 112.125 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.3 t -157.97 166.47 32.5 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 129.285 3.034 . . . . 2.0800000000000001 107.996 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -37.75 -44.74 1.41 Allowed Glycine 0 N--CA 1.479 1.549 0 C-N-CA 126.484 1.992 . . . . 3.4700000000000002 117.558 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.68 -28.08 58.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.828 1.047 . . . . 2.48 113.828 -170.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HE22 ' A' ' 66' ' ' GLN . 24.7 p -68.83 -32.79 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.674 0.99 . . . . 1.78 113.674 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -75.81 -36.15 59.81 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 121.528 -0.733 . . . . 2.6699999999999999 111.096 172.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.67 79.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.71 0.633 . . . . 0.88 112.71 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.9 m -75.14 -39.56 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.38 1.072 . . . . 0.68999999999999995 113.57 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.2 t -73.07 -34.68 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.707 0.803 . . . . 0.70999999999999996 111.623 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -57.93 -50.71 72.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.82 1.248 . . . . 2.1800000000000002 111.141 167.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.99 -41.81 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.539 1.063 . . . . 0.46999999999999997 111.029 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.2 mt -61.31 -58.11 9.59 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.228 0.611 . . . . 0.58999999999999997 112.632 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -62.93 -28.75 70.27 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.216 1.561 . . . . 3.21 115.216 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 mt -66.85 -40.46 87.93 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.787 1.235 . . . . 0.51000000000000001 111.575 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.53 0.75 11.61 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.723 1.009 . . . . 0.51000000000000001 113.723 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.71 1.61 70.72 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-N 119.743 1.156 . . . . 0.71999999999999997 114.518 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.14 115.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.633 1.216 . . . . 0.69999999999999996 111.01 -171.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -129.48 -4.4 4.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 123.761 1.743 . . . . 5.4500000000000002 112.441 173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -94.71 24.75 4.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 130.209 3.404 . . . . 4.1699999999999999 112.311 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 4.4 p90 -70.85 166.85 20.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.068 0.947 . . . . 2.0099999999999998 110.708 163.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.16 115.53 30.06 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.587 -1.264 . . . . 0.45000000000000001 107.587 154.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.53 107.98 19.62 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.364 -0.606 . . . . 0.54000000000000004 109.364 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.52 113.46 19.58 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.545 1.938 . . . . 2.0899999999999999 111.959 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -81.2 101.81 9.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.457 1.103 . . . . 1.98 111.87 170.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.3 m -86.82 13.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.698 1.369 . . . . 1.1100000000000001 114.698 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 73.7 mt -76.69 -32.71 58.07 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.221 -0.924 . . . . 1.53 111.746 164.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -75.62 -46.74 29.93 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.715 1.005 . . . . 2.48 113.715 -169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -110.06 118.57 49.37 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 124.341 1.056 . . . . 2.6200000000000001 112.167 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.9 -21.07 50.83 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.601 1.534 . . . . 1.23 111.615 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -61.33 -48.48 81.15 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.22 1.808 . . . . 3.3599999999999999 112.705 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 64.7 mt -61.58 -44.06 97.72 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.087 0.555 . . . . 0.69999999999999996 109.67 170.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -59.64 -56.23 24.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.949 1.3 . . . . 3.8500000000000001 112.142 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -65.62 -44.71 85.69 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.258 1.023 . . . . 4.1299999999999999 111.788 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.67 -43.5 68.74 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 115.375 -0.829 . . . . 0.58999999999999997 112.498 177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -85.16 -33.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.715 0.806 . . . . 0.81999999999999995 112.616 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -38.36 90.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.823 -0.608 . . . . 2.6200000000000001 111.82 171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.17 -52.1 11.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.221 0.919 . . . . 2.3700000000000001 111.748 173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -60.83 -38.82 86.76 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.357 0.98 . . . . 2.1400000000000001 112.917 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -86.89 -4.78 59.21 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.337 1.455 . . . . 1.96 113.585 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.63 16.8 5.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 116.999 2.222 . . . . 2.0099999999999998 116.999 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -120.83 140.49 30.81 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 120.907 1.685 . . . . 1.4399999999999999 112.631 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.93 -42.18 39.32 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.465 2.776 . . . . 1.71 115.13 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.8 m -167.32 81.87 0.21 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 122.523 1.154 . . . . 2.8900000000000001 112.735 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.0 mm -136.75 150.29 69.56 Favored Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 127.408 2.283 . . . . 3.7999999999999998 108.93 169.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -90.22 153.31 4.64 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.488 2.125 . . . . 0.95999999999999996 113.093 170.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -127.94 166.39 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.868 1.267 . . . . 2.4900000000000002 113.202 -170.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 9.2 p -133.61 134.96 56.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 158.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.532 ' HB2' HG23 ' A' ' 55' ' ' VAL . 44.8 m-85 -108.22 134.17 51.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.257 1.023 . . . . 2.1899999999999999 108.36 172.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.8 132.89 55.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.505 0.722 . . . . 0.5 110.798 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 54.16 31.45 14.0 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 113.485 0.921 . . . . 0.73999999999999999 113.485 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.54 72.94 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 117.253 1.661 . . . . 0.89000000000000001 117.253 -170.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -124.22 145.86 49.08 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.663 1.585 . . . . 1.8400000000000001 112.288 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -87.19 137.13 32.61 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 124.693 2.187 . . . . 2.3700000000000001 113.277 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 t -156.51 -44.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 111.215 -2.721 . . . . 1.48 107.809 -133.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.74 174.72 33.9 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 119.647 -1.264 . . . . 0.66000000000000003 116.204 140.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.19 49.55 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.471 0.557 . . . . 0.56999999999999995 112.263 161.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 48.9 t -55.21 -38.36 68.32 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.51 1.3 . . . . 0.85999999999999999 114.51 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -76.82 -17.52 58.96 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.168 -0.957 . . . . 2.2400000000000002 112.46 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.6 mm -86.07 -44.2 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.48 1.912 . . . . 1.1000000000000001 110.726 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.21 -36.39 60.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.007 0.923 . . . . 0.57999999999999996 111.656 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -22.89 64.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.659 1.584 . . . . 0.91000000000000003 113.13 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -80.51 -54.71 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.812 -1.18 . . . . 1.0600000000000001 109.685 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 84.2 mtp -68.79 -29.56 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.982 1.104 . . . . 0.57999999999999996 113.982 -167.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -54.72 -47.79 73.33 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 123.477 1.608 . . . . 0.68999999999999995 111.622 171.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -93.65 -22.38 18.8 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 112.367 -2.197 . . . . 1.1100000000000001 110.797 -158.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -84.79 -22.34 29.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.467 1.907 . . . . 2.3199999999999998 113.335 160.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 14.71 58.28 Favored Glycine 0 N--CA 1.472 1.058 0 O-C-N 120.48 -1.388 . . . . 0.65000000000000002 112.781 170.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.93 -10.03 59.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.747 1.619 . . . . 1.9099999999999999 112.597 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 77.5 mt -78.72 -32.2 46.75 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.929 0.871 . . . . 0.42999999999999999 110.537 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.475 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.2 t -71.11 -36.99 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 127.476 2.31 . . . . 0.55000000000000004 109.851 -171.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -72.13 -37.81 69.38 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.155 0.982 . . . . 2.73 111.591 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.93 -39.48 94.72 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.018 0.527 . . . . 2.1499999999999999 111.625 172.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.81 -35.47 80.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.103 0.961 . . . . 0.5 112.239 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HE3' HG12 ' A' ' 135' ' ' VAL . 71.6 mttt -65.03 -30.11 71.06 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 117.704 -1.141 . . . . 0.93000000000000005 113.462 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.75 -42.86 89.86 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 119.835 1.198 . . . . 1.74 111.948 171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.6 mt -78.97 -0.21 30.15 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.612 1.965 . . . . 2.52 114.598 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.95 9.71 66.82 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.119 0.866 . . . . 0.76000000000000001 113.745 -172.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 54.0 mt -80.21 140.86 16.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 118.633 1.216 . . . . 0.69999999999999996 110.15 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -92.13 116.33 28.84 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.998 1.319 . . . . 1.3899999999999999 110.475 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 t -62.77 111.78 2.25 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.77 -0.826 . . . . 0.83999999999999997 108.77 161.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.21 -12.3 3.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.238 1.415 . . . . 0.73999999999999999 114.672 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.83 -21.9 66.51 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.846 2.058 . . . . 1.3600000000000001 112.228 170.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.59 -20.01 60.73 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.333 2.253 . . . . 3.5699999999999998 113.066 171.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.6 16.52 18.62 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.521 1.304 . . . . 6.2699999999999996 114.521 -167.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.251 1.18 0 C-N-CA 126.606 1.962 . . . . 4.4400000000000004 114.571 -178.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.585 -0.606 . . . . 18.149999999999999 111.585 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.69 140.05 37.15 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.972 1.101 . . . . 15.869999999999999 113.972 -169.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.4 159.64 34.18 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.458 1.651 . . . . 16.390000000000001 115.458 -165.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -73.91 -68.45 0.51 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.938 1.695 . . . . 12.699999999999999 114.417 -171.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.1 mmt -117.44 -36.62 3.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.613 -1.63 . . . . 11.92 114.667 -159.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.86 158.4 27.03 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.603 1.573 . . . . 8.4299999999999997 114.183 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.6 -1.17 26.23 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 116.642 2.09 . . . . 8.0800000000000001 116.642 -169.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 63.25 24.51 67.41 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 117.416 1.727 . . . . 5.5 117.416 163.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.18 166.46 52.54 Favored Glycine 0 CA--C 1.538 1.471 0 CA-C-N 118.883 1.342 . . . . 4.79 115.661 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.14 97.91 0.95 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.443 1.973 . . . . 4.1200000000000001 110.059 164.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.79 177.46 14.47 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.804 1.192 . . . . 3.2599999999999998 113.476 -161.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.7 t 61.31 176.11 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.916 2.086 . . . . 2.6299999999999999 113.656 -171.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.6 -26.55 63.77 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.365 -1.459 . . . . 1.1599999999999999 114.073 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -69.9 -23.0 63.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.611 1.337 . . . . 4.0300000000000002 114.611 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -76.72 -48.91 17.37 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.075 -1.016 . . . . 1.22 110.633 168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -60.81 -29.83 69.71 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.091 0.957 . . . . 0.51000000000000001 112.058 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.73 -43.27 97.02 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.861 1.315 . . . . 2.3700000000000001 112.439 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.64 67.7 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.73 -1.231 . . . . 0.70999999999999996 109.676 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.13 -47.15 78.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.885 1.674 . . . . 0.89000000000000001 112.363 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.83 -19.1 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 121.133 1.788 . . . . 0.62 113.184 169.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 27.4 mmmt -89.33 6.43 40.54 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 116.232 1.938 . . . . 2.4100000000000001 116.232 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.81 -47.32 78.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.108 0.867 . . . . 1.22 112.575 169.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.24 178.43 5.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 122.133 0.968 . . . . 1.6599999999999999 110.812 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.16 -12.04 29.17 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.949 1.092 . . . . 1.1899999999999999 113.949 172.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -141.89 76.41 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 104.91 -2.256 . . . . 0.78000000000000003 104.91 -177.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.29 114.31 30.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.687 -1.142 . . . . 1.03 108.311 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.89 147.52 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 C-N-CA 125.248 1.419 . . . . 0.32000000000000001 109.706 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -144.95 112.11 6.01 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.757 0.823 . . . . 1.78 109.819 -160.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.07 152.68 28.33 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.078 0.399 . . . . 0.39000000000000001 110.578 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -75.3 61.45 1.2 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.977 -1.702 . . . . 1.3899999999999999 109.035 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.44 -173.57 44.89 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 119.302 -2.124 . . . . 0.82999999999999996 112.549 -162.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 9.6 p -124.2 163.78 33.83 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 123.818 0.847 . . . . 0.72999999999999998 110.582 176.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 88.5 Cg_endo -75.22 -23.52 13.36 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.041 1.827 . . . . 0.69999999999999996 111.705 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -83.3 -19.18 36.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.54 1.136 . . . . 3.6600000000000001 113.56 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -138.43 81.83 24.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 127.06 2.144 . . . . 2.1400000000000001 110.903 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -58.5 108.94 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.16 3.24 . . . . 3.0299999999999998 109.162 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -42.99 86.02 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.065 0.946 . . . . 2.8999999999999999 113.241 -161.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.6 t -159.41 143.42 14.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.378 2.671 . . . . 2.0499999999999998 109.255 -167.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 50.78 -129.42 30.46 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 121.068 -1.02 . . . . 2.9900000000000002 115.646 157.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.63 3.21 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 119.571 3.174 . . . . 3.1400000000000001 119.571 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.1 p -70.63 -24.37 62.7 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 119.687 -1.883 . . . . 2.48 115.977 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -81.51 -27.75 34.34 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.755 0.707 . . . . 2.7599999999999998 112.132 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -32.19 71.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.282 0.946 . . . . 0.82999999999999996 112.381 -174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG13 ' SG ' ' A' ' 122' ' ' CYS . 16.1 m -69.85 -39.64 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 113.391 0.885 . . . . 0.64000000000000001 113.391 171.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.03 -36.12 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.512 1.125 . . . . 0.60999999999999999 111.692 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -55.54 -53.64 53.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.847 2.059 . . . . 2.9300000000000002 110.902 165.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.89 -41.52 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.192 -0.942 . . . . 0.41999999999999998 110.754 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.0 mt -59.86 -58.67 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.342 0.657 . . . . 0.41999999999999998 112.707 174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -60.01 -33.24 71.74 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.682 1.364 . . . . 3.4399999999999999 114.682 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.6 mt -65.88 -40.18 91.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.609 1.164 . . . . 0.56999999999999995 111.866 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -74.33 0.86 13.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.924 0.889 . . . . 0.51000000000000001 113.096 170.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.89 1.96 79.09 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.288 0.946 . . . . 0.81999999999999995 114.754 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.8 t -98.25 121.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 118.711 1.255 . . . . 0.5 111.626 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -11.37 4.14 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 126.86 2.064 . . . . 4.9199999999999999 113.475 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -81.15 20.96 0.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.916 1.686 . . . . 3.3999999999999999 114.143 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 16.6 p90 -68.87 161.83 27.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.852 0.834 . . . . 2.0800000000000001 110.331 166.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.31 117.64 35.17 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.803 -1.184 . . . . 0.41999999999999998 107.803 158.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.22 104.16 16.1 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 109.554 -0.536 . . . . 0.37 109.554 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -83.89 117.37 23.28 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.001 1.72 . . . . 2.04 112.078 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -85.2 106.79 16.9 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.133 0.973 . . . . 2.2400000000000002 112.215 171.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.253 4.3 m -82.83 8.68 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 114.294 1.22 . . . . 0.81000000000000005 114.294 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.5 mt -84.13 -31.68 25.09 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.909 -1.119 . . . . 1.3300000000000001 111.994 163.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -77.02 -34.92 57.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.531 1.132 . . . . 2.3599999999999999 113.731 -166.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.58 123.77 30.91 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.821 1.648 . . . . 2.4300000000000002 111.981 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -67.0 -30.66 38.77 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.511 2.14 . . . . 1.77 111.681 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.85 -36.83 85.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.57 1.548 . . . . 4.25 112.282 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.1 mt -71.14 -45.69 63.05 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.214 0.606 . . . . 0.58999999999999997 110.42 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -54.83 -57.52 11.26 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.0 1.32 . . . . 4.1200000000000001 111.349 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.35 -46.23 87.54 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.654 0.782 . . . . 2.8599999999999999 111.393 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.09 67.23 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.653 -1.082 . . . . 0.82999999999999996 113.562 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.9 tp -93.66 -33.73 5.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 118.701 1.251 . . . . 1.1100000000000001 112.949 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -57.02 -37.08 71.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.038 0.381 . . . . 2.2599999999999998 110.833 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -76.46 -61.29 2.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.301 1.44 . . . . 2.8500000000000001 112.23 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -53.37 -42.33 66.77 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.922 -1.111 . . . . 2.3199999999999998 112.803 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.2 m -95.95 1.54 52.91 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.031 1.123 . . . . 1.73 114.031 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.04 17.71 2.78 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.922 1.452 . . . . 2.3100000000000001 114.922 178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.12 140.19 37.84 Favored Pre-proline 0 N--CA 1.47 0.564 0 C-N-CA 125.668 1.587 . . . . 2.0299999999999998 111.149 -171.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.97 -36.77 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.712 2.275 . . . . 1.9199999999999999 113.407 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -161.62 124.87 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.836 0.855 . . . . 3.5800000000000001 112.247 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.19 132.35 10.87 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 116.661 -1.637 . . . . 4.6299999999999999 108.868 162.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -67.26 136.83 41.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 122.599 1.964 . . . . 1.29 109.296 168.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -130.01 160.28 34.14 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.342 0.974 . . . . 2.0600000000000001 110.65 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.47 140.03 44.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.162 0.506 . . . . 0.65000000000000002 109.783 161.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -117.95 125.02 49.64 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.935 -1.135 . . . . 1.6200000000000001 107.935 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.81 126.62 50.02 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 122.602 0.361 . . . . 0.42999999999999999 110.281 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.404 ' HB2' HD21 ' A' ' 141' ' ' LEU . 8.1 t-20 57.26 27.55 13.82 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.298 0.851 . . . . 0.62 113.298 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 50' ' ' LYS . . . 71.66 15.82 75.78 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 126.89 2.186 . . . . 0.72999999999999998 117.871 -169.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -112.07 143.89 42.35 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.314 1.557 . . . . 2.7999999999999998 111.341 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -85.49 137.64 32.76 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 123.864 1.792 . . . . 2.04 112.421 -173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.63 -39.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 111.108 -2.769 . . . . 1.6000000000000001 108.285 -134.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 161.01 172.87 28.91 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 116.446 1.338 . . . . 0.56000000000000005 116.446 137.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.93 169.93 52.49 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.377 0.989 . . . . 0.46000000000000002 112.435 163.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.429 ' SG ' HG13 ' A' ' 73' ' ' VAL . 13.2 t -61.51 -33.74 74.31 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.239 1.57 . . . . 0.64000000000000001 115.239 -169.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.67 -32.97 71.91 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.812 -1.18 . . . . 2.2400000000000002 112.103 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.9 mm -72.28 -43.7 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.872 1.269 . . . . 1.1699999999999999 110.755 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 6.0 tp -56.66 -34.38 67.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.806 0.443 . . . . 0.55000000000000004 111.955 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.64 -19.61 62.8 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.703 1.601 . . . . 0.63 112.198 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -83.47 -54.39 5.0 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.956 -1.09 . . . . 0.81000000000000005 110.791 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 92.9 mtp -67.1 -28.71 68.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.583 0.957 . . . . 0.45000000000000001 113.583 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -51.18 -46.58 62.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.96 1.362 . . . . 0.55000000000000004 112.067 170.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -92.6 -30.49 15.6 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 112.791 -2.004 . . . . 1.22 109.943 -159.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.56 -35.26 70.54 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 128.235 2.614 . . . . 2.0299999999999998 112.644 166.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.09 13.41 46.03 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.384 0.992 . . . . 0.59999999999999998 113.403 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.18 -15.24 59.59 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.235 1.414 . . . . 2.46 112.074 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.4 mt -73.53 -24.8 60.19 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.217 1.008 . . . . 0.40000000000000002 110.742 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.487 HG12 ' HE3' ' A' ' 139' ' ' LYS . 4.0 t -81.05 -38.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.518 1.527 . . . . 0.55000000000000004 110.228 -166.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.38 -37.49 87.17 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.394 1.078 . . . . 2.6899999999999999 110.816 168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.33 -30.65 71.69 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.337 0.866 . . . . 1.8 113.337 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.7 mt -75.11 -44.18 48.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.311 1.044 . . . . 0.72999999999999998 111.915 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.487 ' HE3' HG12 ' A' ' 135' ' ' VAL . 86.1 mttt -58.16 -34.02 69.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.735 1.214 . . . . 1.1899999999999999 113.277 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . 0.294 15.6 ptpt -76.78 -10.59 59.48 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 116.165 1.913 . . . . 2.2799999999999998 116.165 175.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 115' ' ' ASN . 4.5 mm? -96.35 -3.39 43.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.856 1.662 . . . . 1.3 111.912 165.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.44 7.79 88.19 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.855 1.216 . . . . 1.0700000000000001 113.936 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.68 132.76 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 118.786 1.293 . . . . 0.77000000000000002 111.391 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -77.39 115.59 17.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.971 1.708 . . . . 1.53 110.567 168.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' ' 148' ' ' LEU . 2.0 t -62.72 124.32 20.7 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 120.689 -1.257 . . . . 0.5 109.153 155.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -52.91 -29.51 28.94 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.436 -1.415 . . . . 0.73999999999999999 112.744 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.9 mt -68.8 -9.41 50.91 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.918 2.087 . . . . 0.68999999999999995 113.901 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.427 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.3 OUTLIER -57.04 -49.36 76.08 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.207 1.403 . . . . 2.21 111.532 173.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.07 22.48 4.97 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.504 1.522 . . . . 3.54 113.522 -171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 . . . . . 0 C--O 1.258 1.502 0 C-N-CA 127.73 2.412 . . . . 3.8100000000000001 112.344 176.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 110.408 -1.077 . . . . 16.27 110.408 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 52.32 15.89 0.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.177 2.288 . . . . 14.359999999999999 117.177 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 55.83 26.08 9.21 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.86 1.664 . . . . 11.970000000000001 114.874 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.9 p -103.51 -20.75 13.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.051 1.34 . . . . 13.65 114.562 172.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.38 154.44 26.99 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 129.45 3.1 . . . . 12.890000000000001 109.782 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.37 29.1 74.13 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 121.158 -0.964 . . . . 8.5999999999999996 114.605 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.4 11.35 5.65 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.764 1.282 . . . . 8.3599999999999994 113.819 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -173.99 -178.3 43.82 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.579 2.514 . . . . 5.4100000000000001 110.625 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.44 -161.01 32.5 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 118.545 1.173 . . . . 3.8199999999999998 114.083 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.33 58.68 3.26 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.823 1.678 . . . . 3.1499999999999999 114.062 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.43 -160.7 52.74 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-O 123.239 1.466 . . . . 3.0499999999999998 114.907 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.4 t 64.23 178.12 0.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.898 2.479 . . . . 2.46 114.763 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.93 66.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.344 1.457 . . . . 0.78000000000000003 113.864 -165.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.9 -22.35 59.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.32 1.418 . . . . 3.1800000000000002 114.158 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -80.26 -51.6 8.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.334 1.054 . . . . 1.1000000000000001 110.36 170.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.19 -33.55 69.39 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.887 0.875 . . . . 0.47999999999999998 112.534 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.76 -45.22 93.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.87 1.319 . . . . 2.0099999999999998 112.184 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.48 -33.8 75.86 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 121.037 -1.039 . . . . 0.79000000000000004 108.965 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.26 -43.5 91.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.418 1.487 . . . . 0.90000000000000002 112.774 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.95 -13.89 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.208 1.367 . . . . 0.78000000000000003 112.944 168.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -96.92 3.11 52.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.437 1.643 . . . . 2.46 115.437 171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -21.89 57.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.74 1.216 . . . . 1.71 113.364 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -139.24 -178.11 5.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.704 1.202 . . . . 1.71 110.157 164.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 -14.37 23.07 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.105 1.52 . . . . 1.25 115.105 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -133.33 77.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 105.536 -2.024 . . . . 0.98999999999999999 105.536 -179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.99 112.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.163 -1.051 . . . . 1.1100000000000001 108.163 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -105.86 149.18 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 C-N-CA 124.789 1.236 . . . . 0.37 109.761 -176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -144.97 110.75 5.39 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.698 0.799 . . . . 2.0099999999999998 109.064 -160.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.77 153.95 33.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 117.884 0.311 . . . . 0.40000000000000002 110.208 -175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.94 63.69 3.7 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.263 -1.523 . . . . 2.0299999999999998 111.488 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 66' ' ' GLN . . . 162.53 -161.05 33.34 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.08 1.192 . . . . 0.73999999999999999 116.08 -164.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 33.9 p -131.72 155.76 80.99 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.777 1.631 . . . . 0.66000000000000003 112.099 -175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 76.1 Cg_endo -73.53 -16.8 24.05 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.242 2.628 . . . . 0.71999999999999997 114.022 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -97.61 -15.9 20.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.059 1.744 . . . . 3.4900000000000002 114.133 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -138.98 118.18 9.28 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.064 1.346 . . . . 2.3999999999999999 110.436 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.23 95.46 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.579 2.853 . . . . 2.0299999999999998 111.988 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 1.6 pt20 -32.83 -56.49 0.37 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.364 2.666 . . . . 1.78 114.01 162.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 9.6 t -164.22 -144.74 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.941 2.496 . . . . 1.8700000000000001 107.299 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.78 169.41 20.91 Favored Glycine 0 CA--C 1.538 1.507 0 O-C-N 120.987 -1.071 . . . . 2.1499999999999999 113.978 165.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 67.96 -24.32 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 129.139 2.976 . . . . 2.4500000000000002 117.84 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -68.43 -30.83 69.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.579 1.326 . . . . 2.0299999999999998 114.579 -168.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -84.74 -33.5 23.06 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.138 . . . . 3.0 111.329 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.43 74.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.456 0.703 . . . . 0.76000000000000001 112.886 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 17.2 m -73.19 -39.4 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.499 1.12 . . . . 0.70999999999999996 113.365 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.84 -32.06 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.703 0.801 . . . . 0.51000000000000001 111.911 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -62.08 -47.66 83.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.203 1.001 . . . . 2.25 110.903 168.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.1 -40.53 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 120.364 1.438 . . . . 0.40999999999999998 110.899 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.75 -53.95 51.16 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.1 0.778 . . . . 0.47999999999999998 113.1 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.9 ptt85 -58.39 -37.88 76.19 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.616 1.098 . . . . 6.0499999999999998 113.712 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.68 -31.58 72.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.571 1.148 . . . . 0.56000000000000005 111.914 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -78.95 -0.39 30.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.593 1.557 . . . . 0.5 114.49 167.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.12 6.98 58.74 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.132 1.349 . . . . 0.73999999999999999 115.281 177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.7 t -112.29 124.89 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.608 1.163 . . . . 0.68999999999999995 112.444 -165.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 16.28 4.23 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.728 2.811 . . . . 3.52 110.927 173.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.2 15.5 18.18 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.145 2.978 . . . . 4.1299999999999999 111.428 -160.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 12.3 p90 -71.8 164.62 25.67 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 122.849 1.309 . . . . 2.02 111.358 165.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.41 110.64 23.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.807 -1.542 . . . . 0.58999999999999997 107.482 157.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.2 97.28 11.1 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.976 -0.75 . . . . 0.5 108.976 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -76.93 114.63 15.92 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.719 1.607 . . . . 2.0099999999999998 111.115 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -76.76 107.62 9.2 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.817 -1.083 . . . . 2.2400000000000002 110.789 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 m -80.49 5.4 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 114.198 1.184 . . . . 0.98999999999999999 114.198 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.88 -20.57 23.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.195 0.998 . . . . 1.72 112.233 167.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -38.0 79.35 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.334 0.654 . . . . 2.5299999999999998 112.104 -169.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -130.17 128.88 22.83 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 126.342 1.857 . . . . 1.8500000000000001 110.884 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.71 -19.94 59.43 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.785 2.323 . . . . 1.1100000000000001 111.918 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -63.32 -43.07 98.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.99 2.116 . . . . 3.0499999999999998 112.299 170.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.68 -42.28 74.34 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.815 0.446 . . . . 0.57999999999999996 109.919 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -59.88 -54.96 40.06 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.213 0.605 . . . . 3.8999999999999999 111.87 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.9 82.9 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 121.67 -0.644 . . . . 3.0699999999999998 112.265 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.17 -44.97 57.7 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.823 0.702 . . . . 0.48999999999999999 111.851 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 100' ' ' ILE . 2.8 tp -81.58 -31.36 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.674 1.237 . . . . 0.76000000000000001 112.716 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -59.32 -38.11 79.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.891 0.876 . . . . 2.0699999999999998 112.697 171.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -77.48 -57.86 3.59 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.154 0.434 . . . . 1.8899999999999999 111.867 170.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -62.21 -34.21 76.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.879 1.066 . . . . 1.8799999999999999 113.879 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 44.9 p -98.09 5.88 48.17 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.425 1.269 . . . . 2.3399999999999999 114.425 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.3 t30 59.21 1.72 0.24 Allowed 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 116.305 1.965 . . . . 2.1000000000000001 116.305 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -121.97 133.49 24.34 Favored Pre-proline 0 N--CA 1.472 0.644 0 O-C-N 120.437 -1.414 . . . . 2.3999999999999999 112.673 -167.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -53.73 -38.62 84.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.3 3.333 . . . . 1.8200000000000001 114.23 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.0 t -169.04 123.24 0.83 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.08 1.752 . . . . 3.3100000000000001 109.683 159.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.27 134.74 15.66 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 129.132 2.973 . . . . 3.5800000000000001 107.599 157.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.68 146.71 9.45 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.315 1.505 . . . . 0.89000000000000001 111.14 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -153.72 168.02 27.65 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.043 0.537 . . . . 2.1200000000000001 112.356 -156.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.58 140.87 33.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.203 0.601 . . . . 0.68000000000000005 110.505 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -115.85 132.89 56.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.277 1.431 . . . . 1.6599999999999999 109.135 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.65 123.95 50.98 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.971 0.415 . . . . 0.5 111.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 51.86 35.48 15.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.118 0.967 . . . . 0.77000000000000002 113.387 -174.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.77 7.41 80.34 Favored Glycine 0 CA--C 1.546 1.985 0 N-CA-C 117.688 1.835 . . . . 0.83999999999999997 117.688 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -101.14 141.88 33.38 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.184 1.992 . . . . 2.5800000000000001 111.273 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -75.75 139.22 41.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 124.411 2.053 . . . . 2.48 112.01 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.36 -47.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 111.137 -2.756 . . . . 1.51 106.046 -137.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.53 172.99 31.7 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 119.318 -1.42 . . . . 0.57999999999999996 116.283 137.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 171.02 55.08 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.257 0.456 . . . . 0.46000000000000002 112.025 162.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 34.2 t -55.77 -34.05 64.9 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.193 1.183 . . . . 0.76000000000000001 114.193 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -80.66 -16.9 52.84 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.977 -1.077 . . . . 2.2000000000000002 113.388 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.47 -45.14 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 126.968 2.107 . . . . 1.1000000000000001 110.727 168.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -52.29 -37.97 57.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.137 1.375 . . . . 0.71999999999999997 112.35 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -47.34 86.77 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.612 1.165 . . . . 1.4299999999999999 110.46 177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -59.22 -49.05 79.34 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.039 0.936 . . . . 0.89000000000000001 111.069 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 87.6 mtp -74.66 -29.08 61.12 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.095 1.358 . . . . 0.52000000000000002 113.996 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -54.97 -47.82 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.145 1.45 . . . . 0.78000000000000003 111.366 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -92.74 -22.84 19.14 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 112.537 -2.12 . . . . 1.28 109.822 -161.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -81.58 -28.08 33.98 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 127.237 2.215 . . . . 2.2999999999999998 114.047 164.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.21 14.76 50.38 Favored Glycine 0 N--CA 1.475 1.253 0 C-N-CA 125.109 1.338 . . . . 0.89000000000000001 114.393 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -78.69 -7.2 57.47 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.094 -1.239 . . . . 2.1400000000000001 111.962 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.7 mt -76.91 -26.66 54.38 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.06 -1.025 . . . . 0.47999999999999998 111.057 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.421 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.4 t -78.24 -39.61 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 C-N-CA 126.005 1.722 . . . . 0.80000000000000004 110.141 -173.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' HG3' ' HE3' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -45.65 -50.5 13.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.967 1.707 . . . . 7.4199999999999999 110.793 166.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.95 -43.71 78.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.988 2.115 . . . . 1.9299999999999999 111.789 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.41 -39.98 89.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.898 0.879 . . . . 0.67000000000000004 111.552 171.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' HE3' HG12 ' A' ' 135' ' ' VAL . 93.2 mttt -67.92 -29.25 68.28 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.694 0.998 . . . . 1.1000000000000001 113.694 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HE3' ' HG3' ' A' ' 136' ' ' GLU . 63.8 mttt -60.24 -44.26 95.38 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 120.41 1.459 . . . . 1.8300000000000001 110.874 171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.6 mt -73.0 -5.65 40.23 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.26 1.824 . . . . 2.5800000000000001 114.482 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.12 82.33 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.476 1.036 . . . . 0.81999999999999995 114.45 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 48.2 mt -79.13 138.97 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.641 1.177 . . . . 0.58999999999999997 110.352 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -90.0 112.78 24.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.34 1.856 . . . . 1.1899999999999999 111.254 172.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.9 t -61.84 132.77 54.18 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.388 1.09 . . . . 0.52000000000000002 111.054 163.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.36 -8.89 36.15 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.615 -1.928 . . . . 0.68999999999999995 113.415 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -85.25 -2.65 58.29 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.837 1.655 . . . . 0.97999999999999998 113.272 172.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -24.88 66.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.962 1.305 . . . . 2.3700000000000001 113.575 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.42 30.82 7.07 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.109 1.763 . . . . 3.21 113.708 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 116.318 -1.801 . . . . 3.7400000000000002 115.148 178.583 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.977 0 N-CA-C 110.531 -1.027 . . . . 20.0 110.531 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 t 67.74 151.86 0.08 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.04 2.136 . . . . 17.809999999999999 115.634 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.33 19.1 7.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.892 2.077 . . . . 14.710000000000001 112.285 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -138.69 158.63 43.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.554 1.142 . . . . 12.390000000000001 113.53 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.61 165.35 0.6 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.6 -1.182 . . . . 13.99 112.37 154.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.21 -136.23 32.31 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.964 0.792 . . . . 11.6 113.178 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.91 150.7 22.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.358 1.063 . . . . 10.66 113.093 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.98 -0.72 70.54 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.042 1.306 . . . . 6.8399999999999999 115.7 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.78 150.32 51.86 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.754 1.169 . . . . 5.2300000000000004 113.146 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.91 11.21 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.822 1.201 . . . . 3.48 115.954 -169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.96 -179.79 52.49 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 116.07 1.188 . . . . 3.5299999999999998 116.07 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.7 t 66.3 169.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 128.754 2.822 . . . . 2.48 114.12 -169.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.68 47.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.545 1.538 . . . . 0.97999999999999998 113.499 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -66.58 -22.67 66.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.59 1.156 . . . . 2.6800000000000002 114.075 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.3 tp60 -75.83 -52.16 10.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.028 0.931 . . . . 1.0800000000000001 110.911 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -59.87 -35.11 74.12 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.512 1.125 . . . . 0.54000000000000004 112.596 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.58 -46.96 87.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.193 0.997 . . . . 1.8400000000000001 111.159 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.838 -1.164 . . . . 0.46000000000000002 111.149 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -46.36 85.42 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.644 2.378 . . . . 0.91000000000000003 111.576 173.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -72.43 -19.4 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.005 -1.059 . . . . 0.44 113.675 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -89.97 5.4 46.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 115.131 1.53 . . . . 2.3799999999999999 115.131 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -59.63 -39.76 85.4 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.725 1.21 . . . . 1.27 112.22 167.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.33 175.13 10.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.99 0.916 . . . . 1.6899999999999999 111.788 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -20.97 35.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.973 0.731 . . . . 1.4299999999999999 112.973 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -132.58 119.43 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 125.705 1.602 . . . . 0.85999999999999999 106.999 174.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -136.0 119.23 23.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 107.948 -1.13 . . . . 1.47 107.948 -178.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 112' ' ' VAL . 55.9 t -112.97 146.39 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 125.793 1.637 . . . . 0.26000000000000001 109.053 -169.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -142.04 107.32 4.99 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.146 -1.057 . . . . 1.8200000000000001 108.146 -160.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 152.47 32.96 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 118.124 0.42 . . . . 0.39000000000000001 110.416 -176.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.72 64.12 2.26 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.314 -1.491 . . . . 1.3999999999999999 110.152 173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.71 -162.02 35.49 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 122.76 1.2 . . . . 0.78000000000000003 114.891 -165.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 69.7 p -136.39 161.24 63.26 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.777 2.031 . . . . 0.68999999999999995 111.257 -178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 47.7 Cg_endo -68.61 -26.36 33.66 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.328 2.019 . . . . 0.76000000000000001 114.314 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.4 -2.65 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.025 1.861 . . . . 3.46 116.025 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.87 113.45 8.4 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 2.0800000000000001 109.902 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.29 83.79 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.481 2.787 . . . . 1.8400000000000001 111.103 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -30.63 -52.14 0.16 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.823 3.249 . . . . 1.6899999999999999 114.023 171.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 7.7 t -157.08 -160.78 0.99 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.162 2.185 . . . . 1.5800000000000001 107.488 -169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.49 174.32 5.11 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.322 -0.862 . . . . 2.0499999999999998 112.677 159.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 1.9 m-30 66.41 -36.1 0.25 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 128.667 2.787 . . . . 2.6899999999999999 117.55 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.6 p -63.75 -33.82 76.52 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.085 1.513 . . . . 1.9299999999999999 115.085 -162.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.38 -31.88 22.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.534 -0.746 . . . . 3.3399999999999999 110.86 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.22 82.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.589 1.086 . . . . 0.79000000000000004 111.76 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.65 -37.87 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 113.209 0.818 . . . . 0.70999999999999996 113.209 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.6 t -76.86 -41.91 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.571 1.148 . . . . 0.56999999999999995 112.095 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.06 -43.27 96.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 118.029 -0.986 . . . . 3.8799999999999999 110.258 172.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.3 mt -57.75 -45.11 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 120.251 1.387 . . . . 0.59999999999999998 111.146 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.09 -54.2 47.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 118.83 -0.605 . . . . 0.56999999999999995 112.3 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -68.49 -27.01 65.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.933 1.457 . . . . 4.5599999999999996 114.933 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.93 -37.82 88.82 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.571 1.078 . . . . 0.82999999999999996 111.054 169.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -74.11 1.24 11.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.799 1.24 . . . . 0.45000000000000001 114.134 168.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.51 13.32 67.97 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 120.871 -1.143 . . . . 0.81000000000000005 114.674 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.31 110.38 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.851 1.26 . . . . 0.68999999999999995 110.382 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -2.08 5.44 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 123.663 1.697 . . . . 3.6499999999999999 112.134 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -107.48 28.79 7.78 Favored 'General case' 0 N--CA 1.436 -1.17 1 C-N-CA 132.027 4.131 . . . . 3.73 111.047 -168.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 3.8 p90 -68.36 169.62 10.33 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.366 1.066 . . . . 1.8300000000000001 109.923 157.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.54 112.31 24.82 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.338 -0.986 . . . . 0.42999999999999999 108.338 157.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.85 108.82 19.93 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 109.358 -0.608 . . . . 0.39000000000000001 109.358 -178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -79.29 119.4 22.29 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.124 2.17 . . . . 2.3900000000000001 111.574 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -88.17 104.53 16.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 123.95 0.9 . . . . 2.2999999999999998 112.209 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.39 14.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.642 1.349 . . . . 1.21 114.642 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.7 mt -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.919 1.288 . . . . 1.46 113.494 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.66 -47.29 11.38 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 2.3999999999999999 112.798 -167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.48 104.34 23.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.268 1.827 . . . . 1.8400000000000001 110.953 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.43 -17.64 53.83 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.023 1.816 . . . . 1.1100000000000001 112.428 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.99 -44.35 89.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.246 2.218 . . . . 3.04 113.211 166.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -65.09 -40.88 95.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.283 -0.636 . . . . 0.63 109.283 172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -58.74 -52.7 64.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.237 1.015 . . . . 3.73 112.569 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -36.29 78.91 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.427 -0.796 . . . . 3.9300000000000002 112.06 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.37 -47.53 56.23 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.678 0.656 . . . . 0.53000000000000003 111.917 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 100' ' ' ILE . 3.6 tp -80.85 -33.62 13.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 118.134 0.967 . . . . 0.63 112.675 -176.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.96 -39.52 85.93 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.004 0.82 . . . . 1.6699999999999999 112.116 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.02 -56.32 5.29 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 118.36 0.527 . . . . 2.25 111.294 172.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -65.67 -31.56 72.64 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.576 1.324 . . . . 1.8799999999999999 114.576 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 65.3 p -94.52 -1.4 53.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.756 1.222 . . . . 2.3700000000000001 113.796 171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.95 19.35 1.96 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.929 1.691 . . . . 1.54 115.068 -174.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.7 139.51 35.89 Favored Pre-proline 0 N--CA 1.476 0.875 0 O-C-N 120.08 -1.637 . . . . 2.2599999999999998 113.855 -173.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.52 -28.12 32.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.017 2.478 . . . . 1.1699999999999999 113.907 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 m -154.28 111.49 3.4 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.013 -1.054 . . . . 2.3399999999999999 110.869 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mt -139.76 120.97 9.56 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.983 1.313 . . . . 4.1299999999999999 108.452 160.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.14 130.71 6.51 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 CA-C-N 120.792 1.319 . . . . 1.01 109.608 165.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -146.47 172.34 13.69 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.551 0.74 . . . . 2.5499999999999998 112.228 -162.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 56' ' ' VAL . 11.5 p -135.12 139.81 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 121.701 -0.624 . . . . 0.56000000000000005 109.71 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.514 ' HB2' HG23 ' A' ' 55' ' ' VAL . 72.1 m-85 -109.34 132.52 54.05 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.428 -0.953 . . . . 1.5700000000000001 108.428 171.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.13 127.92 56.07 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.227 0.611 . . . . 0.51000000000000001 109.4 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 56.27 40.93 29.78 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.059 0.944 . . . . 1.1100000000000001 112.572 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.55 8.1 37.45 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.986 1.755 . . . . 0.55000000000000004 117.004 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -114.13 146.8 39.81 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.541 1.67 . . . . 1.72 112.269 -172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -82.28 136.65 35.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.99 2.329 . . . . 2.0099999999999998 113.161 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -156.41 -43.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 110.522 -3.035 . . . . 1.48 107.943 -136.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.84 177.75 28.46 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 115.912 1.125 . . . . 0.57999999999999996 115.912 134.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 177.61 54.16 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.157 0.884 . . . . 0.68000000000000005 113.453 168.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.512 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 28.3 t -58.54 -29.27 66.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.607 1.336 . . . . 0.93999999999999995 114.607 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -68.11 -39.99 82.67 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.843 -1.161 . . . . 3.04 111.904 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 39.9 mm -71.87 -43.85 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.978 0.911 . . . . 1.2 110.322 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.55 -32.65 65.34 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.132 0.573 . . . . 0.75 111.836 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -22.04 61.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.78 0.718 . . . . 0.77000000000000002 112.753 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -80.39 -58.07 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.188 0.994 . . . . 0.87 109.674 168.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.2 mtp -67.37 -33.08 74.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 114.209 1.188 . . . . 0.96999999999999997 114.209 -168.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -56.73 -47.43 80.04 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 123.259 1.504 . . . . 0.72999999999999998 111.221 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.12 -28.32 17.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 111.857 -2.429 . . . . 1.23 109.364 -158.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -70.66 -35.47 72.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.135 1.374 . . . . 2.4399999999999999 113.164 158.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.14 29.08 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 119.466 1.03 . . . . 0.95999999999999996 112.63 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -78.05 -17.26 57.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.866 2.866 . . . . 2.4500000000000002 111.729 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.7 mt -72.69 -28.4 62.66 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.109 0.957 . . . . 0.70999999999999996 110.66 173.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG12 ' HE3' ' A' ' 139' ' ' LYS . 2.8 t -76.55 -33.08 21.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 125.869 1.668 . . . . 0.52000000000000002 109.939 -167.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -75.36 -42.41 54.18 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.986 1.714 . . . . 2.5800000000000001 109.644 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -60.19 -36.4 77.55 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.469 -0.77 . . . . 1.6299999999999999 112.167 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.3 mt -68.12 -40.59 82.48 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.508 1.123 . . . . 0.62 111.662 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HE3' HG12 ' A' ' 135' ' ' VAL . 68.4 mttt -67.03 -23.43 65.9 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.776 1.028 . . . . 0.81999999999999995 113.776 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -59.54 -41.51 90.23 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.017 1.281 . . . . 2.4399999999999999 111.735 170.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.43 -1.15 35.97 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.857 1.663 . . . . 2.3500000000000001 114.586 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.94 12.47 71.3 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.372 0.987 . . . . 0.83999999999999997 113.733 -171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.91 134.4 28.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 119.321 1.561 . . . . 0.90000000000000002 110.474 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -91.58 102.99 15.64 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.899 2.08 . . . . 1.98 110.951 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 148' ' ' LEU . 4.4 t -57.44 127.2 30.81 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 121.994 0.902 . . . . 0.62 110.893 167.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.12 -19.33 61.37 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 119.577 -1.952 . . . . 0.77000000000000002 112.821 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.69 -1.58 38.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.435 1.894 . . . . 0.78000000000000003 113.663 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.4 OUTLIER -51.28 -32.92 26.49 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.089 1.356 . . . . 2.5499999999999998 111.779 168.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -96.53 24.86 5.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.545 1.538 . . . . 3.6099999999999999 114.829 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 126.86 2.064 . . . . 4.5499999999999998 112.803 165.3 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 109.159 -1.577 . . . . 19.800000000000001 109.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.5 m -83.79 90.37 7.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.42 -0.956 . . . . 18.98 108.42 168.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -56.45 140.58 45.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.734 1.213 . . . . 17.899999999999999 113.874 -160.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.9 p -74.25 152.31 39.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.689 1.737 . . . . 15.300000000000001 115.689 -155.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 167.4 3.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.219 2.207 . . . . 14.07 113.816 177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.89 127.51 8.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.885 1.231 . . . . 10.06 113.808 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.43 155.34 45.09 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.959 1.704 . . . . 8.5299999999999994 111.341 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -160.2 159.55 30.88 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.133 1.349 . . . . 5.9100000000000001 112.481 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 163.72 -165.32 36.83 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.081 1.324 . . . . 4.4800000000000004 111.845 -176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.28 134.88 8.52 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.577 1.561 . . . . 4.2599999999999998 112.725 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.21 10.59 1.26 Allowed Glycine 0 N--CA 1.479 1.543 0 C-N-CA 127.325 2.393 . . . . 3.4399999999999999 118.59 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 t -115.66 175.52 5.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.781 2.033 . . . . 2.5899999999999999 110.392 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.57 -35.98 61.4 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 121.066 -1.022 . . . . 0.84999999999999998 113.709 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -68.77 -22.84 64.27 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.611 1.338 . . . . 3.5299999999999998 114.611 175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -71.89 -48.86 42.71 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.793 -1.192 . . . . 1.1899999999999999 110.255 167.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.28 -33.13 69.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.781 0.833 . . . . 0.62 112.289 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -68.1 -37.56 81.32 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.653 -0.654 . . . . 2.5699999999999998 112.135 172.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.63 -26.69 65.47 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.909 -1.12 . . . . 0.62 111.631 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -41.15 70.43 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.544 1.938 . . . . 1.24 111.866 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.5 m -70.14 -31.83 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.377 -0.827 . . . . 0.89000000000000001 112.895 166.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.67 6.5 2.44 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 117.716 2.487 . . . . 3.8199999999999998 117.716 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -57.17 -41.83 79.96 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.526 1.931 . . . . 1.8300000000000001 112.413 165.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -149.21 171.31 16.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.928 0.87 . . . . 2.2200000000000002 112.121 -170.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -21.93 49.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 117.917 -1.039 . . . . 1.0700000000000001 112.304 168.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.23 114.0 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.795 1.283 . . . . 0.80000000000000004 109.149 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -133.43 121.18 41.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 125.086 1.354 . . . . 1.3300000000000001 108.654 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 112' ' ' VAL . 51.6 t -119.8 146.6 24.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.687 0 C-N-CA 124.553 1.141 . . . . 0.35999999999999999 109.568 -165.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.99 110.83 6.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.026 -0.731 . . . . 1.8600000000000001 109.026 -158.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.12 153.03 33.1 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.798 -0.445 . . . . 0.5 109.798 -169.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -84.79 62.81 7.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 119.402 -2.061 . . . . 1.54 109.911 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.42 -170.66 41.11 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.64 0.638 . . . . 0.81999999999999995 113.803 -157.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 61.9 p -125.78 159.88 59.1 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.711 1.604 . . . . 0.87 110.769 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 55.6 Cg_endo -68.34 -25.61 35.99 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.404 1.402 . . . . 1.26 113.631 -172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -87.47 -10.94 50.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.828 1.418 . . . . 3.6200000000000001 114.828 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -118.7 141.28 29.68 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 114.525 1.306 . . . . 2.73 114.525 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.22 78.31 3.26 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.747 2.965 . . . . 2.1699999999999999 110.126 165.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -44.24 -45.16 8.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.905 1.682 . . . . 3.2400000000000002 114.986 177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 13.7 t -159.81 47.78 0.28 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.96 2.904 . . . . 2.8599999999999999 108.948 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.06 0.98 46.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 118.23 2.052 . . . . 3.5099999999999998 118.23 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.46 -31.12 4.11 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.975 1.843 . . . . 2.7000000000000002 115.975 -168.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.0 t -67.64 -32.34 72.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.631 1.173 . . . . 3.0299999999999998 111.41 -173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.92 -36.76 70.04 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.429 1.492 . . . . 3.96 114.043 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.19 83.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.421 1.01 . . . . 0.82999999999999996 113.054 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.48 -35.87 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 124.094 0.957 . . . . 0.54000000000000004 112.943 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.41 -31.19 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.854 0.861 . . . . 0.58999999999999997 112.073 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -58.33 -49.15 78.23 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.357 1.463 . . . . 2.0499999999999998 110.935 165.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.09 -43.3 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.509 1.049 . . . . 0.34999999999999998 111.255 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.44 -58.9 5.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.448 0.699 . . . . 0.34999999999999998 112.502 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -58.18 -33.47 69.28 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.8 1.407 . . . . 4.2199999999999998 114.8 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 mt -64.19 -39.89 94.93 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.471 1.108 . . . . 0.48999999999999999 111.499 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -75.53 4.02 8.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.712 1.205 . . . . 0.46999999999999997 113.806 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.75 2.84 90.29 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 120.821 -1.174 . . . . 0.64000000000000001 114.463 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -91.26 120.78 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.749 1.22 . . . . 0.45000000000000001 110.331 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 -4.5 0.87 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.54 1.936 . . . . 5.2000000000000002 113.424 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -95.86 24.81 5.13 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.4 1.88 . . . . 3.3199999999999998 113.519 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -69.8 165.84 20.61 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.221 -0.924 . . . . 1.96 110.637 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.11 108.2 19.53 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.317 -0.994 . . . . 0.41999999999999998 108.317 159.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.9 106.32 18.02 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 109.433 -0.58 . . . . 0.34999999999999998 109.433 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -79.99 116.17 19.97 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.126 2.171 . . . . 2.21 112.747 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -86.67 106.71 17.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.565 1.146 . . . . 2.3700000000000001 112.216 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 m -72.62 -3.57 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 114.402 1.26 . . . . 0.89000000000000001 114.402 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.4 mt -76.49 -27.67 56.16 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.047 -1.033 . . . . 1.3500000000000001 112.026 169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -68.83 -48.04 64.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.201 1.001 . . . . 2.6600000000000001 111.9 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -123.29 116.12 28.5 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.829 1.252 . . . . 1.8500000000000001 112.091 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -66.39 -22.99 51.7 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.787 1.658 . . . . 1.01 111.461 175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -61.11 -42.62 98.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.978 1.711 . . . . 3.0099999999999998 112.938 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.2 mt -67.13 -45.26 77.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.408 0.683 . . . . 0.70999999999999996 109.62 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -55.69 -56.1 24.43 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.544 1.538 . . . . 3.3199999999999998 112.172 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.56 -41.61 83.93 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.676 0.79 . . . . 2.4399999999999999 111.627 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -48.87 -46.35 31.9 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.305 -0.719 . . . . 0.67000000000000004 112.944 174.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.7 tp -87.14 -36.52 10.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 118.165 0.983 . . . . 0.91000000000000003 113.446 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -58.5 -35.57 72.45 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.608 0.64 . . . . 2.2000000000000002 111.288 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.98 -54.93 6.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.322 0.649 . . . . 2.6299999999999999 112.006 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.77 -32.06 71.39 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.035 1.334 . . . . 2.0499999999999998 114.563 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.8 m -100.85 2.03 40.62 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.05 1.13 . . . . 2.1299999999999999 114.05 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 52.06 35.26 15.8 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.842 1.657 . . . . 2.1000000000000001 114.249 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -129.23 145.21 55.82 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.916 1.686 . . . . 1.6899999999999999 111.575 -166.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.62 -32.21 6.21 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.672 2.248 . . . . 1.0700000000000001 114.101 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.3 m -170.81 138.99 1.43 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.277 1.831 . . . . 2.54 109.594 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.13 4.11 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.863 1.665 . . . . 5.75 110.911 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -98.98 150.21 0.6 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 116.59 -1.807 . . . . 1.1699999999999999 114.713 115.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -131.15 164.57 25.21 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.868 0.867 . . . . 2.8900000000000001 110.891 168.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 56' ' ' VAL . 9.1 p -123.26 156.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 108.177 -1.046 . . . . 0.91000000000000003 108.177 160.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.44 ' HB2' HG23 ' A' ' 55' ' ' VAL . 34.7 m-85 -123.76 138.64 54.48 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.22 1.008 . . . . 1.77 110.048 162.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.2 mp -111.18 125.75 54.13 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.559 0.744 . . . . 0.59999999999999998 111.266 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 53.28 32.66 13.95 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 121.925 0.869 . . . . 0.71999999999999997 112.71 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.39 -2.66 51.83 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 119.535 2.574 . . . . 0.54000000000000004 119.535 -167.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -102.78 150.34 23.57 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 121.752 2.776 . . . . 2.04 112.94 -176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -76.19 139.32 41.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 125.349 2.5 . . . . 2.3500000000000001 114.091 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.82 -48.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 110.363 -3.108 . . . . 2.48 107.928 -157.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 157.75 175.98 29.29 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.5 0.96 . . . . 0.71999999999999997 115.5 160.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.03 170.64 54.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.057 0.837 . . . . 0.5 113.19 166.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 52.3 t -52.03 -40.44 61.06 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.937 1.369 . . . . 0.65000000000000002 113.542 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.69 -18.08 62.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.731 1.212 . . . . 2.0699999999999998 114.215 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.7 mm -88.08 -45.85 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.996 1.718 . . . . 1.2 110.668 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.7 tp -53.79 -35.06 60.93 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 0.46000000000000002 111.764 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -22.92 64.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.908 1.683 . . . . 0.72999999999999998 112.866 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -82.46 -52.67 6.64 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.058 -1.026 . . . . 0.93000000000000005 110.452 169.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 79.3 mtp -68.06 -30.63 69.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.625 1.17 . . . . 0.47999999999999998 113.754 -170.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -54.22 -48.05 71.5 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.979 1.371 . . . . 0.70999999999999996 111.33 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -93.69 -21.05 19.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.548 -2.115 . . . . 0.98999999999999999 110.732 -157.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.54 -31.09 24.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.974 1.709 . . . . 2.8399999999999999 111.943 161.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.37 16.58 36.94 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.932 0.777 . . . . 0.60999999999999999 114.306 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.65 -14.01 62.6 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.96 1.38 . . . . 2.02 112.428 173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 68.7 mt -73.47 -26.4 60.9 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.196 0.998 . . . . 0.40999999999999998 110.288 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.7 t -77.43 -42.35 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 126.275 1.83 . . . . 0.62 110.103 -167.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -67.95 -41.93 81.72 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.426 0.691 . . . . 2.9300000000000002 110.024 172.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.06 -40.26 84.6 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.716 -0.615 . . . . 1.97 112.158 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.99 -43.83 86.62 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.745 0.818 . . . . 0.59999999999999998 111.892 170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.324 0.2 OUTLIER -75.99 -21.13 57.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.972 1.101 . . . . 1.6399999999999999 113.972 -173.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.81 -34.39 78.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.597 1.959 . . . . 2.2400000000000002 112.867 164.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.07 -15.4 60.62 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.599 1.16 . . . . 1.6000000000000001 112.91 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.48 -12.5 64.8 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.611 2.053 . . . . 0.79000000000000004 114.032 -170.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.49 133.91 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.961 1.38 . . . . 0.56000000000000005 111.049 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -90.47 113.08 24.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.922 1.689 . . . . 1.1899999999999999 110.721 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.429 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.3 t -62.31 138.6 58.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 122.391 1.091 . . . . 0.73999999999999999 110.442 162.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.61 -11.33 60.39 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.659 1.184 . . . . 0.65000000000000002 112.663 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.74 -4.11 59.13 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.952 1.701 . . . . 0.75 113.408 176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.0 OUTLIER -49.89 -43.41 49.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.801 1.64 . . . . 2.21 114.153 -170.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.96 26.9 6.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.72 2.008 . . . . 5.2699999999999996 111.76 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 N--CA 1.488 1.441 0 C-N-CA 126.114 1.765 . . . . 4.4500000000000002 112.89 177.919 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.001 0 CA-C-O 119.218 -0.768 . . . . 16.77 111.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -132.98 132.25 41.7 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.015 1.326 . . . . 17.329999999999998 111.776 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -146.35 26.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.13 1.53 . . . . 14.710000000000001 115.13 -164.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.289 14.1 p 56.23 -149.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.72 2.008 . . . . 17.960000000000001 114.451 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.61 172.07 14.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.966 1.707 . . . . 19.390000000000001 111.849 -176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.88 -157.18 10.73 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 114.561 0.585 . . . . 12.18 114.561 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.52 -16.11 5.91 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 115.266 1.58 . . . . 11.33 115.266 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.25 -12.67 1.23 Allowed Glycine 0 CA--C 1.533 1.199 0 N-CA-C 115.795 1.078 . . . . 7.1500000000000004 115.795 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.39 -157.45 18.73 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.656 1.122 . . . . 4.9199999999999999 114.961 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.56 51.2 3.15 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.5 1.048 . . . . 3.4700000000000002 114.093 178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.46 -165.01 47.83 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.466 1.031 . . . . 2.9500000000000002 111.317 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.8 t 62.0 -176.7 0.13 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.87 2.068 . . . . 3.0299999999999998 113.947 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.71 76.58 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.559 -1.338 . . . . 1.0700000000000001 113.547 -168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.43 -22.56 66.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.18 1.178 . . . . 2.77 114.18 172.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -84.29 -51.75 6.76 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 121.003 -1.06 . . . . 1.4299999999999999 110.994 172.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -57.63 -34.14 69.0 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 0.66000000000000003 112.724 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.83 -49.32 71.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.314 1.531 . . . . 2.2400000000000002 111.395 168.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.63 -27.64 65.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.986 -1.006 . . . . 0.84999999999999998 110.342 -176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.89 -48.9 33.33 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.901 2.081 . . . . 0.93000000000000005 112.292 174.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.06 -16.81 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 121.071 -1.018 . . . . 0.53000000000000003 112.449 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -7.46 59.47 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 118.129 2.64 . . . . 4.0099999999999998 118.129 175.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.21 -32.39 73.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.015 1.726 . . . . 1.24 112.335 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.26 178.88 6.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.964 0.888 . . . . 1.9099999999999999 113.333 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -13.71 27.97 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.57 1.322 . . . . 1.47 114.57 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -141.41 78.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 105.114 -2.18 . . . . 0.88 105.114 178.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.82 114.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.786 -1.19 . . . . 0.98999999999999999 107.786 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.7 t -105.71 147.5 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 C-N-CA 124.836 1.254 . . . . 0.33000000000000002 109.398 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -141.96 105.05 4.6 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.367 0.667 . . . . 1.8500000000000001 109.956 -160.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.24 153.64 33.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.039 0.385 . . . . 0.48999999999999999 112.039 -172.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -76.86 59.72 1.65 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.325 -1.485 . . . . 1.99 110.164 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.43 179.91 47.12 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 119.284 -2.135 . . . . 0.90000000000000002 112.594 -164.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 13.8 p -119.78 158.06 50.71 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 123.769 0.828 . . . . 1.3500000000000001 110.027 169.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 89.4 Cg_endo -74.35 -22.94 15.82 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.308 2.005 . . . . 0.98999999999999999 112.308 -175.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.4 -22.68 23.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.795 1.638 . . . . 4.0800000000000001 112.98 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -127.41 75.52 77.25 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.941 1.696 . . . . 2.8300000000000001 109.018 169.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -60.23 114.22 2.01 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.642 2.895 . . . . 3.2400000000000002 110.136 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.464 HE22 ' HB3' ' A' ' 70' ' ' SER . 0.0 OUTLIER -58.17 -48.12 81.26 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.699 1.238 . . . . 2.46 112.027 -165.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.1 t -153.06 162.4 41.36 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.37 3.068 . . . . 2.2999999999999998 107.241 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -33.92 -50.06 0.61 Allowed Glycine 0 N--CA 1.475 1.243 0 C-N-CA 126.916 2.198 . . . . 3.5899999999999999 116.279 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.03 -30.54 70.66 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 114.198 1.185 . . . . 2.5699999999999998 114.198 -172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' HE22 ' A' ' 66' ' ' GLN . 52.8 p -68.19 -28.4 67.23 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.587 0.958 . . . . 1.76 113.587 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -83.08 -36.3 25.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 118.905 -0.569 . . . . 2.71 110.657 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.27 -42.27 73.31 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.417 0.687 . . . . 0.83999999999999997 112.852 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.9 m -74.22 -38.45 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.268 1.027 . . . . 0.64000000000000001 113.539 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 89.3 t -77.12 -30.75 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.902 0.881 . . . . 0.56000000000000005 112.157 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.3 -50.79 72.38 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.169 1.388 . . . . 2.3399999999999999 110.422 165.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.28 -41.74 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.483 1.038 . . . . 0.5 110.838 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 mt -61.91 -57.9 9.99 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.087 0.773 . . . . 0.48999999999999999 113.087 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -63.07 -30.62 71.74 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.757 1.391 . . . . 3.2400000000000002 114.757 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.1 mt -63.2 -39.46 94.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.826 1.193 . . . . 0.92000000000000004 111.384 170.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' HG22 ' A' ' 135' ' ' VAL . 59.7 m-70 -77.31 4.54 10.47 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.736 1.214 . . . . 0.58999999999999997 113.679 169.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.58 2.91 84.42 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.69 1.138 . . . . 1.0 114.88 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.48 122.11 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 118.499 1.15 . . . . 0.60999999999999999 111.129 -171.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.36 0.3 9.45 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 128.04 2.536 . . . . 3.6200000000000001 111.22 167.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -95.97 17.72 14.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 128.657 2.783 . . . . 4.0199999999999996 112.164 -165.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 21.8 p90 -73.31 162.56 29.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.464 1.126 . . . . 2.02 111.312 161.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.3 114.34 28.47 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.345 -1.354 . . . . 0.52000000000000002 107.345 158.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.33 101.61 13.35 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.842 0.457 . . . . 0.45000000000000001 110.016 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -77.77 123.67 27.0 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.554 1.542 . . . . 1.9299999999999999 112.625 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -86.53 99.19 11.51 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 127.171 2.188 . . . . 2.27 111.681 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 m -81.71 1.08 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.588 0.958 . . . . 0.91000000000000003 113.588 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.69 -43.34 76.28 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.282 -0.886 . . . . 1.73 111.89 172.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.38 -46.53 60.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.269 0.557 . . . . 2.7400000000000002 112.178 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -104.35 96.34 9.8 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.17 1.788 . . . . 2.6600000000000001 111.678 -173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.46 -17.58 48.95 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 121.887 1.725 . . . . 1.46 112.408 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -60.38 -46.19 90.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.382 1.873 . . . . 3.2999999999999998 112.168 164.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.35 -40.84 94.13 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.857 -0.527 . . . . 0.70999999999999996 110.42 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 24.5 ttp-105 -60.9 -50.27 74.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.876 0.47 . . . . 3.6899999999999999 111.829 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -62.82 -43.53 98.55 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.231 0.612 . . . . 2.25 111.997 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.92 -46.17 60.97 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.911 -1.041 . . . . 0.56999999999999995 111.788 175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 100' ' ' ILE . 4.3 tp -82.07 -31.45 10.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.969 0.884 . . . . 0.68999999999999995 112.37 -174.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.43 -37.87 88.95 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 1.78 112.705 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -78.63 -49.83 12.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.875 0.761 . . . . 2.5699999999999998 111.944 171.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -63.38 -35.77 81.51 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.459 -1.401 . . . . 1.8100000000000001 114.651 -172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.8 p -89.64 -4.12 57.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.516 1.127 . . . . 1.8700000000000001 113.65 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.66 17.29 1.64 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.896 2.078 . . . . 2.0099999999999998 116.074 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -115.49 135.06 22.55 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 119.983 1.265 . . . . 1.73 110.741 173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.91 -32.56 17.74 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.323 1.349 . . . . 1.25 112.288 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.22 50.99 0.84 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.912 2.19 . . . . 3.4700000000000002 116.912 -160.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 25.7 mm -138.14 137.94 22.04 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 124.959 1.304 . . . . 3.9900000000000002 110.233 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -74.91 150.54 38.75 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.058 2.505 . . . . 1.0 112.449 173.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -125.28 167.14 15.3 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.634 1.174 . . . . 3.4300000000000002 112.252 -166.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -129.12 156.65 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 121.394 -0.816 . . . . 1.1899999999999999 109.213 158.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -128.56 134.04 48.52 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.672 1.589 . . . . 1.78 109.826 163.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.99 123.72 48.43 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.55 0.74 . . . . 0.60999999999999999 111.186 176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 57.14 32.08 21.1 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 121.676 0.75 . . . . 0.78000000000000003 112.51 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.99 -8.55 22.44 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.647 2.07 . . . . 0.68000000000000005 117.529 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -107.08 150.3 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.35 1.575 . . . . 2.77 112.676 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -84.21 141.02 31.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 124.621 2.153 . . . . 2.7200000000000002 114.309 -161.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -53.27 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 110.363 -3.108 . . . . 2.52 107.769 -155.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 146.37 176.87 20.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.522 1.058 . . . . 1.0700000000000001 115.106 164.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.31 175.05 54.9 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.195 0.902 . . . . 0.71999999999999997 113.722 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.81 -39.03 58.02 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.177 -1.19 . . . . 0.84999999999999998 113.549 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.18 -21.97 65.77 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.145 0.978 . . . . 2.6400000000000001 113.25 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.8 mm -88.42 -45.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.855 2.062 . . . . 1.1799999999999999 111.124 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.23 -34.34 60.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.364 1.066 . . . . 0.58999999999999997 111.944 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -24.41 64.59 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.028 1.331 . . . . 0.87 112.363 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -78.98 -54.59 5.88 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.856 -1.153 . . . . 1.1200000000000001 109.745 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.7 mtp -67.47 -28.76 68.13 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.045 1.128 . . . . 0.70999999999999996 114.045 -170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -56.27 -49.39 74.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.339 1.066 . . . . 0.66000000000000003 111.234 171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -93.16 -20.61 20.31 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.362 -1.744 . . . . 1.0600000000000001 110.959 -157.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.7 -30.31 26.86 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 125.593 1.557 . . . . 3.1600000000000001 112.127 158.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.49 19.9 39.77 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 120.267 -1.521 . . . . 0.65000000000000002 113.974 172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -67.47 -15.12 63.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.478 1.139 . . . . 1.8999999999999999 112.119 171.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.44 -29.09 63.38 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.202 0.91 . . . . 0.46000000000000002 110.186 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG12 ' HE3' ' A' ' 139' ' ' LYS . 3.3 t -72.33 -38.75 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 126.859 2.064 . . . . 0.62 109.999 -173.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -70.92 -42.32 70.03 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.281 1.432 . . . . 2.9500000000000002 110.785 173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.49 -34.58 78.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.892 -0.505 . . . . 1.79 112.155 173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt -65.53 -42.48 91.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.14 -0.975 . . . . 0.65000000000000002 111.747 170.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' HG12 ' A' ' 135' ' ' VAL . 75.5 mttt -60.44 -31.4 70.38 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 118.129 -0.939 . . . . 0.88 112.484 176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -65.37 -27.78 68.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.945 1.248 . . . . 2.1699999999999999 113.264 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.81 -1.61 57.91 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.144 1.378 . . . . 1.25 113.335 170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.11 -1.3 88.93 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.863 1.697 . . . . 0.73999999999999999 114.44 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.14 133.6 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.276 1.538 . . . . 0.63 111.852 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -84.35 114.53 21.94 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 127.626 2.371 . . . . 1.45 111.619 172.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.45 ' HB3' HD12 ' A' ' 148' ' ' LEU . 1.6 t -62.87 140.06 58.78 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.555 1.169 . . . . 0.69999999999999996 111.58 162.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.54 -3.03 28.47 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.171 1.788 . . . . 1.2 113.383 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.4 -7.06 39.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.286 1.834 . . . . 0.75 112.6 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 145' ' ' SER . 0.2 OUTLIER -55.15 -27.7 47.42 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.202 1.401 . . . . 2.1699999999999999 112.926 173.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -87.36 19.69 3.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.01 1.724 . . . . 3.8500000000000001 114.914 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.146 1.778 . . . . 6.7400000000000002 111.727 166.014 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 110.812 -0.915 . . . . 15.06 110.812 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -141.78 -12.88 0.86 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.777 1.399 . . . . 13.73 114.777 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -146.48 157.4 43.75 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.086 1.312 . . . . 13.65 111.9 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.3 p -104.46 164.37 11.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.262 1.425 . . . . 12.41 113.733 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.6 mmt 44.21 -119.48 0.68 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.635 1.974 . . . . 13.24 115.257 163.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.97 -134.65 31.94 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 119.147 0.885 . . . . 7.4900000000000002 113.436 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 56.36 -5.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 118.732 2.864 . . . . 6.5499999999999998 118.732 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.71 168.13 53.32 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.77 1.168 . . . . 4.5300000000000002 113.004 171.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.69 149.79 15.99 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 122.177 -0.602 . . . . 3.48 114.1 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.43 18.11 78.31 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.49 0.956 . . . . 3.0 115.49 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.48 -176.31 17.28 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.68 1.61 . . . . 3.3799999999999999 114.293 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t 63.19 167.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.202 2.201 . . . . 2.6099999999999999 113.883 -169.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -29.09 20.49 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.544 1.938 . . . . 0.84999999999999998 113.979 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -70.4 -24.51 62.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.895 1.278 . . . . 3.2999999999999998 114.441 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.77 -50.32 15.56 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.944 0.898 . . . . 1.1499999999999999 110.44 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.39 -33.74 74.17 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.474 0.71 . . . . 0.53000000000000003 111.569 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -60.25 -42.94 96.37 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.276 1.512 . . . . 2.1600000000000001 111.413 171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.45 64.2 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.982 -1.074 . . . . 0.59999999999999998 110.379 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.84 -45.98 69.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.206 1.402 . . . . 1.1000000000000001 112.208 172.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.68 -14.75 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 119.587 1.085 . . . . 0.5 113.277 172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.07 -6.04 58.15 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 117.935 2.569 . . . . 3.9199999999999999 117.935 172.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -72.07 -15.16 62.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.448 1.499 . . . . 1.3999999999999999 113.814 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.43 -177.2 5.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.523 0.729 . . . . 1.9099999999999999 110.712 162.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.17 -11.67 34.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.632 1.345 . . . . 1.5800000000000001 114.632 170.174 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -138.59 76.77 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 105.261 -2.125 . . . . 0.83999999999999997 105.261 -179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.25 117.07 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.109 -0.95 . . . . 0.98999999999999999 108.556 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 HG23 ' A' ' 112' ' ' VAL . 39.0 t -112.23 148.9 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 124.7 1.2 . . . . 0.31 110.356 -172.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -144.05 110.29 5.45 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.562 0.745 . . . . 1.79 110.219 -159.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.87 150.59 31.09 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.75 -0.463 . . . . 0.38 109.75 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -82.66 62.53 6.33 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.045 -1.659 . . . . 1.9199999999999999 109.19 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.8 -170.45 40.59 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.904 -1.044 . . . . 0.72999999999999998 114.153 -151.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.483 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 32.6 p -140.83 158.76 64.55 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.451 1.5 . . . . 0.83999999999999997 111.067 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 41.9 Cg_endo -64.43 -20.1 65.86 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.339 2.693 . . . . 1.04 115.287 -170.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -110.86 -2.93 15.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.042 1.337 . . . . 6.8600000000000003 114.537 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -126.76 122.8 23.6 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 119.976 1.262 . . . . 3.7200000000000002 111.595 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -82.77 53.15 4.3 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.583 2.855 . . . . 2.1800000000000002 114.35 -172.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER 5.32 -69.86 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 129.63 3.172 . . . . 1.79 115.669 160.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 8.6 t -147.12 42.73 1.12 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.132 1.773 . . . . 3.21 109.247 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 71.11 -164.57 53.66 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 121.508 -0.745 . . . . 2.3599999999999999 112.477 -160.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . 0.607 0.0 OUTLIER 39.19 -5.53 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 2 N-CA-C 123.534 4.642 . . . . 3.3799999999999999 123.534 162.674 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -76.14 -23.07 54.81 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.408 -2.058 . . . . 2.8799999999999999 112.517 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -73.8 -40.1 63.65 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 124.958 1.303 . . . . 3.6499999999999999 112.676 163.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.92 80.76 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.639 1.109 . . . . 0.88 112.67 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.49 -39.34 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 112.958 0.725 . . . . 0.94999999999999996 112.958 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' A' ' 62' ' ' PRO . 26.9 t -75.34 -36.95 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.914 1.686 . . . . 0.93000000000000005 112.267 -177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -63.33 -50.45 69.96 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.518 1.127 . . . . 3.5699999999999998 110.298 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.19 -40.49 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.467 1.031 . . . . 0.57999999999999996 110.757 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.13 -56.94 15.77 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 118.529 -0.748 . . . . 0.56000000000000005 112.93 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -66.6 -29.52 69.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.897 1.68 . . . . 4.3099999999999996 114.588 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.56 -36.66 84.54 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.654 1.182 . . . . 0.56000000000000005 111.342 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -78.15 -2.33 37.02 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.577 1.325 . . . . 0.62 114.577 170.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.22 8.95 57.38 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.784 1.174 . . . . 0.89000000000000001 115.033 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.3 t -112.49 123.73 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.517 1.527 . . . . 0.56999999999999995 110.595 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -138.96 -0.96 1.83 Allowed 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.603 1.161 . . . . 4.25 112.603 -177.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -106.58 26.02 10.46 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 129.922 3.289 . . . . 3.8399999999999999 111.67 -165.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -68.32 165.11 19.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.265 1.026 . . . . 1.78 110.321 167.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.73 105.93 16.29 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.386 -1.339 . . . . 0.40999999999999998 107.386 161.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.46 101.58 14.25 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 109.682 -0.488 . . . . 0.40999999999999998 109.682 -175.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -77.77 119.9 21.93 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.88 1.272 . . . . 2.3300000000000001 113.664 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -75.3 105.87 6.54 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.472 1.909 . . . . 2.1800000000000002 110.824 162.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -80.22 -3.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 113.949 1.092 . . . . 0.88 113.949 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.55 -29.38 41.33 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.203 -0.936 . . . . 1.6499999999999999 112.37 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.4 -32.16 72.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.872 1.064 . . . . 2.1499999999999999 113.872 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.02 114.12 21.91 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.822 1.649 . . . . 2.0 111.951 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.03 -20.36 33.66 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.084 1.189 . . . . 0.85999999999999999 111.482 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -56.46 -45.79 80.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.042 1.737 . . . . 2.9700000000000002 112.458 166.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.26 -48.14 71.45 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.443 1.097 . . . . 0.65000000000000002 109.961 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -52.99 -57.86 8.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.277 1.031 . . . . 3.9100000000000001 111.612 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -66.32 -43.15 87.01 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.011 0.925 . . . . 2.4900000000000002 111.373 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.64 -43.39 79.08 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.063 -0.854 . . . . 0.52000000000000002 113.051 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.0 tp -86.0 -36.99 11.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 118.735 1.267 . . . . 0.56000000000000005 112.317 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -59.49 -34.25 72.35 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.423 -0.798 . . . . 1.4099999999999999 111.39 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.23 -46.16 14.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.197 0.908 . . . . 2.25 113.328 172.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -59.8 -37.13 78.26 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.555 -1.34 . . . . 1.9199999999999999 113.832 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -92.93 -6.76 47.85 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.937 1.088 . . . . 2.1499999999999999 113.937 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.57 4.38 0.15 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.195 2.598 . . . . 1.9099999999999999 116.833 -170.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -105.21 135.39 19.33 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 120.318 1.417 . . . . 1.5900000000000001 111.41 -174.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.8 -27.42 26.28 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.8 2.334 . . . . 0.97999999999999998 115.431 -171.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -175.35 113.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.608 1.963 . . . . 2.6800000000000002 110.699 164.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mm -142.46 142.37 23.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 129.525 3.13 . . . . 3.6499999999999999 108.04 161.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -71.0 138.42 33.84 Favored 'Trans proline' 0 C--N 1.356 0.951 0 CA-C-N 122.63 1.975 . . . . 1.01 111.084 171.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -129.38 159.12 37.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.125 0.57 . . . . 1.9399999999999999 111.757 -170.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.529 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -140.22 134.3 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.285 0.564 . . . . 0.55000000000000004 109.608 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -117.5 118.38 32.02 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.726 -1.213 . . . . 1.5900000000000001 107.726 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.51 124.15 44.42 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.152 0.581 . . . . 0.42999999999999999 110.222 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 58.52 25.85 13.58 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 112.878 0.696 . . . . 1.0600000000000001 112.878 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.71 -12.28 35.77 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.539 2.495 . . . . 0.90000000000000002 118.382 -166.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -88.29 140.22 29.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 121.055 2.428 . . . . 1.8 110.511 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -83.12 136.38 34.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 123.849 1.785 . . . . 2.0600000000000001 111.726 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -34.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 111.545 -2.57 . . . . 1.5800000000000001 109.938 -133.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -166.28 137.27 4.57 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 115.802 1.081 . . . . 1.1399999999999999 115.802 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.48 164.83 14.72 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.321 0.962 . . . . 0.68999999999999995 110.858 150.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.44 -17.82 64.85 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 117.222 2.305 . . . . 1.01 117.222 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -79.89 -35.98 37.21 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.348 -0.845 . . . . 2.5 112.109 168.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.28 -39.94 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.897 1.279 . . . . 1.5 110.911 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.65 -34.62 67.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.178 0.991 . . . . 1.01 112.082 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -37.0 83.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.296 0.639 . . . . 1.02 111.202 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -66.22 -54.82 20.57 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.92 -1.112 . . . . 0.85999999999999999 110.07 174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 86.9 mtp -66.75 -29.65 69.67 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 114.083 1.142 . . . . 0.54000000000000004 114.083 -169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -54.78 -49.82 69.98 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.463 1.125 . . . . 0.76000000000000001 111.383 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -93.56 -23.27 18.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.904 -1.953 . . . . 1.1799999999999999 110.526 -160.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -75.3 -31.13 60.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.248 2.219 . . . . 2.27 112.382 161.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.07 56.43 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.803 1.192 . . . . 0.67000000000000004 113.846 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -12.87 60.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.512 1.156 . . . . 1.9399999999999999 112.11 176.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.99 -27.17 63.51 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.095 0.95 . . . . 0.57999999999999996 111.227 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.14 -36.48 30.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 128.346 2.658 . . . . 0.69999999999999996 109.186 -173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -72.05 -36.36 69.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.241 1.416 . . . . 2.5099999999999998 110.97 169.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -64.38 -41.38 96.73 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.034 0.534 . . . . 1.6899999999999999 112.006 173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.9 -35.47 80.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.498 1.119 . . . . 0.76000000000000001 112.218 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -64.36 -27.57 69.11 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.467 1.107 . . . . 0.97999999999999998 112.926 176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -63.69 -31.21 72.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.586 1.084 . . . . 2.1000000000000001 113.463 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.05 -1.45 56.56 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.89 1.676 . . . . 1.51 113.042 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.5 6.65 84.59 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.295 0.95 . . . . 0.67000000000000004 114.51 -173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.3 mt -80.56 146.5 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.588 1.194 . . . . 0.78000000000000003 110.219 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -102.72 118.61 37.22 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.71 1.604 . . . . 2.1400000000000001 110.093 172.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.6 t -56.83 128.33 36.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.432 1.111 . . . . 0.78000000000000003 110.81 170.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.21 -14.81 62.5 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.279 -1.513 . . . . 0.62 112.925 177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 mt -78.39 -25.75 46.26 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.759 2.024 . . . . 0.94999999999999996 112.283 173.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -24.88 62.12 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.816 1.646 . . . . 4.0300000000000002 113.205 169.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -94.73 31.67 1.77 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.599 1.56 . . . . 5.4100000000000001 113.168 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.255 1.374 0 C-N-CA 126.641 1.976 . . . . 4.1299999999999999 114.051 170.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 111.693 -0.563 . . . . 17.66 111.693 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -143.52 18.39 1.86 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.894 1.442 . . . . 17.559999999999999 114.894 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -91.73 147.68 22.81 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.5 1.12 . . . . 17.460000000000001 110.559 172.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.8 p -134.57 159.67 40.46 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.963 1.097 . . . . 12.23 113.963 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 21.5 mmt 43.5 39.98 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 118.503 2.779 . . . . 10.74 118.503 158.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.36 -174.16 45.94 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.409 1.324 . . . . 6.7000000000000002 116.409 171.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.52 120.36 23.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.643 1.177 . . . . 7.6799999999999997 112.198 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.14 10.29 35.29 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 116.648 1.419 . . . . 4.96 116.648 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.48 157.17 30.98 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.639 1.59 . . . . 3.4500000000000002 113.948 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.78 117.91 7.23 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.591 1.091 . . . . 3.2599999999999998 114.189 -170.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.65 8.56 21.28 Favored Glycine 0 CA--C 1.536 1.393 0 N-CA-C 117.034 1.573 . . . . 4.0999999999999996 117.034 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.0 m -66.31 147.21 53.64 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.031 1.416 . . . . 3.54 110.963 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -32.62 71.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.82 -1.175 . . . . 1.03 113.134 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -70.97 -21.7 62.29 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.532 1.308 . . . . 3.2200000000000002 114.532 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -82.52 -48.54 10.9 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.199 -0.938 . . . . 1.3600000000000001 110.455 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -35.0 40.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.816 1.247 . . . . 0.78000000000000003 112.462 171.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.19 -45.45 91.03 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.473 1.509 . . . . 2.25 112.508 170.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.62 -30.98 67.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.168 -0.924 . . . . 0.55000000000000004 110.095 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mt -73.67 -45.76 50.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.999 2.519 . . . . 1.1000000000000001 112.75 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.36 -21.09 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-N 120.026 1.285 . . . . 0.44 111.335 165.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.272 1.4 tptm -90.7 8.14 35.95 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 118.533 2.79 . . . . 2.3799999999999999 118.533 167.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -28.93 66.04 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.515 1.507 . . . . 1.45 112.779 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.37 179.66 6.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.615 1.166 . . . . 2.1200000000000001 110.675 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.96 -17.15 30.09 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.167 1.543 . . . . 1.26 115.167 172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.97 93.0 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.764 0 N-CA-C 104.592 -2.373 . . . . 0.63 104.592 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.84 113.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.328 -1.305 . . . . 1.0700000000000001 107.622 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 112' ' ' VAL . 35.8 t -106.3 147.51 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 124.874 1.269 . . . . 0.40000000000000002 108.839 -173.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -143.96 100.78 3.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.161 -0.311 . . . . 1.8 110.161 -159.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.88 154.65 38.7 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-O 122.048 0.928 . . . . 0.60999999999999999 113.38 -171.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -81.56 60.87 4.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.901 1.281 . . . . 2.2599999999999998 112.326 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.35 -131.1 1.29 Allowed Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.386 0.915 . . . . 2.1099999999999999 115.386 -166.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 62' ' ' PRO . 40.8 p -162.31 160.41 20.93 Favored Pre-proline 0 N--CA 1.479 0.979 1 C-N-CA 133.462 4.705 . . . . 0.94999999999999996 106.558 166.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 61' ' ' THR . 58.6 Cg_endo -71.3 -21.37 26.78 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.181 1.921 . . . . 0.75 113.938 -175.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.71 -0.26 21.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.435 1.494 . . . . 6.4199999999999999 114.188 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 -132.5 116.62 15.16 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.543 1.137 . . . . 3.7999999999999998 109.717 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.9 89.9 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.38 2.72 . . . . 1.8600000000000001 111.354 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -41.89 -49.27 4.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 130.291 3.437 . . . . 1.8899999999999999 114.921 166.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.8 t -158.57 -165.57 1.7 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.797 2.039 . . . . 1.6200000000000001 107.731 -171.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.94 171.03 2.03 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.976 -1.077 . . . . 2.0899999999999999 112.137 158.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 122' ' ' CYS . 2.8 m-30 67.89 -25.57 0.13 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 117.711 2.486 . . . . 2.1499999999999999 117.711 169.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 p -68.55 -30.14 68.85 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.754 1.161 . . . . 1.9199999999999999 113.781 -173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -84.82 -35.42 22.31 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 118.103 -0.951 . . . . 2.8399999999999999 111.803 173.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.07 76.41 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.642 1.11 . . . . 0.65000000000000002 111.96 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.4 m -66.99 -39.91 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 113.517 0.932 . . . . 0.64000000000000001 113.517 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.6 t -77.26 -35.26 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.891 0.876 . . . . 0.51000000000000001 112.212 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -60.35 -50.7 72.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.784 1.634 . . . . 2.25 110.267 168.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.97 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.594 1.088 . . . . 0.46000000000000002 110.323 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -60.9 -56.49 20.54 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.999 0.74 . . . . 0.51000000000000001 112.999 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -64.17 -33.62 76.21 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.994 1.27 . . . . 3.0600000000000001 113.553 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.0 mt -61.58 -38.83 88.99 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.789 1.236 . . . . 0.60999999999999999 111.854 171.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -76.46 3.66 10.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.075 1.139 . . . . 0.68000000000000005 114.075 172.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.42 74.94 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.885 1.221 . . . . 0.92000000000000004 114.363 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.17 110.98 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.712 1.205 . . . . 0.64000000000000001 110.833 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.53 14.08 4.97 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.94 2.496 . . . . 3.79 111.045 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -102.01 11.16 38.91 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 129.23 3.012 . . . . 3.8199999999999998 112.416 -170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -72.94 158.28 35.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.818 0.847 . . . . 2.0299999999999998 112.014 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.33 117.34 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.57 -1.27 . . . . 0.53000000000000003 107.57 156.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.96 99.27 12.31 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.742 -0.836 . . . . 0.48999999999999999 108.742 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -71.97 128.41 35.64 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.668 1.223 . . . . 2.0899999999999999 112.33 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -97.37 93.83 6.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 112.909 -1.951 . . . . 4.9000000000000004 110.025 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.95 -7.31 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 119.391 -0.924 . . . . 1.03 112.141 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 mt -59.35 -33.79 71.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.847 2.059 . . . . 1.8799999999999999 113.803 166.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -38.87 25.86 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.567 0.58 . . . . 2.2400000000000002 112.567 -178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -126.51 107.59 23.52 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.677 1.191 . . . . 2.3500000000000001 113.92 -163.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.6 -27.59 45.52 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.654 2.236 . . . . 1.03 113.529 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.55 -47.0 87.55 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.43 1.492 . . . . 3.0299999999999998 112.501 171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.06 -43.63 94.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.948 0.899 . . . . 1.3 110.0 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -60.34 -51.62 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.147 1.379 . . . . 5.1100000000000003 111.865 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.65 -46.35 76.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.712 0.805 . . . . 2.04 111.709 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -53.46 -44.54 66.97 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.856 -1.065 . . . . 0.92000000000000004 111.25 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 tp -81.98 -32.75 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.435 1.117 . . . . 1.1000000000000001 112.787 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -61.96 -39.1 90.99 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.058 0.943 . . . . 1.6100000000000001 112.246 171.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.92 -52.67 13.72 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.675 0.67 . . . . 2.5 112.094 172.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.21 -37.84 75.6 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.239 -0.913 . . . . 2.3199999999999998 112.209 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -98.11 5.7 48.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.923 1.689 . . . . 2.0600000000000001 113.382 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 23.26 3.83 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.209 2.3 . . . . 2.46 117.209 171.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -122.68 149.56 56.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 119.672 1.124 . . . . 2.5499999999999998 113.507 175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.06 -33.96 8.93 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.187 1.925 . . . . 1.25 113.354 162.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p -122.08 -18.52 6.9 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 121.564 3.912 . . . . 4.6900000000000004 121.564 -155.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.9 pt -103.32 153.81 38.19 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 114.26 1.207 . . . . 3.4399999999999999 114.26 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -90.61 165.29 4.21 Favored 'Trans proline' 0 CA--C 1.542 0.879 1 C-N-CA 125.629 4.219 . . . . 1.0800000000000001 112.207 173.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -135.13 167.07 21.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.666 1.186 . . . . 2.52 112.95 -172.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 56' ' ' VAL . 12.3 p -126.7 154.7 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 108.265 -1.013 . . . . 0.93000000000000005 108.265 153.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -122.98 138.86 54.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.073 1.749 . . . . 1.8 109.657 161.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.68 124.72 52.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.947 1.299 . . . . 0.48999999999999999 111.585 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.37 41.19 32.11 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 122.563 1.173 . . . . 1.26 111.634 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.4 -4.76 3.49 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 127.543 2.497 . . . . 0.68999999999999995 118.207 -167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -108.88 148.25 30.93 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.421 2.61 . . . . 1.9299999999999999 112.499 -168.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . 0.252 2.3 t80 -71.82 144.98 48.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 125.167 2.413 . . . . 2.6200000000000001 114.83 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.88 -63.81 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 131.586 3.954 . . . . 2.5800000000000001 104.629 -160.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 158.49 171.24 24.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 126.241 1.877 . . . . 0.94999999999999996 111.677 163.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.94 174.4 40.3 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.763 -0.845 . . . . 0.71999999999999997 112.563 168.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 69' ' ' PHE . 49.1 t -53.45 -32.51 50.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.477 1.288 . . . . 0.79000000000000004 114.477 -176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.59 -27.3 66.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.214 0.916 . . . . 2.6299999999999999 112.614 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.06 -44.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.877 2.071 . . . . 2.21 110.381 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 16.0 tp -50.33 -38.45 41.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.312 1.045 . . . . 0.58999999999999997 111.786 175.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.77 -22.66 63.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.808 1.643 . . . . 0.81999999999999995 112.165 -178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -85.93 -51.59 6.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.103 -0.998 . . . . 0.76000000000000001 110.976 170.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.36 -30.62 69.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.165 0.986 . . . . 0.66000000000000003 113.444 -175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -49.75 -50.05 45.9 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.915 1.286 . . . . 0.73999999999999999 111.869 171.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -92.81 -32.38 14.67 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 112.685 -2.052 . . . . 2.0099999999999998 110.319 -159.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -72.18 -26.81 62.21 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.471 1.908 . . . . 2.1899999999999999 112.666 163.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.24 13.49 57.32 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 120.945 -1.097 . . . . 0.71999999999999997 113.029 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.74 -10.8 59.89 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.208 -1.172 . . . . 1.8200000000000001 112.329 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.89 -35.47 67.12 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.627 0.727 . . . . 0.41999999999999998 109.789 169.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 139' ' ' LYS . 1.9 t -67.41 -36.45 76.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.659 2.383 . . . . 0.47999999999999998 109.657 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -73.15 -41.06 64.34 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.552 -0.718 . . . . 2.3399999999999999 110.701 173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -62.74 -28.85 70.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.685 0.624 . . . . 2.23 112.685 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.43 -43.54 39.71 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.391 1.076 . . . . 0.57999999999999996 111.449 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 135' ' ' VAL . 61.4 mttt -58.02 -36.79 73.21 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 120.029 1.286 . . . . 1.1699999999999999 112.902 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -67.69 -27.56 66.94 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.484 1.914 . . . . 1.74 113.571 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -19.73 47.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.594 1.957 . . . . 1.6599999999999999 112.718 170.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.82 -13.16 59.7 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.595 1.569 . . . . 0.88 114.584 -164.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 86.3 mt -67.87 141.71 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.199 1.499 . . . . 0.57999999999999996 110.844 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -98.92 113.27 25.34 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.972 1.709 . . . . 1.79 110.939 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.435 ' CB ' HG13 ' A' ' 135' ' ' VAL . 14.1 t -57.04 126.2 26.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.618 0.723 . . . . 0.57999999999999996 110.272 169.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.31 -18.09 60.76 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.752 0.821 . . . . 0.68999999999999995 113.049 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.79 -33.23 72.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.163 2.185 . . . . 1.6100000000000001 113.279 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.53 -39.72 64.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.34 1.456 . . . . 4.4100000000000001 111.441 167.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -100.91 20.88 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.563 1.945 . . . . 4.79 114.051 -170.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.619 2.368 . . . . 5.71 114.825 -174.563 . . . . . . . . 0 0 . 1 stop_ save_